Sentence,class,file
http://dx.doi.org/ 10.1016/j.jpain.2011.02.348 (Aug).,OADS,/arxiv_data1/oa_pdf/f6/66/main.PMC4909324.pdf
http://dx.doi.org/10.1016/S1474- 4422(12)70204-1 .,OADS,/arxiv_data1/oa_pdf/f6/66/main.PMC4909324.pdf
http://dx.doi.org/10.1016/j.nmd.2009.04.012 .211 R. Moshourab et al.,OADS,/arxiv_data1/oa_pdf/f6/66/main.PMC4909324.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: CancerCarcinogenicityChemopreventionDrug evaluationPharmacologyScreening Pharmacoepidemiology Denmark 1.,Non-OADS,/arxiv_data1/oa_pdf/bf/97/main.PMC4909325.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.03.018 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/bf/97/main.PMC4909325.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bf/97/main.PMC4909325.pdf
http://sundhedsdatastyrelsen.dk/da/registre-og- services/om-de-nationale-sundhedsregistr e/sygdomme-laegemidler-og-behandlinger/ cancerregistere .,OADS,/arxiv_data1/oa_pdf/bf/97/main.PMC4909325.pdf
http://www.whocc.no/ ﬁlearchive/ publications/2015_guidelines.pdf ).,Non-OADS,/arxiv_data1/oa_pdf/bf/97/main.PMC4909325.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Allergy prophylaxis Cell-based therapyB-cell toleranceT-cell toleranceAllergen-speci ﬁc tolerance induction 1.,Non-OADS,/arxiv_data1/oa_pdf/8a/12/main.PMC4909362.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.03.028 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/12/main.PMC4909362.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8a/12/main.PMC4909362.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Myocardial infarctionAdipose tissueStem cell therapy Cardiac tissue engineering Regenerative medicineCardiac surgery 1.,Non-OADS,/arxiv_data1/oa_pdf/17/c9/main.PMC4909363.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.03.027 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/17/c9/main.PMC4909363.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/17/c9/main.PMC4909363.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: LincRNA lncRNA pan-cancerRNASeqbiomarkers 1.,Non-OADS,/arxiv_data1/oa_pdf/fa/c1/main.PMC4909364.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.03.023 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/fa/c1/main.PMC4909364.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fa/c1/main.PMC4909364.pdf
"RNA-Seq BAM ﬁles were downloaded from UCSC Cancer Geno- mics Hub ( https://cghub.ucsc.edu /) using the GeneTorrent program (Wilks et al., 2014 ).",OADS,/arxiv_data1/oa_pdf/fa/c1/main.PMC4909364.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Warburg effectAutophagyPTENTP53 Hexokinase 2 AMPKULK-1MCL-12-Deoxy-glucoseChloroquineAndrogen receptorCastration-resistant prostate cancer Genetically-engineered mouse model 1.,Non-OADS,/arxiv_data1/oa_pdf/2a/bb/main.PMC4909365.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.03.022 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2a/bb/main.PMC4909365.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2a/bb/main.PMC4909365.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Matrix-assisted laser desorption/ionization mass spectrometry imaging SphingomyelinChronic kidney diseaseATPAMPKGlycolysis 1.,Non-OADS,/arxiv_data1/oa_pdf/91/cf/main.PMC4909366.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.03.033 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/91/cf/main.PMC4909366.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/91/cf/main.PMC4909366.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Alpha-synucleinLipid raftsPost-synaptic density Long term potentiation Synaptic vesicles' mobilizationCasein kinase 2 1.,Non-OADS,/arxiv_data1/oa_pdf/a3/63/main.PMC4909369.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.03.038 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a3/63/main.PMC4909369.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a3/63/main.PMC4909369.pdf
Num- ber of PSD-95 puncta and the length of dendrites were measured using the open access ImageJ software (http://imagej.nih.gov/ij/ ).,OADS,/arxiv_data1/oa_pdf/a3/63/main.PMC4909369.pdf
Number and size of spines and the length of dendrites were measured using the open access ImageJ software (http://imagej.nih.gov/ij/ ).,OADS,/arxiv_data1/oa_pdf/a3/63/main.PMC4909369.pdf
9 http://repository.edm-forum.org/egems/vol4/iss1/9 DOI: 10.13063/2327-9214.1221,Non-OADS,/arxiv_data1/oa_pdf/44/4d/egems1221.PMC4909373.pdf
9 http://repository.edm-forum.org/egems/vol4/iss1/9 DOI: 10.13063/2327-9214.1221,Non-OADS,/arxiv_data1/oa_pdf/44/4d/egems1221.PMC4909373.pdf
9 http://repository.edm-forum.org/egems/vol4/iss1/9 DOI: 10.13063/2327-9214.1221,Non-OADS,/arxiv_data1/oa_pdf/44/4d/egems1221.PMC4909373.pdf
9 http://repository.edm-forum.org/egems/vol4/iss1/9 DOI: 10.13063/2327-9214.1221,Non-OADS,/arxiv_data1/oa_pdf/44/4d/egems1221.PMC4909373.pdf
8 http://repository.edm-forum.org/egems/vol4/iss1/8 DOI: 10.13063/2327-9214.1247,Non-OADS,/arxiv_data1/oa_pdf/94/ba/egems1247.PMC4909374.pdf
8 http://repository.edm-forum.org/egems/vol4/iss1/8 DOI: 10.13063/2327-9214.1247,Non-OADS,/arxiv_data1/oa_pdf/94/ba/egems1247.PMC4909374.pdf
8 http://repository.edm-forum.org/egems/vol4/iss1/8 DOI: 10.13063/2327-9214.1247,Non-OADS,/arxiv_data1/oa_pdf/94/ba/egems1247.PMC4909374.pdf
8 http://repository.edm-forum.org/egems/vol4/iss1/8 DOI: 10.13063/2327-9214.1247,Non-OADS,/arxiv_data1/oa_pdf/94/ba/egems1247.PMC4909374.pdf
8 http://repository.edm-forum.org/egems/vol4/iss1/8 DOI: 10.13063/2327-9214.1247,Non-OADS,/arxiv_data1/oa_pdf/94/ba/egems1247.PMC4909374.pdf
8 http://repository.edm-forum.org/egems/vol4/iss1/8 DOI: 10.13063/2327-9214.1247,Non-OADS,/arxiv_data1/oa_pdf/94/ba/egems1247.PMC4909374.pdf
"1, e983688 (4 pages)http://dx.doi.org/10.4161/derm.29855",Non-OADS,/arxiv_data1/oa_pdf/ea/80/kder-08-01-983688.PMC4909375.pdf
"J Clin Endocrinol Metab 2008; 93:1526-40;PMID:18334580; http://dx.doi.org/10.1210/jc.2008-0125 [3] Garc /C19ıa-Porr /C19ua C, Gonz /C19alez-Gay MA, V /C19azquez-Caruncho M, L /C19opez-Lazaro L, Lueiro M, Fern /C19andez ML, Alvarez- Ferreira J, Pujol RM.",OADS,/arxiv_data1/oa_pdf/ea/80/kder-08-01-983688.PMC4909375.pdf
"Arthritis Rheum 2000; 43:584-92; PMID:10728752; http://dx.doi.org/10.1002/1529-0131(200003)43:3 <584::AID- ANR15 >3.0.CO;2-6 [4] da Mota F, Murray C, Ezzat S. Overt immune dysfunc- tion after Cushing ’s syndrome remission: a consecutive case series and review of the literature.",Non-OADS,/arxiv_data1/oa_pdf/ea/80/kder-08-01-983688.PMC4909375.pdf
"J Clin Endocrinol Metab 2011; 96:E1670-4; PMID:21816785; http://dx.doi.org/10.1210/jc.2011-1317 [5] McDaniel WE, Bard JW, Blakey LW, Hamilton RD.",Non-OADS,/arxiv_data1/oa_pdf/ea/80/kder-08-01-983688.PMC4909375.pdf
"Arch Dermatol 1970; 101:356-8; PMID:5414894; http://dx.doi.org/10.1001/archderm.1970.04000030100017 [6] Takenaka K, Yanase T, Takayanagi R, Haji M, Ikuyama S, Nawata H. Cushing ’s disease preceding sarcoidosis.",OADS,/arxiv_data1/oa_pdf/ea/80/kder-08-01-983688.PMC4909375.pdf
"Intern Med 1995; 34:580-3; PMID:7549148; http://dx.doi.org/10.2169/internalmedicine.34.580 [7] Marzano AV, Gasparini G, Caputo R, Alessi E. Subcuta- neous sarcoidosis following hypophysectomy for pitui-tary microadenoma inducing Cushing ’s disease.",Non-OADS,/arxiv_data1/oa_pdf/ea/80/kder-08-01-983688.PMC4909375.pdf
"Endocr Pract 1999; 5:43-5; PMID:15251702; http://dx.doi.org/10.4158/EP.5.1.43 [9] Fichtel JC, Duckworth AKW, Soares T, Lesher JL Jr. Subcutaneous sarcoidosis presenting after treatmentof Cushing ’s disease.",Non-OADS,/arxiv_data1/oa_pdf/ea/80/kder-08-01-983688.PMC4909375.pdf
J Am Acad Dermatol 2006; 54:360-1; PMID:16443078; http://dx.doi.org/10.1016/ j.jaad.2005.03.042DERMATO-ENDOCRINOLOGY e983688-3,Non-OADS,/arxiv_data1/oa_pdf/ea/80/kder-08-01-983688.PMC4909375.pdf
"Arq Bras EndocrinolMetabol 2007; 51:1381-91; PMID:18209877; http://dx.doi.org/10.1590/S0004-27302007000800025 [11] B €o h mM ,L u g e rT A ,T o b i nD J ,G a r c /C19ıa-Borr /C19on JC.",Non-OADS,/arxiv_data1/oa_pdf/ea/80/kder-08-01-983688.PMC4909375.pdf
"J Invest Dermatol 2006; 126:1966-75; PMID:16912693; http://dx.doi.org/10.1038/sj.jid.5700421[12] Brzoska T, Luger TA, Maaser C, Abels C, B €ohm M. Alpha-melanocyte-stimulating hormone and related tri-peptides: biochemistry, antiin ﬂammatory and protective effects in vitro and in vivo, and future perspectives forthe treatment of immune-mediated in ﬂammatory dis- eases.",OADS,/arxiv_data1/oa_pdf/ea/80/kder-08-01-983688.PMC4909375.pdf
"Endocr Rev 2008; 29:581-602; PMID:18612139;http://dx.doi.org/10.1210/er.2007-0027 [13] Saag KG, Furst DE.",OADS,/arxiv_data1/oa_pdf/ea/80/kder-08-01-983688.PMC4909375.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: RNANF1Splicing mutationDeep intronic Legius SPRED1Café au laitEBioMedicine 7 (2016) 212 –220 ⁎Corresponding author at: Manchester Centre for Genomic Medicine, Manchester Academic Health Sciences Centre (MAHSC), St Mary's Hospital, Univers ity of Manchester, Manchester M13 9WL, UK.",Non-OADS,/arxiv_data1/oa_pdf/56/03/main.PMC4909377.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.04.005 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/56/03/main.PMC4909377.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/56/03/main.PMC4909377.pdf
"Using the ExAC database (http://exac.broadinstitute.org/gene/ ) from exome sequencing of over 120,000 alleles in humans the prevalence of NF1 missense variants was only 2.2% per allele with 489 variants being seen 2426 times with 28 variants being seen in a homozygous state.",OADS,/arxiv_data1/oa_pdf/56/03/main.PMC4909377.pdf
http://www.acgs.uk.com/ .220 D.G.,Non-OADS,/arxiv_data1/oa_pdf/56/03/main.PMC4909377.pdf
"Towards this more research is needed, adopting within-group repeated measures and randomized controlled cross-over designs to allowEBioMedicine 7 (2016) 23 –24 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2016.03.020 .",Non-OADS,/arxiv_data1/oa_pdf/74/51/main.PMC4909378.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.04.004 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/74/51/main.PMC4909378.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/74/51/main.PMC4909378.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Pancreatic adenocarcinoma Oncolytic viral therapyHerpes simplex virusPeritoneal ﬂuid cytology Diagnostic laparoscopy 1.,Non-OADS,/arxiv_data1/oa_pdf/51/8d/main.PMC4909379.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.03.043 2352-3964/Published by Elsevier B.V.,OADS,/arxiv_data1/oa_pdf/51/8d/main.PMC4909379.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/51/8d/main.PMC4909379.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b2/a9/main.PMC4909380.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.03.040 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b2/a9/main.PMC4909380.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b2/a9/main.PMC4909380.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: CognitionFebrile status epilepticus Hippocampal network Temporal coordination 1.,Non-OADS,/arxiv_data1/oa_pdf/19/d8/main.PMC4909381.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.03.039 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/19/d8/main.PMC4909381.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/19/d8/main.PMC4909381.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Age-related retinal degenerationProlactinAntioxidantSIRT2 TRPM2 channels Retinal pigment epithelium 1.,Non-OADS,/arxiv_data1/oa_pdf/20/3d/main.PMC4909382.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.03.048 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/20/3d/main.PMC4909382.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/20/3d/main.PMC4909382.pdf
"*Correspondence to: Rama Khokha; Email: rkhokha@uhnres.utoronto.caSubmitted: 09/14/2014; Revised: 09/21/2014; Accepted: 09/22/2014 http://dx.doi.org/10.4161/23723556.2014.975082 This is an Open Access article distributed under the terms of the Creative Co mmons Attribution-Non-Commercial License (http://creativecommons.o rg/ licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work i sp r o p - erly cited.",Non-OADS,/arxiv_data1/oa_pdf/70/c3/kmco-03-03-975082.PMC4909426.pdf
Nat Rev Immunol 2013; 13:649-65; PMID:23969736; http://dx.doi.org/10.1038/nri3499 3.,Non-OADS,/arxiv_data1/oa_pdf/70/c3/kmco-03-03-975082.PMC4909426.pdf
Nat Cell Biol 2014; 16:889-901; PMID:25150980; http://dx.doi.org/ 10.1038/ncb3021 4.,OADS,/arxiv_data1/oa_pdf/70/c3/kmco-03-03-975082.PMC4909426.pdf
Semin Cell Dev Biol 2010; 21:19-25; PMID:19857592; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/70/c3/kmco-03-03-975082.PMC4909426.pdf
Proteomics 2013; 13:1608-23; PMID:23505015; http://dx.doi.org/10.1002/ pmic.201200533 6.,OADS,/arxiv_data1/oa_pdf/70/c3/kmco-03-03-975082.PMC4909426.pdf
Nature 2012; 481:85-9; PMID:22158103; http://dx.doi.org/10.1038/nature10694 7.,Non-OADS,/arxiv_data1/oa_pdf/70/c3/kmco-03-03-975082.PMC4909426.pdf
A role for exosomes in the constitutive and stimulus- induced ectodomain cleavage of L1 and CD44.Biochem J 2006; 393:609-18; PMID:16229685; http://dx.doi.org/10.1042/BJ20051013 8.,OADS,/arxiv_data1/oa_pdf/70/c3/kmco-03-03-975082.PMC4909426.pdf
Proteomics 2013; 13:1624-36; PMID:23526769; http://dx.doi.org/10.1002/pmic.201200458 9.,OADS,/arxiv_data1/oa_pdf/70/c3/kmco-03-03-975082.PMC4909426.pdf
"Cell 2012:151, 1542-56; PMID:23260141; http://dx.doi.org/10.1016/j.cell.2012.11.024 www.tandfonline.com e975082-3 Molecular & Cellular Oncology",OADS,/arxiv_data1/oa_pdf/70/c3/kmco-03-03-975082.PMC4909426.pdf
"3, e1156216 (2 pages)http://dx.doi.org/10.1080/23723556.2016.1156216",Non-OADS,/arxiv_data1/oa_pdf/ee/79/kmco-03-03-1156216.PMC4909434.pdf
Nat Rev Genet 2013; 14:496-506;PMID:23774734; http://dx.doi.org/10.1038/nrg3482 2.,OADS,/arxiv_data1/oa_pdf/ee/79/kmco-03-03-1156216.PMC4909434.pdf
Rna 2012; 18:53-64; PMID:22101243; http://dx.doi.org/10.1261/rna.029603.111 3.,OADS,/arxiv_data1/oa_pdf/ee/79/kmco-03-03-1156216.PMC4909434.pdf
Nature 2005; 435:828-33; PMID:15944707; http://dx.doi.org/10.1038/nature03552 5 .,OADS,/arxiv_data1/oa_pdf/ee/79/kmco-03-03-1156216.PMC4909434.pdf
Genes Dev 2009; 23:2806-11; PMID:20008931; http://dx.doi.org/10.1101/gad.1872909 6.,OADS,/arxiv_data1/oa_pdf/ee/79/kmco-03-03-1156216.PMC4909434.pdf
Cell 2009; 138:673-84; PMID:19703394; http://dx.doi.org/10.1016/j.cell.2009.06.016 8.,OADS,/arxiv_data1/oa_pdf/ee/79/kmco-03-03-1156216.PMC4909434.pdf
C ancer Res 2009; 69:9422- 30; PMID:19934316; http://dx.doi.org/10.1158/0008-5472.CAN-09-2236 Figure 1.,OADS,/arxiv_data1/oa_pdf/ee/79/kmco-03-03-1156216.PMC4909434.pdf
"3, e1155006 (2 pages)http://dx.doi.org/10.1080/23723556.2016.1155006",Non-OADS,/arxiv_data1/oa_pdf/ac/18/kmco-03-03-1155006.PMC4909435.pdf
Nat Rev Cancer 2014; 14:662-72; PMID:25176334; http://dx.doi.org/10.1038/nrc3802 2.,Non-OADS,/arxiv_data1/oa_pdf/ac/18/kmco-03-03-1155006.PMC4909435.pdf
2007; 39:673-7; PMID:17401365; http://dx.doi.org/10.1038/ ng2003 3.,Non-OADS,/arxiv_data1/oa_pdf/ac/18/kmco-03-03-1155006.PMC4909435.pdf
2009; 23:2700-4; PMID:19903759; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ac/18/kmco-03-03-1155006.PMC4909435.pdf
Nature 2012; 488:231-5; PMID:22722852; http://dx.doi.org/10.1038/nature11179 5.,Non-OADS,/arxiv_data1/oa_pdf/ac/18/kmco-03-03-1155006.PMC4909435.pdf
Cell 2012; 149:101-12; PMID:22445173;http://dx.doi.org/10.1016/j.cell.2012.03.002 6.,OADS,/arxiv_data1/oa_pdf/ac/18/kmco-03-03-1155006.PMC4909435.pdf
Cell Reports 2016; 14:216-24; PMID:26748703; http://dx.doi.org/10.1016/j.celrep.,OADS,/arxiv_data1/oa_pdf/ac/18/kmco-03-03-1155006.PMC4909435.pdf
Mol Cell 2015; 58:199- 201; PMID:25884366; http://dx.doi.org/10.1016/j.molcel.2015.,OADS,/arxiv_data1/oa_pdf/ac/18/kmco-03-03-1155006.PMC4909435.pdf
PLoS ONE 2015; 10:e0129642; PMID:26091048; http://dx.doi.org/10.1371/journal.pone.0129642 9.,Non-OADS,/arxiv_data1/oa_pdf/ac/18/kmco-03-03-1155006.PMC4909435.pdf
PLoS ONE 2014; 9:e100920; PMID:24979267; http://dx.doi.org/10.1371/journal.pone.0100920 1 0 .,Non-OADS,/arxiv_data1/oa_pdf/ac/18/kmco-03-03-1155006.PMC4909435.pdf
CancerCell 2012; 21:848-855; PMID:22698408; http://dx.doi.org/10.1016/ j.ccr.2012.04.037 Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/ac/18/kmco-03-03-1155006.PMC4909435.pdf
"We next tested whether Fra-1 directly regulates Zeb1 and Zeb2 transcription,focusing on genomic sequences with © Latifa Bakiri and Erwin F. Wagner *Correspondence to: Latifa Bakiri; Email: lbakiri@cnio.esSubmitted: 11/13/2014; Revised: 11/17/2014; Accepted: 11/18/2014 http://dx.doi.org/10.4161/23723556.2014.990307 This is an Open Access article distributed under the terms of the Creative Co mmons Attribution-Non-Commercial License (http://creativecommons.o rg/ licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work i sp r o p - erly cited.",Non-OADS,/arxiv_data1/oa_pdf/e6/3e/kmco-03-03-990307.PMC4909442.pdf
J Clin Invest 2009; 119:1420-8;PMID:19487818; http://dx.doi.org/10.1172/ JCI39104 2.,Non-OADS,/arxiv_data1/oa_pdf/e6/3e/kmco-03-03-990307.PMC4909442.pdf
Nat Med 2013; 19:1438-49; PMID:24202396; http://dx.doi.org/10.1038/nm.3336 3.,OADS,/arxiv_data1/oa_pdf/e6/3e/kmco-03-03-990307.PMC4909442.pdf
Mol Cell 2010; 38:114-27; PMID:20385094; http://dx.doi.org/10.1016/j.molcel.2010.02.020 4.,OADS,/arxiv_data1/oa_pdf/e6/3e/kmco-03-03-990307.PMC4909442.pdf
CancerCell 2013; 24:347-64; PMID:24029232; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e6/3e/kmco-03-03-990307.PMC4909442.pdf
Cell Death Differ Cell Death Dif- fer 2015; 22(2):336-50; http://dx.doi.org/10.1038/ cdd.2014.157 6.,Non-OADS,/arxiv_data1/oa_pdf/e6/3e/kmco-03-03-990307.PMC4909442.pdf
Cell2013; 154:61-74; PMID:23827675; http://dx.doi.org/ 10.1016/j.cell.2013.06.005 8.,OADS,/arxiv_data1/oa_pdf/e6/3e/kmco-03-03-990307.PMC4909442.pdf
Nature Med 2000; 6:980-4; PMID:10973316; http://dx.doi.org/10.1038/79676 9.,Non-OADS,/arxiv_data1/oa_pdf/e6/3e/kmco-03-03-990307.PMC4909442.pdf
Cell Metab 2014; 19:84-95; PMID:24411941; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e6/3e/kmco-03-03-990307.PMC4909442.pdf
Cell 2003; 112:181-92; PMID:12553907; http://dx.doi.org/ 10.1016/S0092-8674(03)00042-4 www.tandfonline.com e990307-3 Molecular & Cellular Oncology,Non-OADS,/arxiv_data1/oa_pdf/e6/3e/kmco-03-03-990307.PMC4909442.pdf
"7The evolution toward luminal tumors might © Marion Chapellier and V /C19eronique Maguer-Satta *Correspondence to: V /C19eronique Maguer-Satta; Email: veronique.maguer-satta@lyon.unicancer.fr Submitted: 02/25/2015; Revised: 03/02/2015; Accepted: 03/02/2015 http://dx.doi.org/10.1080/23723556.2015.1026527 This is an Open Access article distributed under the terms of the Creative Co mmons Attribution-Non-Commercial License (http://creativecommons.o rg/ licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work i sp r o p - erly cited.",Non-OADS,/arxiv_data1/oa_pdf/81/04/kmco-03-03-1026527.PMC4909443.pdf
Stem Cell Reports 2015; 4 (2):239-54; PMID:25601208; http://dx.doi.org/ 10.1016/j.stemcr.2014.12.007 2.,OADS,/arxiv_data1/oa_pdf/81/04/kmco-03-03-1026527.PMC4909443.pdf
FEBS Lett 2012; 586(14):1953-8; PMID:22710171; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/81/04/kmco-03-03-1026527.PMC4909443.pdf
Development 2012; 139(4):709-19;PMID:22219353; http://dx.doi.org/10.1242/ dev.073197 4.,Non-OADS,/arxiv_data1/oa_pdf/81/04/kmco-03-03-1026527.PMC4909443.pdf
Dev Biol 2013; 373(1):95-106; PMID:23103586; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/81/04/kmco-03-03-1026527.PMC4909443.pdf
Blood 2008; 112(8):3154-3163; PMID:18664625; http://dx.doi.org/ 10.1182/blood-2008-03-145326 6.,Non-OADS,/arxiv_data1/oa_pdf/81/04/kmco-03-03-1026527.PMC4909443.pdf
Exp Cell Res 2003; 282 (2):110-20; PMID:12531697; http://dx.doi.org/ 10.1016/S0014-4827(02)00013-7 7.,OADS,/arxiv_data1/oa_pdf/81/04/kmco-03-03-1026527.PMC4909443.pdf
Cell Stem Cell 2010; 7(3):403-17; PMID:20804975; http://dx.doi.org/ 10.1016/j.stem.2010.07.010 8.,OADS,/arxiv_data1/oa_pdf/81/04/kmco-03-03-1026527.PMC4909443.pdf
Effects of bisphenol A on adipokine release from human adi- pose tissue: Implications for the metabolic syndrome.MolCell Endocrinol 2009; 304(1-2):49-54; PMID:19433247; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/81/04/kmco-03-03-1026527.PMC4909443.pdf
Acta Biomater 2013; 9(3):5821-9; PMID:23123301; http://dx.doi.org/ 10.1016/j.actbio.2012.10.030 10.,OADS,/arxiv_data1/oa_pdf/81/04/kmco-03-03-1026527.PMC4909443.pdf
"Supporting this hypothesis, weobserved an inverse correlation betweenUSP11 expression and SMAC mimetic © Eun-Woo Lee and Jaewhan Song *Correspondence to: Jaewhan Song; Email: jso678@yonsei.ac.krSubmitted: 02/23/2015; Revised: 02/24/2015; Accepted: 02/24/2015 http://dx.doi.org/10.1080/23723556.2015.1029829 This is an Open Access article distributed under the terms of the Creative Co mmons Attribution-Non-Commercial License (http://creativecommons.o rg/ licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work i sp r o p - erly cited.",Non-OADS,/arxiv_data1/oa_pdf/6e/ef/kmco-03-03-1029829.PMC4909448.pdf
Nat Rev Drug Discov 2012; 11:109-24; PMID:22293567; http://dx.doi.org/10.1038/nrd3627 2.,Non-OADS,/arxiv_data1/oa_pdf/6e/ef/kmco-03-03-1029829.PMC4909448.pdf
Methods Enzymol 2014; 545:35-65;PMID:25065885; http://dx.doi.org/10.1016/B978-0- 12-801430-1.00002-0 3.,OADS,/arxiv_data1/oa_pdf/6e/ef/kmco-03-03-1029829.PMC4909448.pdf
"Schilling R, Geserick P, Leverkus M. Characteriza- tion of the ripoptosome and its components: impli- cations for anti-inﬂammatory and cancer therapy.Methods Enzymol 2014; 545:83-102; PMID:25065887; http://dx.doi.org/10.1016/B978- 0-12-801430-1.00004-4 5.",OADS,/arxiv_data1/oa_pdf/6e/ef/kmco-03-03-1029829.PMC4909448.pdf
J Biol Chem 2010; 285:40612-23;PMID:20956527; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/6e/ef/kmco-03-03-1029829.PMC4909448.pdf
Mol Cell Biol 2006; 26:699-708; PMID:16382159; http://dx.doi.org/ 10.1128/MCB.26.2.699-708.2006 9.,Non-OADS,/arxiv_data1/oa_pdf/6e/ef/kmco-03-03-1029829.PMC4909448.pdf
"3, e1046582 (3 pages)http://dx.doi.org/10.1080/23723556.2015.1046582",Non-OADS,/arxiv_data1/oa_pdf/e4/11/kmco-03-03-1046582.PMC4909457.pdf
Oncogene 2011; 30:1615-30; PMID:21170083; http://dx.doi.org/ 10.1038/onc.2010.566 3.,Non-OADS,/arxiv_data1/oa_pdf/e4/11/kmco-03-03-1046582.PMC4909457.pdf
Immunol Rev 2012; 246:36-58; PMID:22435546; http://dx.doi.org/10.1111/j.1600-065X.2012.01097.x 4.,Non-OADS,/arxiv_data1/oa_pdf/e4/11/kmco-03-03-1046582.PMC4909457.pdf
Carbo- hydr Res 2008; 343:1222-31; PMID:18374321; http://dx.doi.org/10.1016/j.carres.2008.03.010 5.,OADS,/arxiv_data1/oa_pdf/e4/11/kmco-03-03-1046582.PMC4909457.pdf
Mol Cell 2008; 30:632-41; PMID:18538661; http://dx.doi.org/10.1016/j.molcel.2008.03.017 6.,OADS,/arxiv_data1/oa_pdf/e4/11/kmco-03-03-1046582.PMC4909457.pdf
Cell 2011; 145:178-81; PMID:21496640; http://dx.doi.org/ 10.1016/j.cell.2011.03.014 7.,OADS,/arxiv_data1/oa_pdf/e4/11/kmco-03-03-1046582.PMC4909457.pdf
Nature 2012; 482:339-46; PMID:22337053; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e4/11/kmco-03-03-1046582.PMC4909457.pdf
Science 2014; 344:310-3; PMID:24744378; http://dx.doi.org/10.1126/science.1251456 10.,OADS,/arxiv_data1/oa_pdf/e4/11/kmco-03-03-1046582.PMC4909457.pdf
Trends Genet 2006; 22:1-5; PMID:16290135; http://dx.doi.org/10.1016/j.tig.2005.10.003MOLECULAR & CELLULAR ONCOLOGY e1046582-3,OADS,/arxiv_data1/oa_pdf/e4/11/kmco-03-03-1046582.PMC4909457.pdf
"3, e1134411 (3 pages)http://dx.doi.org/10.1080/23723556.2015.1134411",Non-OADS,/arxiv_data1/oa_pdf/8c/86/kmco-03-03-1134411.PMC4909466.pdf
Cell Rep 2015; 13:1598 –609; PMID:26586426; http://dx.doi.org/10.1016/j.celrep.2015.10.024 Figure 1.,OADS,/arxiv_data1/oa_pdf/8c/86/kmco-03-03-1134411.PMC4909466.pdf
PLoS Genet 2012; 8:e1002460; PMID:22275873; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/8c/86/kmco-03-03-1134411.PMC4909466.pdf
Nat Struct Mol Biol 2014; 21:103 –9; PMID:24336221; http://dx.doi.org/ 10.1038/nsmb.2737 4.,OADS,/arxiv_data1/oa_pdf/8c/86/kmco-03-03-1134411.PMC4909466.pdf
PLoS One 2014; 9:e92640; PMID:24651490; http://dx.doi.org/10.1371/journal.pone.0092640 5.,Non-OADS,/arxiv_data1/oa_pdf/8c/86/kmco-03-03-1134411.PMC4909466.pdf
Exp Cell Res 2011; 317:330 –7; PMID:21056556; http://dx.doi.org/ 10.1016/j.yexcr.2010.10.021 7.,OADS,/arxiv_data1/oa_pdf/8c/86/kmco-03-03-1134411.PMC4909466.pdf
Cell 2014; 159:108 –21; PMID:25259924; http://dx.doi.org/ 10.1016/j.cell.2014.08.030 8.,OADS,/arxiv_data1/oa_pdf/8c/86/kmco-03-03-1134411.PMC4909466.pdf
Sci-ence 2013; 341:660 –4; PMID:23929981; http://dx.doi.org/10.1126/ science.1237150 9.,OADS,/arxiv_data1/oa_pdf/8c/86/kmco-03-03-1134411.PMC4909466.pdf
Elife 2015; 4:e07735; PMID:26287480; http://dx.doi.org/10.7554/eLife.11935 10.,Non-OADS,/arxiv_data1/oa_pdf/8c/86/kmco-03-03-1134411.PMC4909466.pdf
"Groups N Plasma NFL CSF NFL Median ng/L (IQR) Median ng/L (IQR) HIV negative (HIV-neg) 19 9.3 (5.9 –13.1) 363 (264 –487) Primary HIV infection (PHI) 13 11.2 (8.2 –16.6) 732 (456 –1288) Neuroasymtpomatic HIV (NA) CD4 N350 19 9.0 (6.5 –14.3) 488 (374 –694) CD4 200 –349 17 9.7 (7.6 –12.2) 573 (464 –764) CD4 50 –199 19 12.1 (7.8 –44.7) 640 (490 –1530) CD4 b50 20 39.6 (12.0 –103) 2415 (690 –4420) HIV-associated dementia (HAD) 11 114 (46.0 –235) 16,185 (1513 –43,010) HIV, treated-suppressed (ART) 22 11.1 (8.6 –12.8) 582 (322 –706) DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2015.11.036 .",Non-OADS,/arxiv_data1/oa_pdf/e7/40/main.PMC4909478.pdf
Contents lists available at ScienceDirect EBioMedicine journal homepage: www.ebiomedicine.com http://dx.doi.org/10.1016/j.ebiom.2016.04.021 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e7/40/main.PMC4909478.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e7/40/main.PMC4909478.pdf
"Interestingly, when the authors probed hepatic insulin signaling they observed that the chow-fed LRP1 knockout mice had more profound perturbations in insulinEBioMedicine 7 (2016) 17 –18 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2016.04.002 .",Non-OADS,/arxiv_data1/oa_pdf/d3/ea/main.PMC4909479.pdf
demonstrated that loss of LRP1 reduced the cell- surface localization of GLUT2 in primary hepatocytes in the presence http://dx.doi.org/10.1016/j.ebiom.2016.05.018 2352-3964/© 2016 The Authors.,OADS,/arxiv_data1/oa_pdf/d3/ea/main.PMC4909479.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d3/ea/main.PMC4909479.pdf
http://dx.doi.org/10.1038/nature14190 .,Non-OADS,/arxiv_data1/oa_pdf/d3/ea/main.PMC4909479.pdf
http://dx.doi.org/10.1074/jbc.M109.040428 .,Non-OADS,/arxiv_data1/oa_pdf/d3/ea/main.PMC4909479.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d3/ea/main.PMC4909479.pdf
http://dx.doi.org/10.1007/s00125-014-3451-1 .18 S.D.,Non-OADS,/arxiv_data1/oa_pdf/d3/ea/main.PMC4909479.pdf
1The authors are members of the D-BOARD http://www.d-board.eu/dboard/index.aspx and APPROACH http://www.approachproject.eu European Commission funded consortia.,Non-OADS,/arxiv_data1/oa_pdf/00/9f/main.PMC4909481.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.05.004 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/00/9f/main.PMC4909481.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/00/9f/main.PMC4909481.pdf
URL https://www.whitehouse.gov/precision-medicine (accessed 2.5.16).,Non-OADS,/arxiv_data1/oa_pdf/00/9f/main.PMC4909481.pdf
"URL https://www.federalregister.gov/articles/2015/02/13/2015-02976/ identifying-potential-biomarkers-for-quali ﬁcation-and-describing-contexts-of-use-to- address-areas (accessed 2.5.16) 5FDA, 2014.",OADS,/arxiv_data1/oa_pdf/00/9f/main.PMC4909481.pdf
Guidance for Industry and Food and Drug Administration Staff.6http://www.approachproject.eu5 A.-C. Bay-Jensen et al.,Non-OADS,/arxiv_data1/oa_pdf/00/9f/main.PMC4909481.pdf
"Board of the spin-off company of the University of Liège Synolyne Pharma SA ( http://synolyne-pharma.com ), a company developing medical device for the joint viscosupplementation and tissue repair.",Non-OADS,/arxiv_data1/oa_pdf/00/9f/main.PMC4909481.pdf
"24, 9 –20.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/00/9f/main.PMC4909481.pdf
"As pointed out by the pioneers of the pan-cancer project, there are still limitations of analysis across cancer types in terms of inconsistent data acquisition method, incompatible clinical data across cancerEBioMedicine 7 (2016) 7 –8 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2016.03.023 .",Non-OADS,/arxiv_data1/oa_pdf/d7/ed/main.PMC4909482.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.05.013 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d7/ed/main.PMC4909482.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d7/ed/main.PMC4909482.pdf
"http://dx.doi.org/10.1038/nsmb.2678 (Nov, Epub 2013 Oct 6).",OADS,/arxiv_data1/oa_pdf/d7/ed/main.PMC4909482.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d7/ed/main.PMC4909482.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Comparative transcriptomicsPlasmodium species Evolution Microarray TranscriptomeDrug targets 1.,Non-OADS,/arxiv_data1/oa_pdf/eb/59/main.PMC4909483.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.04.011 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/eb/59/main.PMC4909483.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/eb/59/main.PMC4909483.pdf
"However, expression of AR was signi ﬁcantly lower in the GG4 areas of the ﬁnasteride group compared to those of the placebo group ( Kim etEBioMedicine 7 (2016) 13 –14 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2016.03.047 .",Non-OADS,/arxiv_data1/oa_pdf/9f/37/main.PMC4909484.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.04.022 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9f/37/main.PMC4909484.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9f/37/main.PMC4909484.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Anaphylaxis Mast cells TregsDietMicrobiotaImmunotherapy Contents 1 .,Non-OADS,/arxiv_data1/oa_pdf/c8/c4/main.PMC4909486.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.04.012 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c8/c4/main.PMC4909486.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c8/c4/main.PMC4909486.pdf
We fully embrace efforts by journals and policy makers aimed at ensuring scienti ﬁc rigor such as the NIH Principles and Guidelines for Reporting Preclinical Research ( https://www.nih.gov/research-training/rigor- reproducibility/principles-guidelines-reporting-preclinical-research ).,Non-OADS,/arxiv_data1/oa_pdf/7f/39/main.PMC4909494.pdf
EBioMedicineEBioMedicine 7 (2016) 1 http://dx.doi.org/10.1016/j.ebiom.2016.05.020 2352-3964/© 2016 Published by Elsevier B.V.,Non-OADS,/arxiv_data1/oa_pdf/7f/39/main.PMC4909494.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7f/39/main.PMC4909494.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1c/e9/main.PMC4909495.pdf
http://dx.doi.org/10.1016/j.eucr.2016.03.002Urology Case Reports 7 (2016) 1 e2,Non-OADS,/arxiv_data1/oa_pdf/1c/e9/main.PMC4909495.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/29/92/main.PMC4909496.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/29/92/main.PMC4909496.pdf
http://dx.doi.org/10.1016/j.eucr.2016.02.003Urology Case Reports 7 (2016) 14 e16,Non-OADS,/arxiv_data1/oa_pdf/29/92/main.PMC4909496.pdf
http://dx.doi.org/10.3892/ ol.2012.1027 .,Non-OADS,/arxiv_data1/oa_pdf/29/92/main.PMC4909496.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/41/25/main.PMC4909497.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/41/25/main.PMC4909497.pdf
http://dx.doi.org/10.1016/j.eucr.2016.03.009Urology Case Reports 7 (2016) 10 e13,Non-OADS,/arxiv_data1/oa_pdf/41/25/main.PMC4909497.pdf
http://www.jurology.com/ article/S0022-5347(05)62566-9/abstract .,Non-OADS,/arxiv_data1/oa_pdf/41/25/main.PMC4909497.pdf
http://circ.ahajournals.org/content/115/20/ 2666.full .,Non-OADS,/arxiv_data1/oa_pdf/41/25/main.PMC4909497.pdf
http://www.karger.com/Article/Abstract/ 30535 .,Non-OADS,/arxiv_data1/oa_pdf/41/25/main.PMC4909497.pdf
http://www.injuryjournal.com/article/S0020-1383(15) 00135-7/abstract .,Non-OADS,/arxiv_data1/oa_pdf/41/25/main.PMC4909497.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0d/8c/main.PMC4909498.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0d/8c/main.PMC4909498.pdf
http://dx.doi.org/10.1016/j.eucr.2016.04.002Urology Case Reports 7 (2016) 51 e52,Non-OADS,/arxiv_data1/oa_pdf/0d/8c/main.PMC4909498.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b8/ac/main.PMC4909499.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b8/ac/main.PMC4909499.pdf
http://dx.doi.org/10.1016/j.eucr.2016.03.013Urology Case Reports 7 (2016) 26 e27,Non-OADS,/arxiv_data1/oa_pdf/b8/ac/main.PMC4909499.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7b/64/main.PMC4909500.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7b/64/main.PMC4909500.pdf
http://dx.doi.org/10.1016/j.eucr.2016.04.003Urology Case Reports 7 (2016) 37 e38,Non-OADS,/arxiv_data1/oa_pdf/7b/64/main.PMC4909500.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/74/75/main.PMC4909501.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/74/75/main.PMC4909501.pdf
http://dx.doi.org/10.1016/j.eucr.2016.03.007Urology Case Reports 7 (2016) 33 e36,Non-OADS,/arxiv_data1/oa_pdf/74/75/main.PMC4909501.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/47/c0/main.PMC4909502.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/47/c0/main.PMC4909502.pdf
http://dx.doi.org/10.1016/j.eucr.2016.04.005Urology Case Reports 7 (2016) 48 e50,Non-OADS,/arxiv_data1/oa_pdf/47/c0/main.PMC4909502.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f8/c1/main.PMC4909503.pdf
URL:http://www.uonuma-kikan-hospital.jp/ Contents lists available at ScienceDirect Urology Case Reports journal homepage: www.els evier.com/locate/eucr 2214-4420/ /C2112016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f8/c1/main.PMC4909503.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f8/c1/main.PMC4909503.pdf
http://dx.doi.org/10.1016/j.eucr.2016.03.010Urology Case Reports 7 (2016) 7 e9,Non-OADS,/arxiv_data1/oa_pdf/f8/c1/main.PMC4909503.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/51/aa/main.PMC4909504.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/51/aa/main.PMC4909504.pdf
http://dx.doi.org/10.1016/j.eucr.2016.04.001Urology Case Reports 7 (2016) 39 e41,Non-OADS,/arxiv_data1/oa_pdf/51/aa/main.PMC4909504.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/19/17/main.PMC4909516.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/19/17/main.PMC4909516.pdf
http://dx.doi.org/10.1016/j.eucr.2016.04.011Urology Case Reports 7 (2016) 55 e57,Non-OADS,/arxiv_data1/oa_pdf/19/17/main.PMC4909516.pdf
http://dx.doi.org/10.1016/ j.annpat.2015.09.004 .,OADS,/arxiv_data1/oa_pdf/19/17/main.PMC4909516.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a1/71/main.PMC4909517.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a1/71/main.PMC4909517.pdf
http://dx.doi.org/10.1016/j.eucr.2016.04.015Urology Case Reports 7 (2016) 72 e73,Non-OADS,/arxiv_data1/oa_pdf/a1/71/main.PMC4909517.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1e/28/main.PMC4909518.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1e/28/main.PMC4909518.pdf
http://dx.doi.org/10.1016/j.eucr.2016.04.013Urology Case Reports 7 (2016) 53 e54,Non-OADS,/arxiv_data1/oa_pdf/1e/28/main.PMC4909518.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1c/32/main.PMC4909527.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1c/32/main.PMC4909527.pdf
http://dx.doi.org/10.1016/j.eucr.2016.04.012Urology Case Reports 7 (2016) 64 e66,Non-OADS,/arxiv_data1/oa_pdf/1c/32/main.PMC4909527.pdf
2015;314(1):80 e82.http://dx.doi.org/ 10.1001/jama.2015.6036 .,Non-OADS,/arxiv_data1/oa_pdf/1c/32/main.PMC4909527.pdf
http://dx.doi.org/10.1016/j.juro.2010.12.032 .,OADS,/arxiv_data1/oa_pdf/1c/32/main.PMC4909527.pdf
http://dx.doi.org/10.1016/j.eururo.2011.10.038 .,OADS,/arxiv_data1/oa_pdf/1c/32/main.PMC4909527.pdf
http://dx.doi.org/10.1016/j.eururo.2014.10.010 .,OADS,/arxiv_data1/oa_pdf/1c/32/main.PMC4909527.pdf
2016;43:17 e38.http://dx.doi.org/10.1016/j.ucl.2015.08.003 .,OADS,/arxiv_data1/oa_pdf/1c/32/main.PMC4909527.pdf
http://dx.doi.org/10.1200/ JCO.2009.25.7311 .D.,OADS,/arxiv_data1/oa_pdf/1c/32/main.PMC4909527.pdf
"The APOSTEL recommendations are designed to complement existing and well-established reporting guidelines16openly available through the equator net- work (http://www.equator-network.org), but add spe- cific parameters for the reporting of OCT data.",Non-OADS,/arxiv_data1/oa_pdf/cc/49/NEUROLOGY2015708388.PMC4909557.pdf
"A p reliminary version of the manuscript and the checklist was generated by the working groups, discussed and approved during a joint t e l e p h o n ec o n f e r e n c e ,a n dt h e nc i r c u l a t e dt ot h e members of the International Multiple Sclerosis Visual (IMSVISUAL) consortium (http://www.imsvisual.org) in several rounds for comments and revisions.",Non-OADS,/arxiv_data1/oa_pdf/cc/49/NEUROLOGY2015708388.PMC4909557.pdf
This is but one example of the power of those techniques that attempt the difﬁ cult task of bridging the behav- ior of single cells with large ensembles of neurons regionally and acrossEBioMedicine 7 (2016) 19 –20 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2016.03.039 .,Non-OADS,/arxiv_data1/oa_pdf/a2/5b/main.PMC4909601.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.05.001 2352-3964/© 2016 The Author.,Non-OADS,/arxiv_data1/oa_pdf/a2/5b/main.PMC4909601.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a2/5b/main.PMC4909601.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2f/14/main.PMC4909602.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2f/14/main.PMC4909602.pdf
http://dx.doi.org/10.1016/j.eucr.2016.03.012Urology Case Reports 7 (2016) 28 e30,Non-OADS,/arxiv_data1/oa_pdf/2f/14/main.PMC4909602.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8a/10/main.PMC4909603.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8a/10/main.PMC4909603.pdf
http://dx.doi.org/10.1016/j.eucr.2016.03.014Urology Case Reports 7 (2016) 17 e19,Non-OADS,/arxiv_data1/oa_pdf/8a/10/main.PMC4909603.pdf
BMJ Case Rep. 2010;2010. http://dx.doi.org/10.1136/bcr.12.2009.2547 .,Non-OADS,/arxiv_data1/oa_pdf/8a/10/main.PMC4909603.pdf
2010;2010: 3.http://dx.doi.org/10.1155/2010/740642 .,Non-OADS,/arxiv_data1/oa_pdf/8a/10/main.PMC4909603.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/11/27/main.PMC4909604.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/11/27/main.PMC4909604.pdf
http://dx.doi.org/10.1016/j.eucr.2016.04.006Urology Case Reports 7 (2016) 31 e32,Non-OADS,/arxiv_data1/oa_pdf/11/27/main.PMC4909604.pdf
Patients with Legius syndrome have multiple café-au-EBioMedicine 7 (2016) 21 –22 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2016.04.005 .,Non-OADS,/arxiv_data1/oa_pdf/cf/86/main.PMC4909605.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.04.036 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/cf/86/main.PMC4909605.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cf/86/main.PMC4909605.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/58/27/main.PMC4909606.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/58/27/main.PMC4909606.pdf
http://dx.doi.org/10.1016/j.eucr.2016.03.011Urology Case Reports 7 (2016) 23 e25,Non-OADS,/arxiv_data1/oa_pdf/58/27/main.PMC4909606.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/59/73/main.PMC4909607.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/59/73/main.PMC4909607.pdf
http://dx.doi.org/10.1016/j.eucr.2016.03.006Urology Case Reports 7 (2016) 3 e6,Non-OADS,/arxiv_data1/oa_pdf/59/73/main.PMC4909607.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.03.047 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/17/8d/main.PMC4909608.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/17/8d/main.PMC4909608.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/17/8d/main.PMC4909608.pdf
"Also, all sites reported clinical data using the DCP Oracle clinical remote data capture Web- based application managed by DCP's monitoring contractor (see detailed study information at: https://clinicaltrials.gov/ct2/show/ NCT00438464?term= ﬁnasteride&rank=8 ).",OADS,/arxiv_data1/oa_pdf/17/8d/main.PMC4909608.pdf
"Exclusion criteria included active malignancy at any other site; prior radiation therapy for the primary tumor; history of allergic reactions attribut- ed to compounds of chemical or biologic composition similar to that of ﬁnasteride; uncontrolled intercurrent illness; use of anticoagulation agents, except for cardioprotective doses of aspirin; use of all hormonal agents, including testosterone, saw palmetto, dutasteride, or ﬁnasteride six months before study entry (see detailed study information at: https://clinicaltrials.gov/ct2/show/ NCT00438464?term= ﬁnasteride&rank=8 ).",Non-OADS,/arxiv_data1/oa_pdf/17/8d/main.PMC4909608.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Systems nutrigenomics FructoseOmega-3 fatty acidDHAEpigenomeTranscriptomeBrain networksMetabolic diseases Brain disorders Extracellular matrix 1.,Non-OADS,/arxiv_data1/oa_pdf/48/a0/main.PMC4909610.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.04.008 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/48/a0/main.PMC4909610.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/48/a0/main.PMC4909610.pdf
"First, we cross-checked genes identi ﬁed in our study with top GWAS candidate genes reported in the GWAS catalog ( http://www.genome.gov/gwastudies/ )(Hindorff et al., 2009 ) for direct overlap.",OADS,/arxiv_data1/oa_pdf/48/a0/main.PMC4909610.pdf
"Network Modeling and Identi ﬁcation of Key Drivers (KD) of Fructose and DHA Signatures We obtained both protein –protein interaction (PPI) networks from the HPRD database ( http://www.hprd.org )(Keshava Prasad et al., 2009 ) and tissue-speci ﬁc Bayesian networks (BNs) ( Zhu et al., 2004, 2008 ) for hypothalamus and hippocampus constructed based on genet- ic and transcriptomic data from multiple large-scale mouse studies (Supplemental Materials).",OADS,/arxiv_data1/oa_pdf/48/a0/main.PMC4909610.pdf
All statistical and bioinformatics analyses were performed in R(http://www.R-project.org /).,OADS,/arxiv_data1/oa_pdf/48/a0/main.PMC4909610.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Destruxin A5PDGF-B/PDGFR- β Protein –protein interface Selective inhibitor Liver ﬁbrosis 1.,Non-OADS,/arxiv_data1/oa_pdf/42/c6/main.PMC4909612.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.03.042 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/42/c6/main.PMC4909612.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/42/c6/main.PMC4909612.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/83/86/main.PMC4909632.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/83/86/main.PMC4909632.pdf
http://dx.doi.org/10.1016/j.eucr.2016.04.014Urology Case Reports 7 (2016) 58 e60,Non-OADS,/arxiv_data1/oa_pdf/83/86/main.PMC4909632.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4d/5e/main.PMC4909633.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4d/5e/main.PMC4909633.pdf
http://dx.doi.org/10.1016/j.eucr.2016.04.016Urology Case Reports 7 (2016) 61 e63,Non-OADS,/arxiv_data1/oa_pdf/4d/5e/main.PMC4909633.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/47/ce/main.PMC4909634.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/47/ce/main.PMC4909634.pdf
http://dx.doi.org/10.1016/j.eucr.2016.04.008Urology Case Reports 7 (2016) 45 e47,Non-OADS,/arxiv_data1/oa_pdf/47/ce/main.PMC4909634.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/54/0d/main.PMC4909635.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/54/0d/main.PMC4909635.pdf
http://dx.doi.org/10.1016/j.eucr.2016.04.009Urology Case Reports 7 (2016) 42 e44,Non-OADS,/arxiv_data1/oa_pdf/54/0d/main.PMC4909635.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/12/a3/main.PMC4909636.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/12/a3/main.PMC4909636.pdf
http://dx.doi.org/10.1016/j.eucr.2016.04.010Urology Case Reports 7 (2016) 67 e69,Non-OADS,/arxiv_data1/oa_pdf/12/a3/main.PMC4909636.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect Journal of Current Ophthalmology 28 (2016) 55 e56 http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2016.05.007 2452-2325/Copyright ©2016, Iranian Society of Ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/af/d3/main.PMC4909637.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/af/d3/main.PMC4909637.pdf
The feasibility endpoints includedDOI of original article: http://dx.doi.org/10.1016/j.ebiom.2016.03.027 .,OADS,/arxiv_data1/oa_pdf/39/95/main.PMC4909638.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.03.024 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/39/95/main.PMC4909638.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/39/95/main.PMC4909638.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect Journal of Current Ophthalmology 28 (2016) 53 e54 http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2016.04.003 2452-2325/Copyright ©2016, Iranian Society of Ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/7f/bf/main.PMC4909639.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7f/bf/main.PMC4909639.pdf
"Available at: http://icoph.org ; Accessed April 10, 2016.",Non-OADS,/arxiv_data1/oa_pdf/7f/bf/main.PMC4909639.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Gut hormones GLP-1Low-abundant peptidesMass-spectrometryProteomics 1.,Non-OADS,/arxiv_data1/oa_pdf/e6/26/main.PMC4909640.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.03.034 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e6/26/main.PMC4909640.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e6/26/main.PMC4909640.pdf
"Hjollund, KR, Deacon, CF & Holst, JJ 2011, ‘ Dipeptidyl peptidase-4 inhibition increases por- tal concentrations of intact glucagon-like peptide-1 (GLP-1) to a greater extent than peripheral concentrations in anaesthetised pigs ’, paper presented to Diabetologia, 2011, bhttp://dx.doi.org/10.1007/s00125-011-2168-7 N. Holst, J.J., 2013a.",Non-OADS,/arxiv_data1/oa_pdf/e6/26/main.PMC4909640.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: MRIProstate cancer Diffusion weighted imaging 1.,Non-OADS,/arxiv_data1/oa_pdf/ff/6a/main.PMC4909641.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.03.041 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ff/6a/main.PMC4909641.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ff/6a/main.PMC4909641.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3a/5a/main.PMC4909642.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3a/5a/main.PMC4909642.pdf
http://dx.doi.org/10.1016/j.eucr.2016.04.018Urology Case Reports 7 (2016) 70 e71,Non-OADS,/arxiv_data1/oa_pdf/3a/5a/main.PMC4909642.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/af/93/main.PMC4909643.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect Journal of Current Ophthalmology 28 (2016) 85 e90 http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2016.04.002 2452-2325/Copyright ©2016, Iranian Society of Ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/af/93/main.PMC4909643.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/af/93/main.PMC4909643.pdf
Change the Deﬁnition of Blindness ; 2012. http://www.who.int/ blindness/Change%20the%20Deﬁnition%20of%20Blindness.pdf .,Non-OADS,/arxiv_data1/oa_pdf/af/93/main.PMC4909643.pdf
Accessed 16.09.09 http://www.housinginstitute.org/events/amconf/ presentations/Margaret%20Ward%20-%20Universal%20Housing% 20Design.doc .90 A. Riazi et al.,Non-OADS,/arxiv_data1/oa_pdf/af/93/main.PMC4909643.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide alink to the Creative Commons license, and indicate if changes were made.REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/11/ae/40123_2015_Article_43.PMC4909670.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/b4/53/40123_2016_Article_44.PMC4909671.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/5b/b6/40123_2016_Article_45.PMC4909672.pdf
Available from: https://www.medicines.org.uk/ emc/medicine/27636 .,Non-OADS,/arxiv_data1/oa_pdf/5b/b6/40123_2016_Article_45.PMC4909672.pdf
"Besiﬂoxacin is an appropriate option for treatment of bacterial conjunctivitis, and its use in the treatment of bacterial keratitis and lid disorders, as well as for surgical prophylaxis, appears promising and warrants further evaluation.Enhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ E784F06017A19448 .",Non-OADS,/arxiv_data1/oa_pdf/ff/ee/40123_2016_Article_46.PMC4909673.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, providea link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/ff/ee/40123_2016_Article_46.PMC4909673.pdf
Available at: http://www.eyeworld.org/ article-medication-alert-for-lasik-and-prk .,Non-OADS,/arxiv_data1/oa_pdf/ff/ee/40123_2016_Article_46.PMC4909673.pdf
InEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 1E84F0607834233E .,Non-OADS,/arxiv_data1/oa_pdf/62/95/40123_2016_Article_47.PMC4909674.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/62/95/40123_2016_Article_47.PMC4909674.pdf
http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/62/95/40123_2016_Article_47.PMC4909674.pdf
"Despite the advantages of multidiode laserEnhanced content To view enhanced content for this article, go to http://www.medengine.com/Redeem/ F3B4F060519688E0 .",Non-OADS,/arxiv_data1/oa_pdf/99/90/40123_2016_Article_48.PMC4909675.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate creditto the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/99/90/40123_2016_Article_48.PMC4909675.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercialuse, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/cf/b6/40123_2016_Article_49.PMC4909676.pdf
https://www.medicines.org.uk/emc/medicine/27636 .,Non-OADS,/arxiv_data1/oa_pdf/cf/b6/40123_2016_Article_49.PMC4909676.pdf
Conclusion : The new topical drug treatment analyzed herein signiﬁcantly improved nearEnhanced content To view enhance content for this article go to http://www.medengine.com/Redeem/ B2C4F0603E6051FB .,Non-OADS,/arxiv_data1/oa_pdf/05/f4/40123_2016_Article_50.PMC4909677.pdf
This article is distributed under the terms of the Creative Commons Attribution- NonCommercial 4.0 International License(http://creativecommons.org/licenses/by-nc/4.,Non-OADS,/arxiv_data1/oa_pdf/05/f4/40123_2016_Article_50.PMC4909677.pdf
https://www.census.gov/population/ international/data/idb/worldpop.php .,OADS,/arxiv_data1/oa_pdf/05/f4/40123_2016_Article_50.PMC4909677.pdf
"Keywords: Amniotic membrane; Corneal surgery; Fibrin membrane; Platelet-rich plasma; PRP; Tutopatch INTRODUCTION Severe ocular surface disease (OSD) due to thermal and chemical burns, Stevens–Johnson syndrome (SJS), ocular cicatricial pemphigoid (OCP) or otherEnhanced content To view enhance content for this article go to http://www.medengine.com/Redeem/ 43C4F06037E42EFC .",Non-OADS,/arxiv_data1/oa_pdf/d6/3d/40123_2016_Article_51.PMC4909678.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/d6/3d/40123_2016_Article_51.PMC4909678.pdf
PatientsEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/45C4 F0604DE73D4B .,Non-OADS,/arxiv_data1/oa_pdf/29/b9/40123_2016_Article_52.PMC4909679.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate creditto the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/29/b9/40123_2016_Article_52.PMC4909679.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.Ophthalmol Ther (2016) 5:81–94 93",Non-OADS,/arxiv_data1/oa_pdf/ad/5d/40123_2016_Article_53.PMC4909680.pdf
https://www.medicines.org.uk/emc/ medicine/27636 .,Non-OADS,/arxiv_data1/oa_pdf/ad/5d/40123_2016_Article_53.PMC4909680.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/94/ac/main.PMC4909696.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect Journal of Current Ophthalmology 28 (2016) 69 e74 http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2016.03.007 2452-2325/Copyright ©2016, Iranian Society of Ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/94/ac/main.PMC4909696.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/94/ac/main.PMC4909696.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/62/8e/main.PMC4909697.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect Journal of Current Ophthalmology 28 (2016) 91 e92 http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2016.03.005 2452-2325/Copyright ©2016, Iranian Society of Ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/62/8e/main.PMC4909697.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/62/8e/main.PMC4909697.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/18/8e/main.PMC4909699.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect Journal of Current Ophthalmology 28 (2016) 65 e68 http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2016.03.004 2452-2325/Copyright ©2016, Iranian Society of Ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/18/8e/main.PMC4909699.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/18/8e/main.PMC4909699.pdf
Supplementary video related to this article can be found at http://dx.doi.org/10.1016/j.joco.2016.03.004 .,OADS,/arxiv_data1/oa_pdf/18/8e/main.PMC4909699.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/74/ef/main.PMC4909700.pdf
1476-5586http://dx.doi.org/10.1016/j.neo.2016.04.003,OADS,/arxiv_data1/oa_pdf/74/ef/main.PMC4909700.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/37/f4/main.PMC4909701.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect Journal of Current Ophthalmology 28 (2016) 81 e84 http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2016.03.002 2452-2325/Copyright ©2016, Iranian Society of Ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/37/f4/main.PMC4909701.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/37/f4/main.PMC4909701.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ba/dd/main.PMC4909702.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect Journal of Current Ophthalmology 28 (2016) 75 e80 http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2016.03.001 2452-2325/Copyright ©2016, Iranian Society of Ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/ba/dd/main.PMC4909702.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ba/dd/main.PMC4909702.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c8/8d/main.PMC4909703.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect Journal of Current Ophthalmology 28 (2016) 93 e95 http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2015.12.003 2452-2325/Copyright ©2015, Iranian Society of Ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/c8/8d/main.PMC4909703.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c8/8d/main.PMC4909703.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/ by- nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/68/d2/main.PMC4909704.pdf
1476-5586 http://dx.doi.org/10.1016/j.neo.2016.04.006,OADS,/arxiv_data1/oa_pdf/68/d2/main.PMC4909704.pdf
http://dx.doi.org/10.1038/cddis.2013.393 .,Non-OADS,/arxiv_data1/oa_pdf/68/d2/main.PMC4909704.pdf
"Cancer Metab 1, 20. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/68/d2/main.PMC4909704.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b7/1d/main.PMC4909705.pdf
1476-5586http://dx.doi.org/10.1016/j.neo.2016.04.007,OADS,/arxiv_data1/oa_pdf/b7/1d/main.PMC4909705.pdf
http://dx.doi.org/10.1002/hed.24231 .,OADS,/arxiv_data1/oa_pdf/b7/1d/main.PMC4909705.pdf
Oncotarget .http://dx.doi.org/10.18632/oncotarget.6824 .,OADS,/arxiv_data1/oa_pdf/b7/1d/main.PMC4909705.pdf
http://dx.doi.org/10.1111/ jebm.12184 .,Non-OADS,/arxiv_data1/oa_pdf/b7/1d/main.PMC4909705.pdf
http://dx.doi.org/10.1186/ s12885-015-1356-0 .,Non-OADS,/arxiv_data1/oa_pdf/b7/1d/main.PMC4909705.pdf
This is an open access article under the CCBY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/fe/main.PMC4909706.pdf
1476-5586 http://dx.doi.org/10.1016/j.neo.2016.04.002,OADS,/arxiv_data1/oa_pdf/6c/fe/main.PMC4909706.pdf
"GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. http://globocan.iarc.fr/Pages/fact_sheets_cancer.",Non-OADS,/arxiv_data1/oa_pdf/6c/fe/main.PMC4909706.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/af/4b/main.PMC4909707.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect Journal of Current Ophthalmology 28 (2016) 61 e64 http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2016.03.003 2452-2325/Copyright ©2016, Iranian Society of Ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/af/4b/main.PMC4909707.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/af/4b/main.PMC4909707.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Heart failure with reduced ejection fraction Heart failure with preserved ejection fraction Epigenetic modi ﬁcations Chromatin remodeling Contents 1 .,Non-OADS,/arxiv_data1/oa_pdf/42/28/main.PMC4909708.pdf
http://dx.doi.org/10.1016/j.bbacli.2016.05.005 2214-6474/© 2016 The Author.,Non-OADS,/arxiv_data1/oa_pdf/42/28/main.PMC4909708.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/42/28/main.PMC4909708.pdf
5 (2016) http://dx.doi.org/10.5772/ 62797 (ahead of print).,Non-OADS,/arxiv_data1/oa_pdf/42/28/main.PMC4909708.pdf
(2016) http://dx.doi.org/10.1016/j.dsx.2016.,OADS,/arxiv_data1/oa_pdf/42/28/main.PMC4909708.pdf
"[32] A. Berezin, A. Kremzer, T. Berezina, M. Yu, O. Gromenko, Pattern of endothelial progenitor cells and apoptotic endothelial cell-derived microparticles in chronic heart failure patients with preserved and reduced left ventricular ejec- tion fraction, EBioMedicine 4 (2016) 86 –94, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/42/28/main.PMC4909708.pdf
"4 (2013) 219, http://dx.doi.org/10.3389/fgene.",Non-OADS,/arxiv_data1/oa_pdf/42/28/main.PMC4909708.pdf
4 (4) (2015) http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/42/28/main.PMC4909708.pdf
(2016) http://dx.doi.org/10.1002/ejhf.495 (Epub ahead of print).,Non-OADS,/arxiv_data1/oa_pdf/42/28/main.PMC4909708.pdf
(2015) http://dx.doi.org/10.1002/ejhf.332 .,Non-OADS,/arxiv_data1/oa_pdf/42/28/main.PMC4909708.pdf
"(Sunnyvale) 6 (3) (2016) 176 –177, http://dx.doi.org/10.4172/2161-1025.1000176 .37 A. Berezin / BBA Clinical 6 (2016) 31 –37",Non-OADS,/arxiv_data1/oa_pdf/42/28/main.PMC4909708.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/35/ad/main.PMC4909710.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect Journal of Current Ophthalmology 28 (2016) 57 e60 http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2016.04.001 2452-2325/Copyright ©2016, Iranian Society of Ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/35/ad/main.PMC4909710.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/35/ad/main.PMC4909710.pdf
Available at: http://drcrnet.jaeb.,Non-OADS,/arxiv_data1/oa_pdf/35/ad/main.PMC4909710.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: MucopolysaccharidosisMorquio syndromeWhole exome sequencingGlycosaminoglycans 1.,Non-OADS,/arxiv_data1/oa_pdf/8f/d8/main.PMC4909711.pdf
http://dx.doi.org/10.1016/j.ymgmr.2016.05.006 2214-4269/© 2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/8f/d8/main.PMC4909711.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8f/d8/main.PMC4909711.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/af/81/main.PMC4909713.pdf
Kainic acidContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2016.05.004 2213-2317/ &2016 The Authors.,OADS,/arxiv_data1/oa_pdf/af/81/main.PMC4909713.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/af/81/main.PMC4909713.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/44/3e/main.PMC4909714.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/44/3e/main.PMC4909714.pdf
http://dx.doi.org/10.1016/j.eucr.2016.05.004Urology Case Reports 8 (2016) 18 e20,Non-OADS,/arxiv_data1/oa_pdf/44/3e/main.PMC4909714.pdf
1476-5586http://dx.doi.org/10.1016/j.neo.2016.04.008,OADS,/arxiv_data1/oa_pdf/7e/6b/main.PMC4909715.pdf
http://dx.doi.org/10.1016/j.celrep.2015.12.031 .,OADS,/arxiv_data1/oa_pdf/7e/6b/main.PMC4909715.pdf
E-mail address: robin.jump@va.gov (Robin L.P. Jump).Contents lists available at ScienceDirect IDCases journal homepage: www.elsevier.com/locate/idcr http://dx.doi.org/10.1016/j.idcr.2016.05.003 2214-2509/Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/98/17/main.PMC4909719.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/98/17/main.PMC4909719.pdf
http://dx.doi.org/10.1099/00207713-29-2-92 .,Non-OADS,/arxiv_data1/oa_pdf/98/17/main.PMC4909719.pdf
http://dx.doi.org/10.2298/ABS1303899T .,Non-OADS,/arxiv_data1/oa_pdf/98/17/main.PMC4909719.pdf
http://dx.doi.org/10.1016/j.knee.2009.02.008 .,OADS,/arxiv_data1/oa_pdf/98/17/main.PMC4909719.pdf
http://dx.doi.org/10.1007/BF01967080 .,Non-OADS,/arxiv_data1/oa_pdf/98/17/main.PMC4909719.pdf
http://dx.doi.org/10.1016/S0399- 077X(00)80029-3 .,OADS,/arxiv_data1/oa_pdf/98/17/main.PMC4909719.pdf
http://dx.doi.org/10.1128/CMR.00017-11 .,Non-OADS,/arxiv_data1/oa_pdf/98/17/main.PMC4909719.pdf
http://dx.doi.org/ 10.1016/j.tvjl.2007.02.025 .,OADS,/arxiv_data1/oa_pdf/98/17/main.PMC4909719.pdf
J Antimicrob Chemother 2003;51:865– 85.http://dx.doi.org/10.1093/jac/dkg156 .,OADS,/arxiv_data1/oa_pdf/98/17/main.PMC4909719.pdf
http://dx.doi.org/10.1016/j.ijfoodmicro.2015.03.014 .,OADS,/arxiv_data1/oa_pdf/98/17/main.PMC4909719.pdf
http://dx.doi.org/10.1111/j.1469- 0691.2007.01861.x .,Non-OADS,/arxiv_data1/oa_pdf/98/17/main.PMC4909719.pdf
http://dx.doi.org/10.1086/501875 .,Non-OADS,/arxiv_data1/oa_pdf/98/17/main.PMC4909719.pdf
http://www.eucast.org/clinical_breakpoints/ [accessed 22.01.16].,Non-OADS,/arxiv_data1/oa_pdf/98/17/main.PMC4909719.pdf
http://clsi.org/ [accessed 22.01.16].A.,Non-OADS,/arxiv_data1/oa_pdf/98/17/main.PMC4909719.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.04.014,Non-OADS,/arxiv_data1/oa_pdf/19/0a/main.PMC4909720.pdf
MALDI-TOF MS spectrum accession number The MALDI-TOF MS spectrum of Christensenella massiliensis is available online ( http://www.mediterraneeinfection.com/article.,Non-OADS,/arxiv_data1/oa_pdf/19/0a/main.PMC4909720.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,12,6 9 –70 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/19/0a/main.PMC4909720.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/aa/1b/main.PMC4909721.pdf
E-mail address: sengpiseth@yahoo.fr (P. Seng).Contents lists available at ScienceDirect IDCases journal homepage: www.elsevier.com/locate/idcr http://dx.doi.org/10.1016/j.idcr.2016.05.002 2214-2509/ /C2232016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/aa/1b/main.PMC4909721.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/aa/1b/main.PMC4909721.pdf
http://dx.doi.org/ 10.1111/j.1365-2230.2007.02375.x .,Non-OADS,/arxiv_data1/oa_pdf/aa/1b/main.PMC4909721.pdf
http://dx.doi.org/10.1053/ jhin.2002.1314 .,Non-OADS,/arxiv_data1/oa_pdf/aa/1b/main.PMC4909721.pdf
Med Mycol 2015. http://dx.doi.org/10.1093/mmy/myv095 .,Non-OADS,/arxiv_data1/oa_pdf/aa/1b/main.PMC4909721.pdf
http://dx.doi.org/ 10.1086/429916 .,Non-OADS,/arxiv_data1/oa_pdf/aa/1b/main.PMC4909721.pdf
http://dx.doi.org/10.1016/ j.emc.2008.01.005 .,OADS,/arxiv_data1/oa_pdf/aa/1b/main.PMC4909721.pdf
http://dx.doi.org/10.1007/s11751-009-0059-y .,Non-OADS,/arxiv_data1/oa_pdf/aa/1b/main.PMC4909721.pdf
http://dx.doi.org/10.1016/j.avsg.,OADS,/arxiv_data1/oa_pdf/aa/1b/main.PMC4909721.pdf
This  is  an  open access article under the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3a/fa/main.PMC4909724.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.05.036 2210-2612/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/3a/fa/main.PMC4909724.pdf
References [1]  http://www.google.com/ url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&ved=0ahUKEwj1- 6Guc3KAhULpR4KHb5ZBGcQFggdMAA&url=http%3A%2F%2Ftimesoﬁndia.indiatimes.com%2Findia%2FAIIMS-surgeons-remove-worlds-largest-kidney-tumour-weighing-5-018-kg%2Farticleshow%2F47359053.=cms&usg=AFQjCNHSIU5RxZ0ONQHXlPf ftBdM43Big&sig2  Q- KeB1HScgQipq-IpGs4Iw gest  &  third  largest  renal  tumours  removed  in  India .,Non-OADS,/arxiv_data1/oa_pdf/3a/fa/main.PMC4909724.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8d/70/main.PMC4909725.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.05.050 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/8d/70/main.PMC4909725.pdf
*Corresponding author.Contents lists available at ScienceDirect IDCases journal homepage: www.elsevier.com/locate/idcr http://dx.doi.org/10.1016/j.idcr.2016.05.004 2214-2509/ /C2232016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/6c/7a/main.PMC4909726.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/6c/7a/main.PMC4909726.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/55/08/main.PMC4909752.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.05.041 2210-2612/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/55/08/main.PMC4909752.pdf
(https://www.nccn.org/professionals/physician  gls/pdf/nhl.pdf).,Non-OADS,/arxiv_data1/oa_pdf/55/08/main.PMC4909752.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Patient-centered careQualitative researchPatient-physician relationshipOutcomes 1.,Non-OADS,/arxiv_data1/oa_pdf/44/ee/main.PMC4909815.pdf
http://dx.doi.org/10.1016/j.gore.2016.05.011 2352-5789/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/44/ee/main.PMC4909815.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/44/ee/main.PMC4909815.pdf
Code of Medical Ethics 1996 [cited 2013 August 21]; Available from: http://www.ama-assn.org/ama/pub/ physician-resources/legal-topics/patient -physician-relationship-topics/ending- patient-physician-relationship.page .,Non-OADS,/arxiv_data1/oa_pdf/44/ee/main.PMC4909815.pdf
Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor http://dx.doi.org/10.1016/j.gore.2016.05.012 2352-5789/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0f/80/main.PMC4909816.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0f/80/main.PMC4909816.pdf
"Rep. 15, 1 –3.http://dx.doi.org/10.1016/j.gore.2015.07.005 eCollection 2016.",OADS,/arxiv_data1/oa_pdf/0f/80/main.PMC4909816.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Lymphoblastoid cell lineGenotypingSingle nucleotide polymorphism 1.,Non-OADS,/arxiv_data1/oa_pdf/ef/3f/main.PMC4909818.pdf
http://dx.doi.org/10.1016/j.gdata.2016.05.006 2213-5960/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ef/3f/main.PMC4909818.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ef/3f/main.PMC4909818.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Schizotypal personality disorderBehavioral monitoring Neurophysiology Error-related negativityDopaminergic antagonism 1.,Non-OADS,/arxiv_data1/oa_pdf/7a/03/main.PMC4909819.pdf
http://dx.doi.org/10.1016/j.nicl.2016.05.019 2213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/7a/03/main.PMC4909819.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7a/03/main.PMC4909819.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: TBGSERPINA7MutationIran 1.,Non-OADS,/arxiv_data1/oa_pdf/ef/f4/main.PMC4909823.pdf
http://dx.doi.org/10.1016/j.ymgmr.2016.06.0012214-4269/Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/ef/f4/main.PMC4909823.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ef/f4/main.PMC4909823.pdf
"This variant, which is known as TBG-Gary, has been previously reported ( http://www.ncbi.nlm.nih.",Non-OADS,/arxiv_data1/oa_pdf/ef/f4/main.PMC4909823.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Saccharomyces pastorianusLager beerLager yeast Hybrid 1.,Non-OADS,/arxiv_data1/oa_pdf/cd/54/main.PMC4909825.pdf
"With the use of next generation sequencing (NGS) technologies, such as the Illumina Platform, 40,175 prokaryote and eukaryotes ge- nomes have been reported, including 210 different strains of the Saccha- romyces complex ( http://www.ncbi.nlm.nih.gov/genome/browse/ - revised July 22, 2015).",OADS,/arxiv_data1/oa_pdf/cd/54/main.PMC4909825.pdf
http://dx.doi.org/10.1016/j.gdata.2016.05.009 2213-5960/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/cd/54/main.PMC4909825.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cd/54/main.PMC4909825.pdf
Visualization of annotations with IGV Tools v2.3 ( http://www.broadinstitute.org/software/igv/home ).,OADS,/arxiv_data1/oa_pdf/cd/54/main.PMC4909825.pdf
"46(1981) 65 –76,http://dx.doi.org/10.1007/BF02906199 .",Non-OADS,/arxiv_data1/oa_pdf/cd/54/main.PMC4909825.pdf
"14 (1995) 514 –522, http://dx.doi.org/10.1007/ BF01573967 .",Non-OADS,/arxiv_data1/oa_pdf/cd/54/main.PMC4909825.pdf
51 (2001) 1607 –1618 ( http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/cd/54/main.PMC4909825.pdf
"Yeast 22 (2005) 1099 –1115, http://dx.doi.org/10.1002/yea.1298 .",Non-OADS,/arxiv_data1/oa_pdf/cd/54/main.PMC4909825.pdf
96 (2003) 1 –9(http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/cd/54/main.PMC4909825.pdf
"72 (2006) 3968 –3974, http://dx.doi.org/10.1128/AEM.02769-05 .",Non-OADS,/arxiv_data1/oa_pdf/cd/54/main.PMC4909825.pdf
"PLoS ONE 6 (2011), e25821 http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/cd/54/main.PMC4909825.pdf
"16 (2009) 115 –129, http://dx.doi.org/10.1093/dnares/dsp003 .",Non-OADS,/arxiv_data1/oa_pdf/cd/54/main.PMC4909825.pdf
"293 (2009) 1 –10,http://dx.doi.org/10.1111/j.1574-6968.2008.",Non-OADS,/arxiv_data1/oa_pdf/cd/54/main.PMC4909825.pdf
"[13] K. Krogerus, F. Magalhães, V. Vidgren, B. Gibson, New lager yeast strains generated by interspeci ﬁ c hybridization (2015) http://dx.doi.org/10.1007/s10295-015-1597-6 .",Non-OADS,/arxiv_data1/oa_pdf/cd/54/main.PMC4909825.pdf
"15 (2015) fov005, http://dx.doi.org/10.1093/femsyr/ fov005 .",Non-OADS,/arxiv_data1/oa_pdf/cd/54/main.PMC4909825.pdf
"18 (2008) 1610 –1623, http://dx.doi.org/10.1101/gr.076075.108 .",Non-OADS,/arxiv_data1/oa_pdf/cd/54/main.PMC4909825.pdf
"75 (2009) 4573 –4579, http://dx.doi.org/10.1128/AEM.00351-09 .",Non-OADS,/arxiv_data1/oa_pdf/cd/54/main.PMC4909825.pdf
"10 (2009) 61, http://dx.doi.org/10.1186/1471- 2164-10-61 .",Non-OADS,/arxiv_data1/oa_pdf/cd/54/main.PMC4909825.pdf
"Gibson, E. Storgårds, K. Krogerus, V. Vidgren, Comparative Physiology and Fer- mentation Performance of Saaz and Frohberg Lager Yeast Strains and the Parental Species Saccharomyces eubayanus .2 0 1 32 5 5 –266, http://dx.doi.org/10.1002/yea .",OADS,/arxiv_data1/oa_pdf/cd/54/main.PMC4909825.pdf
"18 (2008) 188 –196, http://dx.doi.org/10.1101/gr.6743907 .",Non-OADS,/arxiv_data1/oa_pdf/cd/54/main.PMC4909825.pdf
"12 (2011) 491, http://dx.doi.org/10.1186/1471-2105-12-491 .",Non-OADS,/arxiv_data1/oa_pdf/cd/54/main.PMC4909825.pdf
"13 (2012) 329 –342, http://dx.doi.org/10.1038/nrg3174 .",Non-OADS,/arxiv_data1/oa_pdf/cd/54/main.PMC4909825.pdf
"7 (2011), e1001287 http://dx.doi.org/10.1371/journal.pgen.1001287 .",Non-OADS,/arxiv_data1/oa_pdf/cd/54/main.PMC4909825.pdf
"G3 (Bethesda) 4 (2014) 783 –793, http://dx.doi.org/10.1534/g3.113.010090 .",Non-OADS,/arxiv_data1/oa_pdf/cd/54/main.PMC4909825.pdf
"10 (2009) 421, http://dx.doi.org/10.1186/1471-2105-10-421 .",Non-OADS,/arxiv_data1/oa_pdf/cd/54/main.PMC4909825.pdf
"Cell 19 (2008) 1932 –1941, http://dx.doi.org/10.1091/mbc.E07 .29 P.M. De León-Medina et al.",Non-OADS,/arxiv_data1/oa_pdf/cd/54/main.PMC4909825.pdf
http://dx.doi.org/10.1016/j.mgene.2016.06.002 2214-5400/© 2016 Elsevier B.V. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/92/60/main.PMC4909826.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d9/1c/main.PMC4909827.pdf
http://dx.doi.org/10.1016/j.nicl.2016.05.015 2213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d9/1c/main.PMC4909827.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d9/1c/main.PMC4909827.pdf
"FMRIB's integrated registration and segmentation tool (FIRST) FMRIB's Integrated Registration and Segmentation Tool (abbreviat- ed as FIRST, http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/FIRST )(Patenaude, 2007; Patenaude et al., 2011 ) is a computerized and in the FMRIB's soft- ware library (FSL) implemented ( Smith et al., 2004 ) subcortical seg- mentation tool based on T1-weighted MRI scans using shape and appearance models.",OADS,/arxiv_data1/oa_pdf/d9/1c/main.PMC4909827.pdf
"All these brain images have been provided by the Cen- ter for Morphometric Analysis, Massachusetts General Hospital in Boston, USA ( http://www.cma.mgh.harvard.edu ).",OADS,/arxiv_data1/oa_pdf/d9/1c/main.PMC4909827.pdf
"For more information about the ﬁtting procedure for the mesh models including the mathematical formulas and al-gorithms the reader is referred to the relevant literature (Patenaude, 2007; Patenaude et al., 2011 )a sw e l la st ot h ew e b s i t e of the FIRST tool used for our shape analyses ( http://fsl.fmrib.ox.ac.",Non-OADS,/arxiv_data1/oa_pdf/d9/1c/main.PMC4909827.pdf
Statistical analyses Statistics were done with the randomise tool ( http://fsl.fmrib.ox.,OADS,/arxiv_data1/oa_pdf/d9/1c/main.PMC4909827.pdf
"The mesh outputs were obtained by adding the -surfaceout option to the ﬁrst_utils command, but are based on a multivariate F-statistic because those outputs use an oldvertex-wise analysis method that is no longer recommended for sta-tistical analyses (http://fsl.fmrib.ox.ac .uk/fsl/fslwiki/FIRST ), but can still be used to visualize shape differences (magnitude and direction)and has therefore be applied in the present study.",OADS,/arxiv_data1/oa_pdf/d9/1c/main.PMC4909827.pdf
"Furthermore, a volumetric analysis was performed with fslstats, specifying this command with the respective label number of thestructures of interest, which are visible on http://fsl.fmrib.ox.ac.uk/ fsl/fslwiki/FIRST/UserGuide .",OADS,/arxiv_data1/oa_pdf/d9/1c/main.PMC4909827.pdf
"Thereafter, the values obtained from fslstats (overall volume of each subcortical structure) were exported to IBM SPSS Statistics (version 22.0, http://www-01.ibm.com/ software/analytics/spss/ ) and independent-samples two-tailed t- tests have been applied.",OADS,/arxiv_data1/oa_pdf/d9/1c/main.PMC4909827.pdf
Left panel adapted with permission from http://www.scholarpedia.org/article/Models_of_thalamocortical_ system .,Non-OADS,/arxiv_data1/oa_pdf/d9/1c/main.PMC4909827.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Exosome lncRNA Prostate cancer Speci ﬁcations Organism/cell line/tissueHomo sapiens/prostate cancer cell lines: LNCaP, PC3, DU145, VCaP/healthy prostate cell lines: PNT2 Sex MaleSequencer or array typeAgilent Oligo nucleotide array Data format Raw text ﬁles Experimental factorsTumor vs normal cell line Experimental featuresExtraction of total RNA from exosomes of prostate cancer and healthy cell lines, followed by lncRNA pro ﬁling using the Human lncRNA array v2.0 (8 × 60 K, Arraystar) Consent NA Sample source locationSydney, Australia 1.",Non-OADS,/arxiv_data1/oa_pdf/fa/7d/main.PMC4909828.pdf
Direct link to deposited data [http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE81034 ].2.,OADS,/arxiv_data1/oa_pdf/fa/7d/main.PMC4909828.pdf
http://dx.doi.org/10.1016/j.gdata.2016.05.010 2213-5960/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/fa/7d/main.PMC4909828.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fa/7d/main.PMC4909828.pdf
"However, despite 14 days of continuous administration of ﬁlgrastim, the ANC failed to Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor http://dx.doi.org/10.1016/j.gore.2016.05.013 2352-5789/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/f7/a1/main.PMC4909829.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f7/a1/main.PMC4909829.pdf
http://dx.doi.org/10.1016/j.pcl.2012.,OADS,/arxiv_data1/oa_pdf/f7/a1/main.PMC4909829.pdf
Hematology 127 –131http://dx.doi.org/10.1182/asheducation-2009.1.127 .,Non-OADS,/arxiv_data1/oa_pdf/f7/a1/main.PMC4909829.pdf
"J Blood Med 5, 69 –86.http://dx.doi.org/10.2147/JBM.S46255 .",Non-OADS,/arxiv_data1/oa_pdf/f7/a1/main.PMC4909829.pdf
http://dx.doi.org/10.1002/pbc.21039 .,Non-OADS,/arxiv_data1/oa_pdf/f7/a1/main.PMC4909829.pdf
http://dx.doi.org/ 10.3109/10428194.2010.551153 .,Non-OADS,/arxiv_data1/oa_pdf/f7/a1/main.PMC4909829.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f7/a1/main.PMC4909829.pdf
http://dx.doi.org/ 10.1309/AJCP4ZDKJ4ICOUAT (June).,OADS,/arxiv_data1/oa_pdf/f7/a1/main.PMC4909829.pdf
"68 (1), 35 –37.http://dx.doi.org/10.1006/gyno.1997.4897 .",Non-OADS,/arxiv_data1/oa_pdf/f7/a1/main.PMC4909829.pdf
"Blood 118 (17), 4577. http://dx.doi.org/10.1182/blood-2011-06-356261 .",Non-OADS,/arxiv_data1/oa_pdf/f7/a1/main.PMC4909829.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/f7/a1/main.PMC4909829.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/04/main.PMC4909831.pdf
E-mail address: hgomi-oky@umin.org (H. Gomi).Contents lists available at ScienceDirect IDCases journal homepage: www.elsevier.com/locate/idcr http://dx.doi.org/10.1016/j.idcr.2016.05.001 2214-2509/ /C2232016 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/6c/04/main.PMC4909831.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/6c/04/main.PMC4909831.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/99/7d/main.PMC4909834.pdf
http://dx.doi.org/10.1016/j.ejro.2016.05.004 2352-0477/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/99/7d/main.PMC4909834.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/ 4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/99/7d/main.PMC4909834.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: DevelopmentDifferential gene expressionEmbryo Microarray PigPCR sex typing Speci ﬁcations Organism/cell line/tissueDay 9 and day 30 embryos from primiparous sows exposed to differing intermittent suckling and breeding strategies Sex Male and female embryos Sequencer or array typeAgilent custom made array-031068, EMPV1 (GPL17779) Data format Raw data in gpr ﬁles and LOWESS normalized log2 ratio Experimental factorsUsing without or with C28 as a reference group when comparing IS21FE versus IS21SE from pre-sexed day 9 or day30 embryos respectively(continued ) Speci ﬁcations Experimental featuresTranscriptome response of day 9 and day 30 female and male embryos to two different maternal breeding strategies IS21FE and IS21SE Consent N/ASample source locationEdmonton/Alberta/Canada 1.",Non-OADS,/arxiv_data1/oa_pdf/86/e8/main.PMC4909839.pdf
Direct link to deposited data http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE53576 .Genomics Data 9 (2016) 30 –34 ⁎Corresponding author.,OADS,/arxiv_data1/oa_pdf/86/e8/main.PMC4909839.pdf
http://dx.doi.org/10.1016/j.gdata.2016.06.001 2213-5960/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/86/e8/main.PMC4909839.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/86/e8/main.PMC4909839.pdf
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE73020 SeeFig.,OADS,/arxiv_data1/oa_pdf/86/e8/main.PMC4909839.pdf
"Microarray analyses Microarray data analyses were performed using FlexArray software version 1.6.3 ( http://genomequebec.mcgill.ca/FlexArray ) for data nor- malization methods using simple background subtraction, LOWESS nor- malization within and between arrays ( Fig.",OADS,/arxiv_data1/oa_pdf/86/e8/main.PMC4909839.pdf
Gene annotation Gene annotation was performed using probe sequences from NCBI BLAST program http://blast.ncbi.nlm.nih.gov/Blast.cgi?PAGE_TYPE= BlastSearch&BLAST_SPEC=OGP__9823__10718 by selecting two differ- ent pig nucleotide databases: Annotated RNAs (Annotation Release 105) or Genome (Sscrofa10.2 reference Annotation Release 105) to maximize the search with positive hits.,OADS,/arxiv_data1/oa_pdf/86/e8/main.PMC4909839.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cb/dc/main.PMC4909840.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cb/dc/main.PMC4909840.pdf
http://dx.doi.org/10.1016/j.shaw.2015.11.002Safety and Health at Work 7 (2016) 97 e101,Non-OADS,/arxiv_data1/oa_pdf/cb/dc/main.PMC4909840.pdf
Available from: http://security-today.com/articles/2009/03/09/asis-workplace-violence.,Non-OADS,/arxiv_data1/oa_pdf/cb/dc/main.PMC4909840.pdf
Available from:http://www.bls.gov/iif/oshwc/osch0033.pdf .,Non-OADS,/arxiv_data1/oa_pdf/cb/dc/main.PMC4909840.pdf
Available from: http://www.g4s.us/w/media/Files/USA/PDF-Articles/Hospitals%20and%20Healthcare/Council_ Healthcare_WorkplaceViolence.ashx .,Non-OADS,/arxiv_data1/oa_pdf/cb/dc/main.PMC4909840.pdf
Available from: https://www.osha.gov/SLTC/workplaceviolence/ .,Non-OADS,/arxiv_data1/oa_pdf/cb/dc/main.PMC4909840.pdf
Available from: http://www.bjs.,Non-OADS,/arxiv_data1/oa_pdf/cb/dc/main.PMC4909840.pdf
Available from: https://www.ncci.com/pages/default.aspx .,Non-OADS,/arxiv_data1/oa_pdf/cb/dc/main.PMC4909840.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/17/79/main.PMC4909841.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/17/79/main.PMC4909841.pdf
http://dx.doi.org/10.1016/j.shaw.2015.10.002Safety and Health at Work 7 (2016) 120 e123,Non-OADS,/arxiv_data1/oa_pdf/17/79/main.PMC4909841.pdf
Available from: http://www.nswo.nl/user ﬁles/ﬁles/AASM%20-%20Manual% 20for%20the%20Scoring%20ofSleep%20and%20Associted%20Events%20-% 2005-2007_2.pdf .,Non-OADS,/arxiv_data1/oa_pdf/17/79/main.PMC4909841.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c7/25/main.PMC4909842.pdf
2 ) revealed extensive dermal necrosis with aContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/mmcrMedical Mycology Case Reports http://dx.doi.org/10.1016/j.mmcr.2014.11.003 2211-7539/ &2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c7/25/main.PMC4909842.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c7/25/main.PMC4909842.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/80/fd/main.PMC4909843.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/80/fd/main.PMC4909843.pdf
http://dx.doi.org/10.1016/j.shaw.2015.11.008Safety and Health at Work 7 (2016) 138 e142,Non-OADS,/arxiv_data1/oa_pdf/80/fd/main.PMC4909843.pdf
Available from: http://kostat.go.kr/e_book/kssc/KSIC08/ EBook.htm .,Non-OADS,/arxiv_data1/oa_pdf/80/fd/main.PMC4909843.pdf
Available from: http://kostat.go.kr/e_book/kssc/ KSCO07/EBook.htm .,Non-OADS,/arxiv_data1/oa_pdf/80/fd/main.PMC4909843.pdf
Available from: http://kosis.kr/ [in Korean].,Non-OADS,/arxiv_data1/oa_pdf/80/fd/main.PMC4909843.pdf
Available from: http://www.hse.gov.uk/pubns/waste27.,OADS,/arxiv_data1/oa_pdf/80/fd/main.PMC4909843.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/33/47/main.PMC4909844.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/33/47/main.PMC4909844.pdf
http://dx.doi.org/10.1016/j.shaw.2015.10.001Safety and Health at Work 7 (2016) 166 e170,Non-OADS,/arxiv_data1/oa_pdf/33/47/main.PMC4909844.pdf
Available from: https://www.osha.gov/SLTC/ emergencypreparedness/gettingstarted.html#business .,OADS,/arxiv_data1/oa_pdf/33/47/main.PMC4909844.pdf
Available from: http://www.fritzinstitute.org/ pdfs/whitepaper/disasterpreparedness-concepts.pdf .,Non-OADS,/arxiv_data1/oa_pdf/33/47/main.PMC4909844.pdf
Available from: https://www.osha.gov/ OshDoc/data_General_Facts/factsheet-workplaceevergencies.pdf .,OADS,/arxiv_data1/oa_pdf/33/47/main.PMC4909844.pdf
Available from: https://www.onepetro.org/ journal-paper/ASSE-13-09-50 .L.A.,Non-OADS,/arxiv_data1/oa_pdf/33/47/main.PMC4909844.pdf
Available from: https://www.marcomltd.com/ .Saf Health Work 2016;7:166 e170 170,Non-OADS,/arxiv_data1/oa_pdf/33/47/main.PMC4909844.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fd/37/main.PMC4909845.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fd/37/main.PMC4909845.pdf
http://dx.doi.org/10.1016/j.shaw.2015.11.007Safety and Health at Work 7 (2016) 111 e119,Non-OADS,/arxiv_data1/oa_pdf/fd/37/main.PMC4909845.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/80/24/main.PMC4909846.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/80/24/main.PMC4909846.pdf
http://dx.doi.org/10.1016/j.shaw.2015.11.004Safety and Health at Work 7 (2016) 130 e137,Non-OADS,/arxiv_data1/oa_pdf/80/24/main.PMC4909846.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/41/a3/main.PMC4909847.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/41/a3/main.PMC4909847.pdf
http://dx.doi.org/10.1016/j.shaw.2016.02.005Safety and Health at Work 7 (2016) 161 e165,Non-OADS,/arxiv_data1/oa_pdf/41/a3/main.PMC4909847.pdf
Available from: http://kosis.kr/ statHtml/statHtml.do?orgId=101&tblId=DT_2KAA308_OECD .,OADS,/arxiv_data1/oa_pdf/41/a3/main.PMC4909847.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/17/84/main.PMC4909848.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/17/84/main.PMC4909848.pdf
http://dx.doi.org/10.1016/j.shaw.2015.11.001Safety and Health at Work 7 (2016) 156 e160,Non-OADS,/arxiv_data1/oa_pdf/17/84/main.PMC4909848.pdf
Available from: http://www.epa.gov/oppfead/annual/2002/ 2022 .,OADS,/arxiv_data1/oa_pdf/17/84/main.PMC4909848.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/81/12/main.PMC4909849.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/81/12/main.PMC4909849.pdf
http://dx.doi.org/10.1016/j.shaw.2015.12.004Safety and Health at Work 7 (2016) 143 e149,Non-OADS,/arxiv_data1/oa_pdf/81/12/main.PMC4909849.pdf
Available from: http://www.who.int/occupational_health/5_keys_EN_web.pdf?ua=1.,OADS,/arxiv_data1/oa_pdf/81/12/main.PMC4909849.pdf
Available from: http://www.ttl.,Non-OADS,/arxiv_data1/oa_pdf/81/12/main.PMC4909849.pdf
Available from: http://www.ttl.,Non-OADS,/arxiv_data1/oa_pdf/81/12/main.PMC4909849.pdf
Available from: https://www.som.org.uk/ ﬁleadmin/user_upload/Of ﬁce/docs/Planning_the_ Future-OH_and_its_Workforce-April_2014.pdf .,Non-OADS,/arxiv_data1/oa_pdf/81/12/main.PMC4909849.pdf
Available from: http://www.ilo.org/dyn/normlex/en/f?,Non-OADS,/arxiv_data1/oa_pdf/81/12/main.PMC4909849.pdf
Available from: http://who.int/about/de ﬁnition/en/print.,Non-OADS,/arxiv_data1/oa_pdf/81/12/main.PMC4909849.pdf
Available from: http://www.who.int/ occupational_health/regions/en/oeheurworkplaceprotect.pdf .,OADS,/arxiv_data1/oa_pdf/81/12/main.PMC4909849.pdf
Available from: http://www.who.int/occupational_health/5_keys_EN_web.pdf?ua ¼1.,OADS,/arxiv_data1/oa_pdf/81/12/main.PMC4909849.pdf
2009 [cited 2015 Apr 1].Available from: http://webarchive.nationalarchives.gov.uk/20090609003228/ http://www.berr.gov.uk/ ﬁles/ﬁle52215.pdf .,OADS,/arxiv_data1/oa_pdf/81/12/main.PMC4909849.pdf
Available from: http://www.oecd.org/employment/ emp/42699911.pdf .,Non-OADS,/arxiv_data1/oa_pdf/81/12/main.PMC4909849.pdf
2011 [cited 2015 Feb 25].Available from: https://www.gov.uk/government/uploads/system/uploads/ attachment_data/ ﬁle/181060/health-at-work.pdf .,Non-OADS,/arxiv_data1/oa_pdf/81/12/main.PMC4909849.pdf
Available from: https://www.gov.uk/government/ uploads/system/uploads/attachment_data/ ﬁle/181060/health-at-work.pdf .,Non-OADS,/arxiv_data1/oa_pdf/81/12/main.PMC4909849.pdf
Available from: http://en.wikipedia.org/wiki/Aging_in_the_American_ workforce .,Non-OADS,/arxiv_data1/oa_pdf/81/12/main.PMC4909849.pdf
Available from: http://www.who.int/occupational_health/ healthy_workplaces/en/ .,OADS,/arxiv_data1/oa_pdf/81/12/main.PMC4909849.pdf
Available from: http://www.who.int/occupational_ health/WHO_health_assembly_en_web.pdf?ua ¼1.,OADS,/arxiv_data1/oa_pdf/81/12/main.PMC4909849.pdf
Available from: http://www.who.int/healthinfo/ global_burden_disease/GlobalHealthRisks_report_Front.pdf?ua ¼1.,Non-OADS,/arxiv_data1/oa_pdf/81/12/main.PMC4909849.pdf
Available from: http://www.who.int/ mental_health/media/en/712.pdf .,Non-OADS,/arxiv_data1/oa_pdf/81/12/main.PMC4909849.pdf
Available from: http://www.ilo.org/wcmsp5/groups/public/ —ed_ protect/ —protrav/ —safework/documents/ presentation/wcms_207663.pdf .,Non-OADS,/arxiv_data1/oa_pdf/81/12/main.PMC4909849.pdf
Available from: http://www.who.int/occupational_health/ publications/launch_hwp_22april.pdf .,Non-OADS,/arxiv_data1/oa_pdf/81/12/main.PMC4909849.pdf
Avail- able from: http://www.who.int/publications/almaata_declaration_en.pdf .,Non-OADS,/arxiv_data1/oa_pdf/81/12/main.PMC4909849.pdf
Available from: http://www.ttl.,Non-OADS,/arxiv_data1/oa_pdf/81/12/main.PMC4909849.pdf
Available from: http://www.who.int/occupational_health/publications/globstrategy/en/ index6.html .,OADS,/arxiv_data1/oa_pdf/81/12/main.PMC4909849.pdf
Available from: http://www.ttl.,Non-OADS,/arxiv_data1/oa_pdf/81/12/main.PMC4909849.pdf
Available from: http://www.bitc.org.uk/programmes/wellbeing/workwell- model .,Non-OADS,/arxiv_data1/oa_pdf/81/12/main.PMC4909849.pdf
Available from: https://www.som.org.uk/ ﬁleadmin/user_upload/Of ﬁce/docs/Planning_the_ Future-OH_and_its_Workforce-April_2014.pdf .,Non-OADS,/arxiv_data1/oa_pdf/81/12/main.PMC4909849.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ed/69/main.PMC4909850.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ed/69/main.PMC4909850.pdf
http://dx.doi.org/10.1016/j.shaw.2015.11.003Safety and Health at Work 7 (2016) 124 e129,Non-OADS,/arxiv_data1/oa_pdf/ed/69/main.PMC4909850.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/35/2e/main.PMC4909851.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/35/2e/main.PMC4909851.pdf
http://dx.doi.org/10.1016/j.shaw.2015.12.003Safety and Health at Work 7 (2016) 150 e155,Non-OADS,/arxiv_data1/oa_pdf/35/2e/main.PMC4909851.pdf
Available from: http://www.cdc.gov/niosh/docs/2003-154/method-e.html .,OADS,/arxiv_data1/oa_pdf/35/2e/main.PMC4909851.pdf
Available from:http://www.cdc.gov/niosh/nioshtic-2/20000031.html .,OADS,/arxiv_data1/oa_pdf/35/2e/main.PMC4909851.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3b/2a/main.PMC4909852.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3b/2a/main.PMC4909852.pdf
http://dx.doi.org/10.1016/j.shaw.2016.02.001Safety and Health at Work 7 (2016) 171 e174,Non-OADS,/arxiv_data1/oa_pdf/3b/2a/main.PMC4909852.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/39/a5/main.PMC4909853.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/39/a5/main.PMC4909853.pdf
http://dx.doi.org/10.1016/j.shaw.2015.11.006Safety and Health at Work 7 (2016) 102 e110,Non-OADS,/arxiv_data1/oa_pdf/39/a5/main.PMC4909853.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/20/a3/main.PMC4909854.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/20/a3/main.PMC4909854.pdf
http://dx.doi.org/10.1016/j.shaw.2016.02.002Safety and Health at Work 7 (2016) 89 e96,Non-OADS,/arxiv_data1/oa_pdf/20/a3/main.PMC4909854.pdf
Available from: http://www.ilocarib.org.tt/portal/index.php?,Non-OADS,/arxiv_data1/oa_pdf/20/a3/main.PMC4909854.pdf
Available from: http://www.who.int/occupational_health/ publications/launch_hwp_22april.pdf .,Non-OADS,/arxiv_data1/oa_pdf/20/a3/main.PMC4909854.pdf
Available from: http://www.who.int/occupational_health/ publications/globstrategy/en/index6.html .,OADS,/arxiv_data1/oa_pdf/20/a3/main.PMC4909854.pdf
Available from: http://www-pub.iaea.org/mtcd/ publications/pdf/pub1253_web.pdf .,Non-OADS,/arxiv_data1/oa_pdf/20/a3/main.PMC4909854.pdf
Available from: http://www.new-paradigm.co.uk/culture-complex.htm .,Non-OADS,/arxiv_data1/oa_pdf/20/a3/main.PMC4909854.pdf
Available from:https://www.marxists.org/reference/archive/mao/selected-works/volume-5/ mswv5_59.htm .,Non-OADS,/arxiv_data1/oa_pdf/20/a3/main.PMC4909854.pdf
Available from: http://www.law.go.kr/DRF/MDRFLawService.jsp?OC ¼molab& ID¼7363 .,Non-OADS,/arxiv_data1/oa_pdf/20/a3/main.PMC4909854.pdf
Available from: http://www.ttl.,Non-OADS,/arxiv_data1/oa_pdf/20/a3/main.PMC4909854.pdf
Available from: http://blogs.cdc.gov/niosh-science-blog/2012/07/19/ agingworkforce/ .,Non-OADS,/arxiv_data1/oa_pdf/20/a3/main.PMC4909854.pdf
Available from: http://ec.europa.eu/social/BlobServlet?,Non-OADS,/arxiv_data1/oa_pdf/20/a3/main.PMC4909854.pdf
Available from: http://www.keia.org/sites/default/ ﬁles/publications/04Exchange09.pdf .,Non-OADS,/arxiv_data1/oa_pdf/20/a3/main.PMC4909854.pdf
Available from: http://www.who.int/mental_health/ media/en/712.pdf .,Non-OADS,/arxiv_data1/oa_pdf/20/a3/main.PMC4909854.pdf
Available from: http://www.kosha.or.kr/board.do?menuId ¼554.,Non-OADS,/arxiv_data1/oa_pdf/20/a3/main.PMC4909854.pdf
Available from: http://www.ilo.org/dyn/normlex/en/f?p ¼NORMLEXPUB: 12100:0::NO::P12100_ILO_CODE: C187 .,OADS,/arxiv_data1/oa_pdf/20/a3/main.PMC4909854.pdf
Available from: http://www.ilo.org/wcmsp5/groups/ public/@ed_protect/@protrav/@safework/documents/normativeinstrument/ wcms_107727.pdf .,Non-OADS,/arxiv_data1/oa_pdf/20/a3/main.PMC4909854.pdf
Available from: http://www.seouldeclaration.org .,Non-OADS,/arxiv_data1/oa_pdf/20/a3/main.PMC4909854.pdf
Available from: http://www.iali-aiit.org/ resources/istanbul-declaration.pdf .,Non-OADS,/arxiv_data1/oa_pdf/20/a3/main.PMC4909854.pdf
Available from: http://www.issa.int/ topics/occupational-risks/issa-publications .,Non-OADS,/arxiv_data1/oa_pdf/20/a3/main.PMC4909854.pdf
Available from: http://eur-lex.europa.eu/legal-content/EN/TXT/?uri ¼CELEX%3A52014 DC0332 .,Non-OADS,/arxiv_data1/oa_pdf/20/a3/main.PMC4909854.pdf
"Clinical  details and findings at urine sediment examination are summarised in Tables 1 and 2 respectively.Case Report DOI: http://dx.doi.org/10.4314/ovj.v6i2.3 Submitted: 26/01/2016 Accepted: 19/05/2016 Published: 13/06/201 6 Urinary capillariosis in six dogs from Italy A. Mariacher1,2,*, F. Millanta2, G. Guidi2 and S. Perrucci2 1Istituto Zooprofilattico Sperimentale delle Regioni Lazio e Toscana, Viale Europa 30, 58100 Grosseto, Italy  2Dipartimento di Scienze Veterinarie, Viale delle Piagge 2, 56124 Pisa, Italy Abstract Canine urinary capillariosis is caused by the nematode Pearsonema plica.",Non-OADS,/arxiv_data1/oa_pdf/1e/16/OVJ-6-84.PMC4909855.pdf
85http://www.openveterinaryjournal.com A. Mariacher et al.,OADS,/arxiv_data1/oa_pdf/1e/16/OVJ-6-84.PMC4909855.pdf
86http://www.openveterinaryjournal.com A. Mariacher et al.,OADS,/arxiv_data1/oa_pdf/1e/16/OVJ-6-84.PMC4909855.pdf
87http://www.openveterinaryjournal.com A. Mariacher et al.,OADS,/arxiv_data1/oa_pdf/1e/16/OVJ-6-84.PMC4909855.pdf
88http://www.openveterinaryjournal.com A. Mariacher et al.,OADS,/arxiv_data1/oa_pdf/1e/16/OVJ-6-84.PMC4909855.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/98/8e/main.PMC4909862.pdf
1 a) showed a well-de ﬁnedContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/mmcrMedical Mycology Case Reports http://dx.doi.org/10.1016/j.mmcr.2015.01.002 2211-7539/ &2015 Published by Elsevier B.V. on behalf of International Society for Human and Animal Mycology.,Non-OADS,/arxiv_data1/oa_pdf/98/8e/main.PMC4909862.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/98/8e/main.PMC4909862.pdf
Supplementary material Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.mmcr.2015.01.002 .,Non-OADS,/arxiv_data1/oa_pdf/98/8e/main.PMC4909862.pdf
Crown Copyright &2014 Published by Elsevier B.V. on behalf of International Society for Human and Animal Mycology This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/af/27/main.PMC4909863.pdf
TheContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/mmcrMedical Mycology Case Reports http://dx.doi.org/10.1016/j.mmcr.2014.12.003 2211-7539/Crown Copyright &2014 Published by Elsevier B.V. on behalf of International Society for Human and Animal Mycology This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/af/27/main.PMC4909863.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )4 4,Non-OADS,/arxiv_data1/oa_pdf/07/62/main.PMC4909864.pdf
http://dx.doi.org/10.1016/j.mmcr.2012.08.001nCorresponding author.,OADS,/arxiv_data1/oa_pdf/6f/27/main.PMC4909865.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )4 4,Non-OADS,/arxiv_data1/oa_pdf/76/e6/main.PMC4909866.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )4 4,Non-OADS,/arxiv_data1/oa_pdf/a8/9f/main.PMC4909867.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )4 4,Non-OADS,/arxiv_data1/oa_pdf/e9/73/main.PMC4909868.pdf
http://www.ehealthme.com/ds/clozapine/febrile+neutropenia.,Non-OADS,/arxiv_data1/oa_pdf/e9/73/main.PMC4909868.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f9/07/main.PMC4909869.pdf
Pleural ﬂuid and blood cultures wereContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/mmcrMedical Mycology Case Reports http://dx.doi.org/10.1016/j.mmcr.2014.11.001 2211-7539/ &2014 Published by Elsevier B.V. on behalf of International Society for Human and Animal Mycology.,Non-OADS,/arxiv_data1/oa_pdf/f9/07/main.PMC4909869.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f9/07/main.PMC4909869.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )4 4,Non-OADS,/arxiv_data1/oa_pdf/98/bf/main.PMC4909870.pdf
NEDOCS values were calculated on the basis of our hospital  standard emergency bed number of 42 and a total hospi-tal bed number of 925 on the http://www.nedocs.org/ web site.,OADS,/arxiv_data1/oa_pdf/98/bf/main.PMC4909870.pdf
Access to: http://www.acep.org/content.aspx?id=29156.,Non-OADS,/arxiv_data1/oa_pdf/98/bf/main.PMC4909870.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )4 4,Non-OADS,/arxiv_data1/oa_pdf/f1/46/main.PMC4909871.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )4 4,Non-OADS,/arxiv_data1/oa_pdf/4e/1e/main.PMC4909872.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )4 4,Non-OADS,/arxiv_data1/oa_pdf/bb/53/main.PMC4909873.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )4 4,Non-OADS,/arxiv_data1/oa_pdf/83/d6/main.PMC4909874.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )4 4,Non-OADS,/arxiv_data1/oa_pdf/d9/23/main.PMC4909875.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )4 4,Non-OADS,/arxiv_data1/oa_pdf/e3/2d/main.PMC4909876.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )4 4,Non-OADS,/arxiv_data1/oa_pdf/ec/5e/main.PMC4909877.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/89/f8/main.PMC4909878.pdf
CFS samplesContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/mmcrMedical Mycology Case Reports http://dx.doi.org/10.1016/j.mmcr.2014.11.002 2211-7539/ &2014 The Authors.,OADS,/arxiv_data1/oa_pdf/89/f8/main.PMC4909878.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).☆This work was presented at the 9th Conference on Cryptococcus and Crypto- coccosis, Amsterdam, The Netherlands, May 2014. nCorresponding author.",Non-OADS,/arxiv_data1/oa_pdf/89/f8/main.PMC4909878.pdf
http://dx.doi.org/10.1371/jour- nal.ppat.1002936 .,Non-OADS,/arxiv_data1/oa_pdf/89/f8/main.PMC4909878.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )4 4,Non-OADS,/arxiv_data1/oa_pdf/16/52/main.PMC4909879.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )4 4,Non-OADS,/arxiv_data1/oa_pdf/77/6d/main.PMC4909880.pdf
This is an open access article under the CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/05/27/main.PMC4909881.pdf
Bronchoscopy revealed slight bleeding from left B 1þ2Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/mmcrMedical Mycology Case Reports http://dx.doi.org/10.1016/j.mmcr.2014.12.001 2211-7539/ &2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/05/27/main.PMC4909881.pdf
This is an open access article under the CC BY-NC-SA l icense (http://creativecommons.org/licenses/by-nc-sa/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/05/27/main.PMC4909881.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )4 4,Non-OADS,/arxiv_data1/oa_pdf/13/3b/main.PMC4909882.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )4 4,Non-OADS,/arxiv_data1/oa_pdf/41/51/main.PMC4909883.pdf
Available in: http://www.bsped.org.uk/clinical/docs/DKAManage -mentOfDKAinAdultsMarch20101.pdf.,Non-OADS,/arxiv_data1/oa_pdf/41/51/main.PMC4909883.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )4 4,Non-OADS,/arxiv_data1/oa_pdf/ee/ec/main.PMC4909884.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )4 4,Non-OADS,/arxiv_data1/oa_pdf/62/a7/main.PMC4909885.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )4 4,Non-OADS,/arxiv_data1/oa_pdf/a7/da/main.PMC4909887.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )4 4,Non-OADS,/arxiv_data1/oa_pdf/83/9c/main.PMC4909888.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )4 4,Non-OADS,/arxiv_data1/oa_pdf/ea/e9/main.PMC4909889.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )4 4,Non-OADS,/arxiv_data1/oa_pdf/0b/81/main.PMC4909890.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )4 4,Non-OADS,/arxiv_data1/oa_pdf/f9/81/main.PMC4909891.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )4 4,Non-OADS,/arxiv_data1/oa_pdf/41/c8/main.PMC4909907.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )4 4,Non-OADS,/arxiv_data1/oa_pdf/40/7c/main.PMC4909932.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ),Non-OADS,/arxiv_data1/oa_pdf/db/5d/main.PMC4909933.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )4 4,Non-OADS,/arxiv_data1/oa_pdf/6a/e6/main.PMC4909934.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )4 4,Non-OADS,/arxiv_data1/oa_pdf/76/26/main.PMC4909935.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ),Non-OADS,/arxiv_data1/oa_pdf/14/b2/main.PMC4909939.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ),Non-OADS,/arxiv_data1/oa_pdf/8a/97/main.PMC4909940.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )4 4,Non-OADS,/arxiv_data1/oa_pdf/e3/f0/main.PMC4909941.pdf
CrossRef 12. http://www.saglik.gov.tr/TR/dosya/1-86291/h/sh3.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e3/f0/main.PMC4909941.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ),Non-OADS,/arxiv_data1/oa_pdf/f1/a3/main.PMC4909942.pdf
Data were collected via browsing internet database of  the National Thesis Center (Council of Higher Education) (https://tez.yok.gov.tr/UlusalTezMerkezi/tarama.jsp).,OADS,/arxiv_data1/oa_pdf/f1/a3/main.PMC4909942.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )4 4,Non-OADS,/arxiv_data1/oa_pdf/02/19/main.PMC4909943.pdf
CrossRef 13. http://www.indianexpress.com/news/assam-poisonous-mushrooms-kill-17/292815.,Non-OADS,/arxiv_data1/oa_pdf/02/19/main.PMC4909943.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )4 4,Non-OADS,/arxiv_data1/oa_pdf/d8/92/main.PMC4909944.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ),Non-OADS,/arxiv_data1/oa_pdf/2f/17/main.PMC4909945.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )4 4,Non-OADS,/arxiv_data1/oa_pdf/24/c0/main.PMC4909946.pdf
"Available at: http://www.uptodate.com Accessed October 5, 2013.",Non-OADS,/arxiv_data1/oa_pdf/24/c0/main.PMC4909946.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )4 4,Non-OADS,/arxiv_data1/oa_pdf/14/ab/main.PMC4909948.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )4 4,Non-OADS,/arxiv_data1/oa_pdf/e5/53/main.PMC4909949.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ),Non-OADS,/arxiv_data1/oa_pdf/ab/57/main.PMC4909950.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )4 4,Non-OADS,/arxiv_data1/oa_pdf/08/72/main.PMC4909954.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )4 4,Non-OADS,/arxiv_data1/oa_pdf/4c/f2/main.PMC4909955.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )4 4,Non-OADS,/arxiv_data1/oa_pdf/69/84/main.PMC4909956.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )4 4,Non-OADS,/arxiv_data1/oa_pdf/4b/7c/main.PMC4909957.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ),Non-OADS,/arxiv_data1/oa_pdf/dc/07/main.PMC4909958.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )4 4,Non-OADS,/arxiv_data1/oa_pdf/15/cf/main.PMC4909959.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )4 4,Non-OADS,/arxiv_data1/oa_pdf/7c/4b/main.PMC4909960.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )4 4,Non-OADS,/arxiv_data1/oa_pdf/2c/5c/main.PMC4909961.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ),Non-OADS,/arxiv_data1/oa_pdf/6b/e2/main.PMC4909962.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ),Non-OADS,/arxiv_data1/oa_pdf/f1/b8/main.PMC4909963.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )4 4,Non-OADS,/arxiv_data1/oa_pdf/e1/e6/main.PMC4909964.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ),Non-OADS,/arxiv_data1/oa_pdf/15/e2/main.PMC4909965.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ),Non-OADS,/arxiv_data1/oa_pdf/ff/46/main.PMC4909966.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )4 4,Non-OADS,/arxiv_data1/oa_pdf/79/4c/main.PMC4909967.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )4 4,Non-OADS,/arxiv_data1/oa_pdf/1a/bd/main.PMC4909968.pdf
"Conflict of Interest The authors declare that there is no potential conflicts of in- terest.References 1. http://www.uptodate.com/contents/therapeutic-use-of- warfarin-and-other-vitamin-k-antagonists, last access: De - cember 18, 2013.",Non-OADS,/arxiv_data1/oa_pdf/1a/bd/main.PMC4909968.pdf
"8.  http://www.uptodate.com/contents/antithrombotic-thera-py-in-patients-with-prosthetic-heart-valves, last access: De - cember 12, 2013.",Non-OADS,/arxiv_data1/oa_pdf/1a/bd/main.PMC4909968.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )4 4,Non-OADS,/arxiv_data1/oa_pdf/1a/0c/main.PMC4909969.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ),Non-OADS,/arxiv_data1/oa_pdf/27/14/main.PMC4909970.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )4 4,Non-OADS,/arxiv_data1/oa_pdf/31/66/main.PMC4909971.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ),Non-OADS,/arxiv_data1/oa_pdf/77/ac/main.PMC4909982.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ),Non-OADS,/arxiv_data1/oa_pdf/0d/6d/main.PMC4909983.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ),Non-OADS,/arxiv_data1/oa_pdf/f6/a9/main.PMC4910006.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ),Non-OADS,/arxiv_data1/oa_pdf/b8/94/main.PMC4910007.pdf
"September 30,2014 at http://www.who.int/mediacentre/ factsheets/fs099/en/ 8.",Non-OADS,/arxiv_data1/oa_pdf/b8/94/main.PMC4910007.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ),Non-OADS,/arxiv_data1/oa_pdf/34/d2/main.PMC4910008.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ),Non-OADS,/arxiv_data1/oa_pdf/97/e4/main.PMC4910009.pdf
A v  ailable from: http://www.gold - copd.org/ 4.,Non-OADS,/arxiv_data1/oa_pdf/97/e4/main.PMC4910009.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ),Non-OADS,/arxiv_data1/oa_pdf/08/89/main.PMC4910010.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ),Non-OADS,/arxiv_data1/oa_pdf/8e/a5/main.PMC4910011.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ),Non-OADS,/arxiv_data1/oa_pdf/02/13/main.PMC4910012.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ),Non-OADS,/arxiv_data1/oa_pdf/af/80/main.PMC4910013.pdf
Statistical AnalysisKappa statistics on https://www.statstodo.com were used to  evaluate the inter-observer agreement.,OADS,/arxiv_data1/oa_pdf/af/80/main.PMC4910013.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ),Non-OADS,/arxiv_data1/oa_pdf/39/c1/main.PMC4910014.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ),Non-OADS,/arxiv_data1/oa_pdf/86/17/main.PMC4910024.pdf
"J Rural Med 2016; 11(1): 7–10 ©2016 The Japanese Association of Rural MedicineReceived: November 4, 2015, Accepted: January 8, 2016 Correspondence: Chika Kusano, Department of Gastroenterology & Hepatology, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku- ku, Tokyo 160-8402, Japan E-mail: cksuano2007@yahoo.co.jp This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.",Non-OADS,/arxiv_data1/oa_pdf/e6/a7/jrm-11-007.PMC4910026.pdf
2012. http://www.jpn-geriat-soc.or.jp/info/topics/pdf/jgs_ahn_gl_2012.pdf (in Japanese).,OADS,/arxiv_data1/oa_pdf/e6/a7/jrm-11-007.PMC4910026.pdf
"Consequently, we have worked independently to create an active in-bed leg exercise apparatus, which we have labeled the Leg Exercise Appa - ratus (LEX), in order to enhance the blood flow-increasing J Rural Med 2016; 11(1): 11–16 ©2016 The Japanese Association of Rural MedicineReceived: December 7, 2015, Accepted: January 22, 2016 Correspondence: Hiroshi Kamada, Department of Orthopaedic Sur - gery, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsu- kuba city, Ibaraki 305-8575, Japan E-mail: hkamada@tsukuba-seikei.jp This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.",Non-OADS,/arxiv_data1/oa_pdf/2e/a6/jrm-11-011.PMC4910027.pdf
"The Integrated Community Care Sys - tem aims to support residents so that they can live as in -J Rural Med 2016; 11(1): 17–24 ©2016 The Japanese Association of Rural MedicineReceived: September 24, 2015, Accepted: February 23, 2016 Correspondence: Masako Fukasawa, Gunma University Graduate School of Health Sciences, 3-39-15 Showa-machi, Maebashi, Gunma  371-8514, Japan E-mail: masakof@gunma-u.ac.jp This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.",Non-OADS,/arxiv_data1/oa_pdf/68/34/jrm-11-017.PMC4910028.pdf
Available at:http://www.mhlw.go.jp/english/policy/care-welfare/care-welfare-elderly/dl/ri_130311-01.pdf#search=’The+current+situation+and+th e+future+direction+of+the+Longterm+Care+Insurance+Syst em+in+Japan’ Accessed 22 December 2014.,Non-OADS,/arxiv_data1/oa_pdf/68/34/jrm-11-017.PMC4910028.pdf
Avail- able at: http://www.mhlw.go.jp/seisakunitsuite/bunya/huku - shi_kaigo/kaigo_koureisha/chiiki-houkatsu/dl/link1-3.pdf.,Non-OADS,/arxiv_data1/oa_pdf/68/34/jrm-11-017.PMC4910028.pdf
"Soon after the doctor car was dis - patched to the scene, the same fire station also requested Kobayashi Municipal Hospital, which was the nearest hos - pital from the scene, to send a physician to the scene (Figure J Rural Med 2016; 11(1): 25–29 ©2016 The Japanese Association of Rural MedicineReceived: January 29, 2016, Accepted: March 17, 2016 Correspondence: Tomohiro Abe, Department of Trauma and Critical Care Medicine, University of Miyazaki Hospital, 5200 Kihara, Kiyo- take, Miyazaki 889-1692, Japan E-mail: tomohiro_abe@med.miyazaki-u.ac.jp This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.",Non-OADS,/arxiv_data1/oa_pdf/29/ad/jrm-11-025.PMC4910029.pdf
Available  from: https://www.east.org/education/practice-management-guidelines/penetrating-venous-extremity-trauma-manage - ment-of/.,Non-OADS,/arxiv_data1/oa_pdf/29/ad/jrm-11-025.PMC4910029.pdf
"48, 17475 Greifs- wald, Germany E-mail: katharina.lau@uni-greifswald.de This is an open-access article distributed under the terms of the Cre- ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.",Non-OADS,/arxiv_data1/oa_pdf/e5/ad/jrm-11-030.PMC4910030.pdf
Images were adopted from Servier Medical Art by Servier (http://www.servier.com/Powerpoint-image-bank) and modi ﬁed by the authors under the following terms: CREATIVE COMMONS Attribution 3.0 Unported (CC BY 3.0).Neural regulation of cancer T-H Kim and AC Rowat 3 Clinical & Translational Immunology,Non-OADS,/arxiv_data1/oa_pdf/8a/11/cti201618a.PMC4910118.pdf
Images are adapted from Servier Medical Art by Servier (http://www.servier.com/Powerpoint-image-bank) and modi ﬁed by the authors under the following terms: CREATIVE COMMONS Attribution 3.0 Unported (CC BY 3.0).Neural regulation of cancer T-H Kim and AC Rowat 5 Clinical & Translational Immunology,Non-OADS,/arxiv_data1/oa_pdf/8a/11/cti201618a.PMC4910118.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/Neural regulation of cancer T-H Kim and AC Rowat 9 Clinical & Translational Immunology",Non-OADS,/arxiv_data1/oa_pdf/8a/11/cti201618a.PMC4910118.pdf
Available from http://acrabstracts.org/abstract/ef ﬁcacy- and-safety-of-epratuzumab-in-patients-with-moderate-to-severe-systemic-lupus-erythe-matosus-results-from-two-phase-3-randomized-placebo-controlled-trials/.,Non-OADS,/arxiv_data1/oa_pdf/13/74/cti201626a.PMC4910120.pdf
Available from http://acrabstracts.org/abstract/safety-and-ef ﬁcacy-of-sifalimumab- an-anti-ifn-alpha-monoclonal-antibody-in-a-phase-2b-study-of-moderate-to-severe-sys-temic-lupus-erythematosus-sle/.,Non-OADS,/arxiv_data1/oa_pdf/13/74/cti201626a.PMC4910120.pdf
Available from http://acrabstracts.org/abstract/anifrolumab-an-anti-inter- feron-alpha-receptor-monoclonal-antibody-in-moderate-to-severe-systemic-lupus-erythematosus-sle/.,Non-OADS,/arxiv_data1/oa_pdf/13/74/cti201626a.PMC4910120.pdf
Available from http://acrabstracts.org/abstract/target-modulation-of-a-type-i-interferon-ifn-gene-signature-with-sifalimumab-or-anifrolumab-in-systemic-lupus-erythematosus-sle-patients-in-two-open-label-phase-2-japanese-trials/.Accessed 28 March 2016.,Non-OADS,/arxiv_data1/oa_pdf/13/74/cti201626a.PMC4910120.pdf
Available fromhttp://ir.iderapharma.com/phoenix.zhtml?c =208904&p =irol-newsArticle&ID = 1816887.,OADS,/arxiv_data1/oa_pdf/13/74/cti201626a.PMC4910120.pdf
Available from http://investors.dynavax.,Non-OADS,/arxiv_data1/oa_pdf/13/74/cti201626a.PMC4910120.pdf
Available from http://ir.iderapharma.com/phoenix.zhtml?c =208904&p =irol-newsArticle&ID =1745127.,OADS,/arxiv_data1/oa_pdf/13/74/cti201626a.PMC4910120.pdf
Available from http://www.clinicalleader.com/doc/idera-reports-top-line-trial-data-for-imo-in-psoriasis-0001.,Non-OADS,/arxiv_data1/oa_pdf/13/74/cti201626a.PMC4910120.pdf
Availablefrom http://ir.iderapharma.com/phoenix.zhtml?c =208904&p =irol-newsArticle&ID = 1816887.,OADS,/arxiv_data1/oa_pdf/13/74/cti201626a.PMC4910120.pdf
Available from https://acr.confex.com/acr/2007/web- program/Paper8044.html.,Non-OADS,/arxiv_data1/oa_pdf/13/74/cti201626a.PMC4910120.pdf
Available from http://www.resolvebio.com/rslv/index.,OADS,/arxiv_data1/oa_pdf/13/74/cti201626a.PMC4910120.pdf
Available from http://www.genengnews.com/ gen-news-highlights/rigel-scuttles-r333-after-phase-ii- ﬂop/81249024/ Accessed 31 January 2016.,Non-OADS,/arxiv_data1/oa_pdf/13/74/cti201626a.PMC4910120.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by- nc-nd/4.0/Interferon targeted therapeutics in SLE SO o n et al 10 Clinical & Translational Immunology",Non-OADS,/arxiv_data1/oa_pdf/13/74/cti201626a.PMC4910120.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by- nc-nd/4.0/Epstein –Barr virus dynamics KH Johnson et al 5 Clinical & Translational Immunology",Non-OADS,/arxiv_data1/oa_pdf/19/99/cti201628a.PMC4910122.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/Risk of CVD with anti-in ﬂammatory therapies MJ Kraakman et al 9 Clinical & Translational Immunology",Non-OADS,/arxiv_data1/oa_pdf/bc/18/cti201631a.PMC4910124.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ),Non-OADS,/arxiv_data1/oa_pdf/6d/11/main.PMC4910125.pdf
"3. http://www.mpm.edu/research-collections/artifacts/greco-roman-medical-equipment-reproductions/pompeii-and-greco-roman-m, Accessed 2-26-2015.",Non-OADS,/arxiv_data1/oa_pdf/6d/11/main.PMC4910125.pdf
"6. http://www.usace.army.mil/About/History/HistoricalVi - gnettes/ReliefandRecovery/047AlaskaEarthquake.aspx, Ac - cessed 5/27/2015 7. http://www.usace.army.mil/About/History/HistoricalVi - gnettes/ReliefandRecovery/036DisasterRecovery.aspx, Ac - cessed 5/27/2015 8. http://libpress.colorado.edu/?p=2497, Accessed 5/27/20159.",Non-OADS,/arxiv_data1/oa_pdf/6d/11/main.PMC4910125.pdf
"12.  https://www.fema.gov/about-agency, Accessed 5-19-2015.",Non-OADS,/arxiv_data1/oa_pdf/6d/11/main.PMC4910125.pdf
"Deputy Assistant Secretary, Director, Office of Prepared - ness and Emergency Operations U.S. Department of Health and Human Services Committee on Homeland Security and Governmental Affairs Subcommittee on State, Local, and Pri - vate Sector Preparedness and integration United States Sen-ate, July 22, 2010. http://www.hhs.gov/asl/testify/2010/07/t20100722a.html, Accessed May 22, 2015.",Non-OADS,/arxiv_data1/oa_pdf/6d/11/main.PMC4910125.pdf
"April, 1998. http://www.usfa.fema.gov/pdf/efop/efo28255.pdf, Accessed 5/27/2015.Turk J Emerg Med 2015;15(Suppl 1):1–4 4",Non-OADS,/arxiv_data1/oa_pdf/6d/11/main.PMC4910125.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ),Non-OADS,/arxiv_data1/oa_pdf/f9/c1/main.PMC4910127.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ),Non-OADS,/arxiv_data1/oa_pdf/0d/14/main.PMC4910129.pdf
Available at: https://www.hsaj.org/articles/204 (Accessed 30.05.2015).,Non-OADS,/arxiv_data1/oa_pdf/0d/14/main.PMC4910129.pdf
Available at: http://commons.wikimedia.org/wiki/File:Maslow’s_Hierarchy_of_Needs.svg (Accessed 30.05.2015).,Non-OADS,/arxiv_data1/oa_pdf/0d/14/main.PMC4910129.pdf
Available at: http://www.hsc.usf.edu/nocms/publichealth/cdmha/toolkit_dm/Organizations_English.pdf (Accessed 30.05.2015).,Non-OADS,/arxiv_data1/oa_pdf/0d/14/main.PMC4910129.pdf
Available at: https://www.afad.gov.tr/EN/Index.aspx (Ac - cessed 30.05.2015).,OADS,/arxiv_data1/oa_pdf/0d/14/main.PMC4910129.pdf
Available at: http://www.down - state.edu/emergency_medicine/pdf/KCHCSection02.pdf (Accessed 30.05.2015).,Non-OADS,/arxiv_data1/oa_pdf/0d/14/main.PMC4910129.pdf
Avail - able at: http://www.smgov.net/departments/oem/sems/op - erations/casualty-collection-point-field-treatment-site.pdf (Accessed 30.05.2015).,Non-OADS,/arxiv_data1/oa_pdf/0d/14/main.PMC4910129.pdf
Available at: http://webs.pur - duecal.edu/techgrad/files/2010/10/Directed_Project_Pro - posal_Mark_Kapocius_Spring-11.pdf (Accessed 30.05.2015).,Non-OADS,/arxiv_data1/oa_pdf/0d/14/main.PMC4910129.pdf
p. 220-2 Available at: https://www.ifrc.org/Global/Documents/Secretariat/201410/WDR%202014.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0d/14/main.PMC4910129.pdf
Available at: http://www.phe.gov/Preparedness/responders/ndms/teams/Pages/dmat.aspx (Accessed 30.05.2015).,OADS,/arxiv_data1/oa_pdf/0d/14/main.PMC4910129.pdf
Available at: http://www.phe.gov/Preparedness/responders/ndms/Pages/default.aspx (Accessed 30.05.2015).,OADS,/arxiv_data1/oa_pdf/0d/14/main.PMC4910129.pdf
Available at: http://www.phe.gov/Preparedness/responders/ndms/teams/Pages/default.aspx (Accessed 30.05.2015).,OADS,/arxiv_data1/oa_pdf/0d/14/main.PMC4910129.pdf
Available at: http://www.forces.gc.ca/en/operations-abroad-recurring/dart.page (Accessed 30.05.2015)  28.,Non-OADS,/arxiv_data1/oa_pdf/0d/14/main.PMC4910129.pdf
"Disaster Medical Assistance Teams: A Literature Review 2006, Avail - able at: http://www.public.health.wa.gov.au/cproot/347/2/disaster%20medical%20assistance%20teams%20litera - ture%20review%202006.pdf (Accessed 30.05.2015).",Non-OADS,/arxiv_data1/oa_pdf/0d/14/main.PMC4910129.pdf
Available at: http://www.umke.org/umke-nedir-s3.html (Ac - cessed 30.05.2015).,Non-OADS,/arxiv_data1/oa_pdf/0d/14/main.PMC4910129.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ),Non-OADS,/arxiv_data1/oa_pdf/ca/ae/main.PMC4910130.pdf
https://www1.umn.edu/humanrts/gencomm/esc - gencom15.htm 5.,Non-OADS,/arxiv_data1/oa_pdf/ca/ae/main.PMC4910130.pdf
6.  http://en.wikipedia.org/wiki/Humanitarian_aid 7.,Non-OADS,/arxiv_data1/oa_pdf/ca/ae/main.PMC4910130.pdf
"Technical notes on drinking-water, sanitation  and hygiene in emergencies.Updated:July2013 http://www.who.int/water_sanitation_health/publications/2011/WHO_TN_05_Emergency_treatment_of_drinking_water_at_the_point_of_use.pdf 14.",Non-OADS,/arxiv_data1/oa_pdf/ca/ae/main.PMC4910130.pdf
"The Sphere Project, Humanitarian charter and minimum standards in humanitarian response, Water supply standard 2: Water quality, The Sphere Project 2011, p.100-103 15.  WHO - Water Safety Plan: The Guidelines : a framework for safe drinking water p.22-36 http://www.who.int/water_sani - tation_health/dwq/gdwq3_2.pdf 16.",Non-OADS,/arxiv_data1/oa_pdf/ca/ae/main.PMC4910130.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ),Non-OADS,/arxiv_data1/oa_pdf/5e/96/main.PMC4910131.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ),Non-OADS,/arxiv_data1/oa_pdf/26/74/main.PMC4910138.pdf
London: Overseas Development Institute; 2013. http://www.odi.org/publications/7535-global-history-humanitarian-ac - tion  2.,Non-OADS,/arxiv_data1/oa_pdf/26/74/main.PMC4910138.pdf
Available at: http://www.icrc.,Non-OADS,/arxiv_data1/oa_pdf/26/74/main.PMC4910138.pdf
"Available at: http://www.odi.org/uk/hpg/publications, Accessed May 20, 2015.",Non-OADS,/arxiv_data1/oa_pdf/26/74/main.PMC4910138.pdf
"Available at: http://www.un.org/docu - ments/ga/res/46/a46r182.htm, Published December 1991.",Non-OADS,/arxiv_data1/oa_pdf/26/74/main.PMC4910138.pdf
"Available at: http://www.icrc.org/eng/resources/documents/report/57jmry.htm Accessed May 15, 2015.",OADS,/arxiv_data1/oa_pdf/26/74/main.PMC4910138.pdf
Available at: http://www.unocha.org/about-us/publications.,Non-OADS,/arxiv_data1/oa_pdf/26/74/main.PMC4910138.pdf
"Available at: http://www.ifrc.org/en/publications-and-reports/code-of-conduct/ Ac - cessed May 15, 2015.",Non-OADS,/arxiv_data1/oa_pdf/26/74/main.PMC4910138.pdf
This is an open access article under CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ),Non-OADS,/arxiv_data1/oa_pdf/8c/63/main.PMC4910139.pdf
This  is  an  open access article under the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1c/40/main.PMC4910140.pdf
"The  patient  started  to  develop  a  septic  condition  and  devel- oped  progressive  unbearable  pain  at  both  legs,  so  debridement, evacuation  of  the  epidural  abscess  and  dorsal  instrumentation  of http://dx.doi.org/10.1016/j.ijscr.2016.04.047 2210-2612/© 2016  The  Author(s).",Non-OADS,/arxiv_data1/oa_pdf/1c/40/main.PMC4910140.pdf
"22  (2013)  2787–2799,  http://dx.doi.org/10.1007/ s00586-013-2850-1 .",Non-OADS,/arxiv_data1/oa_pdf/1c/40/main.PMC4910140.pdf
"9  (2009)  10–17,  http://dx.doi.org/10.1016/j.semarthrit.2008.",OADS,/arxiv_data1/oa_pdf/1c/40/main.PMC4910140.pdf
"/  International  Journal  of  Surgery  Case  Reports  24  (2016)  219–222 prolapse,  JAMA  309  (2013)  2016–2024,  http://dx.doi.org/10.1001/jama.2013.",Non-OADS,/arxiv_data1/oa_pdf/1c/40/main.PMC4910140.pdf
"30  (7)  (2010)  744–745,  http://dx.doi.org/10.3109/01443615.2010.",Non-OADS,/arxiv_data1/oa_pdf/1c/40/main.PMC4910140.pdf
"203 (2) (2010)  e11–e13,  http://dx.doi.org/10.1016/j.ajog.2010.04.028 .",OADS,/arxiv_data1/oa_pdf/1c/40/main.PMC4910140.pdf
"25  (2013)  21–31, http://dx.doi.org/10.1007/s00192-013-2138-3 .",Non-OADS,/arxiv_data1/oa_pdf/1c/40/main.PMC4910140.pdf
"53 (2009)  4305–4310,  http://dx.doi.org/10.1128/AAC.00444-09 .",Non-OADS,/arxiv_data1/oa_pdf/1c/40/main.PMC4910140.pdf
"24  (2013)  691–692,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/1c/40/main.PMC4910140.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/11/fc/main.PMC4910141.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/11/fc/main.PMC4910141.pdf
http://dx.doi.org/10.1016/j.eucr.2016.05.008Urology Case Reports 8 (2016) 21 e23,Non-OADS,/arxiv_data1/oa_pdf/11/fc/main.PMC4910141.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/32/7a/main.PMC4910142.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.com/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2016.05.008 2213-0071/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/32/7a/main.PMC4910142.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 19 (2016) 5 e8,Non-OADS,/arxiv_data1/oa_pdf/32/7a/main.PMC4910142.pdf
This family was created by Fisher in 1895 ( http://www.bacterio.net/ Bacillaceae .html ).,Non-OADS,/arxiv_data1/oa_pdf/43/07/main.PMC4910145.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious DiseasesThis is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.05.009,Non-OADS,/arxiv_data1/oa_pdf/43/07/main.PMC4910145.pdf
FAMEs were pre- pared as previously described ( http://www.midi-inc.com/pdf/ MIS_Technote_101.pdf ).,OADS,/arxiv_data1/oa_pdf/43/07/main.PMC4910145.pdf
Antibiotic susceptibility testing was performed using the disk diffusion method according to European Committee on Anti- microbial Susceptibility Testing (EUCAST) 2015 recommenda- tions ( http://www.eucast.org/ ).,Non-OADS,/arxiv_data1/oa_pdf/43/07/main.PMC4910145.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,12,7 6–85 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/43/07/main.PMC4910145.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,12,7 6–85 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/43/07/main.PMC4910145.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,12,7 6–85 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/43/07/main.PMC4910145.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,12,7 6–85 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/43/07/main.PMC4910145.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,12,7 6–85 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/43/07/main.PMC4910145.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,12,7 6–85 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/43/07/main.PMC4910145.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,12,7 6–85 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/43/07/main.PMC4910145.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,12,7 6–85 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/43/07/main.PMC4910145.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,12,7 6–85 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/43/07/main.PMC4910145.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies the paper on Experime ntal & Molecular Medicine website (http://www.nature.com/emm)Rac1 regulates STAT3 –NFkB complexes SJ Kim and S Yoon 11 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/f8/2b/emm201617a.PMC4910147.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/Autoimmune disease-speci ﬁci P S C s M-Y Son et al 10 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/5f/69/emm201627a.PMC4910148.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/4.0/GLCCI1 in podocyte foot processes S-H Kim et al 10 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/41/db/emm201628a.PMC4910149.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on Experimental & Molecular Medicin e website (http://www.nature.com/emm)FBXO9 as a PPAR γE3 ligase KW Lee et al 8 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/cf/01/emm201631a.PMC4910150.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies the paper on Experimental & Molecular Medicin e website (http://www.nature.com/emm)Novel targets in NGF/TrkA-dependent cell death EJ Jung et al 12 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/97/69/emm201633a.PMC4910151.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/Applications of aptamer –nanoparticle conjugates HJ oa n dCB a n 9 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/06/e5/emm201644a.PMC4910152.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9d/d9/main.PMC4910153.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9d/d9/main.PMC4910153.pdf
http://dx.doi.org/10.1016/j.eucr.2016.05.007Urology Case Reports 8 (2016) 24 e25,Non-OADS,/arxiv_data1/oa_pdf/9d/d9/main.PMC4910153.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Schizophrenia Resting-state functional connectivityFunctional magnetic resonance imagingInferior parietal lobuleSubregion 1.,Non-OADS,/arxiv_data1/oa_pdf/f1/ca/main.PMC4910186.pdf
http://dx.doi.org/10.1016/j.nicl.2016.05.021 2213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f1/ca/main.PMC4910186.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f1/ca/main.PMC4910186.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Intravoxel incoherent motion IVIM Arterial spin labelingASLTest-retest reliabilityGlioblastoma multiforme 1.,Non-OADS,/arxiv_data1/oa_pdf/ab/b5/main.PMC4910187.pdf
http://dx.doi.org/10.1016/j.nicl.2016.05.0222213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ab/b5/main.PMC4910187.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ab/b5/main.PMC4910187.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c1/fc/main.PMC4910284.pdf
"Contents lists available at ScienceDirect Journal of Ayurveda and Integrative Medicine journal homepage: http://elsevier.com/locate/jaim http://dx.doi.org/10.1016/j.jaim.2016.03.001 0975-9476/ ©2016 Transdisciplinary University, Bangalore and World Ayurveda Foundation.",Non-OADS,/arxiv_data1/oa_pdf/c1/fc/main.PMC4910284.pdf
This is an open access article un der the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Ayurveda and Integrative Medicine 7 (2016) 11 e13,Non-OADS,/arxiv_data1/oa_pdf/c1/fc/main.PMC4910284.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b6/7a/main.PMC4910286.pdf
"Contents lists available at ScienceDirect Journal of Ayurveda and Integrative Medicine journal homepage: http://elsevier.com/locate/jaim http://dx.doi.org/10.1016/j.jaim.2015.10.001 0975-9476/ ©2016 Transdisciplinary University, Bangalore and World Ayurveda Foundation.",Non-OADS,/arxiv_data1/oa_pdf/b6/7a/main.PMC4910286.pdf
This is an open access article un der the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Ayurveda and Integrative Medicine 7 (2016) 57 e61,Non-OADS,/arxiv_data1/oa_pdf/b6/7a/main.PMC4910286.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f3/be/main.PMC4910290.pdf
"Contents lists available at ScienceDirect Journal of Ayurveda and Integrative Medicine journal homepage: http://elsevier.com/locate/jaim http://dx.doi.org/10.1016/j.jaim.2015.11.002 0975-9476/ ©2016 Transdisciplinary University, Bangalore and World Ayurveda Foundation.",Non-OADS,/arxiv_data1/oa_pdf/f3/be/main.PMC4910290.pdf
This is an open access article un der the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Ayurveda and Integrative Medicine 7 (2016) 44 e47,Non-OADS,/arxiv_data1/oa_pdf/f3/be/main.PMC4910290.pdf
Available from: http://www.graphpad.com/quickcalcs/randMenu/ .,Non-OADS,/arxiv_data1/oa_pdf/f3/be/main.PMC4910290.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9b/40/main.PMC4910291.pdf
"Contents lists available at ScienceDirect Journal of Ayurveda and Integrative Medicine journal homepage: http://elsevier.com/locate/jaim http://dx.doi.org/10.1016/j.jaim.2015.08.002 0975-9476/ ©2016 Transdisciplinary University, Bangalore and World Ayurveda Foundation.",Non-OADS,/arxiv_data1/oa_pdf/9b/40/main.PMC4910291.pdf
This is an open access article un der the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Ayurveda and Integrative Medicine 7 (2016) 69 e72,Non-OADS,/arxiv_data1/oa_pdf/9b/40/main.PMC4910291.pdf
Available from: http://www.cdac.in/index.aspx?id ¼hi_dss_ayusoft [accessed on 12.05.16].,OADS,/arxiv_data1/oa_pdf/9b/40/main.PMC4910291.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0c/0f/main.PMC4910292.pdf
"Contents lists available at ScienceDirect Journal of Ayurveda and Integrative Medicine journal homepage: http://elsevier.com/locate/jaim http://dx.doi.org/10.1016/j.jaim.2015.07.001 0975-9476/ ©2016 Transdisciplinary University, Bangalore and World Ayurveda Foundation.",Non-OADS,/arxiv_data1/oa_pdf/0c/0f/main.PMC4910292.pdf
This is an open access article un der the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Ayurveda and Integrative Medicine 7 (2016) 14 e22,Non-OADS,/arxiv_data1/oa_pdf/0c/0f/main.PMC4910292.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1f/d3/main.PMC4910295.pdf
"On day 2 the patient became febrile, hemodynamicallyContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/mmcrMedical Mycology Case Reports http://dx.doi.org/10.1016/j.mmcr.2016.05.002 2211-7539/ &2016 International Society for Human and Animal Mycology.",Non-OADS,/arxiv_data1/oa_pdf/1f/d3/main.PMC4910295.pdf
This is an o pen access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1f/d3/main.PMC4910295.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Paraneoplastic syndromeOvarian cancerPhantom hCGClinical trialTumor heterogeneityβ-hCG heterophilic antibody 1.,Non-OADS,/arxiv_data1/oa_pdf/d3/ea/main.PMC4910296.pdf
Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor http://dx.doi.org/10.1016/j.gore.2016.05.004 2352-5789/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d3/ea/main.PMC4910296.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d3/ea/main.PMC4910296.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/36/d3/main.PMC4910297.pdf
"Contents lists available at ScienceDirect Journal of Ayurveda and Integrative Medicine journal homepage: http://elsevier.com/locate/jaim http://dx.doi.org/10.1016/j.jaim.2015.11.001 0975-9476/ ©2016 Transdisciplinary University, Bangalore and World Ayurveda Foundation.",Non-OADS,/arxiv_data1/oa_pdf/36/d3/main.PMC4910297.pdf
This is an open access article un der the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Ayurveda and Integrative Medicine 7 (2016) 23 e29,Non-OADS,/arxiv_data1/oa_pdf/36/d3/main.PMC4910297.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b7/43/main.PMC4910298.pdf
"Contents lists available at ScienceDirect Journal of Ayurveda and Integrative Medicine journal homepage: http://elsevier.com/locate/jaim http://dx.doi.org/10.1016/j.jaim.2015.09.001 0975-9476/ ©2016 Transdisciplinary University, Bangalore and World Ayurveda Foundation.",Non-OADS,/arxiv_data1/oa_pdf/b7/43/main.PMC4910298.pdf
This is an open access article un der the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Ayurveda and Integrative Medicine 7 (2016) 62 e68,Non-OADS,/arxiv_data1/oa_pdf/b7/43/main.PMC4910298.pdf
Available from: http://www.longwoodherbal.org/peppermint/ peppermint.pdf [last accessed on 1.10.15].,Non-OADS,/arxiv_data1/oa_pdf/b7/43/main.PMC4910298.pdf
"International Journal of Preventive Medicine 2016, 7:82 http://www.ijpvmjournal.net/content/7/1/82the town of Kuala Selangor, Malaysia.",Non-OADS,/arxiv_data1/oa_pdf/99/19/IJPVM-7-82.PMC4910307.pdf
"International Journal of Preventive Medicine 2016, 7:82 http://www.ijpvmjournal.net/content/7/1/82descriptive and correlation analysis.",Non-OADS,/arxiv_data1/oa_pdf/99/19/IJPVM-7-82.PMC4910307.pdf
"International Journal of Preventive Medicine 2016, 7:82 http://www.ijpvmjournal.net/content/7/1/82among the respondents compared to BMI cutoff points  for Caucasian.",Non-OADS,/arxiv_data1/oa_pdf/99/19/IJPVM-7-82.PMC4910307.pdf
"International Journal of Preventive Medicine 2016, 7:82 http://www.ijpvmjournal.net/content/7/1/82cutoff points, the prevalence of abdominal obesity using  WC were found to be higher than in using WHR, as  the WHR for both Caucasian and Asian cutoffs detect  more underweight and normal respondents as being  abdominally obese.",Non-OADS,/arxiv_data1/oa_pdf/99/19/IJPVM-7-82.PMC4910307.pdf
"International Journal of Preventive Medicine 2016, 7:80 http://www.ijpvmjournal.net/content/7/1/80Each treatment period takes 1 month and there was a  14‑day washout between the treatment periods.",Non-OADS,/arxiv_data1/oa_pdf/d9/54/IJPVM-7-80.PMC4910308.pdf
"International Journal of Preventive Medicine 2016, 7:80 http://www.ijpvmjournal.net/content/7/1/80reasons for the drop‑out.",Non-OADS,/arxiv_data1/oa_pdf/d9/54/IJPVM-7-80.PMC4910308.pdf
"International Journal of Preventive Medicine 2016, 7:80 http://www.ijpvmjournal.net/content/7/1/80research might explore the effects of long‑term statin  therapy on Vitamin D status.",Non-OADS,/arxiv_data1/oa_pdf/d9/54/IJPVM-7-80.PMC4910308.pdf
"International Journal of Preventive Medicine 2016, 7:80 http://www.ijpvmjournal.net/content/7/1/8026.",Non-OADS,/arxiv_data1/oa_pdf/d9/54/IJPVM-7-80.PMC4910308.pdf
Available  from: http://www.who.int/mediacentre/factsheets/fs339/en/.,Non-OADS,/arxiv_data1/oa_pdf/39/67/IJPVM-7-78.PMC4910309.pdf
"International Journal of Preventive Medicine 2016, 7:78 http://www.ijpvmjournal.net/content/7/1/78exposure to tobacco smoke?",Non-OADS,/arxiv_data1/oa_pdf/39/67/IJPVM-7-78.PMC4910309.pdf
Available from: http://www.euro.who.,Non-OADS,/arxiv_data1/oa_pdf/39/67/IJPVM-7-78.PMC4910309.pdf
"International Journal of Preventive Medicine 2016, 7:81 http://www.ijpvmjournal.net/content/7/1/81animals, objects, organisms, etc.).",Non-OADS,/arxiv_data1/oa_pdf/ab/33/IJPVM-7-81.PMC4910310.pdf
Other useful  sites are VassarStats (http://vassarstats.net/) and Graph Pad  QuickCalcs (http://www.graphpad.com/quickcalcs/).,Non-OADS,/arxiv_data1/oa_pdf/ab/33/IJPVM-7-81.PMC4910310.pdf
"International Journal of Preventive Medicine 2016, 7:81 http://www.ijpvmjournal.net/content/7/1/81REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/ab/33/IJPVM-7-81.PMC4910310.pdf
"International Journal of Preventive Medicine 2016, 7:79 http://www.ijpvmjournal.net/content/7/1/79INTRODUCTION Obesity and overweight among children is a major  public health problem in developed and developing  countries.",Non-OADS,/arxiv_data1/oa_pdf/9c/5c/IJPVM-7-79.PMC4910311.pdf
"International Journal of Preventive Medicine 2016, 7:79 http://www.ijpvmjournal.net/content/7/1/79during children is useful for the prevention of obesity  and severe consequences later in adolescence and  adulthood therefore, the aim of the current study was  to evaluate longitudinal changes in prevalence trend  of overweight and obesity in children.",Non-OADS,/arxiv_data1/oa_pdf/9c/5c/IJPVM-7-79.PMC4910311.pdf
"International Journal of Preventive Medicine 2016, 7:79 http://www.ijpvmjournal.net/content/7/1/79population‑based methods.",Non-OADS,/arxiv_data1/oa_pdf/9c/5c/IJPVM-7-79.PMC4910311.pdf
Available from: http://www.stats.gov.cn/ tjsj/ndsj/2015/indexch.htm.,OADS,/arxiv_data1/oa_pdf/23/0e/CMJ-129-1387.PMC4910359.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/25/ab/10.1177_2325967116653946.PMC4910396.pdf
"METHODS A list of MLB pitchers and their date of surgery was com- piled from a publicly available site (http://mlbreports.com/ tj-surgery), and those pitchers who were active during the 2002 to 2015 seasons were considered in this study.",OADS,/arxiv_data1/oa_pdf/25/ab/10.1177_2325967116653946.PMC4910396.pdf
2014. http://m.mlb.,Non-OADS,/arxiv_data1/oa_pdf/25/ab/10.1177_2325967116653946.PMC4910396.pdf
Available at: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/b9/d8/2421-4248-57-E1.PMC4910436.pdf
Available at: http://www.who.int/csr/disease/swineflu/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/b9/d8/2421-4248-57-E1.PMC4910436.pdf
Available at:  http://www.who.int/media- centre/factsheets/2003/fs211/en/ .,Non-OADS,/arxiv_data1/oa_pdf/b9/d8/2421-4248-57-E1.PMC4910436.pdf
"Available at: http://www.salute.gov.it/portale/temi/p2_6.jsp?li ngua=italiano&id=771&area=influenza&menu=sorveglianza [Accessed on 15/02/16] [18] Lai PL, Panatto D, Ansaldi F, Canepa P, Amicizia D, Patria  AG, Gasparini R. Burden of the 1999-2008 seasonal influenza  epidemics in Italy: comparison with the H1N1v (A/Califor - nia/07/09) pandemic.",Non-OADS,/arxiv_data1/oa_pdf/b9/d8/2421-4248-57-E1.PMC4910436.pdf
Available at:: http://www.epicentro.iss.it/problemi/influenza/copertureAntinfluen- zale2014-2015.asp.,Non-OADS,/arxiv_data1/oa_pdf/b9/d8/2421-4248-57-E1.PMC4910436.pdf
Available at: http://www.salute.gov.it/imgs/C_17_ opuscoliPoster_17_allegato.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b9/d8/2421-4248-57-E1.PMC4910436.pdf
Available at: http://www.agenziafar - maco.gov.it/it/content/divieto-di-utilizzo-vaccini-influenzali- della-ditta-novartis-vaccines-and-diagnostics.,Non-OADS,/arxiv_data1/oa_pdf/b9/d8/2421-4248-57-E1.PMC4910436.pdf
Available at: http://www.agenziafar - maco.com/it/content/aifa-dispone-il-divieto-di-utilizzo-due-lot- ti-del-vaccino-antinfluenzale-fluad-0.,Non-OADS,/arxiv_data1/oa_pdf/b9/d8/2421-4248-57-E1.PMC4910436.pdf
Available at: https://group2bsn2g.wordpress.com/2007/01/18/medical- interventions/.,Non-OADS,/arxiv_data1/oa_pdf/b9/d8/2421-4248-57-E1.PMC4910436.pdf
Available at:  http://www.ncsl.org/research/health/immunizations-policy-is-sues-overview.aspx.,Non-OADS,/arxiv_data1/oa_pdf/b9/d8/2421-4248-57-E1.PMC4910436.pdf
Available at: http://www.epicentro.iss.it/problemi/meningiti/ag-giornamenti.asp.,Non-OADS,/arxiv_data1/oa_pdf/b9/d8/2421-4248-57-E1.PMC4910436.pdf
Available at: http://noi-italia.istat.it/index.php?id=7&user_100ind_pi1%5Bid_pagina%5D=41.,Non-OADS,/arxiv_data1/oa_pdf/b9/d8/2421-4248-57-E1.PMC4910436.pdf
Available at: http://www.cdc.gov/flu/.,Non-OADS,/arxiv_data1/oa_pdf/b9/d8/2421-4248-57-E1.PMC4910436.pdf
Documento disponibile al sito web: http://www.phac-aspc.gc.ca/naci-ccni/flu-2015-grippe-eng.php.,Non-OADS,/arxiv_data1/oa_pdf/b9/d8/2421-4248-57-E1.PMC4910436.pdf
Available online at: http://ecdc.europa.eu/en/publications/ Publications/Seasonal-influenza-vaccination-Europe-2012-13.pdf [Accessed 08/02/2016].,Non-OADS,/arxiv_data1/oa_pdf/41/87/2421-4248-57-E13.PMC4910437.pdf
Avail- able online at: http://www.ons.gov.uk/ons/dcp171778_425192.,Non-OADS,/arxiv_data1/oa_pdf/41/87/2421-4248-57-E13.PMC4910437.pdf
"Available online at: http://www.euromomo.eu/  [Accessed 11/02/2016] [12] Mazick A, Gergonne B, Nielsen J, Tersago K, Bossuyt N, Den-issov G, Baburin A, Virtanen M, Fouillet A, Sideroglou T, Gkol-finopoulou K, Paldy A, Bobvos J, van Asten L, de Lange M, Nunes B, da Silva S, Larrauri A, Gomez IL, Tsoumanis A, Jun-ker C, Green H, Pebody R, McMenamin J, Reynolds A, Mazick A.",Non-OADS,/arxiv_data1/oa_pdf/41/87/2421-4248-57-E13.PMC4910437.pdf
"Available online from: http://www.flunewseurope.org/ (last accessed 11/02/2016) [14] Signorelli C, Odone A, Conversano M, Bonanni P. Deaths af-ter Fluad flu vaccine and the epidemic of panic in Italy.",Non-OADS,/arxiv_data1/oa_pdf/41/87/2421-4248-57-E13.PMC4910437.pdf
Available online from: http://ecdc.europa.eu/en/healthtopics/seasonal_influenza/vaccines/Pages/influenza_vaccination.aspx#vaccinationstrategies [Accessed 11/02/2016].,Non-OADS,/arxiv_data1/oa_pdf/41/87/2421-4248-57-E13.PMC4910437.pdf
Available online from: http://www.salute.gov.it/portale/news/p3_2_1_1_1.jsp?lingua=italiano&menu=notizie&p=dalministero&id=2218 [Accessed 12/02/2016] [22] European Centre for Disease Prevention and Control.,Non-OADS,/arxiv_data1/oa_pdf/41/87/2421-4248-57-E13.PMC4910437.pdf
Available online from: http://ecdc.europa.eu/en/publications/Publications/Seasonal-influenza- vaccination-Europe-2012-13.pdf [Accessed 12/02/2016].,Non-OADS,/arxiv_data1/oa_pdf/41/87/2421-4248-57-E13.PMC4910437.pdf
Availa- ble at: http://www.who.int/mediacentre/news/statements/2010/h1n1_vpc_20100810/en/ [accessed 09.02.2016].,Non-OADS,/arxiv_data1/oa_pdf/0b/6f/2421-4248-57-E19.PMC4910438.pdf
Available at: http://www.who.int/influ- enza/gisrs_laboratory/flunet/en/ [accessed 09.02.2016].,OADS,/arxiv_data1/oa_pdf/0b/6f/2421-4248-57-E19.PMC4910438.pdf
Available at: http://www.salute.gov.it/portale/news/p3_2_1_1_1.jsp?lingua=italiano&menu=notizie &p=dalministero&id=2218 [accessed 12/02/2016] [15] Centers for Disease Control and Prevention (CDC).,Non-OADS,/arxiv_data1/oa_pdf/0b/6f/2421-4248-57-E19.PMC4910438.pdf
Available at: http://www.who.int/influenza/gisrs_laboratory/flunet/en/.,Non-OADS,/arxiv_data1/oa_pdf/41/27/2421-4248-57-E23.PMC4910439.pdf
Available at: http://www.salute.gov.it/por - tale/news/p3_2_1_1_1.jsp?menu=notizie&p=dalministero&id=2218 [Accessed 31/01/16].,Non-OADS,/arxiv_data1/oa_pdf/41/27/2421-4248-57-E23.PMC4910439.pdf
Available at: http://www.who.int/ mediacentre/factsheets/fs211/en/ [Accessed on 10/01/16] [4] Zambon MC.,Non-OADS,/arxiv_data1/oa_pdf/ee/89/2421-4248-57-E28.PMC4910440.pdf
Available at: http://www.trovanorme.salute.gov.,Non-OADS,/arxiv_data1/oa_pdf/ee/89/2421-4248-57-E28.PMC4910440.pdf
[16] Fda Available at: http://www.fda.gov/downloads/Advisory-Committees/CommitteesMeetingMaterials/BloodVaccinesan- dOtherBiologics/VaccinesandRelatedBiologicalProductsAdvi- soryCommittee/UCM167159.pdf [Accessed on 10/01/16] [17] World Health Organization.,Non-OADS,/arxiv_data1/oa_pdf/ee/89/2421-4248-57-E28.PMC4910440.pdf
Avail- able at: http://www.who.int/csr/disease/influenza/summary_b_ cvv_reagents_4_may_2011.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ee/89/2421-4248-57-E28.PMC4910440.pdf
Avail-able at: http://www.ema.europa.eu/ema/index.jsp?curl=pages/ news_and_events/news/2012/03/news_detail_001467.,Non-OADS,/arxiv_data1/oa_pdf/ee/89/2421-4248-57-E28.PMC4910440.pdf
Available at:  http://www.salute.gov.it/portale/news/p3_2_1_1_1.jsp?menu=n otizie&p=dalministero&id=2218.,Non-OADS,/arxiv_data1/oa_pdf/4b/94/2421-4248-57-E34.PMC4910441.pdf
"[15] Rapporto Nazionale Passi 2012: vaccinazione antinfluenzale stagionale http://www.epicentro.iss.it/passi/rapporto2012/vac- cinazioneAntinluenzale.asp [16] Turner D, Wailoo A, Nicholson K, Cooper N, Sutton A, Abrams K.  Systematic review and economic decision modeling for the preven- tion and treatment of influenza A and B.",Non-OADS,/arxiv_data1/oa_pdf/4b/94/2421-4248-57-E34.PMC4910441.pdf
Available at: http://www.medicines.org.uk/emc/medicine/2608 [Accessed 05/01/16].,Non-OADS,/arxiv_data1/oa_pdf/4b/94/2421-4248-57-E34.PMC4910441.pdf
Available at  https://www.medicines.org.uk/emc/medicine/10446/SPC/  Tamiflu+75mg+hard+capsule/ [Accessed 05/01/16].,Non-OADS,/arxiv_data1/oa_pdf/4b/94/2421-4248-57-E34.PMC4910441.pdf
Available at: http://ecdc.europa.eu/en/publications/Publica- tions/Seasonal-influenza-vaccination-Europe-2012-13.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d4/44/2421-4248-57-E41.PMC4910442.pdf
Avail-able at: http://www.ecdc.europa.eu/en/publications/Publications/ Seasonal%20influenza%20vaccination%20of%20children%20 and%20pregnant%20women.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d4/44/2421-4248-57-E41.PMC4910442.pdf
Available at: http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32009H1019.,Non-OADS,/arxiv_data1/oa_pdf/d4/44/2421-4248-57-E41.PMC4910442.pdf
Available  at: http://ecdc.europa.eu/en/publications/Report%20Assets/ seasonal-vaccination-coverage-in-europe-2012-13/Seasonal- Influenza-Vaccination-Programme-Country-Profile-Italy.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d4/44/2421-4248-57-E41.PMC4910442.pdf
An example of  this is the website VaccinarSì (http://www.vaccinarsi.,Non-OADS,/arxiv_data1/oa_pdf/0e/68/2421-4248-57-E47.PMC4910443.pdf
"org/), which initially emerged from an idea by Mrs. Ul- rike Schmidleithner (http://vaccinarsi.blogspot.it)  [20].",Non-OADS,/arxiv_data1/oa_pdf/0e/68/2421-4248-57-E47.PMC4910443.pdf
Available at http://www.fimp.veneto.it/sites/default/files/Progetto%20FIMP%20HERMES%5B1%5D.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0e/68/2421-4248-57-E47.PMC4910443.pdf
Available at http://www.who.int/immunization/pro- grammes_systems/vaccine_hesitancy.,Non-OADS,/arxiv_data1/oa_pdf/0e/68/2421-4248-57-E47.PMC4910443.pdf
Available at: http://ecdc.eu- ropa.eu/en/healthtopics/seasonal_influenza/basic_facts/Pages/factsheet_professionals_seasonal_influenza.aspx [Accessed 05/03/03].,Non-OADS,/arxiv_data1/oa_pdf/1e/91/2421-4248-57-E5.PMC4910444.pdf
Available at: http://ecdc.europa.eu/en/healthtop- ics/seasonal_influenza/vaccines/Pages/influenza_vaccination.,Non-OADS,/arxiv_data1/oa_pdf/1e/91/2421-4248-57-E5.PMC4910444.pdf
Available at: http://www.consilium.europa.eu/uedocs/cms_Data/docs/pressdata/en/lsa/122391.pdf [Accessed 05/03/03].,Non-OADS,/arxiv_data1/oa_pdf/1e/91/2421-4248-57-E5.PMC4910444.pdf
Available at:  http://www.consilium.europa.eu/en/workarea/downloadasset.,Non-OADS,/arxiv_data1/oa_pdf/1e/91/2421-4248-57-E5.PMC4910444.pdf
Available at: http://venice.cineca.org/the_pro- ject.html [accessed 05/03/03].,Non-OADS,/arxiv_data1/oa_pdf/1e/91/2421-4248-57-E5.PMC4910444.pdf
Available at: https://sites.google.com/site/epiflu/Home [accessed 05/03/03].,Non-OADS,/arxiv_data1/oa_pdf/1e/91/2421-4248-57-E5.PMC4910444.pdf
Available at: https://eudravigilance.ema.eu- ropa.eu/highres.htm [Accessed 05/03/03].,Non-OADS,/arxiv_data1/oa_pdf/1e/91/2421-4248-57-E5.PMC4910444.pdf
Available at: https://brightoncollaboration.org/vaesco.html [Accessed 05/03/03].,Non-OADS,/arxiv_data1/oa_pdf/1e/91/2421-4248-57-E5.PMC4910444.pdf
Available at: http://ecdc.europa.eu/en/publications/Publications/Vaesco%20report%20FINAL%20 with%20cover.pdf [Accessed 05/03/03].,Non-OADS,/arxiv_data1/oa_pdf/1e/91/2421-4248-57-E5.PMC4910444.pdf
Available at: http://ec.europa.eu/health/pre- paredness_response/policy/decision/index_en.htm [Accessed  05/03/03].,Non-OADS,/arxiv_data1/oa_pdf/1e/91/2421-4248-57-E5.PMC4910444.pdf
Avail- able at: http://www.who.int/mediacentre/factsheets/fs211/en/ [Accessed 15/01/2016] [4] World Health Organization.,Non-OADS,/arxiv_data1/oa_pdf/38/89/2421-4248-57-E9.PMC4910445.pdf
Available at: http://www.who.int/wer  [Accessed 15/01/2016].,OADS,/arxiv_data1/oa_pdf/38/89/2421-4248-57-E9.PMC4910445.pdf
Available at: http://www.iss.it/bi- nary/publ/cont/15_48_web.pdf.,Non-OADS,/arxiv_data1/oa_pdf/38/89/2421-4248-57-E9.PMC4910445.pdf
Available at: http://www.avis.it/ userfiles/file/News/giugno 2015/Report Prevenzione Vaccinale.pdf.,Non-OADS,/arxiv_data1/oa_pdf/38/89/2421-4248-57-E9.PMC4910445.pdf
Available at: http://www.societaitalianaigiene.org/site/new/im-ages/docs/gdl/vaccini/201360enni.pdf [Accessed 15/01/2016] [14] Direzione Generale della Prevenzione.,Non-OADS,/arxiv_data1/oa_pdf/38/89/2421-4248-57-E9.PMC4910445.pdf
"Available at: http://www.salute.gov.it/ imgs/C_17_tavole_19_allegati_iitemAllegati_0_fileAllegati_itemFile_3_file.pdf [Accessed 16/01/2016] [15] Osservatorio Nazionale sull’Impiego dei Medicinali, Agenzia Italiana del Farmaco.",Non-OADS,/arxiv_data1/oa_pdf/38/89/2421-4248-57-E9.PMC4910445.pdf
"Available at: http://www.agen-ziafarmaco.gov.it/sites/default/files/Rapporto_OsMed_gen-naio_settembre_2015.pdf [Accessed 16/01/2016] [16] Osservatorio Nazionale sull’Impiego dei Medicinali, Agenzia Italiana del Farmaco.",Non-OADS,/arxiv_data1/oa_pdf/38/89/2421-4248-57-E9.PMC4910445.pdf
Available at: http://www.agenziafar - maco.gov.it/sites/default/files/Rapporto_OsMed_2014_0.pdf [Accessed 16/01/2016] [17] Centers for Disease Control and Prevention.,Non-OADS,/arxiv_data1/oa_pdf/38/89/2421-4248-57-E9.PMC4910445.pdf
"Available at: http://www.who.int/influ- enza_vaccines_plan/resources/Summary_report_communica-tion_workshop_GAP_2013.pdf [Accessed 17/01/2016] [18] Michel JP, Chidiac C, Grubeck-Loebenstein B, Johnson RW, Lambert PH, Maggi S, Moulias R, Nicholson K, Werner H. Co-alition of advocates to vaccinate of Western European citizens  aged 60 years and older.",Non-OADS,/arxiv_data1/oa_pdf/38/89/2421-4248-57-E9.PMC4910445.pdf
Available at: http://health.gov/hcq/pdfs/hai-action-plan- hcp-flu.PDF [Accessed 18/01/2016].,Non-OADS,/arxiv_data1/oa_pdf/38/89/2421-4248-57-E9.PMC4910445.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/ yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/5f/3e/JBCP-7-70.PMC4910470.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free  applications.,Non-OADS,/arxiv_data1/oa_pdf/5f/3e/JBCP-7-70.PMC4910470.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/ce/22/JBCP-7-75.PMC4910471.pdf
Available from: http://www.WHO-UMC.,Non-OADS,/arxiv_data1/oa_pdf/05/f3/JBCP-7-80.PMC4910472.pdf
Visit http://www.njisa.org for details.,Non-OADS,/arxiv_data1/oa_pdf/95/f0/IJA-60-388.PMC4910477.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/ yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/36/aa/IJA-60-403.PMC4910480.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free  applications.,Non-OADS,/arxiv_data1/oa_pdf/36/aa/IJA-60-403.PMC4910480.pdf
50Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/65/95/IJA-60-409.PMC4910481.pdf
Available from: http://www.iem.sagepub.com 1 Oct. 2015.,Non-OADS,/arxiv_data1/oa_pdf/7e/0b/IJA-60-427.PMC4910485.pdf
Available from: http://www.iem.sagepub.com 1 Oct. 2015.,Non-OADS,/arxiv_data1/oa_pdf/49/f3/IJA-60-429.PMC4910486.pdf
Available from: http://www.intersurgical.com/products/ anaesthesia/explorer‑endoscopy‑masks/uploads.,Non-OADS,/arxiv_data1/oa_pdf/b7/5a/IJA-60-439.PMC4910491.pdf
Available from: http://www.curaplex.com/docs/pom/ Curaplex_POM_Brochure.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b7/5a/IJA-60-439.PMC4910491.pdf
Available from: http://www.intersurgical.com/products/ anaesthesia/explorer‑endoscopy‑masks/uploads.,Non-OADS,/arxiv_data1/oa_pdf/61/32/IJA-60-441.PMC4910492.pdf
Available from: http://www.curaplex.com/docs/pom/ Curaplex_POM_Brochure.pdf.,Non-OADS,/arxiv_data1/oa_pdf/61/32/IJA-60-441.PMC4910492.pdf
Available from: http://www.practicalclinicalskills.,Non-OADS,/arxiv_data1/oa_pdf/61/32/IJA-60-441.PMC4910492.pdf
Available from: http://www.practicalclinicalskills.,Non-OADS,/arxiv_data1/oa_pdf/7d/2c/IJA-60-442.PMC4910493.pdf
Available from: http://ispub.com/IJA/22/1/12842.,Non-OADS,/arxiv_data1/oa_pdf/7d/2c/IJA-60-442.PMC4910493.pdf
The partial specific volume at 20 °C and the molecu- lar weight of the protein were calculated based on its amino acidcomposition using the software SEDFIT (https://sedfitsedphat.nibib.nih.gov/software/default.aspx).,OADS,/arxiv_data1/oa_pdf/40/60/EMBJ-35-1254.PMC4910529.pdf
"Global leastsquares modeling was performed at multiple rotor speeds with thesoftware SEDPHAT (https://sedfitsedphat.nibib.nih.gov/software/default.aspx) using the reversible monomer –dimer self-association model (Zhao et al, 2013a).",OADS,/arxiv_data1/oa_pdf/40/60/EMBJ-35-1254.PMC4910529.pdf
"One major component of this large multi-centre randomised clinical trial will be the use of a sophisticated software tool to optimise medication therapy and to deter - mine whether the applied intervention can improve clinical outcomes such as drug-related admissions (DRAs), human-istic outcomes such as quality of life and reduce healthcare costs (https://operam2020.tp21.com).",Non-OADS,/arxiv_data1/oa_pdf/f2/1e/10.1177_2050312116652568.PMC4910534.pdf
Materials and Methods: Registered clinical trials in World Health Organization International Clinical Trials Registry Platform ( http://apps.who.int/trialsearch/AdvSearch.aspx ) in the following ﬁelds were extracted: Acupuncture; Ayurveda; biofeedback; complementary and alternate medicine; herbal; ho-meopathy; massage; naturopathy; Reiki; Siddha; Unani; and yoga.,Non-OADS,/arxiv_data1/oa_pdf/1c/e0/main.PMC4910572.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1c/e0/main.PMC4910572.pdf
"Contents lists available at ScienceDirect Journal of Ayurveda and Integrative Medicine journal homepage: http://elsevier.com/locate/jaim http://dx.doi.org/10.1016/j.jaim.2015.09.003 0975-9476/ ©2016 Transdisciplinary University, Bangalore and World Ayurveda Foundation.",Non-OADS,/arxiv_data1/oa_pdf/1c/e0/main.PMC4910572.pdf
This is an open access article un der the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Ayurveda and Integrative Medicine 7 (2016) 48 e52,Non-OADS,/arxiv_data1/oa_pdf/1c/e0/main.PMC4910572.pdf
Following keywords were used for the search in WHO-ICTRP (http://apps.who.int/trialsearch/AdvSearch.aspx ): Acupuncture; Ayurveda; biofeedback; complementary and alternate medicine (CAM); herbal; homeopathy; massage; naturopathy; Reiki; Siddha; Unani; and yoga.,OADS,/arxiv_data1/oa_pdf/1c/e0/main.PMC4910572.pdf
Available from: http://www.ncbi.nlm.nih.gov/books/NBK2659/ [accessed on 14.12.29].,Non-OADS,/arxiv_data1/oa_pdf/1c/e0/main.PMC4910572.pdf
Available from: http://www.apps.who.int/iris/bitstream/10665/76705/ 1/9789241504294_eng.pdf?ua ¼1.,Non-OADS,/arxiv_data1/oa_pdf/1c/e0/main.PMC4910572.pdf
Available from: http://www.consort-statement.org/ .,Non-OADS,/arxiv_data1/oa_pdf/1c/e0/main.PMC4910572.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/36/a8/main.PMC4910573.pdf
"Contents lists available at ScienceDirect Journal of Ayurveda and Integrative Medicine journal homepage: http://elsevier.com/locate/jaim http://dx.doi.org/10.1016/j.jaim.2016.05.002 0975-9476/ ©2016 Transdisciplinary University, Bangalore and World Ayurveda Foundation.",Non-OADS,/arxiv_data1/oa_pdf/36/a8/main.PMC4910573.pdf
This is an open access article un der the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Ayurveda and Integrative Medicine 7 (2016) 6 e10,Non-OADS,/arxiv_data1/oa_pdf/36/a8/main.PMC4910573.pdf
Available at: http://pib.nic.in/newsite/PrintRelease.aspx?relid ¼134132 .,Non-OADS,/arxiv_data1/oa_pdf/36/a8/main.PMC4910573.pdf
Available at: http://www.tkdl.res.in/ tkdl/langdefault/common/Home.asp .,Non-OADS,/arxiv_data1/oa_pdf/36/a8/main.PMC4910573.pdf
Indian J Pharmacol 2014;46(4): 363e71.http://dx.doi.org/10.4103/0253-7613.135946 .,Non-OADS,/arxiv_data1/oa_pdf/36/a8/main.PMC4910573.pdf
EPMA J 2014;5(1):19. http://dx.doi.org/10.1186/1878-5085-5-19 .,Non-OADS,/arxiv_data1/oa_pdf/36/a8/main.PMC4910573.pdf
Indian J Urology IJU J Urological Soc India 2009;25(3):384 e8.http://dx.doi.org/10.4103/0970- 1591.56208 .S.,Non-OADS,/arxiv_data1/oa_pdf/36/a8/main.PMC4910573.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/58/15/main.PMC4910574.pdf
"Contents lists available at ScienceDirect Journal of Ayurveda and Integrative Medicine journal homepage: http://elsevier.com/locate/jaim http://dx.doi.org/10.1016/j.jaim.2015.10.002 0975-9476/ ©2016 Transdisciplinary University, Bangalore and World Ayurveda Foundation.",Non-OADS,/arxiv_data1/oa_pdf/58/15/main.PMC4910574.pdf
This is an open access article un der the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Ayurveda and Integrative Medicine 7 (2016) 53 e56,Non-OADS,/arxiv_data1/oa_pdf/58/15/main.PMC4910574.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0b/de/main.PMC4910575.pdf
"Contents lists available at ScienceDirect Journal of Ayurveda and Integrative Medicine journal homepage: http://elsevier.com/locate/jaim http://dx.doi.org/10.1016/j.jaim.2015.09.002 0975-9476/ ©2016 Transdisciplinary University, Bangalore and World Ayurveda Foundation.",Non-OADS,/arxiv_data1/oa_pdf/0b/de/main.PMC4910575.pdf
This is an open access article un der the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Ayurveda and Integrative Medicine 7 (2016) 38 e43,Non-OADS,/arxiv_data1/oa_pdf/0b/de/main.PMC4910575.pdf
"Contents lists available at ScienceDirect Journal of Ayurveda and Integrative Medicine journal homepage: http://elsevier.com/locate/jaim Journal of Ayurveda and Integrative Medicine 7 (2016) 1 e2 http://dx.doi.org/10.1016/j.jaim.2016.05.001 0975-9476/ ©2016 Transdisciplinary University, Bangalore and World Ayurveda Foundation.",Non-OADS,/arxiv_data1/oa_pdf/40/08/main.PMC4910576.pdf
This is an open access article un der the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/40/08/main.PMC4910576.pdf
"Contents lists available at ScienceDirect Journal of Ayurveda and Integrative Medicine journal homepage: http://elsevier.com/locate/jaim Journal of Ayurveda and Integrative Medicine 7 (2016) 3 e5 http://dx.doi.org/10.1016/j.jaim.2016.03.002 0975-9476/ ©2016 Transdisciplinary University, Bangalore and World Ayurveda Foundation.",Non-OADS,/arxiv_data1/oa_pdf/f4/a6/main.PMC4910577.pdf
This is an open access article un der the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f4/a6/main.PMC4910577.pdf
[6]http://www.mciindia.org/circulars/Circular-03.09.2015-TEQ-Promotion- Publication.pdf (accessed on 8.12.15).,Non-OADS,/arxiv_data1/oa_pdf/f4/a6/main.PMC4910577.pdf
Issues in Science and Technology Librarianship; 2002. http://dx.doi.org/10.5062/F41V5BZM .,Non-OADS,/arxiv_data1/oa_pdf/f4/a6/main.PMC4910577.pdf
[9]http://en.indexcopernicus.com/ (accessed on 1.12.15).,Non-OADS,/arxiv_data1/oa_pdf/f4/a6/main.PMC4910577.pdf
[10] http://scholarlyoa.com/publishers/ (accessed on 20.12.15).,Non-OADS,/arxiv_data1/oa_pdf/f4/a6/main.PMC4910577.pdf
[11] http://scholarlyoa.com/2013/11/21/index-copernicus-has-no-value (accessed on 20.12.15).,Non-OADS,/arxiv_data1/oa_pdf/f4/a6/main.PMC4910577.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/62/7b/ppa-10-1051.PMC4910608.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 1051–1062Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1051Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S10433 5 Patients’ management of type 2 diabetes in Middle  eastern countries: review of studies Zahra Khalil Alsairafi1 Kevin Michael Geoffrey  Taylor2 Felicity J Smith1 Abdulnabi T Alattar3 1Research Department of Practice and  Policy, 2Department of Pharmaceutics,   School of Pharmacy, University  College of London, London, UK;   3Diabetes Unit, Al-Amiri Hospital,   Ministry of Health, Safat, KuwaitAbstract:  The increased prevalence of diabetes in Middle Eastern countries is a health policy  priority.",Non-OADS,/arxiv_data1/oa_pdf/62/7b/ppa-10-1051.PMC4910608.pdf
"As a consequence, there is decreased physical activity  along with rising levels of obesity and smoking.5–9 Many people in the Middle East have been found not to appreciate the potential  seriousness of diabetes, its complications, or early detection signs.10 Patients’ beliefs Correspondence: Zahra Khalil Alsairafi Research Department of Practice  and Policy, School of Pharmacy,  University College of London,  London wC1N 1AX, UK Tel +44 745 028 0767 email jumanapharmacy@hotmail.co.u k Journal name: Patient Preference and Adherence Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Alsairafi et al Running head recto: Patients’ management of T2DM in the Middle East DOI: http://dx.doi.org/10.2147/PPA.S104335",Non-OADS,/arxiv_data1/oa_pdf/62/7b/ppa-10-1051.PMC4910608.pdf
"Available from: http://who.int/diabetes/e n. Accessed July 17, 2013.",Non-OADS,/arxiv_data1/oa_pdf/62/7b/ppa-10-1051.PMC4910608.pdf
Available from: http://knowledge.insead.edu/csr/ healthcare/combatting-diabetes-some-things-money-cant-buy-58 3.,Non-OADS,/arxiv_data1/oa_pdf/62/7b/ppa-10-1051.PMC4910608.pdf
"Available from: http://idf.org/diabetesatlas/5e/ middle-east-and-north-afric a. Accessed July 17, 2013.",Non-OADS,/arxiv_data1/oa_pdf/62/7b/ppa-10-1051.PMC4910608.pdf
Available from: http://who.int/chp/knowledge/ publications/adherence_report/en/.,OADS,/arxiv_data1/oa_pdf/62/7b/ppa-10-1051.PMC4910608.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/62/7b/ppa-10-1051.PMC4910608.pdf
"Available from:  http://nature.com/ nmiddleeast/2012/120724/full/nmiddleeast.2012.103.htm l. Accessed  July 20, 2013.",OADS,/arxiv_data1/oa_pdf/62/7b/ppa-10-1051.PMC4910608.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/bb/9a/ppa-10-1011.PMC4910609.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 1011–1019Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1011OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S10729 9 Treatment-related decisional conflict in patients  with depressive and anxious disorders carlos De las cuevas1 ramsés Marrero1 casimiro cabrera2 1Department of internal Medicine,   Dermatology and Psychiatry,   University of la laguna, san cristóbal  de la laguna, canary islands, spain;   2Department of Psychiatry, Queen’s  University, Kingston, On , canadaPurpose:  To determine the level of treatment-related decisional conflict in patients with emotional  disorders and to establish its relationship with sociodemographic and clinical variables.",Non-OADS,/arxiv_data1/oa_pdf/bb/9a/ppa-10-1011.PMC4910609.pdf
"But, psychiatry remains just an  uncertain science with many clinical situations in which more than one reasonable  possibility of intervention is available with no evidence that any of the options is  better than another.1 In this context, and despite the fact that patient participation in decision making  meets the ethical principle of patient autonomy and the legal requirement of informed  consent2 and has also been associated to better patients’ outcome measures,3 current  literature on the topic reports significant variability in how much patients want to  participate in this process.4–6 Moreover, making the right medical choices is harder  than ever since patients are overwhelmed by information from all sides: their doctors’ correspondence: carlos De las cuevas Department of internal Medicine,  Dermatology and Psychiatry, school  of health sciences, Medicine section,  University of la laguna, campus de  Ofra, 38071 san cristóbal de la laguna,  canary islands, spain Tel +34 609 521 405 email cdelascuevas@gmail.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: De las Cuevas et al Running head recto: Decisional conflict and treatment adherence DOI: http://dx.doi.org/10.2147/PPA.S107299",Non-OADS,/arxiv_data1/oa_pdf/bb/9a/ppa-10-1011.PMC4910609.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/bb/9a/ppa-10-1011.PMC4910609.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/f4/94/imcrj-9-145.PMC4910610.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/f4/94/imcrj-9-145.PMC4910610.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Medical Case Reports Journal 2016:9 145–148International Medical Case Reports Journal Dovepress submit your manuscript | www.dovepress.com Dovepress 145 CASE REPORT open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IMCRJ.S101011Dilemma in the emergency setting:  hypomagnesemia mimicking acute stroke María Rico Laura Martinez-Rodriguez Davinia Larrosa-Campo Sergio Calleja Neurology Department, Central  University Hospital of Asturias,  Oviedo, SpainBackground: Stroke mimics may account for up to 30% of all acute stroke consultations.",Non-OADS,/arxiv_data1/oa_pdf/f4/94/imcrj-9-145.PMC4910610.pdf
"Correspondence: María Rico Neurology Department, Central University Hospital of Asturias, José María Marcilla St 2C 7B Oviedo, 33006, SpainTel +34 407 606 369 776Email mricos@gmail.comJournal name: International Medical Case Reports Journal Article Designation: CASE REPORTY ear: 2016V olume: 9Running head verso: Rico et alRunning head recto: Hypomagnesemia mimicking acute strokeDOI: http://dx.doi.org/10.2147/IMCRJ.S101011",Non-OADS,/arxiv_data1/oa_pdf/f4/94/imcrj-9-145.PMC4910610.pdf
"International Medical Case Reports Journal 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/international-medical-case-reports-journal-journalThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/f4/94/imcrj-9-145.PMC4910610.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 148 Rico et al A low magnesium serum level as cause for SM, although  rare, is not unheard of.",Non-OADS,/arxiv_data1/oa_pdf/f4/94/imcrj-9-145.PMC4910610.pdf
http://www.fda.gov/Drugs/DrugSafety/ucm245011.htm.,Non-OADS,/arxiv_data1/oa_pdf/f4/94/imcrj-9-145.PMC4910610.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/33/7b/mder-9-139.PMC4910611.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/33/7b/mder-9-139.PMC4910611.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Medical Devices: Evidence and Research 2016:9 139–142Medical Devices: Evidence and Research Dovepress submit your manuscript | www.dovepress.com Dovepress 139 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/MDER.S104786 Thyroid surgery with a harmonic scalpel: an  experimental study Didier Dequanter1 Martin Lammens2 Nathalie Nagy1 Mohammad Shahla1 Yasmine Deniz1 Christine Aubert1 Y ouri Vanhemelrijck1 Philippe Lothaire1 1Department of Head and Neck  Surgery, Centre Hospitalier  Universitaire Charleroi, Charleroi,   2Department of Pathology,   Universitair Ziekenhuis Antwerpen,  Antwerp, BelgiumBackground: The goal of the study was to determinate the safety of the harmonic scalpel,  widely used in thyroidectomy, near the recurrent laryngeal nerve (RLN).",Non-OADS,/arxiv_data1/oa_pdf/33/7b/mder-9-139.PMC4910611.pdf
"After dissection, the pigs were euthanized and both RLNs were Correspondence: Didier Dequanter Department of Head and Neck Surgery, Centre Hospitalier Universitaire Charleroi, Maandal, 6, 1652 Alsemberg, BelgiumEmail: didier.dequanter@pandora.beJournal name: Medical Devices: Evidence and Research Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Dequanter et alRunning head recto: Safety of harmonic scalpel in thyroid surgeryDOI: http://dx.doi.org/10.2147/MDER.S104786",Non-OADS,/arxiv_data1/oa_pdf/33/7b/mder-9-139.PMC4910611.pdf
"Medical Devices: Evidence and Research 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Medical Devices: Evidence and Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/medical-devices-evidence-and-research-journalMedical Devices: Evidence and Research is an international, peer- reviewed, open access journal that focuses on the evidence, technology, research, and expert opinion supporting the use and application of   medical devices in the diagnosis, monitoring, treatment and management of clinical conditions and physiological processes.",Non-OADS,/arxiv_data1/oa_pdf/33/7b/mder-9-139.PMC4910611.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/94/f2/opth-10-1083.PMC4910612.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 1083–1094Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1083Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S11055 7 Development of lifitegrast: a novel T -cell inhibitor  for the treatment of dry eye disease Charles P Semba1 Thomas R Gadek2 1vascular and interventional  Radiology, Stanford University School  of Medicine, Stanford, CA, USA;   2Ophthalma Logic Consulting, Park  City, UT, USAAbstract:  Dry eye disease (DED) is a multifactorial disorder of the ocular surface characterized  by symptoms of discomfort, decreased tear quality, and chronic inflammation that affects an  estimated 20 million patients in the US alone.",Non-OADS,/arxiv_data1/oa_pdf/94/f2/opth-10-1083.PMC4910612.pdf
"For patients, the symptoms of chronic ocular dis - comfort, dryness, and irritation are associated with significant impairment in their  visual-related quality of life.1 For eye care specialists, DED remains one of the most  common reasons for patient visits and the burden is increasing as the population  ages.2 Attempts to advance new drug treatments to the marketplace have not been Correspondence: Charles P Semba vascular and interventional Radiology,  Stanford University Medical Center,  300 Pasteur Drive, H-3630, Stanford,   CA, 94304, USA Tel +1 650 736 6096 email csemba@stanford.ed u Journal name: Clinical Ophthalmology Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Semba and Gadek Running head recto: Development of lifitegrast DOI: http://dx.doi.org/10.2147/OPTH.S110557",Non-OADS,/arxiv_data1/oa_pdf/94/f2/opth-10-1083.PMC4910612.pdf
Available from: https://www.accessdata.fda.gov/scripts/cder/ drugsatfda /.,Non-OADS,/arxiv_data1/oa_pdf/94/f2/opth-10-1083.PMC4910612.pdf
"Available from: http://www.allergan.com/assets/pdf/ restasis_pi.pd f. Accessed March 12, 2016.",OADS,/arxiv_data1/oa_pdf/94/f2/opth-10-1083.PMC4910612.pdf
Available from: https://www.shire.com/ newsroom/2016/february/lifitegrast-resubmission-press-release-fda- acknowledgement-2-4-1 6.,Non-OADS,/arxiv_data1/oa_pdf/94/f2/opth-10-1083.PMC4910612.pdf
Available from: http://www.dryeyesummit.,Non-OADS,/arxiv_data1/oa_pdf/94/f2/opth-10-1083.PMC4910612.pdf
"Available from: https://www.shire.com/newsroom/2015/ october/shires-opus-3-phase-3-trial-with-lifitegrast-meets-primary-and- key-secondary-endpoint s. Accessed March 12, 2016.",Non-OADS,/arxiv_data1/oa_pdf/94/f2/opth-10-1083.PMC4910612.pdf
"Available from: https://www.shire.com/newsroom/2015/ march/shire-submits-application-to-the-us-fda-for-approval-   of-lifitegrast-for-treatment-o f. Accessed March 12, 2016.",Non-OADS,/arxiv_data1/oa_pdf/94/f2/opth-10-1083.PMC4910612.pdf
Available from:  http://www.fda.gov/downloads/Drugs/GuidanceCompliance% 20 RegulatoryInformation /Guidances/UCM078749.pdf +Providing +clin ical+evidence +of+effectiveness +for+human +and+bio&client =FDAg ov&site =FDAgov&lr =&proxystylesheet =FDAgov&outpu t=xml_no_ dtd&ie =UTF-8&access =p&oe =UTF- 8.,OADS,/arxiv_data1/oa_pdf/94/f2/opth-10-1083.PMC4910612.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/94/f2/opth-10-1083.PMC4910612.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/94/f2/opth-10-1083.PMC4910612.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/58/10/copd-11-1287.PMC4910613.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 1287–1295International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1287OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S10145 9Depression symptoms reduce physical activity in  COPD patients: a prospective multicenter study Iván Dueñas-espín1–5 heleen Demeyer6 elena gimeno-santos1–3 Michael I Polkey7 nicholas s hopkinson7 roberto a rabinovich8 Fabienne Dobbels9 niklas Karlsson10 Thierry Troosters6,11 Judith garcia-a ymerich1–3 On behalf of the P rOactive  Consortium 1Isglobal, Centre for research in  environmental epidemiology (Creal),  2Universitat Pompeu Fabra (UPF),  3CIBerepidemiología y salud Pública  (CIBeresP), Barcelona, spain; 4secretaría  nacional de educación superior, Ciencia,  T ecnología e Innovación del ecuador  (senesCYT), Quito, ecuador; 5Institut  d’investigacions Biomèdiques august Pi  i sunyer (IDIB aPs), Barcelona, spain;  6Department of rehabilitation sciences, KU  leuven, leuven, Belgium; 7nIhr respiratory  Biomedical research Unit at the royal  Brompton and harefield nhs Foundation  Trust and Imperial College, london,  UK; 8eleg I Colt laboratory, Centre for  Inflammation research, The Queen’s Medical  research Institute, University of edinburgh,  edinburgh, UK; 9Department of Public  health and Primary Care, academic Centre  for nursing and Midwifery, KU leuven,  leuven, Belgium; 10health economics  and Outcomes research, astraZeneca  r&D, Mölndal, sweden; 11Department of  respiratory Diseases, University hospitals  leuven, leuven, BelgiumBackground:  The role of anxiety and depression in the physical activity (PA) of patients  with COPD is controversial.",Non-OADS,/arxiv_data1/oa_pdf/58/10/copd-11-1287.PMC4910613.pdf
"This lack of information is in contrast with the  importance of PA in COPD, as regular PA has been consistently related to a reduced  risk of hospitalizations and death.1 Among the potential determinants of PA that can be modified at the clinical setting,  anxiety and depression are relevant because they are highly prevalent in COPD patients  and affect COPD prognosis.2–4 Anxiety has been reported in ∼40% of COPD patients.5  It can lead to tachypnea, which may worsen lung hyperinflation, leading to increased  exertional dyspnea, reduced exercise capacity, and poor quality of life.6 Depression,  in turn, has been identified in ∼25% of COPD patients5 and is also associated with  poorer exercise capacity and worse health status.2 Previous studies have assessed the association between anxiety and depres - sion symptoms with PA.7–15 However, they have a cross-sectional design so the  directionality of the association (eg, whether anxiety/depression reduces PA or Correspondence: Judith garcia-aymerich Centre for research in environmental  epidemiology, Doctor aiguader 88, 08003  Barcelona, spain Tel +34 93 214 7350 Fax +34 93 214 7302 email jgarcia@creal.ca t Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Dueñas-Espín et al Running head recto: The effects of anxiety and depression on physical activity in COPD DOI: http://dx.doi.org/10.2147/COPD.S101459",Non-OADS,/arxiv_data1/oa_pdf/58/10/copd-11-1287.PMC4910613.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/58/10/copd-11-1287.PMC4910613.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/58/10/copd-11-1287.PMC4910613.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/68/8a/copd-11-1279.PMC4910614.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 1279–1286International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1279OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S10571 7α1-antitrypsin reduces rhinovirus infection in  primary human airway epithelial cells exposed  to cigarette smoke reena Berman Di Jiang Qun Wu hong Wei Chu Department of Medicine, national  Jewish health, Denver, CO, UsaAbstract:  Human rhinovirus (HRV) infections target airway epithelium and are the leading  cause of acute exacerbations of COPD.",Non-OADS,/arxiv_data1/oa_pdf/68/8a/copd-11-1279.PMC4910614.pdf
"Serotyped strains of HRV are  categorized as either minor or major group viruses, depending on their entry receptor.8  Approximately 90% of identified serotypes are major group viruses (eg, HRV -16), which  use intercellular adhesion molecule-1 (ICAM-1) as their receptor.8 ICAM-1 is a trans - membrane glycoprotein receptor of the immunoglobulin superfamily and it functions in Correspondence: hong Wei Chu room a639, Department of Medicine,  national Jewish health, 1400 Jackson  street, Denver, CO 80206, Usa Tel +1 303 398 1689 Fax +1 303 270 2319 email chuhw@njhealth.or g Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Berman et al Running head recto: Antiviral function of α1-antitrypsin DOI: http://dx.doi.org/10.2147/COPD.S105717",Non-OADS,/arxiv_data1/oa_pdf/68/8a/copd-11-1279.PMC4910614.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/68/8a/copd-11-1279.PMC4910614.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/68/8a/copd-11-1279.PMC4910614.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7c/dc/opth-10-1079.PMC4910615.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 1079–1082Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1079Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S10639 2 The effect of long-term use of intranasal steroids  on intraocular pressure  Ali Şimşek1 Cem Bayraktar2 Sedat Dog ˘an2 Mehmet Karataş2 Yasin Sarıkaya2 1Department of Ophthalmology,   2Department of Otolaryngology  Head and Neck Surgery, Adıyaman  University research and education  Hospital, Adıyaman, T urkeyAbstract:  Long-term use of topical nasal steroids (especially older generation steroids) has  been shown to elevate intraocular pressure (IOP), but newer intranasal steroids are thought to  have a minimal effect on IOP because of their low bioavailability.",Non-OADS,/arxiv_data1/oa_pdf/7c/dc/opth-10-1079.PMC4910615.pdf
"All eye measurements were carried  Correspondence: Ali Şimşek  Department of Ophthalmology, Adıyaman  University research and education  Hospital, 1164 Street, Adıyaman 02200,  Turkey Tel +90 530 222 7060 Fax +90 416 214 5599 email alisimsek1980@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Şimşek et al Running head recto: Intranasal steroids and intraocular pressure DOI: http://dx.doi.org/10.2147/OPTH.S106392",Non-OADS,/arxiv_data1/oa_pdf/7c/dc/opth-10-1079.PMC4910615.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/7c/dc/opth-10-1079.PMC4910615.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/7c/dc/opth-10-1079.PMC4910615.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a9/ec/tcrm-12-957.PMC4910616.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 957–964Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  957Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S8013 1 Treatment of patients with chronic  thrombo embolic pulmonary hypertension:  focus on riociguat Zachary R Smith1 Charles T Makowski1 Rana L Awdish2 1Department of Pharmacy Services,   2Pulmonary and Critical Care  Medicine Division, Henry Ford  Hospital, Detroit, M i, USAAbstract:  Chronic thromboembolic pulmonary hypertension (CTEPH) is a disease of the  pulmonary vascular bed that is characterized by elevations in the mean pulmonary artery pressure  in the setting of perfusion defects on ventilation–perfusion scan, and subsequently confirmed  by pulmonary angiography.",Non-OADS,/arxiv_data1/oa_pdf/a9/ec/tcrm-12-957.PMC4910616.pdf
"The estimated prevalence of CTEPH after an acute PE is  0.1%–4.0% after 2 years.4 However, up to 25% of patients have no previous diagnosis  of PE.5 If suspected, CTEPH is screened for with a transthoracic echocardiogram and  radionuclide ventilation/perfusion (VQ) scan, followed by an RHC with pulmonary  angiography for disease confirmation and assessment of operability.6 The current  treatment of choice for CTEPH includes lifelong anticoagulation and referral to Correspondence: Zachary R Smith Department of Pharmacy Services,  Henry Ford Hospital, 2799 west Grand  Boulevard, Detroit, Mi 48202, USA Tel +1 313 916 1799 email zsmith1@hfhs.or g Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2016 Volume: 12 Running head verso: Smith et al Running head recto: Riociguat’s role in CTEPH DOI: http://dx.doi.org/10.2147/TCRM.S80131",Non-OADS,/arxiv_data1/oa_pdf/a9/ec/tcrm-12-957.PMC4910616.pdf
Available from: http://www.accessdata.fda.,OADS,/arxiv_data1/oa_pdf/a9/ec/tcrm-12-957.PMC4910616.pdf
Available from: http://www.accessdata.fda.,OADS,/arxiv_data1/oa_pdf/a9/ec/tcrm-12-957.PMC4910616.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/a9/ec/tcrm-12-957.PMC4910616.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a9/ec/tcrm-12-957.PMC4910616.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/89/d2/ceor-8-243.PMC4910617.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/89/d2/ceor-8-243.PMC4910617.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).ClinicoEconomics and Outcomes Research 2016:8 243–252ClinicoEconomics and Outcomes Research Dovepress submit your manuscript | www.dovepress.com Dovepress  243 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEOR.S105579Cost-effectiveness of tiotropium versus  glycopyrronium in moderate to very severe  chronic obstructive pulmonary disease in Canada,  Spain, Sweden, and the UK Oskar Eklund1  Faraz Afzal2  Fredrik Borgström1  Jason Flavin3  Andrew T ernouth4  Maria Eugenia Ojanguren5  Carlos Crespo5  Mike Baldwin6 1Quantify Research AB, Stockholm,   Sweden; 2Boehringer Ingelheim, Asker,   Norway; 3Boehringer Ingelheim,   Burlington, ON, Canada; 4Boehringer  Ingelheim, Bracknell, Berkshire, UK;   5Boehringer Ingelheim, Sant Cugat del  Vallès, Barcelona, Spain; 6Boehringer  Ingelheim, Ingelheim, GermanyObjectives:  Tiotropium (TIO), Spiriva® Handihaler®, is a well-established bronchodilator,  LAMA (long acting muscarinic antagonist), for the treatment of moderate to very severe chronic  obstructive pulmonary disease (COPD).",Non-OADS,/arxiv_data1/oa_pdf/89/d2/ceor-8-243.PMC4910617.pdf
"Keywords: COPD, exacerbations, tiotropium, glycopyrronium, cost-effectiveness, Markov  cohort model Introduction Background Chronic obstructive pulmonary disease (COPD) is a chronic respiratory disease  affecting ~5%–10% of the adult population.1–4 In the European Union, COPD stands Correspondence: Oskar Eklund Quantify Research AB, Hantverkargatan 8, 11221 Stockholm, SwedenEmail: oskar.eklund@quantifyresearch.comJournal name: ClinicoEconomics and Outcomes Research Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 8Running head verso: Eklund et alRunning head recto: Cost-effectiveness of TIO versus GL Y in moderate to very severe COPDDOI: http://dx.doi.org/10.2147/CEOR.S105579",Non-OADS,/arxiv_data1/oa_pdf/89/d2/ceor-8-243.PMC4910617.pdf
"ClinicoEconomics and Outcomes Research 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinicoeconomics-and-outcomes-research-journalClinicoEconomics and Outcomes Research is an international, peer- reviewed open-access journal focusing on health technology assess-ment, pharmacoeconomics and outcomes research in the areas of   diagnosis, medical devices, and clinical, surgical and pharmacological intervention.",Non-OADS,/arxiv_data1/oa_pdf/89/d2/ceor-8-243.PMC4910617.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 252 Eklund et al 26.,Non-OADS,/arxiv_data1/oa_pdf/89/d2/ceor-8-243.PMC4910617.pdf
Available from: http://www.ons.gov.uk/ons/rel/vsob1/mortality-statistics--deaths-registered-in-england-and-wales--series-dr-/2012/dr-tables-2012.xls.,Non-OADS,/arxiv_data1/oa_pdf/89/d2/ceor-8-243.PMC4910617.pdf
Available from: http://www5.statcan.gc.ca/cansim/a26?id=1020551&retrLang=eng&lang=eng.,OADS,/arxiv_data1/oa_pdf/89/d2/ceor-8-243.PMC4910617.pdf
Available from: http://www.socialstyrelsen.se/statistik/statistikefteramne/dodsorsaker.,OADS,/arxiv_data1/oa_pdf/89/d2/ceor-8-243.PMC4910617.pdf
Available from: http://apps.who.int/healthinfo/statistics/mortality/causeofdeath_query/definitions/definitions.html.,Non-OADS,/arxiv_data1/oa_pdf/89/d2/ceor-8-243.PMC4910617.pdf
Available from: https://www.healthinfo.moh.gov.on.ca/formulary/.,Non-OADS,/arxiv_data1/oa_pdf/89/d2/ceor-8-243.PMC4910617.pdf
Available from: https://botplusweb.portalfarma.com/botplus.aspx.,Non-OADS,/arxiv_data1/oa_pdf/89/d2/ceor-8-243.PMC4910617.pdf
Available from: https://www.msssi.gob.es/profesionales/farmacia.,Non-OADS,/arxiv_data1/oa_pdf/89/d2/ceor-8-243.PMC4910617.pdf
Available from: http://www.tlv.se/beslut/sok/lakemedel/.,Non-OADS,/arxiv_data1/oa_pdf/89/d2/ceor-8-243.PMC4910617.pdf
Available from: http://www.mims.co.uk/.,Non-OADS,/arxiv_data1/oa_pdf/89/d2/ceor-8-243.PMC4910617.pdf
Available from: http://www.bankofcanada.ca/stats/ assets/pdf/nraa-2014-en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/89/d2/ceor-8-243.PMC4910617.pdf
Available from: http://www.riksbank.se/sv/Rantor-och-valutakurser/Arsgenomsnitt-valutakurser/?y= 2014&m= 12 &s=Comma#search.,OADS,/arxiv_data1/oa_pdf/89/d2/ceor-8-243.PMC4910617.pdf
Available from: http://www.bankofengland.co.uk/statistics/Pages/default.aspx.,Non-OADS,/arxiv_data1/oa_pdf/89/d2/ceor-8-243.PMC4910617.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e5/84/main.PMC4910650.pdf
"Contents lists available at ScienceDirect Journal of Ayurveda and Integrative Medicine journal homepage: http://elsevier.com/locate/jaim http://dx.doi.org/10.1016/j.jaim.2015.08.001 0975-9476/ ©2016 Transdisciplinary University, Bangalore and World Ayurveda Foundation.",Non-OADS,/arxiv_data1/oa_pdf/e5/84/main.PMC4910650.pdf
This is an open access article un der the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Ayurveda and Integrative Medicine 7 (2016) 30 e37,Non-OADS,/arxiv_data1/oa_pdf/e5/84/main.PMC4910650.pdf
Available from: http://www.dx.doi.org/10.1787/9789264070684-en [Last cited on 2015 Jun 04].,Non-OADS,/arxiv_data1/oa_pdf/e5/84/main.PMC4910650.pdf
Available from: http://www.dx.,Non-OADS,/arxiv_data1/oa_pdf/e5/84/main.PMC4910650.pdf
"415Chemical Senses , 2016, Vol 41, 415–425 doi:10.1093/chemse/bjw016 Original Article Advance Access publication March 2, 2016 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ad/89/bjw016.PMC4910673.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/47/f8/clep-8-185.PMC4910677.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/47/f8/clep-8-185.PMC4910677.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical Epidemiology 2016:8 185–193Clinical Epidemiology Dovepress submit your manuscript | www.dovepress.com Dovepress 185 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CLEP .S103346Validation of self-reported and hospital-diagnosed  atrial fibrillation: the HUNT study Vegard Malmo1,2  Arnulf Langhammer3  Kaare H Bønaa2,3,4  Jan P Loennechen1,2  Hanne Ellekjaer5,6 1Department of Circulation and  Medical Imaging, Norwegian  University of Science and T echnology,   2Department of Cardiology, St  Olav’s Hospital, 3Department of  Public Health and General Practice,  Norwegian University of Science and T echnology, Trondheim,  4Department  of Community Medicine, UiT The Arctic University of Norway,  Tromso,  5Stroke Unit, Department of  Internal Medicine, St Olav’s Hospital,   6Department of Neuroscience,   Norwegian University of Science and T echnology, Trondheim, NorwayBackground: Self-reported atrial fibrillation (AF) and diagnoses from hospital registers are  often used to identify persons with AF .",Non-OADS,/arxiv_data1/oa_pdf/47/f8/clep-8-185.PMC4910677.pdf
"To our knowledge, no studies have compared self-reported and hospital-diagnosed AF .Correspondence: Vegard Malmo Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, PO Box 8905, 7491 Trondheim, NorwayTel +47 72 82 97 56Fax +47 73 86 79 66   Email vegard.malmo@ntnu.noJournal name: Clinical Epidemiology Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 8Running head verso: Malmo et alRunning head recto: Validation of self-reported and hospital-diagnosed AFDOI: http://dx.doi.org/10.2147/CLEP .S103346",Non-OADS,/arxiv_data1/oa_pdf/47/f8/clep-8-185.PMC4910677.pdf
"Clinical Epidemiology 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical Epidemiology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-epidemiology-journalClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica-tion of risk factors and screening procedures to develop optimal pre-ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/47/f8/clep-8-185.PMC4910677.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/12/f8/ijgm-9-205.PMC4910678.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/12/f8/ijgm-9-205.PMC4910678.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Journal of General Medicine International Journal of General Medicine 2016:9 205Dovepress submit your manuscript | www.dovepress.com Dovepress 205 CORRIGENDUM open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJGM.S110164Amino acid management of Parkinson’s disease: a case study  [Corrigendum]Journal name: International Journal of General Medicine Article Designation: CORRIGENDUMY ear: 2016V olume: 9Running head verso: Hinz  et alRunning head recto: DOI: http://dx.doi.org/10.2147/IJGM.S110164 International Journal of General Medicine Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/international-journal-of-general-medicine-journalThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat-ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/12/f8/ijgm-9-205.PMC4910678.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.DovepressHinz M, Stein A, Uncini T. Int J Gen Med.",Non-OADS,/arxiv_data1/oa_pdf/12/f8/ijgm-9-205.PMC4910678.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/7b/b2/clep-8-195.PMC4910679.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/7b/b2/clep-8-195.PMC4910679.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical Epidemiology 2016:8 195–200Clinical Epidemiology Dovepress submit your manuscript | www.dovepress.com Dovepress 195 REviEw open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/DOI: 10.2147/CLEP .S97874 Challenges in translating endpoints from trials to  observational cohort studies in oncology Anne Gulbech Ording1 Deirdre Cronin-Fenton1 vera Ehrenstein1 Timothy L Lash1,2 John Acquavella1 Mikael Rørth1 Henrik T oft Sørensen1 1Department of Clinical  Epidemiology, Aarhus University  Hospital, Aarhus, Denmark;   2Department of Epidemiology,   Rollins  School of Public Health,   Emory University, Atlanta,  GA, USAAbstract: Clinical trials are considered the gold standard for examining drug efficacy and for  approval of new drugs.",Non-OADS,/arxiv_data1/oa_pdf/7b/b2/clep-8-195.PMC4910679.pdf
"5,6 After authorization, regulatory agencies may require studies that identify,  characterize, or quantify safety hazards to refine the safety profile of new drugs.5,6 Large databases have been established in many countries to measure national  cancer incidence and outcomes, such as the Surveillance, Epidemiology and End Correspondence: Anne Gulbech Ording Department of Clinical Epidemiology, Aarhus University Hospital, Olof Palmes Allé 43-45, 8200 Aarhus, DenmarkTel +45 8716 8063Fax +45 8716 7215Email ao@clin.au.dkJournal name: Clinical Epidemiology Article Designation: ReviewY ear: 2016V olume: 8Running head verso: Ording et alRunning head recto: Endpoints in oncology research studiesDOI: http://dx.doi.org/DOI: 10.2147/CLEP .S97874",Non-OADS,/arxiv_data1/oa_pdf/7b/b2/clep-8-195.PMC4910679.pdf
"Clinical Epidemiology 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical Epidemiology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-epidemiology-journalClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica-tion of risk factors and screening procedures to develop optimal pre-ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/7b/b2/clep-8-195.PMC4910679.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/51/87/ijgm-9-183.PMC4910680.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/51/87/ijgm-9-183.PMC4910680.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Journal of General Medicine 2016:9 183–189International Journal of General Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress 183 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJGM.S100237Novel biomarker analysis of pleural effusion  enhances differentiation of tuberculous from  malignant pleural effusion Kuan-Yuan Chen1,2 Po-Hao Feng1,2 Chih-Cheng Chang1 Tzu-Tao Chen1 Hsiao-Chi Chuang1,3 Chun-Nin Lee1,3 Chien-Ling Su1,3 Lian-Yu Lin4 Kang-Yun Lee1,2 1Division of Pulmonary Medicine,   Department of Internal Medicine,   Shuang Ho Hospital, 2Department of  Internal Medicine, School of Medicine,   3School of Respiratory Therapy,   College of Medicine, Taipei Medical University,  4Division of Cardiology,   Department of Internal Medicine,  National Taiwan University Hospital,  Taipei, Taiwan, Republic of ChinaAbstract: Lymphocytic pleurisy is commonly observed in tuberculosis and cancer.",Non-OADS,/arxiv_data1/oa_pdf/51/87/ijgm-9-183.PMC4910680.pdf
"5,6 During TB and malignancy, T lymphocytes with a helper/ inducer phenotype form the major lymphocyte population in the pleural fluid,7 but  different subpopulations, activation states, and subsequent immune responses are Correspondence: Kang-Yun Lee   Division of Pulmonary Medicine,  Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, No 291 Zhongzheng Road, Zhonghe District, New Taipei City, Taiwan 235, Republic of ChinaTel +886 2 2736 1661 ext3516   Fax +886 2 2739 1143   Email kangyunlee68@gmail.comJournal name: International Journal of General Medicine Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Chen et alRunning head recto: Novel biomarkers in TB and malignant pleural effusionDOI: http://dx.doi.org/10.2147/IJGM.S100237",Non-OADS,/arxiv_data1/oa_pdf/51/87/ijgm-9-183.PMC4910680.pdf
"International Journal of General Medicine 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress International Journal of General Medicine Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/international-journal-of-general-medicine-journalThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat-ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/51/87/ijgm-9-183.PMC4910680.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 189 Novel biomarkers in TB and malignant pleural effusion 38.,Non-OADS,/arxiv_data1/oa_pdf/51/87/ijgm-9-183.PMC4910680.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/80/04/amep-7-341.PMC4910681.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/80/04/amep-7-341.PMC4910681.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2016:7 341–346Advances in Medical Education and Practice Dovepress submit your manuscript | www.dovepress.com Dovepress 341 OriginAl rEsEArch open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S108477 study on personality dimension negative  emotionality affecting academic achievement  among Malaysian medical students studying  in Malaysia and overseas Vidya Bhagat1 Mainul haque2 nordin Bin simbak1 Kamarudin Jaalam3 1Faculty of Medicine, Universiti  sultan Zainal Abidin, Jalan sultan  Mahmud, Kuala T erengganu, Malaysia;    2Faculty of Medicine and Defense  health, national Defence University  of Malaysia, Kuala lumpur, Malaysia;   3UsM-K lE international Medical  Program, Belgaum, Karnataka, indiaAbstract:  Personality dimension negative emotionality is known to be associated with academic  achievement.",Non-OADS,/arxiv_data1/oa_pdf/80/04/amep-7-341.PMC4910681.pdf
"Generally, it is believed that lack of correspondence: Vidya Bhagat Unit of Psychological Medicine, Faculty of Medicine (FP), Medical campus, Universiti sultan Zainal Abidin, Jalan sultan Mahmud, 20400 Kuala Terengganu, Terengganu, MalaysiaEmail 55vidya42@gmail.comJournal name: Advances in Medical Education and Practice Article Designation: Original ResearchY ear: 2016V olume: 7Running head verso: Bhagat et alRunning head recto: Negative emotionality affecting the academic achievement of medical studentsDOI: http://dx.doi.org/10.2147/AMEP .S108477 Video abstract Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/80/04/amep-7-341.PMC4910681.pdf
Or use: http://youtu.be/9moKhsjsT18,Non-OADS,/arxiv_data1/oa_pdf/80/04/amep-7-341.PMC4910681.pdf
Available from: http://catalogue.pearson   ed.co.uk/samplechapter/0132431564.pdf.,Non-OADS,/arxiv_data1/oa_pdf/80/04/amep-7-341.PMC4910681.pdf
Available from: http://www.turkpsikiyatri.org/arsiv/personality.disorders.millon.pdf.,Non-OADS,/arxiv_data1/oa_pdf/80/04/amep-7-341.PMC4910681.pdf
Available from: http://www.mentalhealthpromotion.net/resources/occupational-stress-fractors-that-contribute-to-its-occurrence-and-effective-management.pdf.,Non-OADS,/arxiv_data1/oa_pdf/80/04/amep-7-341.PMC4910681.pdf
Available from: http://www.gmc-uk.org/Identifying_good_practice_among_medcal_schools_in_the_support_of_students_with_mental_health_concerns.pdf_52884825.pdf.,Non-OADS,/arxiv_data1/oa_pdf/80/04/amep-7-341.PMC4910681.pdf
Available  from: http://susannabarlow.com/healing/the-five-stages-of-emotional-healing/.,Non-OADS,/arxiv_data1/oa_pdf/80/04/amep-7-341.PMC4910681.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-  reviewed, open access journal that aims to present and publish research on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/80/04/amep-7-341.PMC4910681.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Advances in Medical Education and Practice 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Dovepress 346 Bhagat et al  31.,Non-OADS,/arxiv_data1/oa_pdf/80/04/amep-7-341.PMC4910681.pdf
Available from: https://www.nafsa.org/_/File/_/InternationalEducator/Edu   cationAbroadNovDec05.pdf.,Non-OADS,/arxiv_data1/oa_pdf/80/04/amep-7-341.PMC4910681.pdf
Available from: https://www.theseus.fi/bitstream/handle/10024/44723/KEMI_OMODONA.pdf?sequence=1.,Non-OADS,/arxiv_data1/oa_pdf/80/04/amep-7-341.PMC4910681.pdf
Available from: http://www.uky.edu/~ kdbrad2/InternationalStudents.pdf.,Non-OADS,/arxiv_data1/oa_pdf/80/04/amep-7-341.PMC4910681.pdf
Available from: http://aiec.idp.com/uploads/pdf/Thomson%20(Paper)%20Fri%201050%20MR5.pdf.,Non-OADS,/arxiv_data1/oa_pdf/80/04/amep-7-341.PMC4910681.pdf
Organized by http://WorldConferences.net.,Non-OADS,/arxiv_data1/oa_pdf/80/04/amep-7-341.PMC4910681.pdf
Available from: http://worldconferences.net/proceedings/icssr2014/toc/papers_icssr2014/IC%20063%20NUR%20SAFWATI%20BINTI%20IBRAHIM%20-%20A%20Meta-Analysis%20Of%20The%20Relationship%20Between.pdf.,Non-OADS,/arxiv_data1/oa_pdf/80/04/amep-7-341.PMC4910681.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b2/38/ndt-12-1341.PMC4910682.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 1341–1349Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1341Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S10193 8Randomized controlled trials – a matter of design Peter Markus Spieth1,2 Anne Sophie Kubasch3 Ana isabel Penzlin4 Ben Min-w oo illigens2,5 Kristian Barlinn6 Timo Siepmann2,6,7 1Department of Anesthesiology and  Critical Care Medicine, University  Hospital Carl Gustav Carus,   T echnische Universität Dresden,   2Center for Clinical Research and  Management education, Division  of Health Care Sciences, Dresden  international University, 3Pediatric  Rheumatology and immunology,   Children’s Hospital, University  Hospital Carl Gustav Carus,   T echnische Universität Dresden,   4institute of Clinical Pharmacology,   University Hospital Carl Gustav  Carus, Technische Universität  Dresden, Dresden, Saxony, Germany;   5Department of Neurology, Beth  israel Deaconess Medical Center,   Harvard Medical School, Boston, MA,   USA; 6Department of Neurology,   University Hospital Carl Gustav  Carus, Technische Universität  Dresden, Dresden, Saxony, Germany;   7Radcliffe Department of Medicine,   John Radcliffe Hospital, University  of Oxford, Oxford, Oxfordshire, UKAbstract:  Randomized controlled trials (RCTs) are the hallmark of evidence-based medicine  and form the basis for translating research data into clinical practice.",Non-OADS,/arxiv_data1/oa_pdf/b2/38/ndt-12-1341.PMC4910682.pdf
"These types Correspondence: Timo Siepmann Department of Neurology, University  Hospital Carl Gustav Carus, Technische  Universität Dresden, Fetscherstr 74,  01307 Dresden, Saxony, Germany Tel +49 351 458 3565 Fax +49 351 458 4365 email timo.siepmann@uniklinikum- dresden.d e Journal name: Neuropsychiatric Disease and Treatment Article Designation: Review Y ear: 2016 Volume: 12 Running head verso: Spieth et al Running head recto: Randomized controlled trials DOI: http://dx.doi.org/10.2147/NDT.S101938",Non-OADS,/arxiv_data1/oa_pdf/b2/38/ndt-12-1341.PMC4910682.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/b2/38/ndt-12-1341.PMC4910682.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b2/38/ndt-12-1341.PMC4910682.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/64/c4/clep-8-165.PMC4910683.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/64/c4/clep-8-165.PMC4910683.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical Epidemiology 2016:8 165–175Clinical Epidemiology Dovepress submit your manuscript | www.dovepress.com Dovepress 165 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CLEP .S102029Changing prevalence and the risk factors for  antenatal obstetric hospitalizations in Denmark  2003–2012 Jane Bendix1 Hanne Kristine Hegaard2 Jens Langhoff-Roos3 Thomas Bergholt3 1Department of Gynaecology and  Obstetrics, Nordsjaellands Hospital  Hillerod, University of Copenhagen,  Hillerod, Denmark;  2The Research  Unit of Women’s and Children’s Health, The Juliane Marie Centre for Women, Children and Reproduction,  Rigshospitalet, University of Copenhagen, Copenhagen, Denmark;   3Department of Obstetrics, The  Juliane Marie Centre, Rigshospitalet,  University of Copenhagen,  Copenhagen, DenmarkPurpose: Population-based studies evaluating the use and extent of antenatal obstetric hospi- talizations (AOH) are sparse.",Non-OADS,/arxiv_data1/oa_pdf/64/c4/clep-8-165.PMC4910683.pdf
"3,5,6 Hospitalization may also be used to restrict the pregnant women’ s  physical  activity, which is traditionally considered beneficial despite the lack of evidence to Correspondence: Jane Bendix Department of Gynaecology and Obstetrics, Nordsjaellands Hospital, Hillerod, Dyrehavevej 29, G0111, 3400 Hillerod, DenmarkTel +45 4829 6443Email Jane.Bendix@regionh.dkJournal name: Clinical Epidemiology Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 8Running head verso: Bendix et alRunning head recto: Antenatal obstetric hospitalizations in Denmark 2003–2012DOI: http://dx.doi.org/10.2147/CLEP .S102029",Non-OADS,/arxiv_data1/oa_pdf/64/c4/clep-8-165.PMC4910683.pdf
Available from: http://apps.who.int/classifications/icd10/browse/2016/en#/XV .,OADS,/arxiv_data1/oa_pdf/64/c4/clep-8-165.PMC4910683.pdf
Available from: http://www.phac-aspc.gc.ca/rhs-ssg/pdf/survey-eng.pdf.,OADS,/arxiv_data1/oa_pdf/64/c4/clep-8-165.PMC4910683.pdf
Available from: http://sundhedsstyrelsen.dk/publ/tidsskrifter/nyetal/pdf/2007/14_07.pdf.,Non-OADS,/arxiv_data1/oa_pdf/64/c4/clep-8-165.PMC4910683.pdf
Available from: https://stps.dk/da/udgivelser/2012/~/media/E8FC80BA99F14573AE-6BE7649381503F .ashx.,Non-OADS,/arxiv_data1/oa_pdf/64/c4/clep-8-165.PMC4910683.pdf
Available from: https://sundhedsstyrelsen.dk/da/nyheder/2013/~ /media/122F19FC1C8147EB 8184D09BF98CC3E4.ashx.,Non-OADS,/arxiv_data1/oa_pdf/64/c4/clep-8-165.PMC4910683.pdf
"Clinical Epidemiology 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical Epidemiology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-epidemiology-journalClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica-tion of risk factors and screening procedures to develop optimal pre-ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/64/c4/clep-8-165.PMC4910683.pdf
Available from: http://sundheds-styrelsen.dk/publ/Publ2003/LPR.pdf.,Non-OADS,/arxiv_data1/oa_pdf/64/c4/clep-8-165.PMC4910683.pdf
Available from: https://www.rcog.org.uk/globalassets/docu-ments/guidelines/gtg44pprom28022011.pdf.,Non-OADS,/arxiv_data1/oa_pdf/64/c4/clep-8-165.PMC4910683.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/f0/06/ijgm-9-199.PMC4910684.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/f0/06/ijgm-9-199.PMC4910684.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Journal of General Medicine 2016:9 199–204International Journal of General Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress 199 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJGM.S101556Utilizing a medical questionnaire to predict  anxiety and depression in outpatients Hideki Kajiwara1  Y oshiyuki Ohira1  Akiko Ikegami1  Nao Hanazawa1  Takako Masuyama1,2  T omoko Yamashita1  Takeshi Kondo1  Kiyoshi Shikino1  Masatomi Ikusaka1 1Department of General Medicine,   Chiba University Hospital, Chiba-shi,   2Department of General Medicine,   Kimitsu Chuo Hospital, Kisarazu-shi,   Chiba, JapanIntroduction: Anxiety and depressive symptoms are seen in patients with anxiety and mood  disorders but are also common in those with organic disorders.",Non-OADS,/arxiv_data1/oa_pdf/f0/06/ijgm-9-199.PMC4910684.pdf
"1 Symptoms of anxiety and depression commonly develop in other psychi- atric disorders2–7 and may also develop in physical disorders, including heart disease,  central nervous system disease, diabetes mellitus, and cancer.8 When patients with  such disorders visit primary care outpatient clinics or hospital outpatient departments of general medicine, physical, rather than anxiety and depressive, symptoms are the Correspondence: Hideki Kajiwara   Department of General Medicine, Chiba  University Hospital, 1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba 260-8677, Japan   Tel +81 43 222 7171   Fax +81 43 224 4758   Email hidamaru@lapis.plala.or.jpJournal name: International Journal of General Medicine Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Kajiwara et alRunning head recto: Medical questionnaire to predict anxiety and depressionDOI: http://dx.doi.org/10.2147/IJGM.S101556",Non-OADS,/arxiv_data1/oa_pdf/f0/06/ijgm-9-199.PMC4910684.pdf
"International Journal of General Medicine 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress International Journal of General Medicine Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/international-journal-of-general-medicine-journalThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat-ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/f0/06/ijgm-9-199.PMC4910684.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 204 Kajiwara et al 26.,Non-OADS,/arxiv_data1/oa_pdf/f0/06/ijgm-9-199.PMC4910684.pdf
Available from: http://www8.cao.go.jp/jisatsutaisaku/whitepaper/en/w-2013/summary.html.,OADS,/arxiv_data1/oa_pdf/f0/06/ijgm-9-199.PMC4910684.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/14/27/clep-8-177.PMC4910685.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/14/27/clep-8-177.PMC4910685.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical Epidemiology 2016:8 177–184Clinical Epidemiology Dovepress submit your manuscript | www.dovepress.com Dovepress 177 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CLEP .S107060 Doubling of serum creatinine and the risk of  cardiovascular outcomes in patients with chronic  kidney disease and type 2 diabetes mellitus: a  cohort study Cornelia Schneider1,2 Blai Coll3 Susan S Jick4 Christoph R Meier1,2,4 1Basel Pharmacoepidemiology  Unit, Division of Clinical Pharmacy  and Epidemiology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland;  2Hospital  Pharmacy, University Hospital Basel, Basel, Switzerland;  3Renal  Development, AbbVie, North Chicago,  IL, USA;  4Boston Collaborative  Drug Surveillance Program, Boston University School of Public Health,  MA, USABackground: Doubling of serum creatinine is often used as a marker for worsening kidney  function in nephrology trials.",Non-OADS,/arxiv_data1/oa_pdf/14/27/clep-8-177.PMC4910685.pdf
"3Correspondence: Christoph R Meier Basel Pharmacoepidemiology Unit, Hospital Pharmacy, University Hospital Basel, Spitalstrasse 26, CH-4031 Basel, SwitzerlandTel +41 61 556 53 69Email christoph.meier@usb.chJournal name: Clinical Epidemiology Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 8Running head verso: Schneider et alRunning head recto: DSC and cardiovascular outcomes in patients with CKD and T2DMDOI: http://dx.doi.org/10.2147/CLEP .S107060",Non-OADS,/arxiv_data1/oa_pdf/14/27/clep-8-177.PMC4910685.pdf
"Clinical Epidemiology 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical Epidemiology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-epidemiology-journalClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica-tion of risk factors and screening procedures to develop optimal pre-ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/14/27/clep-8-177.PMC4910685.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e4/04/ndt-12-1351.PMC4910686.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 1351–1354Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1351Case repor Topen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/NDT .S10684 5 Bilateral internal carotid artery dissection  associated with prior syphilis: a case report  and review of the literature antonio Marangi1 Giuseppe Moretto2 Manuel Cappellari2 Nicola Micheletti2 Giampaolo T omelleri2 paolo Bovi2 1section of Neurology, Department  of Neurosciences, Biomedicine and  Movement sciences, policlinico G.B  rossi, University of Verona, Verona,   2stroke Unit, Division of Neurology,   azienda ospedaliera Universitaria  Integrata Verona, Verona, ItalyAbstract:  Bilateral internal carotid artery dissection is a rare entity, and its presentation may  include cerebral ischemia.",Non-OADS,/arxiv_data1/oa_pdf/e4/04/ndt-12-1351.PMC4910686.pdf
"After obtaining written informed consent,  intravenous recombinant tissue plasminogen activator was administered per standard Correspondence: antonio Marangi Department of Neurosciences,  Biomedicine and Movement sciences,  University of Verona, policlinico Borgo  roma, piazzale La scuro 10, Verona  37134, Italy Tel +39 334 355 5087 Fax +39 045 802 7492  email marangi2010@libero.i t Journal name: Neuropsychiatric Disease and Treatment Article Designation: Case report Y ear: 2016 Volume: 12 Running head verso: Marangi et al Running head recto: Bilateral carotid dissection and prior syphilis DOI: http://dx.doi.org/10.2147/NDT.S106845",Non-OADS,/arxiv_data1/oa_pdf/e4/04/ndt-12-1351.PMC4910686.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/e4/04/ndt-12-1351.PMC4910686.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e4/04/ndt-12-1351.PMC4910686.pdf
"5, e1122158 (9 pages)http://dx.doi.org/10.1080/2162402X.2015.1122158",Non-OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
Stem Cells 1997; 15:443-54;PMID:9402657; http://dx.doi.org/10.1002/stem.150443 2.,Non-OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
J Immunol 2001; 167:6356-65; PMID:11714800; http://dx.doi.org/10.4049/jimmunol.167.11.6356 3.,Non-OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
J Immunother 2003; 26:190- 201; PMID:12806273; http://dx.doi.org/10.1097/00002371- 200305000-00003 4.,Non-OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
Adv Drug Deliv Rev 2010; 62:1167-74; PMID:20920540; http://dx.doi.org/10.1016/j.addr.2010.09.013 5.,Non-OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
Nat Med 2000; 6:1282-6; PMID:11062543; http://dx.doi.org/10.1038/81395 6.,OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
Gene Ther 2012; 19:1-7; PMID:21562594; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
Nat Biotechnol 2014; 32:252-60; PMID:24561556; http://dx.doi.org/10.1038/nbt.2816 8.,OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
Gene Ther 2008; 15:716-29; PMID:18369326; http://dx.doi.org/ 10.1038/gt.2008.38 9.,OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
Adv Drug Deliv Rev 2012; 64:739-48; PMID:21740940; http://dx.doi.org/10.1016/j.addr.2011.06.010 10.,OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
Tumour Biol 2015; 36:4213-21; PMID:25586349; http://dx.doi.org/ 10.1007/s13277-015-3058-2 11.,Non-OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
Transl Res 2010; 156:136-46; PMID:20801410; http://dx.doi.org/10.1016/j.trsl.2010.07.003 12.,OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
Blood 2011; 118:5420-8; PMID:21937702; http://dx.doi.org/10.1182/blood-2011-08-372946 13.,Non-OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
Gene Ther 2010; 17:745-51; PMID:20336155; http://dx.doi.org/ 10.1038/gt.2010.33 14.,OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
J Clin Invest 2006; 116:2857-60; PMID:17080190; http://dx.doi.org/10.1172/ JCI30230 15.,Non-OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
Curr Oncol Rep 2012; 14:468-74; PMID:22878966; http://dx.doi.org/10.1007/s11912-012-0257-5 16.,Non-OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
Clin Transl Immunol 2014; 3:e16; PMID:25505964; http://dx.doi.org/10.1038/ cti.2014.7 17.,Non-OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
Curr Opin Immunol 2009; 21:215-23;PMID:19327974; http://dx.doi.org/10.1016/j.coi.2009.02.009 18.,Non-OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
Cancer Discov 2013; 3:388-98;PMID:23550147; http://dx.doi.org/10.1158/2159-8290.CD-12-0548 19.,Non-OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
Nat Med 2015; 21:914-21; PMID:26193344; http://dx.doi.org/10.1038/nm.3910 20.,Non-OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
Curr Gene Ther 2013; 13:65-70; PMID:23256743; http://dx.doi.org/10.2174/156652313804806570 21.,OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
Immunity 2013; 39:49-60;PMID:23890063; http://dx.doi.org/10.1016/j.immuni.2013.07.002 22.,OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
Mol Ther 2010; 18:843-51; PMID:20179677; http://dx.doi.org/10.1038/mt.2010.24 23.,Non-OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
J Immunother 2013; 36:133-51; PMID:23377668; http://dx.doi.org/10.1097/CJI.0b013e3182829903 24.,Non-OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
Blood 2013; 122:863-71; PMID:23770775; http://dx.doi.org/10.1182/blood-2013-03-490565 25.,Non-OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
N Engl J Med 2011; 365:725-33; PMID:21830940; http://dx.doi.org/10.1056/ NEJMoa1103849 26.,OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
Sci Transl Med 2011; 3:95ra73; PMID:21832238; http://dx.doi.org/ 10.1126/scitranslmed.3002842 27.,Non-OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
Blood 2012; 119:2709-20; PMID:22160384; http://dx.doi.org/10.1182/blood-2011-10-384388 28.,Non-OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
Sci Transl Med 2013; 5:177ra38; PMID:23515080; http://dx.doi.org/10.1126/scitranslmed.3005930 29.,Non-OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
Nat Rev Cancer 2008; 8:299-308; PMID:18354418; http://dx.doi.org/ 10.1038/nrc2355 31.,Non-OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
Nat Rev Clin Oncol 2011; 8:577-85; PMID:21808266; http://dx.doi.org/10.1038/nrclinonc.2011.116 32.,Non-OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
Trends Immunol 2012;33:579-89; PMID:22926201; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
Immunity 2013; 39:61-73; PMID:23890064; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
J Immunol 2007; 178:1505-11; PMID:17237399; http://dx.doi.org/10.4049/jimmunol.178.3.1505 35.,Non-OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
Cancer Res 2012; 72:6325-32; PMID:23222302; http://dx.doi.org/10.1158/0008-5472.CAN-12-2027 36.,Non-OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
Clin Exp Immunol 2014; 178:1-8; PMID:24828133; http://dx.doi.org/10.1111/cei.12382 37.,Non-OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
Nat Med 1998; 4:415-20; PMID:9546786; http://dx.doi.org/10.1038/nm0498-415 38.,OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
Eur J Immunol 2003; 33:3117-26; PMID:14579280; http://dx.doi.org/10.1002/eji.200324270 39.,Non-OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
Nat Rev Immunol 2009; 9:162-74;PMID:19197294; http://dx.doi.org/10.1038/nri250640.,Non-OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
Clin DevImmunol 2012; 2012:948098; PMID:22778768; http://dx.doi.org/10.1155/2012/948098 41.,Non-OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
J Cancer 2013; 4:36-44; PMID:23386903; http://dx.doi.org/10.7150/jca.5046 42.,Non-OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
Biochim Biophys Acta2014; 1845:182-201; PMID:24440852; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
J Exp Med 2000; 192:1027-34; PMID:11015443; http://dx.doi.org/10.1084/ jem.192.7.1027 45.,Non-OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
Blood 2007; 110:2793-802; PMID:17638856; http://dx.doi.org/10.1182/blood-2007-02-072843 4 7 .,Non-OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
Hum Gene Ther 2008; 19:496-510; PMID:18444786; http://dx.doi.org/10.1089/hum.2007.0171 48.,OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
J Immunol 2005; 175:7226-34; PMID:16301627; http://dx.doi.org/10.4049/jimmunol.175.11.7226 50.,Non-OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
Blood 2007; 109:5168- 77; PMID:17353346; http://dx.doi.org/10.1182/blood-2006-06-029173 51.,Non-OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
Leukemia2010; 24:1160-70; PMID:20428207; http://dx.doi.org/10.1038/leu.2010.75 52.,Non-OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
Cancer Gene Ther 2004; 11:81-91; PMID:14685154; http://dx.doi.org/10.1038/sj.cgt.7700664 53.,Non-OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
Cancer Res 2010; 70:6725-34;PMID:20647327; http://dx.doi.org/10.1158/0008-5472.CAN-10-0735 54.,Non-OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
Clin Cancer Res 2012; 18:1672-83; PMID:22291136; http://dx.doi.org/ 10.1158/1078-0432.CCR-11-3050 55.,Non-OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
Mol Ther 2011; 19:751- 9; PMID:21285960; http://dx.doi.org/10.1038/mt.2010.313 56.,OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
J Immunother 2012; 35:430-9; PMID:22576348; http://dx.doi.org/10.1097/CJI.0b013e31825898e8 57.,Non-OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
Blood2012; 119:4133-41; PMID:22354001; http://dx.doi.org/10.1182/blood- 2011-12-400044 58.,Non-OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
Oncoimmunology 2015; 4:e994446; PMID:25949921; http://dx.doi.org/10.4161/2162402X.2014.994446 59.,Non-OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
Leukemia 2015; 29:415-22; PMID:25005243; http://dx.doi.org/10.1038/leu.2014.215 60.,Non-OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
ClinCancer Res 2015; 21:2278-88; PMID:25695689; http://dx.doi.org/ 10.1158/1078-0432.CCR-14-2085 61.,Non-OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
Blood 2010; 115:3508-19; PMID:20190192; http://dx.doi.org/10.1182/blood-2009-09-241398 62.,Non-OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
Cancer Gene Ther 2007;14:380-8; PMID:17218946; http://dx.doi.org/10.1038/sj.cgt.7701021 63.,Non-OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
Mol Ther 2015; 23:171-8;PMID:25142939; http://dx.doi.org/10.1038/mt.2014.156 64.,OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
Cancer Immunol Immunother 2012; 61:751-9;PMID:22488275; http://dx.doi.org/10.1007/s00262-012-1253-1 65.,Non-OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
Immunol Rev 2006; 213:48-65; PMID:16972896; http://dx.doi.org/10.1111/j.1600-065X.2006.00441.x 66.,Non-OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
Immunol Rev 2006; 213:66-81; PMID:16972897; http://dx.doi.org/10.1111/j.1600- 065X.2006.00438.x 67.,Non-OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
Immunology 2007; 120:1- 7; PMID:17233737; http://dx.doi.org/10.1111/j.1365-2567.2006.02511.x 68.,Non-OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
J Control Release 2012; 164:221-35;PMID:22705248; http://dx.doi.org/10.1016/j.jconrel.2012.05.045 69.,OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
J Am Acad Dermatol 2006; 55:807-13; PMID:17052486;PMID:12391195; http://dx.doi.org/10.1016/j.jaad.2006.06.038 72.,Non-OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
J Immunol 2002;169:4850-60; PMID:12391195; http://dx.doi.org/10.4049/jimmunol.169.9.4850 73.,Non-OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
J Transl Med 2015; 13:102; PMID:25890361; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
Hum Gene Ther 2002; 13:1971-80; PMID:12427307; http://dx.doi.org/10.1089/10430340260355374 75.,OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
J Immunother2010; 33:780-8; PMID:20842059; http://dx.doi.org/10.1097/CJI.0b013e3181ee6675 76.,Non-OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
J Immunother 2008; 31:500-5; PMID:18463534; http://dx.doi.org/10.1097/CJI.0b013e318177092b 77.,Non-OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
Nat Rev Cancer 2009; 9:798-809;PMID:19851315; http://dx.doi.org/10.1038/nrc2734 79.,Non-OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
Jak-Stat 2013; 2:e23010;PMID:24058791; http://dx.doi.org/10.4161/jkst.23010 80.,OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
J Clin Oncol 2012; 30:1005-14;PMID:22355058; http://dx.doi.org/10.1200/JCO.2010.31.8907 81.,Non-OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
J Leukoc Biol 2013; 93:847-63; PMID:23475577; http://dx.doi.org/10.1189/jlb.1012501 82.,Non-OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
Cancer Res 2015; 75:1959-71; PMID:25795705; http://dx.doi.org/10.1158/0008-5472.CAN-14-2467 83.,Non-OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
N Engl J Med 2011; 365:1673-83; PMID:22047558; http://dx.doi.org/10.1056/NEJMoa1106152 84.,OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
J Control Release 2013; 170:358-64;PMID:23791976; http://dx.doi.org/10.1016/j.jconrel.2013.06.010ONCOIMMUNOLOGY e1122158-9,Non-OADS,/arxiv_data1/oa_pdf/49/4f/koni-05-05-1122158.PMC4910704.pdf
"5, e1134412 (7 pages)http://dx.doi.org/10.1080/2162402X.2015.1134412",Non-OADS,/arxiv_data1/oa_pdf/86/7e/koni-05-05-1134412.PMC4910705.pdf
CA Cancer J Clin 2015; 65:5-29; PMID:25559415; http://dx.doi.org/10.3322/caac.21254 2.,Non-OADS,/arxiv_data1/oa_pdf/86/7e/koni-05-05-1134412.PMC4910705.pdf
J Urol 2002; 167:1573-83; PMID:11912367; http://dx.doi.org/10.1016/S0022-5347(05)65157-9 3.,OADS,/arxiv_data1/oa_pdf/86/7e/koni-05-05-1134412.PMC4910705.pdf
Urology 2007; 69:62-79; PMID:17280909; http://dx.doi.org/10.1016/j.urology.2006.10.041 4.,Non-OADS,/arxiv_data1/oa_pdf/86/7e/koni-05-05-1134412.PMC4910705.pdf
Curr Opin Oncol 2014; 26:305-20; PMID:24685646; http://dx.doi.org/10.1097/CCO.0000000000000064 5.,OADS,/arxiv_data1/oa_pdf/86/7e/koni-05-05-1134412.PMC4910705.pdf
"Eur Urol 2005;48:202,5; discussion 205 –6; PMID:15939524; http://dx.doi.org/ 10.1016/j.eururo.2005.04.006 6.",OADS,/arxiv_data1/oa_pdf/86/7e/koni-05-05-1134412.PMC4910705.pdf
N Engl J Med 2003; 349:859-66; PMID:12944571; http://dx.doi.org/10.1056/ NEJMoa022148 7.,OADS,/arxiv_data1/oa_pdf/86/7e/koni-05-05-1134412.PMC4910705.pdf
Urol Oncol 2015; 33(5):204.e1-7; PMID:25814145; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/86/7e/koni-05-05-1134412.PMC4910705.pdf
J Cancer 2014; 5:166-72; PMID:24563671; http://dx.doi.org/10.7150/jca.8167 10.,Non-OADS,/arxiv_data1/oa_pdf/86/7e/koni-05-05-1134412.PMC4910705.pdf
Cancer Cell 2015; 27:450-61; PMID:25858804; http://dx.doi.org/10.1016/j.ccell.2015.03.001 11.,Non-OADS,/arxiv_data1/oa_pdf/86/7e/koni-05-05-1134412.PMC4910705.pdf
Cancer Res 2006; 66:3381-5; PMID:16585157;http://dx.doi.org/10.1158/0008-5472.CAN-05-4303 12.,Non-OADS,/arxiv_data1/oa_pdf/86/7e/koni-05-05-1134412.PMC4910705.pdf
Clin Genitourin Cancer 2006; 5:206-11; PMID:17239274;http://dx.doi.org/10.3816/CGC.2006.n.038 13.,Non-OADS,/arxiv_data1/oa_pdf/86/7e/koni-05-05-1134412.PMC4910705.pdf
Eur J Surg Oncol 2014; 40:121-7; PMID:24140000; http://dx.doi.org/ 10.1016/j.ejso.2013.08.023 14.,OADS,/arxiv_data1/oa_pdf/86/7e/koni-05-05-1134412.PMC4910705.pdf
Clin Cancer Res 2008; 14:4800-8;PMID:18676751; http://dx.doi.org/10.1158/1078-0432.CCR-08-0731 15.,Non-OADS,/arxiv_data1/oa_pdf/86/7e/koni-05-05-1134412.PMC4910705.pdf
"Urology 2015; 85:703.e1,703.e6; PMID:25733301; http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/86/7e/koni-05-05-1134412.PMC4910705.pdf
Tumour Biol 2012; 33:507-13; PMID:22143939; http://dx.doi.org/10.1007/s13277-011-0283-1 17.,Non-OADS,/arxiv_data1/oa_pdf/86/7e/koni-05-05-1134412.PMC4910705.pdf
Asian Pac J Cancer Prev 2012; 13:867- 72; PMID:22631663; http://dx.doi.org/10.7314/APJCP.2012.13.3.867 18.,Non-OADS,/arxiv_data1/oa_pdf/86/7e/koni-05-05-1134412.PMC4910705.pdf
BJU Int 2011; 108:1672-8; PMID:21244603; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/86/7e/koni-05-05-1134412.PMC4910705.pdf
Clin Cancer Res 2009; 15:1052-8; PMID:19188179; http://dx.doi.org/10.1158/1078-0432.CCR-08-1296 20.,Non-OADS,/arxiv_data1/oa_pdf/86/7e/koni-05-05-1134412.PMC4910705.pdf
"Transl Oncol 2013; 6:282-9; PMID:23730407; http://dx.doi.org/10.1593/tlo.13256 21. deLeeuw RJ, Kost SE, Kakal JA, Nelson BH.",OADS,/arxiv_data1/oa_pdf/86/7e/koni-05-05-1134412.PMC4910705.pdf
Clin Cancer Res 2012; 18:3022-9; PMID:22510350; http://dx.doi.org/10.1158/1078-0432.CCR-11-3216 22.,Non-OADS,/arxiv_data1/oa_pdf/86/7e/koni-05-05-1134412.PMC4910705.pdf
Clin Cancer Res 2007; 13:4407-14; PMID:17671123; http://dx.doi.org/10.1158/1078-0432.CCR-07-010923.,Non-OADS,/arxiv_data1/oa_pdf/86/7e/koni-05-05-1134412.PMC4910705.pdf
PLoS One 2015; 10:e0131245; PMID:26230923; http://dx.doi.org/10.1371/ journal.pone.0131245 24.,Non-OADS,/arxiv_data1/oa_pdf/86/7e/koni-05-05-1134412.PMC4910705.pdf
Clin Cancer Res 2014; 20:5064-74; PMID:24714771; http://dx.doi.org/10.1158/1078-0432.,Non-OADS,/arxiv_data1/oa_pdf/86/7e/koni-05-05-1134412.PMC4910705.pdf
Cancer 2007; 109:1499-505; PMID:17340590; http://dx.doi.org/10.1002/cncr.22588 26.,Non-OADS,/arxiv_data1/oa_pdf/86/7e/koni-05-05-1134412.PMC4910705.pdf
Nature 2014; 515:558-62; PMID:25428503; http://dx.doi.org/10.1038/nature13904 27.,Non-OADS,/arxiv_data1/oa_pdf/86/7e/koni-05-05-1134412.PMC4910705.pdf
Sci Transl Med 2012; 4:127ra37; PMID:22461641; http://dx.doi.org/ 10.1126/scitranslmed.3003689 28.,Non-OADS,/arxiv_data1/oa_pdf/86/7e/koni-05-05-1134412.PMC4910705.pdf
Clin Cancer Res 2015; 21:3969-76; PMID:25944800; http://dx.doi.org/10.1158/1078-0432.CCR-15-0244 31.,Non-OADS,/arxiv_data1/oa_pdf/86/7e/koni-05-05-1134412.PMC4910705.pdf
Cancer Cell 2014; 25:152-65; PMID:24525232; http://dx.doi.org/10.1016/j.ccr.2014.01.009 34.,Non-OADS,/arxiv_data1/oa_pdf/86/7e/koni-05-05-1134412.PMC4910705.pdf
Nature 2014; 507:315-22; PMID:24476821; http://dx.doi.org/10.1038/nature12965 3 5 .,Non-OADS,/arxiv_data1/oa_pdf/86/7e/koni-05-05-1134412.PMC4910705.pdf
Cancer Discov 2014; 4:1140-53; PMID:25096233; http://dx.doi.org/10.1158/2159-8290.,Non-OADS,/arxiv_data1/oa_pdf/86/7e/koni-05-05-1134412.PMC4910705.pdf
Mod Pathol 2013; 27(2):271-80; PMID:23887298;http://dx.doi.org/10.1038/modpathol.2013.135e1134412-6 A. S. BARAS ET AL.,OADS,/arxiv_data1/oa_pdf/86/7e/koni-05-05-1134412.PMC4910705.pdf
2016 Mar; 69(3):384-8; PMID:25636205; http://dx.doi.org/ 10.1016/j.eururo.2015.01.014.,OADS,/arxiv_data1/oa_pdf/86/7e/koni-05-05-1134412.PMC4910705.pdf
Mod Pathol 2009; 22 Suppl 2:S96- S118; PMID:19494856; http://dx.do i.org/10.1038/modpathol.2009.26 39.,Non-OADS,/arxiv_data1/oa_pdf/86/7e/koni-05-05-1134412.PMC4910705.pdf
Cancer Res 2010; 70:3463-72; PMID:20406976;http://dx.doi.org/10.1158/0008-5472.CAN-09-4213 40.,Non-OADS,/arxiv_data1/oa_pdf/86/7e/koni-05-05-1134412.PMC4910705.pdf
PLoS One 2012; 7:e38863;PMID:22685613; http://dx.doi.org/10.1371/journal.pone.0038863 41.,Non-OADS,/arxiv_data1/oa_pdf/86/7e/koni-05-05-1134412.PMC4910705.pdf
UrolOncol 2010; 28:429-40; PMID:20610280; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/86/7e/koni-05-05-1134412.PMC4910705.pdf
Clin Cancer Res 2012; 18:3377-86; PMID:22553347; http://dx.doi.org/10.1158/1078-0432.CCR-12-0077-T 43.,Non-OADS,/arxiv_data1/oa_pdf/86/7e/koni-05-05-1134412.PMC4910705.pdf
Am J Pathol 2013; 183:681-91; PMID:23827819; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/86/7e/koni-05-05-1134412.PMC4910705.pdf
"5, e1108513 (13 pages)http://dx.doi.org/10.1080/2162402X.2015.1108513",Non-OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
N Engl J Med 2005; 352:987-96; PMID:15758009; http://dx.doi.org/10.1056/NEJMoa043330 2.,OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
Lancet Oncol 2009; 10:459-66; PMID:19269895; http://dx.doi.org/10.1016/S1470-2045(09)70025-7 3.,Non-OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
Nat Rev Immunol 2008; 8:59-73; PMID:18097448; http://dx.doi.org/10.1038/nri2216 4.,Non-OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
Available from: http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
nlm.nih.gov/pubmed/22301798; PMID:22301798; http://dx.doi.org/ 10.1038/nrd3626 5.,OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
Cancer Res 2005; 65:8059-64; PMID:16166275; http://dx.doi.org/10.1158/0008-5472.CAN-05-1797 6.,Non-OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
Neuro Oncol 2011; 13:324-33; PMID:21149254; http://dx.doi.org/10.1093/neuonc/noq157 7.,Non-OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
Available from: http://www.ncbi.nlm.nih.gov/pubmed/17522861; PMID:17522861; http://dx.doi.org/10.1007/s00262-007-0336-x 8.,OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
Clin Vaccine Immunol [Internet] 2010 [cited 2014 Jan 9]; 17:143-53.Available from: http://www.pubmedcen tral.nih.gov/articlerender.fcgi?,Non-OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
artidD2812079&tool Dpmcentrez&rendertype Dabstract; PMID:19889936; http://dx.doi.org/10.1128/CVI.00292-09 9.,OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
Clin Cancer Res 2010; 16:3399- 408; PMID:20570924; http://dx.doi.org/10.1158/1078-0432.CCR-09-3087 1 0 .,Non-OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
Available from: http://w ww.pubmedcentral.nih.gov/arti clerender.fcgi?artid D3489744&tool Dpmcentrez&rendertype Dabstract; PMID:23162756; http://dx.doi.org/10.4161/onci.20637 11.,OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
Available from: http://www.pubmedcentral.nih.gov/articleren der.fcgi?artid D3661164&tool Dpmcentrez&rendertype Dabstract; PMID:23802079; http://dx.doi.org/10.4161/onci.23401 12.,OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
Cancer Immunol Immunother 2009; 58:1627-34; PMID:19221744;http://dx.doi.org/10.1007/s00262-009-0671-1 13.,Non-OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
Eur J Haematol 2003; 71:119-23; PMID:12890151; http://dx.doi.org/ 10.1034/j.1600-0609.2003.00100.x 14.,Non-OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
Transplantation 2004; 77:1699-706; PMID:15201669; http://dx.doi.org/10.1097/01.TP.0000131163.43015.85 15.,Non-OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
J LeukocBiol 2009; 86:1075-87; PMID:19745159; http://dx.doi.org/10.1189/jlb.0309147 16.,Non-OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
Availabl e from: http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
nih.gov/pubmed/14634619; PMID:14634619; http://dx.doi.org/ 10.1038/sj.onc.1207101 18.,Non-OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
Am J Pathol [Internet] 2003 [cited 2015 Feb 9]; 162:837-47.Available from:http://www.pubmedcentral.nih.gov/articlerender.fcgi?,OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
artid=1868086&tool Dpmcentrez&rendertype Dabstract; PMID:12598318; http://dx.doi.org/10.1016/S0002-9440(10)63880-1 19.,OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
Available from: http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
gov/pubmed/24887481; PMID:24887481; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
Available from: http://www.ncbi .nlm.nih.gov/pubmed/24145738; PMID:24145738; http://dx.doi.org/10.3892/mmr.2013.1746 21.,Non-OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
Cell Immunol [Internet] 2006 [cited 2015 Feb 9]; 242:99-109.Available from: http://www.ncbi.nlm.nih.gov/pubmed/17123494; PMID:17123494; http://dx.doi.org/10.1016/j.cellimm.2006.10.001 22.,OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
Available from: http://www.pubmedcentral.nih.gov/article render.fcgi?artid=3839648&tool=pmcentrez&rendertype=abstract; PMID:23866045; http://dx.doi.org/10.1111/imm.12154 23.,OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
Avail- able from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3252830&tool=pmcentrez&rendertype=abstract; PMID:22052191; http://dx.doi.org/10.1038/cdd.2011.153 24.,OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
Clin Cancer Res 2004; 10:3728-36; PMID:15173079; http://dx.doi.org/10.1158/1078-0432.,Non-OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
Available from: http://www.jimmunol.org/cgi/doi/10.4049/jimmunol.172.12.7583; PMID:15187138; http://dx.doi.org/10.4049/ jimmunol.172.12.7583 26.,Non-OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
Nat Immunol2002; 3:515-21; PMID:12032565; http://dx.doi.org/10.1038/ni0602- 515 27.,Non-OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
J Neuroimmunol 2012; 247:9-15; PMID:22503411; http://dx.doi.org/ 10.1016/j.jneuroim.2012.03.011 28.,OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
Available from: http://www.ncbi.nlm.nih.gov/pubmed/19234143; PMID:19234143; http://dx.doi.org/10.1182/blood-2008-10-187179 29.,Non-OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
Immunology [Internet] 2011 [cited 2013 Dec 7]; 133:350-9.Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?,OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
artid=3112344&tool=pmcentrez &rendertype=abstract; PMID:21506999; http://dx.doi.org/10.1111/j.1365-2567.2011.03446.x 30.,OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
Cancer Res [Internet] 2014 [cited 2014 Oct 21]; 74:5079-90.Available from: http://www.ncbi.nlm.nih.gov/pubmed/25038230; PMID:25038230; http://dx.doi.org/10.1158/0008-5472.CAN-14-1203 31.,Non-OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
Chem 2014; 289:33311-9; PMID:25315772; http://dx.doi.org/10.1074/ jbc.M114.603464 32.,OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3624298&tool=pmcentrez&ren dertype=abstract; PMID:23408620; http://dx.doi.org/10.1128/ JVI.01085-12 33.,OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
Neuro Oncol 2010; 12:377-88; PMID:20308315; http://dx.doi.org/10.1093/neuonc/nop024 34.,Non-OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
J Immunother 2010; 33:382-90; PMID:20386468; http://dx.doi.org/10.1097/CJI.0b013e3181cd872d 35.,Non-OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
Eur J Immunol 2015; 45:192-202; PMID:25308526; http://dx.doi.org/10.1002/eji.201444699 36.,Non-OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
PLoS One 2015; 10:e0126022; PMID:25978454; http://dx.doi.org/10.1371/journal.pone.0126022 37.,Non-OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
Cancer Lett 2007; 252:86-92; PMID:17257744; http://dx.doi.org/10.1016/j.canlet.2006.12.012 38.,OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
Available from: http://www.ncbi.nlm.nih.gov/pubmed/ 18538864; PMID:18538864; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
Cancer Res 2010; 70:490-500; PMID:20068181; http://dx.doi.org/10.1158/ 0008-5472.CAN-09-1890 41.,Non-OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
Br J Cancer 2001; 85:1564-71; PMID:11720446; http://dx.doi.org/10.1054/bjoc.2001.2144 42.,Non-OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
J Transl Med [Internet] 2012; 10:252.Available from: http://www.pubmedcent ral.nih.gov/arti clerender.fcgi?,Non-OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
artidD3551789&tool Dpmcentrez&rendertype Dabstract; PMID:23259744; http://dx.doi.org/10.1186/1479-5876-10-252 43.,OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
Cancer Res.2005; 94:29-86; PMID:16095999; http://dx.doi.org/10.1016/S0065- 230X(05)94002-5 44.,Non-OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
Leukemia 2007; 21:427-38; PMID:17215852; http://dx.doi.org/10.1038/sj.leu.2404523 46.,Non-OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
Cell Stem Cell 2009; 4:226-35; PMID:19265662; http://dx.doi.org/10.1016/j.stem.2009.01.007 47.,OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
Bone Marrow Transplant 2012; 47:73-81; PMID:21358682; http://dx.doi.org/10.1038/bmt.2011.22 48.,Non-OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
J Immunol 2009; 182:6933-42; PMID:19454690; http://dx.doi.org/10.4049/jimmunol.0803840 49.,Non-OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
Blood 2007; 110:3202-8;PMID:17644738; http://dx.doi.org/10.1182/blood-2007-02-075366 50.,Non-OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
"Rapamycin, But Not Cyclosporine or FK506, Alters Natural Killer Cell Function.Transplantation 2008; 85:145-9; PMID:18192925; http://dx.doi.org/10.1097/01.tp.0000296817.28053.7b 51.",Non-OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
Cancer Res 2005; 65:6660-7; PMID:16061646; http://dx.doi.org/10.1158/0008-5472.CAN-04-3478 52.,Non-OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
J Clin Invest 2003; 111:627-37; PMID:12618517; http://dx.doi.org/10.1172/JCI200316200 53.,Non-OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
Cancer Res 2012; 72:6325-32; PMID:23222302; http://dx.doi.org/10.1158/0008-5472.CAN-12-2027 55.,Non-OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
Available from: http://www.ncbi.nlm.nih.gov/ pubmed/10202929; PMID:10202929; http://dx.doi.org/10.1038/7403 58.,OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
Available from: http://www.ncbi.nlm.nih.gov/pubmed/ 12461568; PMID:12461568; http://dx.doi.org/10.1038/nri956 59.,OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
Available from: http://www.ncbi.nlm.nih.gov/pubmed/24590885; PMID:24590885; http://dx.doi.org/10.1158/1078-0432.,OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
Available from:http://www.ncbi.nlm.nih.gov/pubmed/14651745; PMID:14651745; http://dx.doi.org/10.1111/j.1365-3148.2003.00467.x 61.,Non-OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
Available from: http://www.ncbi.nlm.nih.gov/pubmed/17518506; PMID:17518506; http://dx.doi.org/10.2165/ 00003088-200746060-00001 62.,OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
"Sengupta S, Marrinan J, Frishman C, Sampath P. Impact of temozolo- mide on immune response during malignant glioma chemotherapy.Clin Dev Immunol 2012; 2012:831090; PMID:23133490; http://dx.doi.org/10.1155/2012/831090 63.",OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
J Immunol [Internet] 2013 [cited 2013 May 28]; PMID:23686484; http://dx.doi.org/10.4049/ jimmunol.1203539.,OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
Oncogene 2004; 23:359-67; PMID:14724564; http://dx.doi.org/10.1038/sj.onc.1207080 65.,OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
Proc Natl Acad Sci U S A2002; 99:931-6; PMID:11792864; http://dx.doi.org/10.1073/ pnas.022634999 66.,OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
pubmedcentral.nih.gov/articlerender.fcgi?artid=3601076&tool=pmcen trez&rendertype=abstract; PMID:23527092; http://dx.doi.org/ 10.1371/journal.pone.0059082 67.,OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
Available from:http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3601183& tool=pmcentrez&rendertype=abstract; PMID:23525955; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
Neuro Oncol 2011; 13:393-400;PMID:21339188; http://dx.doi.org/10.1093/neuonc/noq204 69.,Non-OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
J Immunol 2003; 170:4881-5; PMID:12734329; http://dx.doi.org/ 10.4049/jimmunol.170.10.4881 70.,Non-OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
J Immunol 2004; 173:174- 80; PMID:15210772; http://dx.doi.org/10.4049/jimmunol.173.1.174ONCOIMMUNOLOGY e1108513-13,Non-OADS,/arxiv_data1/oa_pdf/10/55/koni-05-05-1108513.PMC4910710.pdf
"5, e1141857 (9 pages)http://dx.doi.org/10.1080/2162402X.2016.1141857",Non-OADS,/arxiv_data1/oa_pdf/06/88/koni-05-05-1141857.PMC4910717.pdf
Nat Rev Immunol 2002; 2:116-26; PMID:11910893; http://dx.doi.org/10.1038/nri727 2.,Non-OADS,/arxiv_data1/oa_pdf/06/88/koni-05-05-1141857.PMC4910717.pdf
Trends Immunol 2013; 34:556-63; PMID:23954143; http://dx.doi.org/10.1016/j.it.2013.07.003 3.,OADS,/arxiv_data1/oa_pdf/06/88/koni-05-05-1141857.PMC4910717.pdf
Immunity 1999; 11:423-32;PMID:10549624; http://dx.doi.org/10.1016/S1074-7613(00)80117-X 4.,OADS,/arxiv_data1/oa_pdf/06/88/koni-05-05-1141857.PMC4910717.pdf
Cancer Res 2012; 72:6130-41; PMID: 23026134; http://dx.doi.org/10.1158/0008-5472.CAN-12-2409 5.,Non-OADS,/arxiv_data1/oa_pdf/06/88/koni-05-05-1141857.PMC4910717.pdf
Nature 1999;397:263-6; PMID:9930702; http://dx.doi.org/10.1038/16717 7.,Non-OADS,/arxiv_data1/oa_pdf/06/88/koni-05-05-1141857.PMC4910717.pdf
The CD28-related moleculeICOS is required for effective T cell-dependent immune responses.Immunity 2000; 13:95-105; PMID:10933398; http://dx.doi.org/ 10.1016/S1074-7613(00)00011-X 8.,Non-OADS,/arxiv_data1/oa_pdf/06/88/koni-05-05-1141857.PMC4910717.pdf
Eur J Cancer 2013; 49:2233-42; PMID:23478000; http://dx.doi.org/10.1016/j.ejca.2013.02.015 10.,Non-OADS,/arxiv_data1/oa_pdf/06/88/koni-05-05-1141857.PMC4910717.pdf
Crit Rev Oncol Hematol2003; 46:33-57; PMID:12672517; http://dx.doi.org/10.1016/S1040-8428(02)00159-2 11.,OADS,/arxiv_data1/oa_pdf/06/88/koni-05-05-1141857.PMC4910717.pdf
"Dong H, Zhu G, Tamada K, Chen L. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion.Nat Med 1999; 5:1365-9; PMID:10581077; http://dx.doi.org/10.1038/ 70932 14.",OADS,/arxiv_data1/oa_pdf/06/88/koni-05-05-1141857.PMC4910717.pdf
Nature 1999; 402:827- 32; PMID:10617205; http://dx.doi.org/10.1038/45582 15.,Non-OADS,/arxiv_data1/oa_pdf/06/88/koni-05-05-1141857.PMC4910717.pdf
Cell Res 2013; 23:394-408; PMID:23266888; http://dx.doi.org/10.1038/cr.2012.178 16.,OADS,/arxiv_data1/oa_pdf/06/88/koni-05-05-1141857.PMC4910717.pdf
Annu Rev Immunol 2002; 20:29-53; PMID:11861596; http://dx.doi.org/10.1146/annurev.immunol.20.091101.091806 17.,Non-OADS,/arxiv_data1/oa_pdf/06/88/koni-05-05-1141857.PMC4910717.pdf
Eur J Immu- nol 2000; 30:1040-7; PMID:10760791; http://dx.doi.org/10.1002/ (SICI)1521-4141(200004)30:4 <1040::AID-IMMU1040 >3.0.CO;2-6 18.,OADS,/arxiv_data1/oa_pdf/06/88/koni-05-05-1141857.PMC4910717.pdf
Immunity 1996; 4:535-43; PMID:8673700; http://dx.doi.org/10.1016/S1074-7613(00)80480-X 19.,OADS,/arxiv_data1/oa_pdf/06/88/koni-05-05-1141857.PMC4910717.pdf
Immunity 1994; 1:405-13; PMID:7882171; http://dx.doi.org/10.1016/1074-7613(94)90071-X 20.,OADS,/arxiv_data1/oa_pdf/06/88/koni-05-05-1141857.PMC4910717.pdf
J Exp Med 1996; 183:2541-50;PMID:8676075; http://dx.doi.org/10.1084/jem.183.6.2541 21.,Non-OADS,/arxiv_data1/oa_pdf/06/88/koni-05-05-1141857.PMC4910717.pdf
J Exp Med 2000;192(7):1027-34; PMID:11015443; http://dx.doi.org/10.1084/jem.192.7.1027 22.,Non-OADS,/arxiv_data1/oa_pdf/06/88/koni-05-05-1141857.PMC4910717.pdf
NatImmunol 2001; 2:261-8; PMID:11224527; http://dx.doi.org/10.1038/85330 23.,Non-OADS,/arxiv_data1/oa_pdf/06/88/koni-05-05-1141857.PMC4910717.pdf
Nat Rev Drug Discov 2003; 2:962-72; PMID:14654795; http://dx.doi.org/10.1038/nrd1254ONCOIMMUNOLOGY e1141857-9,Non-OADS,/arxiv_data1/oa_pdf/06/88/koni-05-05-1141857.PMC4910717.pdf
"5, e1093722 (12 pages)http://dx.doi.org/10.1080/2162402X.2015.1093722",Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Lancet Oncol 2013; 14:e218-28; PMID:23639322; http://dx.doi.org/10.1016/S1470-2045(12)70582-X2.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Nature 2008; 454:436-44; PMID:18650914; http://dx.doi.org/10.1038/nature07205 3.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Cell 2010; 140:883-99; PMID:20303878; http://dx.doi.org/ 10.1016/j.cell.2010.01.025 4.,OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Oncoimmunology 2013; 2:e25444; PMID:24073383; http://dx.doi.org/10.4161/onci.25444 5.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Trends Immunol 2003; 24:25-9; PMID:12495721; http://dx.doi.org/10.1016/S1471-4906(02)00013-3 7.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Immunity 2001; 14:705-14; PMID:11420041; http://dx.doi.org/10.1016/S1074- 7613(01)00151-0 8.,OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
J Immu- nol 2001; 167:3435-42; PMID:11544336; http://dx.doi.org/10.4049/jimmunol.167.6.3435 9.,OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Nature 1986; 324:73-6;PMID:3491322; http://dx.doi.org/10.1038/324073a0 11.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Nature 2006;441:235-8; PMID:16648838; http://dx.doi.org/10.1038/nature04753 12.,OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Nature 2006; 441:231-4; PMID:16648837; http://dx.doi.org/10.1038/ nature04754 13.,OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Immunity 2006; 24:179- 89; PMID:16473830; http://dx.doi.org/10.1016/j.immuni.2006.01.001 14.,OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Int Immuno- pharmacol 2011; 11:319-22; PMID:21035432; http://dx.doi.org/ 10.1016/j.intimp.2010.10.004 15.,OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Cytokine Growth Factor Rev 2011; 22:83-9; PMID:21377916; http://dx.doi.org/ 10.1016/j.cytogfr.2011.02.003 16.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
J Exp Med 2003; 198:1875-86; PMID:14676299;http://dx.doi.org/10.1084/jem.20030152 17.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
J Immunol 2004; 172:5149-53; PMID:15100250; http://dx.doi.org/10.4049/jimmunol.172.9.5149 18.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
J Immunol 2011; 186:32-40; PMID:21106853; http://dx.doi.org/10.4049/jimmunol.0903314 19.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
J Immunol 2007; 179:2041-5; PMID:17675459; http://dx.doi.org/10.4049/jimmunol.179.4.2041 20.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Interleukin-6 and its signalling in atherosclerosis.Thromb Haemost 2009; 102:215-22; PMID:19652871; http://dx.doi.org/10.1160/TH09-05-0297 21.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
J Nippon Med Sch 2007; 74:11-22; PMID:17384473;http://dx.doi.org/10.1272/jnms.74.11 23.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
J Immunol 2004; 172:4630-6;PMID:15034082; http://dx.doi.org/10.4049/jimmunol.172.7.4630 25.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Immunol Rev 2008; 226:205-18; PMID:19161426; http://dx.doi.org/10.1111/j.1600-065X.2008.00706.x 26.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Clin Can- cer Res 2013; 19:6957-66; PMID:24097873; http://dx.doi.org/ 10.1158/1078-0432.CCR-13-0926 27.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
BMC Cancer 2011; 11:95; PMID:21406082; http://dx.doi.org/10.1186/1471-2407-11-95 28.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
BJU Int 2008; 102:125-9; PMID:18336617; http://dx.doi.org/10.1111/ j.1464-410X.2008.07466.x 29.,OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Support Care Cancer 2013; 21:3071-7; PMID:23828393; http://dx.doi.org/10.1007/s00520-013-1878-4 32.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
J Cachexia Sarcopenia Muscle 2012; 3:245- 51; PMID:22648739; http://dx.doi.org/10.1007/s13539-012-0075-5 33.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Eur J Cancer Care (Engl) 2008; 17:454-62;PMID:18637115; http://dx.doi.org/10.1111/j.1365-2354.2007.00874.x34.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Cancer Epidemiol Biomarkers Prev 2007; 16:1155-9; PMID:17548678; http://dx.doi.org/10.1158/1055-9965.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Cancer2005; 104:2275-81; PMID:16216004; http://dx.doi.org/10.1002/cncr.21485 36.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
J Mol Med (Berl) 2001; 79:406-14; PMID:11466563; http://dx.doi.org/ 10.1007/s001090100234 37.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
J Neurooncol 2011; 102:35-41; PMID:20607353; http://dx.doi.org/10.1007/s11060-010-0290-x 38.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
AnnThorac Cardiovasc Surg 2011; 17:454-60; PMID:21881374; http://dx.doi.org/10.5761/atcs.oa.10.01627 41.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Clin Cancer Res 2007; 13:2385-91; PMID:17438097; http://dx.doi.org/10.1158/1078-0432.CCR-06-1828 43.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Gynecol Oncol 1997; 66:27-30; PMID:9234916; http://dx.doi.org/10.1006/ gyno.1997.4726 44.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Int J Cancer 1994; 57:318- 23; PMID:8168990; http://dx.doi.org/10.1002/ijc.2910570305 45.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Ann Hematol 2005; 84:510-6; PMID:15834569; http://dx.doi.org/10.1007/s00277-005-1020-x 46.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Chirurg 2005;76:837-44; PMID:16094522; http://dx.doi.org/10.1007/s00104-005-1077-z 47.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Cytokine 2001; 15:232-6; PMID:11563884; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Eur J Emerg Med 2008; 15:26-33;PMID:18180663; http://dx.doi.org/10.1097/MEJ.0b013e3280ec539b 49.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Inﬂamm Res 2009; 58(7):385-93; PMID:19262987; http://dx.doi.org/ 10.1007/s00011-009-0003-0 50.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Clin Immunol 2003; 106:106-15; PMID:12672401; http://dx.doi.org/10.1016/S1521-6616(02)00025-6 52.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Br J Surg 1994; 81:1306-8; PMID:7953393; http://dx.doi.org/10.1002/bjs.1800810914 53.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Shock 2005; 23:488-93; PMID:15897799; http://dx.doi.org/10.1097/01.shk.0000163802.46355.59 55.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Immunity 2004; 21:137-48; PMID:15308095; http://dx.doi.org/10.1016/j.immuni.2004.07.017 56.,OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Exp Ther Med 2012; 4:70-8; PMID:23060925; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Med Oncol 2011; 28:1453-7; PMID:20714944; http://dx.doi.org/10.1007/s12032-010-9645-6 58.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Reprod Sci 2013; 20:828-37; PMID:23239818;http://dx.doi.org/10.1177/1933719112466299 59.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
BMC Cancer 2010; 10:203;PMID:20465852; http://dx.doi.org/10.1186/1471-2407-10-203 60.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Ann Hematol 2010; 89:25-33; PMID:19582455; http://dx.doi.org/10.1007/ s00277-009-0777-8 62.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Clin Chem Lab Med 2008; 46:1423-8; PMID:18844497; http://dx.doi.org/10.1515/CCLM.2008.278 63.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Clin Exp Med 2011; 11:89-96;PMID:20938721; http://dx.doi.org/10.1007/s10238-010-0114-564.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
J Urol 1998; 159:718-22; PMID:9474133; http://dx.doi.org/10.1016/S0022-5347(01)63709-1 66.,OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Melanoma Res 2000; 10:237-41; PMID:10890377; http://dx.doi.org/10.1097/00008390-200010030-00005 67.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Int J Cancer J Int Du Cancer 2003; 107:22-9; PMID:12925952; http://dx.doi.org/10.1002/ijc.11287 68.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Eur J Immunol 2002; 32:2965-70; PMID:12355450; http://dx.doi.org/10.1002/1521-4141(2002010)32:10%3c2965::AID-IMMU2965%3e3.0.CO;2-V 69.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Scand J Immunol 2006; 63:321-9; PMID:16640655; http://dx.doi.org/10.1111/j.1365-3083.2006.01750.x 70.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Clin Rev Allergy Immunol 2005; 28:187-96; PMID:16129903; http://dx.doi.org/10.1385/CRIAI:28:3:187 71.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Cancer 2007; 110:1911-28; PMID:17849470; http://dx.doi.org/10.1002/cncr.22999 72.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Cytokine Growth Factor Rev 2012; 23:99-107; PMID:22561547; http://dx.doi.org/10.1016/j.cytogfr.2012.04.003 73.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Proc Natl Acad Sci U S A 1987; 84:7251-5; PMID:2444978; http://dx.doi.org/10.1073/ pnas.84.20.7251 74.,OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Ann Rev Immunol 2009; 27:485-517; PMID:19132915; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
J Biol Chem 2009; 284:34342-54; PMID:19833726; http://dx.doi.org/10.1074/jbc.M109.042671 78.,OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Prog Mol Biol Transl Sci 2010; 95:31-53; PMID:21075328;http://dx.doi.org/10.1016/B978-0-12-385071-3.00003-4 79.,OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Nat Rev Cancer 2004; 4:540-50; PMID:15229479; http://dx.doi.org/10.1038/nrc1388 80.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Annu Rev Immunol 1990; 8:253-78; PMID:2188664; http://dx.doi.org/10.1146/ annurev.iy.08.040190.001345 82.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Cancer 1999; 85:2526-31; PMID:10375098; http://dx.doi.org/10.1002/(SICI)1097-0142 (19990615)85:12%3c2526::AID-CNCR6%3e3.0.CO;2-3 83.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Mol Cancer 2013; 12:26; PMID:23561329; http://dx.doi.org/10.1186/1476-4598-12-26 84.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Cancer Sci 2007; 98:1048-54.; PMID:17511773;http://dx.doi.org/10.1111/j.1349-7006.2007.00507.x 86.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Cancer Immunol Immunother 2006; 55:684-98; PMID:16094523; http://dx.doi.org/10.1007/s00262-005- 0047-0 87.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Leuk Lymphoma 2012; 53:1735-42; PMID:22475215;http://dx.doi.org/10.3109/10428194.2012.666662 90.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
BJU Int 2008; 102:756-61; PMID:18384626; http://dx.doi.org/10.1111/j.1464- 410X.2008.07666.x 91.,OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Oncol Rep 2009; 21:1091-5; PMID:19288013; http://dx.doi.org/10.3892/or_00000328 92.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Clin Cancer Res 2005; 11:5802-8; PMID:16115919;http://dx.doi.org/10.1158/1078-0432.CCR-05-0185 93.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Br J Cancer 1993; 68:465-8; PMID:8353036; http://dx.doi.org/10.1038/ bjc.1993.371 94.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Clin Exp Dermatol 2013; 38:185-8;PMID:23397947; http://dx.doi.org/10.1111/ced.12018 95.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
"Yue C, You X, Zhao L, Wang H, Tang F, Zhang F, Zhang X, He W. The effects of adalimumab and methotrexate treatment on peripheralTh17 cells and IL-17/IL-6 secretion in rheumatoid arthritis patients.Rheumatol Int 2010; 30:1553-7; PMID:19847432; http://dx.doi.org/ 10.1007/s00296-009-1179-x 96.",Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
BioDrugs 2014; 28:75-106; PMID:24255004; http://dx.doi.org/10.1007/s40259-013-0076-8 97.,OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Joint Bone Spine 2010; 77:532-6; PMID:20869898; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
PLoS One 2013; 8:e67059; PMID:23840582; http://dx.doi.org/10.1371/journal.pone.0067059 99.,OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Br J Cancer 2013; 108:2063-9; PMID:23591198;http://dx.doi.org/10.1038/bjc.2013.174 100.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
J Clin Lab Anal 2010; 24:256-61;PMID:20626020; http://dx.doi.org/10.1002/jcla.20395 102.,OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Clin Chem Lab Med 2010; 48:1481-6; PMID:20578967; http://dx.doi.org/10.1515/CCLM.2010.278 104.,OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Cyto-kine 2004; 27:58-65; PMID:15242694; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Br J Cancer 2003; 88:1721-6; PMID:12771987; http://dx.doi.org/10.1038/sj.bjc.6600956 106.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Int J Cancer J Int Du Cancer 2003; 103:642-6; PMID:12494472; http://dx.doi.org/10.1002/ijc.10833 107.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Breast Cancer Res Treat 2013; 137:631-6; PMID:23242617; http://dx.doi.org/10.1007/s10549-012-2374-0 109.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Oncology 2013; 84:356- 61; PMID:23689116; http://dx.doi.org/10.1159/000350836 110.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Jpn J Clin Oncol 2010; 40:580-7; PMID:20194250; http://dx.doi.org/10.1093/jjco/hyq010 111.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
J Surg Oncol 2003; 83:222-6;PMID:12884234; http://dx.doi.org/10.1002/jso.10269 113.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Cancer Med 2013; 2:234-42; PMID:23634291; http://dx.doi.org/10.1002/cam4.71 115.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Clin Colorectal Cancer2008; 7:331-7; PMID:18794066; http://dx.doi.org/10.3816/ CCC.2008.n.044 116.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Dis Esophagus 2012; 25:242-9; PMID:21895853; http://dx.doi.org/10.1111/j.1442-2050.2011.01242.x 117.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Med Oncol 2013; 30:333;PMID:23269580; http://dx.doi.org/10.1007/s12032-012-0333-6 118.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
"Scambia G, Testa U, Benedetti Panici P, Foti E, Martucci R, Gadducci A, Perillo A, Facchini V, Peschle C, Mancuso S. Prognostic signi ﬁ- cance of interleukin 6 serum levels in patients with ovarian cancer.Br J Cancer 1995; 71:354-6; PMID:7841052; http://dx.doi.org/10.1038/bjc.1995.71 119.",Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Chin Med J (Engl) 2013; 126:3931-5; PMID: 24157160; http://dx.doi.org/10.3760/cma.j.issn.0366-6999.20130578 120.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Int J Cancer 2013;132:1977-85; PMID:23034889; http://dx.doi.org/10.1002/ijc.27892 121.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Nutr Can- cer 2012; 64:526-34; PMID:22489794; http://dx.doi.org/10.1080/01635581.2012.668744 123.,OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Int J Surg Pathol 2012; 20:233-9; PMID:22334615;http://dx.doi.org/10.1177/1066896911436274 124.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Int J RadiatOncol Biol Phys 2011; 81:360-8; PMID:20888135; http://dx.doi.org/ 10.1016/j.ijrobp.2010.06.011 125.,OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Cancer Epide- miol Biomarkers Prev 2009; 18:215-22; PMID:19124500; http://dx.doi.org/10.1158/1055-9965.EPI-08-0705 127.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Cytokine 1999; 11:80-6; PMID:10080883; http://dx.doi.org/10.1006/cyto.1998.0398 128.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Oncology 2006;70:115-25; PMID:16645324; http://dx.doi.org/10.1159/000093002 130.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
BMC Cancer 2009; 9:155; PMID:19457231; http://dx.doi.org/ 10.1186/1471-2407-9-155 133.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Gastric Cancer 2009; 12:95-100; PMID:19562463; http://dx.doi.org/10.1007/s10120-009-0509-8 134.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Gas- tric Cancer 2005; 8:124-31; PMID:15864720; http://dx.doi.org/10.1007/s10120-005-0315-x 135.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
J Interferon Cytokine Res 2001; 21:45-52; PMID:11177580; http://dx.doi.org/10.1089/107999001459150 136.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Exp Ther Med 2012;3:463-9; PMID:22969912; http://dx.doi.org/10.3892/etm.2011.424 137.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Lancet Oncol 2012; 13:827-37; PMID:22759480; http://dx.doi.org/10.1016/S1470-2045(12)70241-3ONCOIMMUNOLOGY e1093722-11,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Ann Oncol 2009; 20:1682-7; PMID:19541791; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
J Transl Med 2007; 5:51; PMID:17953739; http://dx.doi.org/10.1186/1479-5876-5-51 140.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
J Clin Oncol 2004; 22:2371-8; PMID:15197198; http://dx.doi.org/10.1200/JCO.2004.06.121 141.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Urol Oncol 1997; 3:51-8; PMID:21227060; http://dx.doi.org/10.1016/S1078-1439(97)00036-7 143.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Cancer 2008; 113:750-7; PMID:18536030; http://dx.doi.org/10.1002/cncr.23615 144.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Clin Cancer Res 2005;11:1815-20; PMID:15756004; http://dx.doi.org/10.1158/1078-0432.CCR- 04-1560 145.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
British J Cancer 2004; 90:2312-6; PMID:15150588; http://dx.doi.org/10.1038/sj.bjc.6601814 146.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
J Urol 2002; 167:1475-81; PMID:11832773; http://dx.doi.org/ 10.1016/S0022-5347(05)65348-7 148.,OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
J Surg Oncol 2003; 84:151-9; PMID:14598359; http://dx.doi.org/10.1002/jso.10305 149.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Int J Cancer J Int Du Cancer 2002; 100:463-71; PMID:12115531; http://dx.doi.org/10.1002/ijc.10496 150.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Melanoma Res 2012; 22:287-93; PMID:22617301; http://dx.doi.org/10.1097/CMR.0b013e3283550aa5 151.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Medical Oncol 2005; 22:241-6; PMID:16110135; http://dx.doi.org/ 10.1385/MO:22:3:241 154.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Melanoma Res 2005; 15:199-204;PMID:15917702; http://dx.doi.org/10.1097/00008390-200506000-00009 155.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
J Clin Oncol 2007; 25:1732-40; PMID:17389336; http://dx.doi.org/10.1200/JCO.2006.08.1331 156.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Leuk Lym-phoma 2012; 53:411-6; PMID:21902578; http://dx.doi.org/10.3109/ 10428194.2011.621566 159.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
"Leuk Lymphoma 2006; 47:603-11; PMID:16690518; http://dx.doi.org/10.1080/10428190500361029 160. el-Far M, Fouda M, Yahya R, el-Baz H. Serum IL-10 and IL-6 levels at diagnosis as independent predictors of outcome in non-Hodgkin ’s lymphoma.",Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
J Physiol Biochem 2004; 60:253-8; PMID:15957243;http://dx.doi.org/10.1007/BF03167070 161.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Eur J Haematol 2002; 68:91-100; PMID:12038454; http://dx.doi.org/10.1034/j.1600-0609.2002.01609.x 162.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Br J Haematol 1998; 100:129-34; PMID:9450801; http://dx.doi.org/10.1046/j.1365-2141.1998.00538.x 165.,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
Clin Cancer Res 2008;14:7028-34; PMID:18980999; http://dx.doi.org/10.1158/1078- 0432.CCR-07-5017e1093722-12 B. E. LIPPITZ AND R. A. HARRIS,Non-OADS,/arxiv_data1/oa_pdf/32/30/koni-05-05-1093722.PMC4910721.pdf
"5, e1123366 (12 pages)http://dx.doi.org/10.1080/2162402X.2015.1123366",Non-OADS,/arxiv_data1/oa_pdf/bb/b2/koni-05-05-1123366.PMC4910723.pdf
Expression data were analyzed using SUMOsoftware (SUMO —Statistical Utility for Micro array and Omics data; http://angiogenesis.dkfz.de/oncoexpress/software/sumo) using ANOVA with Bonferroni correction.,OADS,/arxiv_data1/oa_pdf/bb/b2/koni-05-05-1123366.PMC4910723.pdf
Int J Radiat Oncol Biol Phys 2006; 66:1281-93;PMID:17126203; http://dx.doi.org/10.1016/j.ijrobp.2006.08.058 2.,OADS,/arxiv_data1/oa_pdf/bb/b2/koni-05-05-1123366.PMC4910723.pdf
J Exp Med 2005; 201:925-35; PMID:15781583; http://dx.doi.org/10.1084/ jem.20041393 3.,Non-OADS,/arxiv_data1/oa_pdf/bb/b2/koni-05-05-1123366.PMC4910723.pdf
CancerLett 2015; 366:133-40; PMID:26166559; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/bb/b2/koni-05-05-1123366.PMC4910723.pdf
Hematol Oncol Clin North Am 2006; 20:363-400;PMID:16730299; http://dx.doi.org/10.1016/j.hoc.2006.01.021 6.,Non-OADS,/arxiv_data1/oa_pdf/bb/b2/koni-05-05-1123366.PMC4910723.pdf
Strahlenther Onkol 2010; 186:149-56; PMID:20165822; http://dx.doi.org/10.1007/s00066-010-2018-4 7.,Non-OADS,/arxiv_data1/oa_pdf/bb/b2/koni-05-05-1123366.PMC4910723.pdf
Radiother Oncol 2010; 97:149-61; PMID:20888056; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bb/b2/koni-05-05-1123366.PMC4910723.pdf
Int J Radiat Oncol Biol Phys 1995; 33:99-109; PMID:7642437; http://dx.doi.org/10.1016/0360-3016(95)00095-G 9.,OADS,/arxiv_data1/oa_pdf/bb/b2/koni-05-05-1123366.PMC4910723.pdf
Curr Drug Targets 2010; 11:1386-94;PMID:20583979; http://dx.doi.org/10.2174/1389450111009011386 10.,Non-OADS,/arxiv_data1/oa_pdf/bb/b2/koni-05-05-1123366.PMC4910723.pdf
FASEB J 2013; 27(11):4444-54; PMID:23913859; http://dx.doi.org/10.1096/fj.12-224907 11.,OADS,/arxiv_data1/oa_pdf/bb/b2/koni-05-05-1123366.PMC4910723.pdf
J Clin Invest 2001; 107:1529-36; PMID:11413160; http://dx.doi.org/10.1172/JCI12568 12.,Non-OADS,/arxiv_data1/oa_pdf/bb/b2/koni-05-05-1123366.PMC4910723.pdf
Tumour Biol 2011; 32:1057-70;PMID:21769672; http://dx.doi.org/10.1007/s13277-011-0212-3 13.,Non-OADS,/arxiv_data1/oa_pdf/bb/b2/koni-05-05-1123366.PMC4910723.pdf
Eur Respir J 2007; 29:976-85; PMID:17301095; http://dx.doi.org/10.1183/09031936.00152106 14.,Non-OADS,/arxiv_data1/oa_pdf/bb/b2/koni-05-05-1123366.PMC4910723.pdf
Am J Respir Crit Care Med 2008; 177:82-90; PMID:17916808; http://dx.doi.org/10.1164/rccm.200706-806OC 16.,Non-OADS,/arxiv_data1/oa_pdf/bb/b2/koni-05-05-1123366.PMC4910723.pdf
Am J Pathol 2012; 181:2126-37; PMID:23031257; http://dx.doi.org/10.1016/j.ajpath.2012.08.019 17.,Non-OADS,/arxiv_data1/oa_pdf/bb/b2/koni-05-05-1123366.PMC4910723.pdf
FASEB J 2004; 18:816-27; PMID:15117886; http://dx.doi.org/10.1096/ fj.03-1273rev 18.,OADS,/arxiv_data1/oa_pdf/bb/b2/koni-05-05-1123366.PMC4910723.pdf
Science 2002; 296:1646-7; PMID:12040180; http://dx.doi.org/10.1126/ science.1071809 19.,OADS,/arxiv_data1/oa_pdf/bb/b2/koni-05-05-1123366.PMC4910723.pdf
Eur J Cancer 2008; 44:142-50; PMID:18039567; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bb/b2/koni-05-05-1123366.PMC4910723.pdf
Am J Pathol 2013; 183:758-73; PMID:23886891; http://dx.doi.org/10.1016/j.ajpath.2013.06.005 22.,OADS,/arxiv_data1/oa_pdf/bb/b2/koni-05-05-1123366.PMC4910723.pdf
FASEB J 2010; 24:70-80;PMID:19720619; http://dx.doi.org/10.1096/fj.09-140772 23.,Non-OADS,/arxiv_data1/oa_pdf/bb/b2/koni-05-05-1123366.PMC4910723.pdf
Transl Res 2012; 159:218-27; PMID:22424426; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bb/b2/koni-05-05-1123366.PMC4910723.pdf
Antioxid Redox Signal 2008; 10:333-42;PMID:17961070; http://dx.doi.org/10.1089/ars.2007.1914 25.,Non-OADS,/arxiv_data1/oa_pdf/bb/b2/koni-05-05-1123366.PMC4910723.pdf
Curr Mol Med 2006; 6:409-21; PMID:16900664; http://dx.doi.org/10.2174/156652406777435426ONCOIMMUNOLOGY e1123366-11,Non-OADS,/arxiv_data1/oa_pdf/bb/b2/koni-05-05-1123366.PMC4910723.pdf
Int J Radiat Oncol Biol Phys 2000; 47:1033-42; PMID:10863076; http://dx.doi.org/10.1016/S0360-3016(00)00482-X 27.,OADS,/arxiv_data1/oa_pdf/bb/b2/koni-05-05-1123366.PMC4910723.pdf
In ﬂam- mation 1996; 20:339-52; PMID:8872498; http://dx.doi.org/10.1007/BF01486737 28.,Non-OADS,/arxiv_data1/oa_pdf/bb/b2/koni-05-05-1123366.PMC4910723.pdf
Clin Exp Immunol 1996; 103:67-73; PMID:8565289; http://dx.doi.org/10.1046/j.1365-2249.1996.898598.x 29.,Non-OADS,/arxiv_data1/oa_pdf/bb/b2/koni-05-05-1123366.PMC4910723.pdf
Circ Res 2001; 88:630-6; PMID:11282898; http://dx.doi.org/10.1161/01.RES.88.6.630 3 0 .,OADS,/arxiv_data1/oa_pdf/bb/b2/koni-05-05-1123366.PMC4910723.pdf
BMC Cancer 2006; 6:79; PMID:16556328; http://dx.doi.org/10.1186/1471-2407-6-79 31.,Non-OADS,/arxiv_data1/oa_pdf/bb/b2/koni-05-05-1123366.PMC4910723.pdf
Recent Results Cancer Res 2010; 184:3- 20; PMID:20072827; http://dx.doi.org/10.1007/978-3-642-54490-3_1 32.,Non-OADS,/arxiv_data1/oa_pdf/bb/b2/koni-05-05-1123366.PMC4910723.pdf
Respiration 2011; 82:273- 87; PMID:21659722; http://dx.doi.org/10.1159/000327719 33.,Non-OADS,/arxiv_data1/oa_pdf/bb/b2/koni-05-05-1123366.PMC4910723.pdf
Am J Respir Cell Mol Biol 1995; 13:496-505; PMID:7546780; http://dx.doi.org/10.1165/ajrcmb.13.4.7546780 34.,OADS,/arxiv_data1/oa_pdf/bb/b2/koni-05-05-1123366.PMC4910723.pdf
Two hits are better than one: tar- geting both phosphatidylinositol 3-kinase and mammalian target ofrapamycin as a therapeutic strategy for acute leukemia treatment.Oncotarget 2012; 3:371-94; PMID:22564882; http://dx.doi.org/ 10.18632/oncotarget.477 35.,Non-OADS,/arxiv_data1/oa_pdf/bb/b2/koni-05-05-1123366.PMC4910723.pdf
Current Opin Obstet Gynecol 2013; 25:55-65; PMID:23241641; http://dx.doi.org/10.1097/GCO.0b013e32835c5e90 36.,Non-OADS,/arxiv_data1/oa_pdf/bb/b2/koni-05-05-1123366.PMC4910723.pdf
Cancer TreatRev 2011; 37:611-7; PMID:21641723; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/bb/b2/koni-05-05-1123366.PMC4910723.pdf
Am J Respir Crit Care Med 2011; 183:788-824; PMID:21471066; http://dx.doi.org/10.1164/rccm.2009-040GL 38.,Non-OADS,/arxiv_data1/oa_pdf/bb/b2/koni-05-05-1123366.PMC4910723.pdf
PloSOne 2013; 8:e56837; PMID:23437252; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/bb/b2/koni-05-05-1123366.PMC4910723.pdf
Respir Med 2014; 108:1023-30; PMID:24834811; http://dx.doi.org/10.1016/j.rmed.2014.04.01141.,OADS,/arxiv_data1/oa_pdf/bb/b2/koni-05-05-1123366.PMC4910723.pdf
Radiat Res 1989; 119:15-31;PMID:2756106; http://dx.doi.org/10.2307/3577364 42.,Non-OADS,/arxiv_data1/oa_pdf/bb/b2/koni-05-05-1123366.PMC4910723.pdf
Chest 1996; 109:780-6; PMID:8617091; http://dx.doi.org/10.1378/chest.109.3.780 44.,Non-OADS,/arxiv_data1/oa_pdf/bb/b2/koni-05-05-1123366.PMC4910723.pdf
J Clin Invest 2004; 114:1308-16; PMID:15520863; http://dx.doi.org/10.1172/JCI200419603 45.,Non-OADS,/arxiv_data1/oa_pdf/bb/b2/koni-05-05-1123366.PMC4910723.pdf
Clin Sci 1986; 70:39-45; PMID:3943276; http://dx.doi.org/10.1042/cs0700039 46.,OADS,/arxiv_data1/oa_pdf/bb/b2/koni-05-05-1123366.PMC4910723.pdf
Hum Pathol 2009; 40:1278-87; PMID:19386353; http://dx.doi.org/10.1016/j.humpath.2009.01.014 47.,Non-OADS,/arxiv_data1/oa_pdf/bb/b2/koni-05-05-1123366.PMC4910723.pdf
Am J Pathol 2011; 178:1975-85; PMID:21514415; http://dx.doi.org/10.1016/j.ajpath.2011.01.048 48.,Non-OADS,/arxiv_data1/oa_pdf/bb/b2/koni-05-05-1123366.PMC4910723.pdf
PLoS Med 2005; 2:e251; PMID:16128620; http://dx.doi.org/10.1371/journal.pmed.0020251 49.,Non-OADS,/arxiv_data1/oa_pdf/bb/b2/koni-05-05-1123366.PMC4910723.pdf
Int J Biol Sci 2012; 8:964-78; PMID:22811618; http://dx.doi.org/10.7150/ijbs.4564 50.,OADS,/arxiv_data1/oa_pdf/bb/b2/koni-05-05-1123366.PMC4910723.pdf
Front Physiol 2012; 3:69; PMID:22493582; http://dx.doi.org/ 10.3389/fphys.2012.00069 51.,Non-OADS,/arxiv_data1/oa_pdf/bb/b2/koni-05-05-1123366.PMC4910723.pdf
Oncologist 2015; 20:1154-60; PMID:26304912; http://dx.doi.org/10.1634/theoncologist.2015-0094 52.,Non-OADS,/arxiv_data1/oa_pdf/bb/b2/koni-05-05-1123366.PMC4910723.pdf
Biochem Cell Biol 2014; 92:370-8; PMID:25263949; http://dx.doi.org/10.1139/bcb-2014-0075 53.,Non-OADS,/arxiv_data1/oa_pdf/bb/b2/koni-05-05-1123366.PMC4910723.pdf
Mol Cell Biochem2015; 407:77-87; PMID:26033204; http://dx.doi.org/10.1007/s11010- 015-2456-5 55.,Non-OADS,/arxiv_data1/oa_pdf/bb/b2/koni-05-05-1123366.PMC4910723.pdf
Nephrol Dial Transpl 2014; 29:791-9; PMID:24463190; http://dx.doi.org/10.1093/ndt/gfu003 56.,Non-OADS,/arxiv_data1/oa_pdf/bb/b2/koni-05-05-1123366.PMC4910723.pdf
Clin Cancer Res 2008; 14:2210-9; PMID:18381963; http://dx.doi.org/10.1158/1078-0432.CCR-07-1893e1123366-12 M. DADRICH ET AL.,Non-OADS,/arxiv_data1/oa_pdf/bb/b2/koni-05-05-1123366.PMC4910723.pdf
"5, e1128613 (7 pages)http://dx.doi.org/10.1080/2162402X.2015.1128613",Non-OADS,/arxiv_data1/oa_pdf/e2/dd/koni-05-05-1128613.PMC4910727.pdf
We then identi ﬁed the presence of MHC class I-restricted epitopes within these 15-mer peptides using an in silico prediction anal- ysis (http://www.cbs.dtu.dk/services/NetMHCpan/) ( Fig.,OADS,/arxiv_data1/oa_pdf/e2/dd/koni-05-05-1128613.PMC4910727.pdf
Nature 2011; 480:480-9; PMID:22193102; http://dx.doi.org/ 10.1038/nature10673 2.,Non-OADS,/arxiv_data1/oa_pdf/e2/dd/koni-05-05-1128613.PMC4910727.pdf
Curr Opin Immunol 2015; 33:23- 35; PMID:25621841; http://dx.doi.org/10.1016/j.coi.2015.01.006 3.,OADS,/arxiv_data1/oa_pdf/e2/dd/koni-05-05-1128613.PMC4910727.pdf
Curr OpinImmunol 2009; 21:233-40; PMID:19304471; http://dx.doi.org/ 10.1016/j.coi.2009.03.002 5.,OADS,/arxiv_data1/oa_pdf/e2/dd/koni-05-05-1128613.PMC4910727.pdf
N Engl J Med 2014; 371:2189-99; PMID:25409260; http://dx.doi.org/10.1056/NEJMoa1406498 6.,OADS,/arxiv_data1/oa_pdf/e2/dd/koni-05-05-1128613.PMC4910727.pdf
Science 2015; 348:124-8; PMID:25765070; http://dx.doi.org/10.1126/science.aaa1348 7.,Non-OADS,/arxiv_data1/oa_pdf/e2/dd/koni-05-05-1128613.PMC4910727.pdf
Annu Rev Immu- nol 2009; 27:83-117; PMID:19007331; http://dx.doi.org/10.1146/annurev.immunol.021908.132544 8.,Non-OADS,/arxiv_data1/oa_pdf/e2/dd/koni-05-05-1128613.PMC4910727.pdf
Nat Rev Immunol 2003; 3:630-41; PMID:12974478; http://dx.doi.org/10.1038/nri1150 9.,Non-OADS,/arxiv_data1/oa_pdf/e2/dd/koni-05-05-1128613.PMC4910727.pdf
Oncotarget 2011; 2:313-20; PMID:21487158; http://dx.doi.org/10.18632/oncotarget.259 10.,OADS,/arxiv_data1/oa_pdf/e2/dd/koni-05-05-1128613.PMC4910727.pdf
Expert Opin Ther Pat 2010; 20:1739-49; PMID:21073352; http://dx.doi.org/10.1517/13543776.2010.530659 11.,Non-OADS,/arxiv_data1/oa_pdf/e2/dd/koni-05-05-1128613.PMC4910727.pdf
Curr Top Dev Biol 2005; 67:85-133;PMID:15949532; http://dx.doi.org/10.1016/S0070-2153(05)67003-2 12.,OADS,/arxiv_data1/oa_pdf/e2/dd/koni-05-05-1128613.PMC4910727.pdf
Cell 2011; 144:646-74; PMID:21376230; http://dx.doi.org/10.1016/j.cell.2011.02.013 13.,OADS,/arxiv_data1/oa_pdf/e2/dd/koni-05-05-1128613.PMC4910727.pdf
Cell Cycle 2013; 12:1450-6; PMID:23574716; http://dx.doi.org/10.4161/cc.24601 14.,OADS,/arxiv_data1/oa_pdf/e2/dd/koni-05-05-1128613.PMC4910727.pdf
Oncotarget 2012; 3:22-30; PMID:22289880;http://dx.doi.org/10.18632/oncotarget.437 15.,OADS,/arxiv_data1/oa_pdf/e2/dd/koni-05-05-1128613.PMC4910727.pdf
Cancer Immunol Immunother 2009; 59:81-92; PMID:19526360; http://dx.doi.org/10.1007/s00262-009- 0725-4 16.,Non-OADS,/arxiv_data1/oa_pdf/e2/dd/koni-05-05-1128613.PMC4910727.pdf
Exp Cell Res 2001; 266:95-105; PMID:11339828; http://dx.doi.org/10.1006/excr.2001.5195 17.,OADS,/arxiv_data1/oa_pdf/e2/dd/koni-05-05-1128613.PMC4910727.pdf
Oncogene 1998; 17:1885-8; PMID: 9778055; http://dx.doi.org/10.1038/sj.onc.1202077 19.,Non-OADS,/arxiv_data1/oa_pdf/e2/dd/koni-05-05-1128613.PMC4910727.pdf
Life Sci 2002; 70:791-8; PMID:11833741; http://dx.doi.org/10.1016/S0024- 3205(01)01454-0 20.,OADS,/arxiv_data1/oa_pdf/e2/dd/koni-05-05-1128613.PMC4910727.pdf
Science 1977; 197:893-5; PMID:887927; http://dx.doi.org/10.1126/science.887927 21.,Non-OADS,/arxiv_data1/oa_pdf/e2/dd/koni-05-05-1128613.PMC4910727.pdf
PLoS One 2011; 6:e18784; PMID:21526207;http://dx.doi.org/10.1371/journal.pone.0018784 22.,Non-OADS,/arxiv_data1/oa_pdf/e2/dd/koni-05-05-1128613.PMC4910727.pdf
Proc Natl Acad Sci USA2004; 101:6062-7; PMID:15075390; http://dx.doi.org/10.1073/ pnas.0400782101 24.,OADS,/arxiv_data1/oa_pdf/e2/dd/koni-05-05-1128613.PMC4910727.pdf
J Exp Med 1997; 185:453-9; PMID:9053445; http://dx.doi.org/10.1084/jem.185.3.453 25.,Non-OADS,/arxiv_data1/oa_pdf/e2/dd/koni-05-05-1128613.PMC4910727.pdf
Available from; PMID:16488983; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e2/dd/koni-05-05-1128613.PMC4910727.pdf
Br J Cancer 2011; 105:1030-8; PMID:21863025; http://dx.doi.org/10.1038/bjc.2011.324 27.,Non-OADS,/arxiv_data1/oa_pdf/e2/dd/koni-05-05-1128613.PMC4910727.pdf
Exp Eye Res2007; 84:1060-6; PMID:17412323; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e2/dd/koni-05-05-1128613.PMC4910727.pdf
Am J Pathol 2010; 177:532-40; PMID:20616345; http://dx.doi.org/10.2353/ajpath.2010.100102 29.,Non-OADS,/arxiv_data1/oa_pdf/e2/dd/koni-05-05-1128613.PMC4910727.pdf
Oncogene 2009; 29:1093-102; PMID:23884215; http://dx.doi.org/10.1038/onc.2009.416 30.,Non-OADS,/arxiv_data1/oa_pdf/e2/dd/koni-05-05-1128613.PMC4910727.pdf
Vaccine 2009; 27:3398-400; PMID:19200836; http://dx.doi.org/10.1016/j.vaccine.2009.01.070 31.,Non-OADS,/arxiv_data1/oa_pdf/e2/dd/koni-05-05-1128613.PMC4910727.pdf
JCell Biol 2009; 187:343-53; PMID:19948478; http://dx.doi.org/10.1083/jcb.200905105 33.,Non-OADS,/arxiv_data1/oa_pdf/e2/dd/koni-05-05-1128613.PMC4910727.pdf
Nature 1990; 346:476-80; PMID:2198471; http://dx.doi.org/10.1038/346476a0ONCOIMMUNOLOGY e1128613-7,Non-OADS,/arxiv_data1/oa_pdf/e2/dd/koni-05-05-1128613.PMC4910727.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p  and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d6/53/nss-8-181.PMC4910729.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Associations of self-reported and objectively  measured sleep disturbances with depression  among primary caregivers of children with  disabilities Olivia R Orta1 Clarita Barbosa1 Juan Carlos Velez2 Bizu Gelaye1 Xiaoli Chen1 Lee Stoner3 Michelle A Williams1 1Harvard T.H.",Non-OADS,/arxiv_data1/oa_pdf/d6/53/nss-8-181.PMC4910729.pdf
"Nature and Science of Sleep Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/nature-and-science-of-sleep-journa lNature and Science of Sleep is an international, peer-reviewed, open  access journal covering all aspects of sleep science and sleep medicine,  including the neurophysiology and functions of sleep, the genetics of  sleep, sleep and society, biological rhythms, dreaming, sleep disorders and  therapy, and strategies to optimize healthy sleep.",Non-OADS,/arxiv_data1/oa_pdf/d6/53/nss-8-181.PMC4910729.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d6/53/nss-8-181.PMC4910729.pdf
"5, e1114203 (15 pages)http://dx.doi.org/10.1080/2162402X.2015.1114203",Non-OADS,/arxiv_data1/oa_pdf/97/e3/koni-05-05-1114203.PMC4910730.pdf
Int J Cancer 2009; 124:130-9; PMID:18839429; http://dx.doi.org/10.1002/ ijc.23886 2.,Non-OADS,/arxiv_data1/oa_pdf/97/e3/koni-05-05-1114203.PMC4910730.pdf
Cancer Res 2010; 70:7084-92; PMID:20823160; http://dx.doi.org/10.1158/0008-5472.CAN-10-1326 3.,Non-OADS,/arxiv_data1/oa_pdf/97/e3/koni-05-05-1114203.PMC4910730.pdf
J Clin Invest 2002; 109:295-299; PMID:11827987; http://dx.doi.org/10.1172/JCI0214941 4.,Non-OADS,/arxiv_data1/oa_pdf/97/e3/koni-05-05-1114203.PMC4910730.pdf
Nat Rev Cancer 2012; 12:252-64; PMID:22437870; http://dx.doi.org/10.1038/nrc3239 5.,Non-OADS,/arxiv_data1/oa_pdf/97/e3/koni-05-05-1114203.PMC4910730.pdf
Annu Rev Immunol 1996; 14:233-58; PMID:8717514; http://dx.doi.org/10.1146/annurev.immunol.14.1.233 6.,Non-OADS,/arxiv_data1/oa_pdf/97/e3/koni-05-05-1114203.PMC4910730.pdf
Nat Rev Immunol 2003; 3:939-51; PMID:14647476; http://dx.doi.org/10.1038/nri1248 7.,Non-OADS,/arxiv_data1/oa_pdf/97/e3/koni-05-05-1114203.PMC4910730.pdf
J Leukoc Biol 2011; 89:195-203; PMID:20699361; http://dx.doi.org/10.1189/jlb.0610351 9.,Non-OADS,/arxiv_data1/oa_pdf/97/e3/koni-05-05-1114203.PMC4910730.pdf
Nat Med 2002; 8:379-85; PMID:11927944; http://dx.doi.org/ 10.1038/nm0402-379 10.,Non-OADS,/arxiv_data1/oa_pdf/97/e3/koni-05-05-1114203.PMC4910730.pdf
Mech Ageing Dev 2005; 126:855-65;PMID:15992610; http://dx.doi.org/10.1016/j.mad.2005.03.00611.,OADS,/arxiv_data1/oa_pdf/97/e3/koni-05-05-1114203.PMC4910730.pdf
J Immunol2007; 178:7710-9; PMID:17548608; http://dx.doi.org/10.4049/jimmunol.178.12.7710 13.,Non-OADS,/arxiv_data1/oa_pdf/97/e3/koni-05-05-1114203.PMC4910730.pdf
Nature 2001; 409:97-101; PMID:11343121; http://dx.doi.org/10.1038/35051100 14.,Non-OADS,/arxiv_data1/oa_pdf/97/e3/koni-05-05-1114203.PMC4910730.pdf
Nature 1999; 397:263-6;PMID:9930702; http://dx.doi.org/10.1038/16717 15.,Non-OADS,/arxiv_data1/oa_pdf/97/e3/koni-05-05-1114203.PMC4910730.pdf
Nat Rev Immu- nol 2002; 2:116-26; PMID:11910893; http://dx.doi.org/10.1038/nri727 16.,OADS,/arxiv_data1/oa_pdf/97/e3/koni-05-05-1114203.PMC4910730.pdf
J Immunol 2009; 182:5515-27; PMID:19380800; http://dx.doi.org/10.4049/jimmunol.0803256 17.,Non-OADS,/arxiv_data1/oa_pdf/97/e3/koni-05-05-1114203.PMC4910730.pdf
Immunity 2007; 27:670-84; PMID:17950003; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/97/e3/koni-05-05-1114203.PMC4910730.pdf
J Clin Invest 2010; 120:4546-57; PMID:21084749; http://dx.doi.org/10.1172/JCI43127 20.,Non-OADS,/arxiv_data1/oa_pdf/97/e3/koni-05-05-1114203.PMC4910730.pdf
J Clin Invest 2014; 124:2246-59; PMID:24667641; http://dx.doi.org/10.1172/ JCI73639 21.,Non-OADS,/arxiv_data1/oa_pdf/97/e3/koni-05-05-1114203.PMC4910730.pdf
J Immunol 2011; 186:4200-12; PMID:21383243; http://dx.doi.org/10.4049/jimmunol.1001783 22.,Non-OADS,/arxiv_data1/oa_pdf/97/e3/koni-05-05-1114203.PMC4910730.pdf
PLoS One 2012; 7:30852; PMID:22347406; http://dx.doi.org/10.1371/journal.pone.0030852 23.,Non-OADS,/arxiv_data1/oa_pdf/97/e3/koni-05-05-1114203.PMC4910730.pdf
Front Immunol 2013; 4:455; PMID:24391639; http://dx.doi.org/10.3389/ﬁmmu.2013.00455 24.,Non-OADS,/arxiv_data1/oa_pdf/97/e3/koni-05-05-1114203.PMC4910730.pdf
Mol CellBiol 2005; 25:9543-53; PMID:16227604; http://dx.doi.org/10.1128/MCB.25.21.9543-9553.2005 25.,Non-OADS,/arxiv_data1/oa_pdf/97/e3/koni-05-05-1114203.PMC4910730.pdf
Immunol Rev 2003; 192:7-20; PMID:12670391; http://dx.doi.org/10.1034/j.1600-065X.2003.00008.xONCOIMMUNOLOGY e1114203-13,Non-OADS,/arxiv_data1/oa_pdf/97/e3/koni-05-05-1114203.PMC4910730.pdf
Nat Rev Immunol 2011; 11:109-17; PMID:21233853;http://dx.doi.org/10.1038/nri2888 27.,Non-OADS,/arxiv_data1/oa_pdf/97/e3/koni-05-05-1114203.PMC4910730.pdf
Blood 2009; 113:6619-28; PMID:19406987; http://dx.doi.org/10.1182/blood-2009- 01-199588 29.,Non-OADS,/arxiv_data1/oa_pdf/97/e3/koni-05-05-1114203.PMC4910730.pdf
Immunity 2011; 34:224-36; PMID:21295499; http://dx.doi.org/10.1016/j.immuni.2011.01.012 30.,OADS,/arxiv_data1/oa_pdf/97/e3/koni-05-05-1114203.PMC4910730.pdf
Blood 2012; 120:2229-39; PMID:22859605; http://dx.doi.org/10.1182/blood-2011-12-398321 31.,Non-OADS,/arxiv_data1/oa_pdf/97/e3/koni-05-05-1114203.PMC4910730.pdf
J Virol 2014; 88:10134-45; PMID:24965450; http://dx.doi.org/10.1128/JVI.00647-14 32.,Non-OADS,/arxiv_data1/oa_pdf/97/e3/koni-05-05-1114203.PMC4910730.pdf
J Clin Invest 2014; 124:198-208; PMID:24292711; http://dx.doi.org/10.1172/JCI70510 33.,Non-OADS,/arxiv_data1/oa_pdf/97/e3/koni-05-05-1114203.PMC4910730.pdf
Nat Med 2007; 13:843-50; PMID:17558415; http://dx.doi.org/10.1038/nm1592 34.,Non-OADS,/arxiv_data1/oa_pdf/97/e3/koni-05-05-1114203.PMC4910730.pdf
J Transl Med2005; 3:35; PMID:16174302; http://dx.doi.org/10.1186/1479-5876-3-35 35.,Non-OADS,/arxiv_data1/oa_pdf/97/e3/koni-05-05-1114203.PMC4910730.pdf
Immunology 2010; 129:474-81; PMID:20201977; http://dx.doi.org/10.1111/j.1365-2567.2010.03255.x 36.,Non-OADS,/arxiv_data1/oa_pdf/97/e3/koni-05-05-1114203.PMC4910730.pdf
Immunology 2012; 135:355-63; PMID:22211948;http://dx.doi.org/10.1111/j.1365-2567.2011.03550.x 37.,Non-OADS,/arxiv_data1/oa_pdf/97/e3/koni-05-05-1114203.PMC4910730.pdf
Blood 2002; 100:3698-702; PMID:12393723;http://dx.doi.org/10.1182/blood-2002-02-0657 3 8 .,Non-OADS,/arxiv_data1/oa_pdf/97/e3/koni-05-05-1114203.PMC4910730.pdf
J Exp Med 2007; 204:105-15;PMID:17200410; http://dx.doi.org/10.1084/jem.20061660 39.,Non-OADS,/arxiv_data1/oa_pdf/97/e3/koni-05-05-1114203.PMC4910730.pdf
PLoS One 2013; 8:82203;PMID:24312642; http://dx.doi.org/10.1371/journal.pone.0082203 40.,Non-OADS,/arxiv_data1/oa_pdf/97/e3/koni-05-05-1114203.PMC4910730.pdf
Cancer Res 2010; 70:9581- 90; PMID:21098714; http://dx.doi.org/10.1158/0008-5472.CAN-10- 1379 41.,Non-OADS,/arxiv_data1/oa_pdf/97/e3/koni-05-05-1114203.PMC4910730.pdf
J Virol 2008; 820:10017-31; PMID:18667516; http://dx.doi.org/10.1128/JVI.01083-08 42.,Non-OADS,/arxiv_data1/oa_pdf/97/e3/koni-05-05-1114203.PMC4910730.pdf
J Exp Med2007; 204:2473-85; PMID:17893201; http://dx.doi.org/10.1084/ jem.20070784 43.,OADS,/arxiv_data1/oa_pdf/97/e3/koni-05-05-1114203.PMC4910730.pdf
J Immunol 2012; 188:1156-67; PMID:22210916; http://dx.doi.org/10.4049/jimmunol.1102610 44.,Non-OADS,/arxiv_data1/oa_pdf/97/e3/koni-05-05-1114203.PMC4910730.pdf
"J Immunol 2012; 188:4305-14; PMID: 22467649; http://dx.doi.org/10.4049/jimmunol.1103568 48. van der Waart AB, van de Weem NM, Maas F, Kramer CS, Kester MG, Falkenburg JH, Schaap N, Jansen JH, van der Voort R, Gattinoni L et al.",OADS,/arxiv_data1/oa_pdf/97/e3/koni-05-05-1114203.PMC4910730.pdf
Blood 2014;124:3490-500; PMID:25336630; http://dx.doi.org/10.1182/blood- 2014-05-578583 49.,Non-OADS,/arxiv_data1/oa_pdf/97/e3/koni-05-05-1114203.PMC4910730.pdf
Cancer Res 2015; 75:296- 305; PMID:25432172; http://dx.doi.org/10.1158/0008-5472.CAN-14-2277 50.,Non-OADS,/arxiv_data1/oa_pdf/97/e3/koni-05-05-1114203.PMC4910730.pdf
Oncoimmunology 2015; 4:1005448; PMID:26155399; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/e3/koni-05-05-1114203.PMC4910730.pdf
Eur J Immunol 2003; 33:446-54; PMID:12645943; http://dx.doi.org/10.1002/immu.200310020 52.,Non-OADS,/arxiv_data1/oa_pdf/97/e3/koni-05-05-1114203.PMC4910730.pdf
Nat Rev Immunol 2006;6:595-601; PMID:16868550; http://dx.doi.org/10.1038/nri1901 53.,Non-OADS,/arxiv_data1/oa_pdf/97/e3/koni-05-05-1114203.PMC4910730.pdf
Int Immunol 2002; 14:555-66;PMID:12039907; http://dx.doi.org/10.1093/intimm/dxf022 54.,OADS,/arxiv_data1/oa_pdf/97/e3/koni-05-05-1114203.PMC4910730.pdf
J Immunol 2009; 182:5515-27; PMID:19380800; http://dx.doi.org/10.4049/jimmunol.0803256 55.,Non-OADS,/arxiv_data1/oa_pdf/97/e3/koni-05-05-1114203.PMC4910730.pdf
Cancer Invest 2009; 27:244-50; PMID:19194830; http://dx.doi.org/10.1080/07357900802239124 56.,Non-OADS,/arxiv_data1/oa_pdf/97/e3/koni-05-05-1114203.PMC4910730.pdf
J Exp Med 2014; 211:715-25;PMID:24687957; http://dx.doi.org/10.1084/jem.20130590e1114203-14 O. FRANZESE ET AL.,OADS,/arxiv_data1/oa_pdf/97/e3/koni-05-05-1114203.PMC4910730.pdf
Nat Immunol 2013; 14:1212-8;PMID:24240160; http://dx.doi.org/10.1038/ni.2762 58.,Non-OADS,/arxiv_data1/oa_pdf/97/e3/koni-05-05-1114203.PMC4910730.pdf
Oncoimmunology 2012; 1:1223-1225; PMID:23243584; http://dx.doi.org/10.4161/onci.21335 59.,Non-OADS,/arxiv_data1/oa_pdf/97/e3/koni-05-05-1114203.PMC4910730.pdf
Oncoimmunology 2014; 3:27297;http://dx.doi.org/10.4161/onci.27297 60.,Non-OADS,/arxiv_data1/oa_pdf/97/e3/koni-05-05-1114203.PMC4910730.pdf
J Clin Oncol 2014; 32:1020-30; PMID:24590637; http://dx.doi.org/10.1200/JCO.2013.53.0105 61.,Non-OADS,/arxiv_data1/oa_pdf/97/e3/koni-05-05-1114203.PMC4910730.pdf
Mol Pharmacol 2008; 74:173-83; PMID:18413665; http://dx.doi.org/10.1124/mol.107.04474362.,Non-OADS,/arxiv_data1/oa_pdf/97/e3/koni-05-05-1114203.PMC4910730.pdf
J InterferonCytokine Res 2012; 32:235-47; PMID:22490303; http://dx.doi.org/10.1089/jir.2011.0077 63.,Non-OADS,/arxiv_data1/oa_pdf/97/e3/koni-05-05-1114203.PMC4910730.pdf
Oncogene 2004; 23:5968-77; PMID:15195137; http://dx.doi.org/ 10.1038/sj.onc.1207780 64.,OADS,/arxiv_data1/oa_pdf/97/e3/koni-05-05-1114203.PMC4910730.pdf
Evidence of bypass of intratumor susceptibility to cell lysis in human melanoma.J Clin Invest 1992; 90:1093-9; PMID:1387883; http://dx.doi.org/10.1172/JCI1-15925 65.,Non-OADS,/arxiv_data1/oa_pdf/97/e3/koni-05-05-1114203.PMC4910730.pdf
Cancer Immunol Immun- other 2012; 61:817-26; PMID:22080404; http://dx.doi.org/10.1007/ s00262-011-1140-1ONCOIMMUNOLOGY e1114203-15,Non-OADS,/arxiv_data1/oa_pdf/97/e3/koni-05-05-1114203.PMC4910730.pdf
"5, e1123367 (10 pages)http://dx.doi.org/10.1080/2162402X.2015.1123367",Non-OADS,/arxiv_data1/oa_pdf/29/5e/koni-05-05-1123367.PMC4910733.pdf
Anti- b-actin HRP-con- jugated antibody (Cell Signaling) was used as a loading control.Densitometric analysis was performed using the ImageJ com-puter program (http://imagej.nih.gov/ij/download.html) and itis reported as fold change relative to controls set to 1.,OADS,/arxiv_data1/oa_pdf/29/5e/koni-05-05-1123367.PMC4910733.pdf
Biochimie 2008; 90:369-79;PMID:17920749; http://dx.doi.org/10.1016/j.biochi.2007.08.008 2.,OADS,/arxiv_data1/oa_pdf/29/5e/koni-05-05-1123367.PMC4910733.pdf
Eur J Cell Biol 2011; 90:527-35; PMID:21194787; http://dx.doi.org/10.1016/j.ejcb.2010.11.005 3.,OADS,/arxiv_data1/oa_pdf/29/5e/koni-05-05-1123367.PMC4910733.pdf
Clin Proteomics 2011; 8:9-13;PMID:21906355; http://dx.doi.org/10.1186/1559-0275-8-9 4.,OADS,/arxiv_data1/oa_pdf/29/5e/koni-05-05-1123367.PMC4910733.pdf
Nature Rev Cancer 2005; 6:32-43; PMID:15688065; http://dx.doi.org/10.1038/nrm1548 5.,Non-OADS,/arxiv_data1/oa_pdf/29/5e/koni-05-05-1123367.PMC4910733.pdf
Clin Cancer Res 2007; 13:2335- 43; PMID:17438092; http://dx.doi.org/10.1158/1078-0432.CCR-06-2092 6.,Non-OADS,/arxiv_data1/oa_pdf/29/5e/koni-05-05-1123367.PMC4910733.pdf
Cancer Res 2006; 66(5):2520-26; PMID:16510567; http://dx.doi.org/10.1158/0008-5472.CAN-05-2520 8.,Non-OADS,/arxiv_data1/oa_pdf/29/5e/koni-05-05-1123367.PMC4910733.pdf
Cancer Res 2008; 68 (15):6368-76; PMID:18676862; http://dx.doi.org/10.1158/0008-5472.CAN-07-6768 9.,Non-OADS,/arxiv_data1/oa_pdf/29/5e/koni-05-05-1123367.PMC4910733.pdf
Onco- gene 2008; 27:5944-58; PMID:18836475; http://dx.doi.org/10.1038/ onc.2008.272 10.,OADS,/arxiv_data1/oa_pdf/29/5e/koni-05-05-1123367.PMC4910733.pdf
Immunol Rev 2010; 235:267-85; PMID:20536569; http://dx.doi.org/10.1111/j.0105-2896.2010.00893.x 11.,Non-OADS,/arxiv_data1/oa_pdf/29/5e/koni-05-05-1123367.PMC4910733.pdf
Blood 2003; 102:1389-96; PMID:12714493; http://dx.doi.org/10.1182/blood-2003-01-0019 12.,Non-OADS,/arxiv_data1/oa_pdf/29/5e/koni-05-05-1123367.PMC4910733.pdf
Immunity 2009; 31:184-96; PMID:19699170; http://dx.doi.org/ 10.1016/j.immuni.2009.08.006 13.,Non-OADS,/arxiv_data1/oa_pdf/29/5e/koni-05-05-1123367.PMC4910733.pdf
Cancer Res 2004; 64:9172-9; PMID:15604289; http://dx.doi.org/10.1158/0008-5472.CAN-04-2417 14.,Non-OADS,/arxiv_data1/oa_pdf/29/5e/koni-05-05-1123367.PMC4910733.pdf
Leukemia 2009; 23:641-8; PMID:19151770;http://dx.doi.org/10.1038/leu.2008.354 15.,Non-OADS,/arxiv_data1/oa_pdf/29/5e/koni-05-05-1123367.PMC4910733.pdf
Expansion of Vdelta1 T lymphocytes producing IL-4 in low- grade non-Hodgkin lymphomas ex pressing UL-16-binding proteins.Blood 2007; 109:2078-85; PMID:16973957; http://dx.doi.org/10.1182/blood-2006-06-028985 16.,Non-OADS,/arxiv_data1/oa_pdf/29/5e/koni-05-05-1123367.PMC4910733.pdf
Blood 2012; 119:1479-89; PMID:22167753; http://dx.doi.org/10.1182/blood-2011-07-370841 17.,Non-OADS,/arxiv_data1/oa_pdf/29/5e/koni-05-05-1123367.PMC4910733.pdf
Nature 2002; 419:734-8; PMID:12384702; http://dx.doi.org/10.1038/nature01112 18.,Non-OADS,/arxiv_data1/oa_pdf/29/5e/koni-05-05-1123367.PMC4910733.pdf
"N €uckel H, Switala M, Sellmann L, Horn PA, D €urig J, D €uhrsen U, K€uppers R, Grosse-Wilde H, Rebmann V. The prognostic signi ﬁcance of soluble NKG2D ligands in B-cell chronic lymphocytic leukemia.Leukemia 2010; 24:1152-59; PMID:20428196; http://dx.doi.org/ 10.1038/leu.2010.74 20.",Non-OADS,/arxiv_data1/oa_pdf/29/5e/koni-05-05-1123367.PMC4910733.pdf
Cancer Cell 2006; 10:39-50; PMID:16843264; http://dx.doi.org/ 10.1016/j.ccr.2006.05.024 21.,Non-OADS,/arxiv_data1/oa_pdf/29/5e/koni-05-05-1123367.PMC4910733.pdf
Cancer Res 2008; 68:7082-89;PMID:18757423; http://dx.doi.org/10.1158/0008-5472.CAN-08-0739 22.,Non-OADS,/arxiv_data1/oa_pdf/29/5e/koni-05-05-1123367.PMC4910733.pdf
Curr Pharm Biotechnol 2008; 9:2-8;PMID:18289051; http://dx.doi.org/10.2174/138920108783497613 24.,Non-OADS,/arxiv_data1/oa_pdf/29/5e/koni-05-05-1123367.PMC4910733.pdf
FEBS J 2014; 281:5023-42; PMID:25333340; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/29/5e/koni-05-05-1123367.PMC4910733.pdf
Models J Med Chem 2013; 56:8089-103; PMID:24044434; http://dx.doi.org/10.1021/jm4011753 26.,OADS,/arxiv_data1/oa_pdf/29/5e/koni-05-05-1123367.PMC4910733.pdf
J Med Chem 2010; 53:2622-35; PMID:20180536; http://dx.doi.org/10.1021/jm901868z 27.,Non-OADS,/arxiv_data1/oa_pdf/29/5e/koni-05-05-1123367.PMC4910733.pdf
Int J Cancer 2011; 129:387-96; PMID:20853320; http://dx.doi.org/10.1002/ijc.25682 28.,Non-OADS,/arxiv_data1/oa_pdf/29/5e/koni-05-05-1123367.PMC4910733.pdf
Int J Cancer 2013; 133:1557-67; PMID:23526433; http://dx.doi.org/10.1002/ijc.28174 29.,Non-OADS,/arxiv_data1/oa_pdf/29/5e/koni-05-05-1123367.PMC4910733.pdf
Blood 2003;102:1186-95; PMID:12714508; http://dx.doi.org/10.1182/blood- 2002-12-3775 30.,Non-OADS,/arxiv_data1/oa_pdf/29/5e/koni-05-05-1123367.PMC4910733.pdf
J Exp Med 2003; 197:163-68; PMID:12538656; http://dx.doi.org/10.1084/jem.20021500 31.,Non-OADS,/arxiv_data1/oa_pdf/29/5e/koni-05-05-1123367.PMC4910733.pdf
Nat Rev Immunol 2010; 10:467-78; PMID:20539306; http://dx.doi.org/ 10.1038/nri2781 32.,Non-OADS,/arxiv_data1/oa_pdf/29/5e/koni-05-05-1123367.PMC4910733.pdf
Haematolog- ica 2014; 99:131-9; PMID:24162786; http://dx.doi.org/10.3324/ haematol.2013.097311 34.,Non-OADS,/arxiv_data1/oa_pdf/29/5e/koni-05-05-1123367.PMC4910733.pdf
Br J Haematol 2014; 167:574-7; PMID:25039986; http://dx.doi.org/ 10.1111/bjh.13015 35.,Non-OADS,/arxiv_data1/oa_pdf/29/5e/koni-05-05-1123367.PMC4910733.pdf
2007; 67:332-8; PMID:17210715; http://dx.doi.org/10.1158/0008-5472.CAN-06-2470e1123367-10 M. R. ZOCCHI ET AL.,OADS,/arxiv_data1/oa_pdf/29/5e/koni-05-05-1123367.PMC4910733.pdf
"5, e1137417 (7 pages)http://dx.doi.org/10.1080/2162402X.2015.1137417",Non-OADS,/arxiv_data1/oa_pdf/c6/f8/koni-05-05-1137417.PMC4910735.pdf
Toxicol Pathol 2006; 34:515-47; PMID:17067942; http://dx.doi.org/10.1080/01926230600978458 2.,Non-OADS,/arxiv_data1/oa_pdf/c6/f8/koni-05-05-1137417.PMC4910735.pdf
AJR Am J Roentgenol 1987; 149:269-72; PMID:3496749; http://dx.doi.org/ 10.2214/ajr.149.2.269 3.,Non-OADS,/arxiv_data1/oa_pdf/c6/f8/koni-05-05-1137417.PMC4910735.pdf
AJR Am J Roentgenol 1980; 135:151- 6; PMID:6771982; http://dx.doi.org/10.2214/ajr.135.1.151 4.,Non-OADS,/arxiv_data1/oa_pdf/c6/f8/koni-05-05-1137417.PMC4910735.pdf
Jpn J Clin Oncol 2010; 40:1128-34; PMID:20693549; http://dx.doi.org/10.1093/jjco/hyq149 5.,Non-OADS,/arxiv_data1/oa_pdf/c6/f8/koni-05-05-1137417.PMC4910735.pdf
Int J Clin Pract 2007; 61:562-8; PMID:17263694; http://dx.doi.org/10.1111/j.1742-1241.,OADS,/arxiv_data1/oa_pdf/c6/f8/koni-05-05-1137417.PMC4910735.pdf
AJR Am J Roentgenol 1999; 173:1341-4; PMID:10541115; http://dx.doi.org/10.2214/ajr.173.5.10541115 7.,Non-OADS,/arxiv_data1/oa_pdf/c6/f8/koni-05-05-1137417.PMC4910735.pdf
J Thorac Imag- ing 2006; 21:43-6; PMID:16538156; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/c6/f8/koni-05-05-1137417.PMC4910735.pdf
Age (Dordr) 2011; 33:197-207; PMID:20700658; http://dx.doi.org/10.1007/s11357-010-9170-8 9.,Non-OADS,/arxiv_data1/oa_pdf/c6/f8/koni-05-05-1137417.PMC4910735.pdf
N Engl J Med 1995; 332:143-9;PMID:7800006; http://dx.doi.org/10.1056/NEJM199501193320303 10.,OADS,/arxiv_data1/oa_pdf/c6/f8/koni-05-05-1137417.PMC4910735.pdf
J Clin Invest 2005; 115:930-9; PMID:15776111; http://dx.doi.org/10.1172/JCI200522492 11.,Non-OADS,/arxiv_data1/oa_pdf/c6/f8/koni-05-05-1137417.PMC4910735.pdf
Blood 2009; 113:769-74; PMID:18583570; http://dx.doi.org/10.1182/blood-2008-02-139154 12.,Non-OADS,/arxiv_data1/oa_pdf/c6/f8/koni-05-05-1137417.PMC4910735.pdf
AIDS 2014; 28:209-14; PMID:24072195; http://dx.doi.org/10.1097/QAD.0000000000000063 13.,Non-OADS,/arxiv_data1/oa_pdf/c6/f8/koni-05-05-1137417.PMC4910735.pdf
Clin Exp Immunol 2002; 129:346-53; PMID:12165093; http://dx.doi.org/ 10.1046/j.1365-2249.2002.01893.x 14.,Non-OADS,/arxiv_data1/oa_pdf/c6/f8/koni-05-05-1137417.PMC4910735.pdf
BMC Infect Dis 2006; 6:112; PMID:16839416; http://dx.doi.org/ 10.1186/1471-2334-6-112 15.,Non-OADS,/arxiv_data1/oa_pdf/c6/f8/koni-05-05-1137417.PMC4910735.pdf
Scand J Immu-nol 2009; 69:547-54; PMID:19439016; http://dx.doi.org/10.1111/ j.1365-3083.2009.02252.x 17.,OADS,/arxiv_data1/oa_pdf/c6/f8/koni-05-05-1137417.PMC4910735.pdf
Lancet 2000; 355:1875-81; PMID:10866444; http://dx.doi.org/10.1016/S0140-6736(00)02293-5 18.,OADS,/arxiv_data1/oa_pdf/c6/f8/koni-05-05-1137417.PMC4910735.pdf
Trends Immunol 2009; 30:366-73; PMID:19540807; http://dx.doi.org/ 10.1016/j.it.2009.04.003 19.,Non-OADS,/arxiv_data1/oa_pdf/c6/f8/koni-05-05-1137417.PMC4910735.pdf
Eur J Clin Invest2005; 35:380-7; PMID:15948899; http://dx.doi.org/10.1111/j.1365-2362.2005.01499.x 20.,Non-OADS,/arxiv_data1/oa_pdf/c6/f8/koni-05-05-1137417.PMC4910735.pdf
Semin Immunol 2007; 19:318-30;PMID:18023361; http://dx.doi.org/10.1016/j.smim.2007.10.004 21.,Non-OADS,/arxiv_data1/oa_pdf/c6/f8/koni-05-05-1137417.PMC4910735.pdf
Front Immunol 2013; 4:169; PMID:23818888; http://dx.doi.org/10.3389/ ﬁmmu.2013.00169 22.,Non-OADS,/arxiv_data1/oa_pdf/c6/f8/koni-05-05-1137417.PMC4910735.pdf
AJR Am J Roentgenol 1985; 145:249-54; PMID:3875220; http://dx.doi.org/10.2214/ajr.145.2.249 23.,Non-OADS,/arxiv_data1/oa_pdf/c6/f8/koni-05-05-1137417.PMC4910735.pdf
Immunity 1999; 10:569-75;PMID:10367902; http://dx.doi.org/10.1016/S1074-7613(00)80056-4 24.,OADS,/arxiv_data1/oa_pdf/c6/f8/koni-05-05-1137417.PMC4910735.pdf
Nat Rev Immunol 2013; 13:831-8; PMID:24052146; http://dx.doi.org/10.1038/nri3534 25.,Non-OADS,/arxiv_data1/oa_pdf/c6/f8/koni-05-05-1137417.PMC4910735.pdf
Leuk Lymphoma 2003; 44:343-8; PMID:12688355; http://dx.doi.org/10.1080/1042819021000029696 26.,Non-OADS,/arxiv_data1/oa_pdf/c6/f8/koni-05-05-1137417.PMC4910735.pdf
Clin Exp Immunol 2002; 130:121-6; PMID:12296862; http://dx.doi.org/10.1046/j.1365-2249.2002.01950.x 28.,Non-OADS,/arxiv_data1/oa_pdf/c6/f8/koni-05-05-1137417.PMC4910735.pdf
Blood2011; 117:608-17; PMID:20935254; http://dx.doi.org/10.1182/blood-2010-04-277939 29.,Non-OADS,/arxiv_data1/oa_pdf/c6/f8/koni-05-05-1137417.PMC4910735.pdf
AIDS 2013; 27:1059-69; PMID:23299175; http://dx.doi.org/10.1097/QAD.0b013e32835e2b99 30.,Non-OADS,/arxiv_data1/oa_pdf/c6/f8/koni-05-05-1137417.PMC4910735.pdf
Clin Exp Immunol 2009; 155:44-52; PMID:19016807; http://dx.doi.org/10.1111/j.1365-2249.2008.03803.x 31.,Non-OADS,/arxiv_data1/oa_pdf/c6/f8/koni-05-05-1137417.PMC4910735.pdf
Arch Neurol 2008; 65:1434-9; PMID:19001161; http://dx.doi.org/10.1001/ archneur.65.11.1434 32.,Non-OADS,/arxiv_data1/oa_pdf/c6/f8/koni-05-05-1137417.PMC4910735.pdf
J Immunol Methods 2010; 352:111-7; PMID:19919841; http://dx.doi.org/10.1016/j.jim.2009.11.007 33.,Non-OADS,/arxiv_data1/oa_pdf/c6/f8/koni-05-05-1137417.PMC4910735.pdf
Blood 2009; 113:2999-3007; PMID:19008454; http://dx.doi.org/10.1182/blood-2008-07-166223 34.,Non-OADS,/arxiv_data1/oa_pdf/c6/f8/koni-05-05-1137417.PMC4910735.pdf
J Hepatol 2013; 59:723-30; PMID:23742913; http://dx.doi.org/10.1016/j.jhep.2013.05.042 35.,OADS,/arxiv_data1/oa_pdf/c6/f8/koni-05-05-1137417.PMC4910735.pdf
PLoS One 2011; 6:e24272; PMID:21935395; http://dx.doi.org/10.1371/ journal.pone.0024272ONCOIMMUNOLOGY e1137417-7,Non-OADS,/arxiv_data1/oa_pdf/c6/f8/koni-05-05-1137417.PMC4910735.pdf
"5, e1126037 (3 pages)http://dx.doi.org/10.1080/2162402X.2015.1126037",Non-OADS,/arxiv_data1/oa_pdf/10/87/koni-05-05-1126037.PMC4910739.pdf
Nat Immunol 2010; 11(5):373-84; PMID:20404851; http://dx.doi.org/10.1038/ ni.1863 2.,Non-OADS,/arxiv_data1/oa_pdf/10/87/koni-05-05-1126037.PMC4910739.pdf
Cell Immunol 2006; 243(1):48-57; PMID:17250816; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/10/87/koni-05-05-1126037.PMC4910739.pdf
J Immunol 2005; 174:1259-68; PMID:15661881; http://dx.doi.org/10.4049/jimmunol.174.3.1259 4.,Non-OADS,/arxiv_data1/oa_pdf/10/87/koni-05-05-1126037.PMC4910739.pdf
Clin Cancer Res 2012; 18:499-509; PMID:22128302; http://dx.doi.org/10.1158/1078-0432.CCR-11-1625 5.,Non-OADS,/arxiv_data1/oa_pdf/10/87/koni-05-05-1126037.PMC4910739.pdf
Cancer 1976; 37(2 Suppl):1058-69; PMID:766953;http://dx.doi.org/10.1002/1097-0142(197602)37:2 C%3c1058::AID- CNCR2820370813%3e3.0.CO;2-O 6.,Non-OADS,/arxiv_data1/oa_pdf/10/87/koni-05-05-1126037.PMC4910739.pdf
(6):1853-63; PMID:15579430; http://dx.doi.org/10.1016/S0002-9440 (10)63238-5 8.,Non-OADS,/arxiv_data1/oa_pdf/10/87/koni-05-05-1126037.PMC4910739.pdf
Nat Med 2014; 20(6):607-15; PMID:24793239; http://dx.doi.org/10.1038/nm.3541 9.,OADS,/arxiv_data1/oa_pdf/10/87/koni-05-05-1126037.PMC4910739.pdf
"5, e1123370 (3 pages)http://dx.doi.org/10.1080/2162402X.2015.1123370",Non-OADS,/arxiv_data1/oa_pdf/8c/93/koni-05-05-1123370.PMC4910741.pdf
Cell 2015; 161:205-14; PMID:25860605; http://dx.do i.org/10.1016/j.cell.2015.03.030 2.,OADS,/arxiv_data1/oa_pdf/8c/93/koni-05-05-1123370.PMC4910741.pdf
Cell 2015; 162(6):1257-70; PMID:26343581; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/93/koni-05-05-1123370.PMC4910741.pdf
Science 2011; 331:1565-70; PMID:21436444; http://dx.doi.org/10.1126/science.1203486 4.,Non-OADS,/arxiv_data1/oa_pdf/8c/93/koni-05-05-1123370.PMC4910741.pdf
Trends Immunol 2013; 34:329-35; PMID:23608152; http://dx.doi.org/10.1016/j.it.2013.03.005 5.,OADS,/arxiv_data1/oa_pdf/8c/93/koni-05-05-1123370.PMC4910741.pdf
Cell 2015; 160:48-61; PMID:25594174; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/8c/93/koni-05-05-1123370.PMC4910741.pdf
Cancer Cell2009; 15:294-303; PMID:19345328; http://dx.doi.org/10.1016/j.ccr.2009.,OADS,/arxiv_data1/oa_pdf/8c/93/koni-05-05-1123370.PMC4910741.pdf
Nature Rev Cancer 2010; 10:181-93; PMID:20168319; http://dx.doi.org/10.1038/nrc2809 10. http://www.cancerresearchuk.org/about-us/cancer-news/press-release/ 2015-10-22-worlds-largest-clinical -trial-on-aspirin-to-stop-cancer- returning-launches-todayONCOIMMUNOLOGY e1123370-3,Non-OADS,/arxiv_data1/oa_pdf/8c/93/koni-05-05-1123370.PMC4910741.pdf
"5, e1116675 (3 pages)http://dx.doi.org/10.1080/2162402X.2015.1116675",Non-OADS,/arxiv_data1/oa_pdf/07/b5/koni-05-05-1116675.PMC4910745.pdf
Annu Rev Immunol 2013; 31:51-72; PMID:23157435; http://dx.doi.org/10.1146/annurev-immunol-032712-100008 2.,Non-OADS,/arxiv_data1/oa_pdf/07/b5/koni-05-05-1116675.PMC4910745.pdf
Annu Rev Med 2013; 64:71-90; PMID:23092383; http://dx.doi.org/10.1146/annurev-med-112311-083918 3.,Non-OADS,/arxiv_data1/oa_pdf/07/b5/koni-05-05-1116675.PMC4910745.pdf
Science 2015; 348(6230):74-80; PMID:25838376; http://dx.doi.org/10.1126/science.aaa6204 4.,Non-OADS,/arxiv_data1/oa_pdf/07/b5/koni-05-05-1116675.PMC4910745.pdf
Annu Rev Immunol 2014; 32:659-702; PMID:24655300; http://dx.doi.org/10.1146/annurev-immunol-032713-120145 5.,Non-OADS,/arxiv_data1/oa_pdf/07/b5/koni-05-05-1116675.PMC4910745.pdf
Nat Commun 2015; 6:7458; PMID:26109379; http://dx.doi.org/ 10.1038/ncomms8458 6.,OADS,/arxiv_data1/oa_pdf/07/b5/koni-05-05-1116675.PMC4910745.pdf
J Clin Invest 2013; 123(6):2663-71; PMID:23676459; http://dx.doi.org/10.1172/JCI66722 7.,Non-OADS,/arxiv_data1/oa_pdf/07/b5/koni-05-05-1116675.PMC4910745.pdf
Nat Med 2014; 20(11):1301-9; PMID:25344738; http://dx.doi.org/10.1038/nm.3708 8.,OADS,/arxiv_data1/oa_pdf/07/b5/koni-05-05-1116675.PMC4910745.pdf
Annu Rev Immunol 2015; 33:445-74; PMID:25622193; http://dx.doi.org/10.1146/annurev-immunol-032414-112043 9.,Non-OADS,/arxiv_data1/oa_pdf/07/b5/koni-05-05-1116675.PMC4910745.pdf
Cancer Res 2011; 71(4):1214-8;PMID:21212413; http://dx.doi.org/10.1158/0008-5472.CAN-10-3277ONCOIMMUNOLOGY e1116675-3,Non-OADS,/arxiv_data1/oa_pdf/07/b5/koni-05-05-1116675.PMC4910745.pdf
"5, e1108511 (8 pages)http://dx.doi.org/10.1080/2162402X.2015.1108511",Non-OADS,/arxiv_data1/oa_pdf/c1/e2/koni-05-05-1108511.PMC4910748.pdf
"About 64% of patients are diagnosed at the local stage.However, despite development of various new treatmentoptions only 12% of patients diagnosed at metastasized stagesurvive 5 y (National Cancer Institute, http://seer.cancer.gov/statfacts/html/kidrp.html, July 2014).",Non-OADS,/arxiv_data1/oa_pdf/c1/e2/koni-05-05-1108511.PMC4910748.pdf
Annu Rev Immunol 2000; 18:767-811; PMID:10837075; http://dx.doi.org/10.1146/annurev.immunol.18.1.767 2.,Non-OADS,/arxiv_data1/oa_pdf/c1/e2/koni-05-05-1108511.PMC4910748.pdf
Can- cer Lett 2000; 159:103-8; PMID:10974412; http://dx.doi.org/10.1016/ S0304-3835(00)00542-5 3.,OADS,/arxiv_data1/oa_pdf/c1/e2/koni-05-05-1108511.PMC4910748.pdf
Oncol Rep 2003; 10:1237-40; PMID:12883687; http://dx.doi.org/10.3892/ or.10.5.1237 4.,Non-OADS,/arxiv_data1/oa_pdf/c1/e2/koni-05-05-1108511.PMC4910748.pdf
Int J Cancer 2003; 104:92-7; PMID:12532424; http://dx.doi.org/10.1002/ijc.10915 5.,Non-OADS,/arxiv_data1/oa_pdf/c1/e2/koni-05-05-1108511.PMC4910748.pdf
Oncogene 2008; 27:5920-31;PMID:18836473; http://dx.doi.org/10.1038/onc.2008.270 6.,Non-OADS,/arxiv_data1/oa_pdf/c1/e2/koni-05-05-1108511.PMC4910748.pdf
Ann Rev Immunol 2013; 31:51-72; PMID:23157435; http://dx.doi.org/10.1146/annurev-immunol-032712-100008 7.,Non-OADS,/arxiv_data1/oa_pdf/c1/e2/koni-05-05-1108511.PMC4910748.pdf
Oncoimmunology 2012; 1:1451-3; PMID:23243626;http://dx.doi.org/10.4161/onci.21356 8.,Non-OADS,/arxiv_data1/oa_pdf/c1/e2/koni-05-05-1108511.PMC4910748.pdf
Cancer Res 2012; 72:5188-97; PMID:22836755; http://dx.doi.org/ 10.1158/0008-5472.CAN-11-3468 9.,Non-OADS,/arxiv_data1/oa_pdf/c1/e2/koni-05-05-1108511.PMC4910748.pdf
Immunol Rev 2004; 199:251-63; PMID:15233739; http://dx.doi.org/10.1111/j.0105-2896.2004.00139.x 10.,Non-OADS,/arxiv_data1/oa_pdf/c1/e2/koni-05-05-1108511.PMC4910748.pdf
J Immunol 2000; 164:5508-14; PMID:10799919; http://dx.doi.org/10.4049/jimmunol.164.10.5508 11.,Non-OADS,/arxiv_data1/oa_pdf/c1/e2/koni-05-05-1108511.PMC4910748.pdf
Cell Mol Life Sci 2004; 61:2418-24; PMID:15378210; http://dx.doi.org/10.1007/s00018-004-4255-0 13.,OADS,/arxiv_data1/oa_pdf/c1/e2/koni-05-05-1108511.PMC4910748.pdf
Eur J Immunol 2000; 30:1-7; PMID:10602021; http://dx.doi.org/10.1002/1521-4141(200001)30:1 <1::AID-IMMU1 >3.0.CO;2- 14.,Non-OADS,/arxiv_data1/oa_pdf/c1/e2/koni-05-05-1108511.PMC4910748.pdf
Hum VaccinImmunother 2013; 9:2263-76; PMID:23921513; http://dx.doi.org/10.4161/hv.25181 16.,Non-OADS,/arxiv_data1/oa_pdf/c1/e2/koni-05-05-1108511.PMC4910748.pdf
RNA Biol 2011; 8:627-36; PMID:21654214; http://dx.doi.org/10.4161/rna.8.4.15394 17.,OADS,/arxiv_data1/oa_pdf/c1/e2/koni-05-05-1108511.PMC4910748.pdf
Oncoimmunology 2013 Oct 1; 2(10); PMID:24286020; http://dx.doi.org/10.4161/onci.25771 18.,Non-OADS,/arxiv_data1/oa_pdf/c1/e2/koni-05-05-1108511.PMC4910748.pdf
N Engl J Med 2010; 363:411-22; PMID:20818862; http://dx.doi.org/10.1056/NEJMoa1001294 19.,OADS,/arxiv_data1/oa_pdf/c1/e2/koni-05-05-1108511.PMC4910748.pdf
Nat Med 2012;18:1254-61; PMID:22842478; http://dx.doi.org/10.1038/nm.2883 20.,OADS,/arxiv_data1/oa_pdf/c1/e2/koni-05-05-1108511.PMC4910748.pdf
Ann Oncol 2012; 23:65-71; PMID:21436185; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c1/e2/koni-05-05-1108511.PMC4910748.pdf
MolTher 2011; 19:990-9; PMID:21189474; http://dx.doi.org/10.1038/mt.2010.289 22.,Non-OADS,/arxiv_data1/oa_pdf/c1/e2/koni-05-05-1108511.PMC4910748.pdf
J ClinOncol 2009; 27:5794-9; PMID:19826129; http://dx.doi.org/10.1200/JCO.2008.21.4809 24.,Non-OADS,/arxiv_data1/oa_pdf/c1/e2/koni-05-05-1108511.PMC4910748.pdf
PLoS One 2013; 8 (5):e63341; PMID:23658823; http://dx.doi.org/10.1371/journal.pone.0063341 25.,Non-OADS,/arxiv_data1/oa_pdf/c1/e2/koni-05-05-1108511.PMC4910748.pdf
Cancer 2013; 119:2999- 3006; PMID:23696129; http://dx.doi.org/10.1002/cncr.28151 26.,Non-OADS,/arxiv_data1/oa_pdf/c1/e2/koni-05-05-1108511.PMC4910748.pdf
Lancet Oncol 2013;14:141-8; PMID:23312463; http://dx.doi.org/10.1016/S1470-2045(12) 70559-4 27.,Non-OADS,/arxiv_data1/oa_pdf/c1/e2/koni-05-05-1108511.PMC4910748.pdf
J OncolPract 2014; 10(2):e63-72; PMID:24281152; http://dx.doi.org/10.1200/JOP.2013.001180 28.,Non-OADS,/arxiv_data1/oa_pdf/c1/e2/koni-05-05-1108511.PMC4910748.pdf
World J Urol 2011; 29(3):361-6; PMID:21461939; http://dx.doi.org/10.1007/s00345-011- 0673-4 29.,Non-OADS,/arxiv_data1/oa_pdf/c1/e2/koni-05-05-1108511.PMC4910748.pdf
Br J Cancer 2013; 108(7):1541-9; PMID:23531701; http://dx.doi.org/10.1038/bjc.2013.119 30.,Non-OADS,/arxiv_data1/oa_pdf/c1/e2/koni-05-05-1108511.PMC4910748.pdf
ClinGenitourinCancer 2012; 10(2):93-98; PMID:22382008; http://dx.doi.org/10.1016/j.clgc.2012.01.007 31.,OADS,/arxiv_data1/oa_pdf/c1/e2/koni-05-05-1108511.PMC4910748.pdf
N Engl J Med 2015; Nov 5; 373(19):1803-13; PMID:26406148; http://dx.doi.org/ 10.1056/NEJMoa1510665.,OADS,/arxiv_data1/oa_pdf/c1/e2/koni-05-05-1108511.PMC4910748.pdf
Oncoimmunology 2014; 3:e27588; PMID:24800168; http://dx.doi.org/10.4161/onci.27588 33.,Non-OADS,/arxiv_data1/oa_pdf/c1/e2/koni-05-05-1108511.PMC4910748.pdf
"5, e1065369 (10 pages)http://dx.doi.org/10.1080/2162402X.2015.1065369",Non-OADS,/arxiv_data1/oa_pdf/20/f2/koni-05-05-1065369.PMC4910750.pdf
CA Cancer J Clin 2010; 60:277-300; PMID:20610543; http://dx.doi.org/10.3322/caac.20073 2.,Non-OADS,/arxiv_data1/oa_pdf/20/f2/koni-05-05-1065369.PMC4910750.pdf
NatRev Cancer 2011; 11:719-25; PMID:21941283; http://dx.doi.org/10.1038/nrc3144 3.,Non-OADS,/arxiv_data1/oa_pdf/20/f2/koni-05-05-1065369.PMC4910750.pdf
N Engl J Med 2003; 348:203-13; PMID:12529460; http://dx.doi.org/10.1056/NEJMoa020177 5.,OADS,/arxiv_data1/oa_pdf/20/f2/koni-05-05-1065369.PMC4910750.pdf
Gynecol Oncol 2012; 124:192-8; PMID:22040834;http://dx.doi.org/10.1016/j.ygyno.2011.09.039 6.,Non-OADS,/arxiv_data1/oa_pdf/20/f2/koni-05-05-1065369.PMC4910750.pdf
J Transl Med 2012; 10:205; PMID:23034130; http://dx.doi.org/10.1186/1479-5876-10-205 7.,Non-OADS,/arxiv_data1/oa_pdf/20/f2/koni-05-05-1065369.PMC4910750.pdf
N Engl J Med 2010; 363:711-23; PMID:20525992; http://dx.doi.org/ 10.1056/NEJMoa1003466 8.,OADS,/arxiv_data1/oa_pdf/20/f2/koni-05-05-1065369.PMC4910750.pdf
Nature 2014; 515:563-7; PMID:25428504; http://dx.doi.org/10.1038/nature14011 9.,Non-OADS,/arxiv_data1/oa_pdf/20/f2/koni-05-05-1065369.PMC4910750.pdf
J Clin Oncol 2011; 29:4828-36; PMID:22042955; http://dx.doi.org/10.1200/JCO.2011.38.0899 10.,Non-OADS,/arxiv_data1/oa_pdf/20/f2/koni-05-05-1065369.PMC4910750.pdf
J Clin Oncol 2002; 20:2624-32; PMID:12039923; http://dx.doi.org/10.1200/JCO.2002.06.171 12.,Non-OADS,/arxiv_data1/oa_pdf/20/f2/koni-05-05-1065369.PMC4910750.pdf
Mol Cell Proteomics 2007; 6:102-13; PMID:17074750; http://dx.doi.org/10.1074/mcp.M600310-MCP200 13.,OADS,/arxiv_data1/oa_pdf/20/f2/koni-05-05-1065369.PMC4910750.pdf
Nat Med 2012; 18:1254-61; PMID:22842478; http://dx.doi.org/10.1038/ nm.2883 14.,OADS,/arxiv_data1/oa_pdf/20/f2/koni-05-05-1065369.PMC4910750.pdf
Int J Cancer 2010; 127:1332-46; PMID:20049841;http://dx.doi.org/10.1002/ijc.25151 16.,Non-OADS,/arxiv_data1/oa_pdf/20/f2/koni-05-05-1065369.PMC4910750.pdf
Oncogene 2007; 26:5420-32; PMID:17694083; http://dx.doi.org/10.1038/sj.onc.1210610 17.,OADS,/arxiv_data1/oa_pdf/20/f2/koni-05-05-1065369.PMC4910750.pdf
Mol Immunol 2013; 53:126-31; PMID:22898188; http://dx.doi.org/10.1016/j.molimm.2012.07.009 18.,Non-OADS,/arxiv_data1/oa_pdf/20/f2/koni-05-05-1065369.PMC4910750.pdf
Proc Natl Acad Sci U S A 2008; 105:20410-5; PMID:19074257; http://dx.doi.org/10.1073/ pnas.0810114105 20.,OADS,/arxiv_data1/oa_pdf/20/f2/koni-05-05-1065369.PMC4910750.pdf
Cancer ImmunolImmunother 2012; 61:373-84; PMID:21927947; http://dx.doi.org/ 10.1007/s00262-011-1100-9 21.,Non-OADS,/arxiv_data1/oa_pdf/20/f2/koni-05-05-1065369.PMC4910750.pdf
Clin Cancer Res 2011; 17:3408-19;PMID:21300761; http://dx.doi.org/10.1158/1078-0432.CCR-10- 2614 23.,Non-OADS,/arxiv_data1/oa_pdf/20/f2/koni-05-05-1065369.PMC4910750.pdf
Cancer Biol Ther 2007; 6:795-801; PMID:17387270; http://dx.doi.org/10.4161/cbt.6.5.4007 24.,Non-OADS,/arxiv_data1/oa_pdf/20/f2/koni-05-05-1065369.PMC4910750.pdf
J Gynecol Oncol 2008; 19:185-90; PMID:19471575; http://dx.doi.org/ 10.3802/jgo.2008.19.3.185 25.,Non-OADS,/arxiv_data1/oa_pdf/20/f2/koni-05-05-1065369.PMC4910750.pdf
Gyne- col Oncol 2008; 108:415-20; PMID:18037158; http://dx.doi.org/10.1016/j.ygyno.2007.10.016 26.,OADS,/arxiv_data1/oa_pdf/20/f2/koni-05-05-1065369.PMC4910750.pdf
Science 1996; 274:94-6; PMID:8810254; http://dx.doi.org/10.1126/science.274.5284.94 27.,Non-OADS,/arxiv_data1/oa_pdf/20/f2/koni-05-05-1065369.PMC4910750.pdf
J CancerRes Clin Oncol 2003; 129:397-409; PMID:12836015; http://dx.doi.org/10.1007/s00432-003-0445-7 28.,Non-OADS,/arxiv_data1/oa_pdf/20/f2/koni-05-05-1065369.PMC4910750.pdf
J Clin Invest 1997; 100:2757-65; PMID:9389740; http://dx.doi.org/10.1172/JCI119822 30.,Non-OADS,/arxiv_data1/oa_pdf/20/f2/koni-05-05-1065369.PMC4910750.pdf
Cancer Immunol Immunother2008; 57:289-302; PMID:17721783; http://dx.doi.org/10.1007/s00262-007-0378-0 32.,Non-OADS,/arxiv_data1/oa_pdf/20/f2/koni-05-05-1065369.PMC4910750.pdf
Methods Mol Biol 2013; 960:145-57;PMID:23329485; http://dx.doi.org/10.1007/978-1-62703-218-6_12 34.,OADS,/arxiv_data1/oa_pdf/20/f2/koni-05-05-1065369.PMC4910750.pdf
Int J Gynecol Pathol 2013; 32:358-67; PMID:23722508; http://dx.doi.org/10.1097/PGP.0b013e31826a642b 36.,Non-OADS,/arxiv_data1/oa_pdf/20/f2/koni-05-05-1065369.PMC4910750.pdf
"5, e1129483 (8 pages)http://dx.doi.org/10.1080/2162402X.2015.1129483",Non-OADS,/arxiv_data1/oa_pdf/6d/1e/koni-05-05-1129483.PMC4910752.pdf
CA Cancer J Clin 2011; 61:69-90; PMID:21296855; http://dx.doi.org/10.3322/caac.20107 2.,Non-OADS,/arxiv_data1/oa_pdf/6d/1e/koni-05-05-1129483.PMC4910752.pdf
Gastroenterology 2007; 132:2557-76; PMID:17570226; http://dx.doi.org/10.1053/j.gastro.2007.04.061 3.,Non-OADS,/arxiv_data1/oa_pdf/6d/1e/koni-05-05-1129483.PMC4910752.pdf
Am J Gastroenterol 2012; 107:569-77; PMID:22158026;http://dx.doi.org/10.1038/ajg.2011.425 5.,Non-OADS,/arxiv_data1/oa_pdf/6d/1e/koni-05-05-1129483.PMC4910752.pdf
Hepatol- ogy 1997; 25:87-92; PMID:8985270; http://dx.doi.org/10.1002/hep.510250116 6.,Non-OADS,/arxiv_data1/oa_pdf/6d/1e/koni-05-05-1129483.PMC4910752.pdf
2015; 16(13):1344- 54; PMID:26361969; http://dx.doi.org/10.1016/S1470-2045(15)00198-9 7.,OADS,/arxiv_data1/oa_pdf/6d/1e/koni-05-05-1129483.PMC4910752.pdf
JAMA 2004; 292:358-61; PMID:15265851; http://dx.doi.org/10.1001/jama.292.3.358 8.,OADS,/arxiv_data1/oa_pdf/6d/1e/koni-05-05-1129483.PMC4910752.pdf
N Engl J Med 1996; 334:1561-7; PMID:8628336; http://dx.doi.org/10.1056/NEJM199606133342402 9.,Non-OADS,/arxiv_data1/oa_pdf/6d/1e/koni-05-05-1129483.PMC4910752.pdf
Hepatology 2000; 32:228-32; PMID:10915728; http://dx.doi.org/10.1053/jhep.2000.9409 10.,Non-OADS,/arxiv_data1/oa_pdf/6d/1e/koni-05-05-1129483.PMC4910752.pdf
Lancet 2000; 356:802-7; PMID:11022927; http://dx.doi.org/10.1016/S0140-6736(00)02654-4 11.,OADS,/arxiv_data1/oa_pdf/6d/1e/koni-05-05-1129483.PMC4910752.pdf
Clin Cancer Res 2004; 10:1574-9; PMID:15014006; http://dx.doi.org/10.1158/1078-0432.CCR-03-0071 12.,Non-OADS,/arxiv_data1/oa_pdf/6d/1e/koni-05-05-1129483.PMC4910752.pdf
Biochem Biophys Res Commun 2003; 306:16-25; PMID:12788060; http://dx.doi.org/10.1016/S0006-291X(03)00908-2 13.,OADS,/arxiv_data1/oa_pdf/6d/1e/koni-05-05-1129483.PMC4910752.pdf
Gastroenterology 2003; 125:89-97; PMID:12851874; http://dx.doi.org/10.1016/S0016-5085(03)00689-9 14.,Non-OADS,/arxiv_data1/oa_pdf/6d/1e/koni-05-05-1129483.PMC4910752.pdf
Cancer Sci 2009; 100:1403-7; PMID:19496787; http://dx.doi.org/10.1111/j.1349-7006.2009.01206.x 15.,Non-OADS,/arxiv_data1/oa_pdf/6d/1e/koni-05-05-1129483.PMC4910752.pdf
Clin Cancer Res 2012; 18:3686-96; PMID:22577059; http://dx.doi.org/10.1158/1078-0432.CCR-11-3044 16.,Non-OADS,/arxiv_data1/oa_pdf/6d/1e/koni-05-05-1129483.PMC4910752.pdf
2013; 9(7):1228-1233; PMID:23466818; http://dx.doi.org/10.4161/hv.24179 17.,Non-OADS,/arxiv_data1/oa_pdf/6d/1e/koni-05-05-1129483.PMC4910752.pdf
Cancer Res 2006; 66:1139- 46; PMID:16424051; http://dx.do i.org/10.1158/0008-5472.CAN-05-224419.,Non-OADS,/arxiv_data1/oa_pdf/6d/1e/koni-05-05-1129483.PMC4910752.pdf
"Mizukoshi E, Yamashita T, Arai K, Sunagozaka H, Ueda T, Arihara F, Kagaya T, Yamashita T, Fushimi K, Kaneko S. Enhancement oftumor-associated antigen-speci ﬁc T cell responses by radiofrequency ablation of hepatocellular carcinoma Hepatology 2013; 57(4):1448-57; PMID:23174905; http://dx.doi.org/10.1002/hep.26153 20.",OADS,/arxiv_data1/oa_pdf/6d/1e/koni-05-05-1129483.PMC4910752.pdf
Int J Oncol 2012; 40:63 –70; PMID:21922136; http://dx.doi.org/10.3892/ijo.2011.1202 21.,OADS,/arxiv_data1/oa_pdf/6d/1e/koni-05-05-1129483.PMC4910752.pdf
Cancer Sci 2011; 102:918-25; PMID:21281401; http://dx.doi.org/10.1111/j.1349-7006.2011.01896.x 22.,Non-OADS,/arxiv_data1/oa_pdf/6d/1e/koni-05-05-1129483.PMC4910752.pdf
Ann Surg Oncol 2013; 20:4305-11; PMID:23892527; http://dx.doi.org/10.1245/s10434-013-3144-x 23.,Non-OADS,/arxiv_data1/oa_pdf/6d/1e/koni-05-05-1129483.PMC4910752.pdf
59-90 p;http://dx.doi.org/10.5772/54594 24.,Non-OADS,/arxiv_data1/oa_pdf/6d/1e/koni-05-05-1129483.PMC4910752.pdf
Journ al of Hepatology 2008; 48:S20-S37; PMID:18304676; http://dx.doi.org/10.1016/j.jhep.2008.01.022 25.,OADS,/arxiv_data1/oa_pdf/6d/1e/koni-05-05-1129483.PMC4910752.pdf
Clin Cancer Res 2013; 19:4228-38; PMID:23653149; http://dx.doi.org/10.1158/1078-0432.CCR-13-0002 27.,Non-OADS,/arxiv_data1/oa_pdf/6d/1e/koni-05-05-1129483.PMC4910752.pdf
Cancer Res 2014; 74(4):1045-55; PMID:24343228;http://dx.doi.org/10.1158/0008-5472.CAN-13-2908 28.,Non-OADS,/arxiv_data1/oa_pdf/6d/1e/koni-05-05-1129483.PMC4910752.pdf
Nat Med 2013; 19:465-72; PMID:23455713; http://dx.doi.org/10.1038/nm.3105 29.,OADS,/arxiv_data1/oa_pdf/6d/1e/koni-05-05-1129483.PMC4910752.pdf
Cancer Immunol Immunother 2013; 62:1149-59; PMID:23657629; http://dx.doi.org/10.1007/s00262-013-1435-5 30.,Non-OADS,/arxiv_data1/oa_pdf/6d/1e/koni-05-05-1129483.PMC4910752.pdf
J Immunol 2005; 175:6169-76; PMID:16237114; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6d/1e/koni-05-05-1129483.PMC4910752.pdf
CA Cancer J Clin 2012; 62:309-335; PMID:22576456; http://dx.doi.org/10.3322/ caac.20132 32.,Non-OADS,/arxiv_data1/oa_pdf/6d/1e/koni-05-05-1129483.PMC4910752.pdf
Int J Oncol 2015; 46:28-36; PMID:25354479; http://dx.doi.org/10.3892/ijo.2014.2737e1129483-8 Y. SAWADA ET AL.,OADS,/arxiv_data1/oa_pdf/6d/1e/koni-05-05-1129483.PMC4910752.pdf
"Keywords: Local neoplasm recurrence; Risk assessment; Urinary bladder neoplasms; Watchful waiting This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Review Article Received: 28 March, 2016  •  Accepted: 22 April, 2016 Corresponding Author: Yoshihiko Hirao Department of Urology, Osaka Gyoumeikan Hospital, 5-4-8 Nishi- kujo, Konohana-ku, Osaka 554-0012, JapanTEL: +81-6-6462-0261, FAX: +81-6-6462-0362, E-mail: hiraoyos@gmail.com ⓒ The Korean Urological Association, 2016 such as prostate cancer [1,2], small renal masses [3,4],  nonseminomatous germ cell tumors of clinical stage I [5],  and papillary thyroid carcinoma [6].",Non-OADS,/arxiv_data1/oa_pdf/be/9b/icu-57-S4.PMC4910757.pdf
http://dx.doi.org/10.4111/icu.2016.57.S1.S4pISSN 2466-0493  •  eISSN 2466-054X,OADS,/arxiv_data1/oa_pdf/be/9b/icu-57-S4.PMC4910757.pdf
S6 www.icurology.orgMiyake et al http://dx.doi.org/10.4111/icu.2016.57.S1.S4 papillary in nature and less aggressive.,Non-OADS,/arxiv_data1/oa_pdf/be/9b/icu-57-S4.PMC4910757.pdf
S8 www.icurology.orgMiyake et al http://dx.doi.org/10.4111/icu.2016.57.S1.S4 Surveillance cystoscopy was performed in the office every  3 to 6 months.,OADS,/arxiv_data1/oa_pdf/be/9b/icu-57-S4.PMC4910757.pdf
S10 www.icurology.orgMiyake et al http://dx.doi.org/10.4111/icu.2016.57.S1.S4 follow-up strategies.,Non-OADS,/arxiv_data1/oa_pdf/be/9b/icu-57-S4.PMC4910757.pdf
S12 www.icurology.orgMiyake et al http://dx.doi.org/10.4111/icu.2016.57.S1.S4 tions of endoscopic treatment for superficial bladder tumors.,OADS,/arxiv_data1/oa_pdf/be/9b/icu-57-S4.PMC4910757.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/be/9b/icu-57-S4.PMC4910757.pdf
"Keywords: Bladder cancer; Cystectomy; Elderly; Geriatric; Treatment This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Review Article Received: 3 May, 2016  •  Accepted: 12 May, 2016 Corresponding Author: Alexandre R. Zlotta Division of Urology, Department of Surgery, Mount Sinai Hospital, 60 Murray St. 6th floor, Room 6004, Box 19, Toronto, ON, M5T 3L9, CanadaTEL: +1-416-586-4800, FAX: +1-416-586-8354, E-mail: azlotta@mtsinai.on.ca ⓒ The Korean Urological Association, 2016 alone [4] .",Non-OADS,/arxiv_data1/oa_pdf/e9/75/icu-57-S26.PMC4910758.pdf
"In 2012, over 5.2 million people in Canada were over 65  www.icurology.orgInvestig Clin Urol 2016;57 Suppl 1:S26-35.http://dx.doi.org/10.4111/icu.2016.57.S1.S26pISSN 2466-0493  •  eISSN 2466-054X",Non-OADS,/arxiv_data1/oa_pdf/e9/75/icu-57-S26.PMC4910758.pdf
S28 www.icurology.orgErlich and Zlotta http://dx.doi.org/10.4111/icu.2016.57.S1.S26 of treatments.,Non-OADS,/arxiv_data1/oa_pdf/e9/75/icu-57-S26.PMC4910758.pdf
S30 www.icurology.orgErlich and Zlotta http://dx.doi.org/10.4111/icu.2016.57.S1.S26 Continence rates were found to be lower in younger  patients with an ileal neobladder.,Non-OADS,/arxiv_data1/oa_pdf/e9/75/icu-57-S26.PMC4910758.pdf
"S32 www.icurology.orgErlich and Zlotta http://dx.doi.org/10.4111/icu.2016.57.S1.S26 in assuring the patient that they are indeed receiving the  best care and above all, not denied care when they could  receive it.",Non-OADS,/arxiv_data1/oa_pdf/e9/75/icu-57-S26.PMC4910758.pdf
Available  from: http://seer.cancer.gov/statfacts/html/urinb.html.,Non-OADS,/arxiv_data1/oa_pdf/e9/75/icu-57-S26.PMC4910758.pdf
Available from:  http://www5.statcan.gc.ca/olc-cel/olc.action?objId=91-520- X&objType=2&lang=en&limit=0.,OADS,/arxiv_data1/oa_pdf/e9/75/icu-57-S26.PMC4910758.pdf
S34 www.icurology.orgErlich and Zlotta http://dx.doi.org/10.4111/icu.2016.57.S1.S26 Vanderbilt Cystectomy Index.,Non-OADS,/arxiv_data1/oa_pdf/e9/75/icu-57-S26.PMC4910758.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e9/75/icu-57-S26.PMC4910758.pdf
"Keywords: Diet; Risk; Urinary bladder neoplasms This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Review Article Received: 26 January, 2016  •  Accepted: 22 March, 2016 Corresponding Author: Chandrika Piyathilake Department of Nutrition Sciences, University of Alabama at Birmingham, UAB Wallace Tumor Institute 420 D, 1824 6th Avenue South, Birmingham, AL 35294-3300, USATEL: +1-205-975-5398, FAX: +1-205-975-5398, E-mail: piyathic@uab.edu ⓒ The Korean Urological Association, 2016 Age, gender, cigarette smoking, exposures to aromatic  amines, polycyclic aromatic hydrocarbons or arsenic, certain  medications (phenacetin, cyclophosphamide, chlornaphazine),  radiation and genetic factors are established risk factors  for developing BC while there is suggestive evidence for  several other factors, including diet [4] .",Non-OADS,/arxiv_data1/oa_pdf/ec/bf/icu-57-S14.PMC4910759.pdf
http://dx.doi.org/10.4111/icu.2016.57.S1.S14pISSN 2466-0493  •  eISSN 2466-054X,OADS,/arxiv_data1/oa_pdf/ec/bf/icu-57-S14.PMC4910759.pdf
S16 www.icurology.orgPiyathilake http://dx.doi.org/10.4111/icu.2016.57.S1.S14 Table 1.,Non-OADS,/arxiv_data1/oa_pdf/ec/bf/icu-57-S14.PMC4910759.pdf
S18 www.icurology.orgPiyathilake http://dx.doi.org/10.4111/icu.2016.57.S1.S14 Table 2.,Non-OADS,/arxiv_data1/oa_pdf/ec/bf/icu-57-S14.PMC4910759.pdf
S20 www.icurology.orgPiyathilake http://dx.doi.org/10.4111/icu.2016.57.S1.S14 Table 3.,Non-OADS,/arxiv_data1/oa_pdf/ec/bf/icu-57-S14.PMC4910759.pdf
S22 www.icurology.orgPiyathilake http://dx.doi.org/10.4111/icu.2016.57.S1.S14 Table 5.,Non-OADS,/arxiv_data1/oa_pdf/ec/bf/icu-57-S14.PMC4910759.pdf
Avaiable from: http://seer.cancer.gov/statfacts/html/urinb.html 4.,Non-OADS,/arxiv_data1/oa_pdf/ec/bf/icu-57-S14.PMC4910759.pdf
S24 www.icurology.orgPiyathilake http://dx.doi.org/10.4111/icu.2016.57.S1.S14 22.,Non-OADS,/arxiv_data1/oa_pdf/ec/bf/icu-57-S14.PMC4910759.pdf
"Keywords: Diagnosis; Methylation; Prognosis; Urinary bladder neoplasms This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Review Article Received: 2 February, 2016  •  Accepted: 17 February, 2016 Corresponding Author: Wun-Jae Kim Department of Urology, Chungbuk National University College of Medicine, 1 Chungdae-ro, Seowon-gu, Cheongju 28644, KoreaTEL: +82-43-269-6371, FAX: +82-43-269-6144, E-mail: wjkim@chungbuk.ac.kr ⓒ The Korean Urological Association, 2016 sensitive and noninvasive tumor markers that can detect  and predict tumor recurrence, progression, and metastasis  are required.",Non-OADS,/arxiv_data1/oa_pdf/73/9a/icu-57-S77.PMC4910760.pdf
http://dx.doi.org/10.4111/icu.2016.57.S1.S77pISSN 2466-0493  •  eISSN 2466-054X,Non-OADS,/arxiv_data1/oa_pdf/73/9a/icu-57-S77.PMC4910760.pdf
S78 www.icurology.orgKim and Kim http://dx.doi.org/10.4111/icu.2016.57.S1.S77 the detection and prediction of BC.,Non-OADS,/arxiv_data1/oa_pdf/73/9a/icu-57-S77.PMC4910760.pdf
S80 www.icurology.orgKim and Kim http://dx.doi.org/10.4111/icu.2016.57.S1.S77 assay that combined TWIST1  and NID2 .,OADS,/arxiv_data1/oa_pdf/73/9a/icu-57-S77.PMC4910760.pdf
S82 www.icurology.orgKim and Kim http://dx.doi.org/10.4111/icu.2016.57.S1.S77 Table 2.,Non-OADS,/arxiv_data1/oa_pdf/73/9a/icu-57-S77.PMC4910760.pdf
"S84 www.icurology.orgKim and Kim http://dx.doi.org/10.4111/icu.2016.57.S1.S77 p16INK4a  promoter methylation was detected in 87% and  40%, respectively, of  samples.",OADS,/arxiv_data1/oa_pdf/73/9a/icu-57-S77.PMC4910760.pdf
S86 www.icurology.orgKim and Kim http://dx.doi.org/10.4111/icu.2016.57.S1.S77 29.,Non-OADS,/arxiv_data1/oa_pdf/73/9a/icu-57-S77.PMC4910760.pdf
S88 www.icurology.orgKim and Kim http://dx.doi.org/10.4111/icu.2016.57.S1.S77 2011;39:179-86.,Non-OADS,/arxiv_data1/oa_pdf/73/9a/icu-57-S77.PMC4910760.pdf
"Keywords: Immune checkpoint; PD-1; PD-L1; Bladder cancer; Immune therapy This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Review Article Received: 1 April, 2016  •  Accepted: 1 May, 2016 Corresponding Author: Jayoung Kim Departments of Surgery and Biomedical Sciences, Cedars-Sinai Medical Center, 8700 Beverly Blvd., Los Angeles, CA 90048, USATEL: +1-310-423-7168, FAX: +1-310-967-3809, E-mail: Jayoung.Kim@cshs.org ⓒ The Korean Urological Association, 2016 are in use in various cancer types–T-cell therapy and  immune checkpoint blockade.",Non-OADS,/arxiv_data1/oa_pdf/68/b9/icu-57-S98.PMC4910761.pdf
http://dx.doi.org/10.4111/icu.2016.57.S1.S98pISSN 2466-0493  •  eISSN 2466-054X,Non-OADS,/arxiv_data1/oa_pdf/68/b9/icu-57-S98.PMC4910761.pdf
S100 www.icurology.orgKim http://dx.doi.org/10.4111/icu.2016.57.S1.S98 lymphocyte-associated antigen-4 (CTLA-4) and programmed  death receptor ligand (PD-L1) et al.,OADS,/arxiv_data1/oa_pdf/68/b9/icu-57-S98.PMC4910761.pdf
S102 www.icurology.orgKim http://dx.doi.org/10.4111/icu.2016.57.S1.S98 Homolog) et al.,OADS,/arxiv_data1/oa_pdf/68/b9/icu-57-S98.PMC4910761.pdf
S104 www.icurology.orgKim http://dx.doi.org/10.4111/icu.2016.57.S1.S98 Opin Urol 2013;23:466-71.,Non-OADS,/arxiv_data1/oa_pdf/68/b9/icu-57-S98.PMC4910761.pdf
http://dx.doi.org/10.1200/JCO.2015.64.4070.,OADS,/arxiv_data1/oa_pdf/68/b9/icu-57-S98.PMC4910761.pdf
http://dx.doi.org/10.1016/S0140- 6736(16)00561-4.,OADS,/arxiv_data1/oa_pdf/68/b9/icu-57-S98.PMC4910761.pdf
"Keywords: Disease progression; Therapeutics; Urinary bladder neoplasms This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Review Article Received: 14 April, 2016  •  Accepted: 6 May, 2016 Corresponding Author: Seok Joong Yun Department of Urology, Chungbuk National University College of Medicine, 776 1(il)sunhwan-ro, Heungdeok-gu, Cheongju 28644, KoreaTEL: +82-43-269-6142, FAX: +82-43-269-6144, E-mail: sjyun@chungbuk.ac.kr ⓒ The Korean Urological Association, 2016 differentiated high-grade disease have a poor prognosis due  to a higher incidence of recurrence and progression than  other NMIBC; thus patients with high-grade T1 have to be  carefully monitored or managed.",Non-OADS,/arxiv_data1/oa_pdf/b5/d3/icu-57-S44.PMC4910762.pdf
"Herein, this review describes  www.icurology.orgInvestig Clin Urol 2016;57 Suppl 1:S44-51.http://dx.doi.org/10.4111/icu.2016.57.S1.S44pISSN 2466-0493  •  eISSN 2466-054X",Non-OADS,/arxiv_data1/oa_pdf/b5/d3/icu-57-S44.PMC4910762.pdf
S46 www.icurology.orgYun et al http://dx.doi.org/10.4111/icu.2016.57.S1.S44 induction therapy.,Non-OADS,/arxiv_data1/oa_pdf/b5/d3/icu-57-S44.PMC4910762.pdf
"S48 www.icurology.orgYun et al http://dx.doi.org/10.4111/icu.2016.57.S1.S44 ratio, 3.38; p=0.048) or progression (hazard ratio, 10.49;  p=0.048).",OADS,/arxiv_data1/oa_pdf/b5/d3/icu-57-S44.PMC4910762.pdf
S50 www.icurology.orgYun et al http://dx.doi.org/10.4111/icu.2016.57.S1.S44 705.,Non-OADS,/arxiv_data1/oa_pdf/b5/d3/icu-57-S44.PMC4910762.pdf
"Keywords: MicroRNAs; Neoplasms; Urinary bladder neoplasms This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Review Article Received: 12 April, 2016  •  Accepted: 1 May, 2016 Corresponding Author: Seong-Jin Kim Theragen Etex Bio Institute, 2F, B-dong, AICT bldg, 145 Gwanggyo-ro, Yeongtong-gu, Suwon 16229, KoreaTEL: +82-31-888-9310, FAX: +82-31-888-9335, E-mail: jasonsjkim@therabio.kr ⓒ The Korean Urological Association, 2016 bladder cancer (MIBC) [3,4], as defined by pathology and  clinical features [5,6].",Non-OADS,/arxiv_data1/oa_pdf/d1/cb/icu-57-S52.PMC4910763.pdf
http://dx.doi.org/10.4111/icu.2016.57.S1.S52pISSN 2466-0493  •  eISSN 2466-054X,OADS,/arxiv_data1/oa_pdf/d1/cb/icu-57-S52.PMC4910763.pdf
"S54 www.icurology.orgLee et al http://dx.doi.org/10.4111/icu.2016.57.S1.S52 NGS sequencing miRNA identification miRNA target prediction and validation miRNA interactionLibrary preparation forsubsequent cluster generations according tospecies -Proper final library size (140 160bpinthecase ofhuman) Sequencing ontheNGS platform Comparative method forsequence andstructural properties forknown miRNA Machine learning based onthepreviously verified miRNA fornovel miRNA Identification ofdifferentially expressed miRNA Statistics significance forprediction sensitivity oraccuracy level considering 5features: (1)seed complementarity between miRNA andmRNA strand, (2)evolutionary conservation ofmiRNA target sites among species, (3)free energy ofthemiRNA:mRNA duplex, (4)target siteaccessibility ,and (5)thecontribution ofmultiple binding sites Enrichment miRNA function ortarget interaction tothewell organized database with statistic significance Constructing miRNA regulatory network with mRNA considering their metabolic andsignaling pathway miRNA andtranscription factor interaction Integrating analysis result with disease andother meaningful informationFig.",OADS,/arxiv_data1/oa_pdf/d1/cb/icu-57-S52.PMC4910763.pdf
"S56 www.icurology.orgLee et al http://dx.doi.org/10.4111/icu.2016.57.S1.S52 miRNA-binding sites even when the targeting miRNA  is unknown, RNAhybrid [41] predicts multiple potential  miRNA-binding sites in large target RNAs by looking at the  most energetically favorable hybridization sites between two  separate RNA sequences.",Non-OADS,/arxiv_data1/oa_pdf/d1/cb/icu-57-S52.PMC4910763.pdf
DIANA-miRPath can be accessed  on the web (http://www.microrna.gr/miRPathv3).,OADS,/arxiv_data1/oa_pdf/d1/cb/icu-57-S52.PMC4910763.pdf
S58 www.icurology.orgLee et al http://dx.doi.org/10.4111/icu.2016.57.S1.S52 Nat Rev Cancer 2005;5:713-25.,Non-OADS,/arxiv_data1/oa_pdf/d1/cb/icu-57-S52.PMC4910763.pdf
"Keywords: Autophagy; Drug resistance; Urinary bladder neoplasms This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Review Article Received: 14 March, 2016  •  Accepted: 8 April, 2016 Corresponding Author: Christopher P .",Non-OADS,/arxiv_data1/oa_pdf/54/41/icu-57-S89.PMC4910764.pdf
http://dx.doi.org/10.4111/icu.2016.57.S1.S89pISSN 2466-0493  •  eISSN 2466-054X,Non-OADS,/arxiv_data1/oa_pdf/54/41/icu-57-S89.PMC4910764.pdf
"S90 www.icurology.orgChandrasekar and Evans http://dx.doi.org/10.4111/icu.2016.57.S1.S89 AUTOPHAGY Most cancer therapies, such as chemotherapy or radio - therapy, mediate their effect by promoting apoptotic cell  death, or programmed cell death.",Non-OADS,/arxiv_data1/oa_pdf/54/41/icu-57-S89.PMC4910764.pdf
"S92 www.icurology.orgChandrasekar and Evans http://dx.doi.org/10.4111/icu.2016.57.S1.S89 the complexity of the management of this disease process,  there are multiple published evidence-based guidelines that  help guide therapy.",Non-OADS,/arxiv_data1/oa_pdf/54/41/icu-57-S89.PMC4910764.pdf
"S94 www.icurology.orgChandrasekar and Evans http://dx.doi.org/10.4111/icu.2016.57.S1.S89 pan Bcl-2 inhibitor (-)-gossypol to demonstrate that the  chemotherapy-resistant cell lines utilized autophagy  to escape apoptotic cell death; indeed, they note that  overexpression of Bcl-2 proteins has been associated  with poor chemotherapeutic response in bladder cancer.",Non-OADS,/arxiv_data1/oa_pdf/54/41/icu-57-S89.PMC4910764.pdf
http://dx.doi.org/10.1016/j.juro.2015.10.128.,OADS,/arxiv_data1/oa_pdf/54/41/icu-57-S89.PMC4910764.pdf
S96 www.icurology.orgChandrasekar and Evans http://dx.doi.org/10.4111/icu.2016.57.S1.S89 25.,Non-OADS,/arxiv_data1/oa_pdf/54/41/icu-57-S89.PMC4910764.pdf
"Keywords: Cystectomy; Outcome assessment; Robotic surgical procedures; Urinary bladder neoplasms; Urinary diversion This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Review Article Received: 28 March, 2016  •  Accepted: 18 April, 2016 Corresponding Author: Sammy E. Elsamra Division of Urology, Department of Surgery, Rutgers – Robert Wood Johnson Medical School, 1 Robert Wood Johnson Place, MEB Suite 584, New Brunswick, NJ, 08902, USA.TEL: +1-732-235-7775, FAX: +1-732-235-6042, E-mail: elsamrsa@rutgers.edu ⓒ The Korean Urological Association, 2016 invasive surgery (MIS) techniques, robotic-assisted radical  cystectomy (RARC) is increasing in popularity.",Non-OADS,/arxiv_data1/oa_pdf/5e/e3/icu-57-S36.PMC4910765.pdf
"However, it remains  unclear if there is a difference between ORC and RARC  for perioperative factors, postoperative complications, total  costs, morbidity and mortality, quality of life and oncologic  www.icurology.orgInvestig Clin Urol 2016;57 Suppl 1:S36-43.http://dx.doi.org/10.4111/icu.2016.57.S1.S36pISSN 2466-0493  •  eISSN 2466-054X",Non-OADS,/arxiv_data1/oa_pdf/5e/e3/icu-57-S36.PMC4910765.pdf
S38 www.icurology.orgDavis et al http://dx.doi.org/10.4111/icu.2016.57.S1.S36 2.,Non-OADS,/arxiv_data1/oa_pdf/5e/e3/icu-57-S36.PMC4910765.pdf
S40 www.icurology.orgDavis et al http://dx.doi.org/10.4111/icu.2016.57.S1.S36 al.,Non-OADS,/arxiv_data1/oa_pdf/5e/e3/icu-57-S36.PMC4910765.pdf
S42 www.icurology.orgDavis et al http://dx.doi.org/10.4111/icu.2016.57.S1.S36 ORC (n=120) and RARC (n=263) at a single institution.,OADS,/arxiv_data1/oa_pdf/5e/e3/icu-57-S36.PMC4910765.pdf
Available from: http://globocan.iarc.fr/Pages/refer - ences.aspx.,Non-OADS,/arxiv_data1/oa_pdf/5e/e3/icu-57-S36.PMC4910765.pdf
http://dx.doi.org/10.4111/icu.2016.57.S1.S1pISSN 2466-0493  •  eISSN 2466-054X,OADS,/arxiv_data1/oa_pdf/50/58/icu-57-S1.PMC4910766.pdf
S2 www.icurology.orgKim http://dx.doi.org/10.4111/icu.2016.57.S1.S1 management algorithm for elderly patients with muscle- invasive bladder cancer.,Non-OADS,/arxiv_data1/oa_pdf/50/58/icu-57-S1.PMC4910766.pdf
"Keywords: MicroRNA; Tumor biomarkers; Urinary bladder neoplasms This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Review Article Received: 30 March, 2016  •  Accepted: 17 April, 2016 Corresponding Author: Hideki Enokida Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima 890-8520, JapanTEL: +81-99-275-5395, FAX: +81-99-275-6637, E-mail: enokida@m.kufm.kagoshima-u.ac.jp ⓒ The Korean Urological Association, 2016 by radical surgery or radiotherapy, but often still have  poor outcomes, despite administration of these systemic  therapies [2] .",Non-OADS,/arxiv_data1/oa_pdf/02/8b/icu-57-S60.PMC4910767.pdf
http://dx.doi.org/10.4111/icu.2016.57.S1.S60pISSN 2466-0493  •  eISSN 2466-054X,OADS,/arxiv_data1/oa_pdf/02/8b/icu-57-S60.PMC4910767.pdf
S62 www.icurology.orgEnokida et al http://dx.doi.org/10.4111/icu.2016.57.S1.S60 size.,OADS,/arxiv_data1/oa_pdf/02/8b/icu-57-S60.PMC4910767.pdf
S64 www.icurology.orgEnokida et al http://dx.doi.org/10.4111/icu.2016.57.S1.S60 Table 1.,OADS,/arxiv_data1/oa_pdf/02/8b/icu-57-S60.PMC4910767.pdf
S66 www.icurology.orgEnokida et al http://dx.doi.org/10.4111/icu.2016.57.S1.S60 Table 2.,Non-OADS,/arxiv_data1/oa_pdf/02/8b/icu-57-S60.PMC4910767.pdf
"S68 www.icurology.orgEnokida et al http://dx.doi.org/10.4111/icu.2016.57.S1.S60 miR­ 27b, miR­ 101) [24,43].",Non-OADS,/arxiv_data1/oa_pdf/02/8b/icu-57-S60.PMC4910767.pdf
"S70 www.icurology.orgEnokida et al http://dx.doi.org/10.4111/icu.2016.57.S1.S60 approaches with limited whole ­genome sequencing, and a  detailed characterization of miRNA profiles based on the  genomic features of BC has not been reported.",Non-OADS,/arxiv_data1/oa_pdf/02/8b/icu-57-S60.PMC4910767.pdf
S72 www.icurology.orgEnokida et al http://dx.doi.org/10.4111/icu.2016.57.S1.S60 factor serine/arginine-rich 9 (SRSF9/SRp30c) in bladder can- cer.,Non-OADS,/arxiv_data1/oa_pdf/02/8b/icu-57-S60.PMC4910767.pdf
S74 www.icurology.orgEnokida et al http://dx.doi.org/10.4111/icu.2016.57.S1.S60 miR-27a and increasing the target RUNX-1 expression.,Non-OADS,/arxiv_data1/oa_pdf/02/8b/icu-57-S60.PMC4910767.pdf
http://dx.doi.org/10.1111/bju.13407.,Non-OADS,/arxiv_data1/oa_pdf/02/8b/icu-57-S60.PMC4910767.pdf
http://dx.doi.org/10.1007/s13277-015-4698-y.,Non-OADS,/arxiv_data1/oa_pdf/02/8b/icu-57-S60.PMC4910767.pdf
S76 www.icurology.orgEnokida et al http://dx.doi.org/10.4111/icu.2016.57.S1.S60 cinoma using microRNA expression.,OADS,/arxiv_data1/oa_pdf/02/8b/icu-57-S60.PMC4910767.pdf
"4, 457 –466 http://dx.doi.org/10.1080/15384047.2016.1156258",Non-OADS,/arxiv_data1/oa_pdf/52/b4/kcbt-17-04-1156258.PMC4910914.pdf
Ann Med Surg 2012 2014; 3:71-6; PMID:25568791; http://dx.doi.org/10.1016/j.amsu.2014.06.006 2.,OADS,/arxiv_data1/oa_pdf/52/b4/kcbt-17-04-1156258.PMC4910914.pdf
Gut 2000; 47:131-6; PMID:10861275; http://dx.doi.org/ 10.1136/gut.47.1.131 3.,Non-OADS,/arxiv_data1/oa_pdf/52/b4/kcbt-17-04-1156258.PMC4910914.pdf
Ann Intern Med 2006; 144:70514; PMID: 16702586; http://dx.doi.org/10.7326/0003-4819-144-10-200605160- 00004 4.,Non-OADS,/arxiv_data1/oa_pdf/52/b4/kcbt-17-04-1156258.PMC4910914.pdf
J Clin Oncol Off J Am Soc Clin Oncol 2009; 27:1485-91; PMID: 19224838; http://dx.doi.org/10.1200/JCO.2008.20.7753 6.,OADS,/arxiv_data1/oa_pdf/52/b4/kcbt-17-04-1156258.PMC4910914.pdf
Int J Radiat Oncol BiolPhys 2013; 87:22-32; PMID:23219567; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/52/b4/kcbt-17-04-1156258.PMC4910914.pdf
Invest New Drugs 2015 Feb;33 (1):128-37; PMID:25248753; http://dx.doi.org/10.1007/s10637-014-0164-8 9.,Non-OADS,/arxiv_data1/oa_pdf/52/b4/kcbt-17-04-1156258.PMC4910914.pdf
Nat Rev Cancer 2002; 2:48-58; PMID:11902585; http://dx.doi.org/10.1038/nrc706 10.,Non-OADS,/arxiv_data1/oa_pdf/52/b4/kcbt-17-04-1156258.PMC4910914.pdf
Cell 2009; 136:823-37; PMID:19269363; http://dx.doi.org/10.1016/j.cell.2009.02.024 11.,OADS,/arxiv_data1/oa_pdf/52/b4/kcbt-17-04-1156258.PMC4910914.pdf
Cancer Biol Ther 2013; 14:347-56; PMID:23358469; http://dx.doi.org/10.4161/cbt.23626 12.,Non-OADS,/arxiv_data1/oa_pdf/52/b4/kcbt-17-04-1156258.PMC4910914.pdf
Mol Cancer Ther 2012; 11:475-84; PMID:22144665; http://dx.doi.org/10.1158/1535-7163.MCT-11-0755 13.,Non-OADS,/arxiv_data1/oa_pdf/52/b4/kcbt-17-04-1156258.PMC4910914.pdf
Clin Breast Cancer 2014; 14:154-60; PMID:24512858; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/52/b4/kcbt-17-04-1156258.PMC4910914.pdf
Nat Genet 2012; 44:694-8; PMID:22561517; http://dx.doi.org/10.1038/ng.2256 1 6 .,OADS,/arxiv_data1/oa_pdf/52/b4/kcbt-17-04-1156258.PMC4910914.pdf
Hepatol Baltim Md2013; 58:239-50; PMID: 23460382; http://dx.doi.org/10.1002/hep.26352 17.,Non-OADS,/arxiv_data1/oa_pdf/52/b4/kcbt-17-04-1156258.PMC4910914.pdf
Oncotarget 2015 Feb 20;6(5):2903-16; PMID: 25609201; http://dx.doi.org/10.18632/oncotarget.3093; 29 18.,OADS,/arxiv_data1/oa_pdf/52/b4/kcbt-17-04-1156258.PMC4910914.pdf
Semin Liver Dis 2007; 27:55-76; PMID:17295177; http://dx.doi.org/10.1055/s-2006-960171 19.,Non-OADS,/arxiv_data1/oa_pdf/52/b4/kcbt-17-04-1156258.PMC4910914.pdf
Oncogene 2006; 25:3778-86; PMID:16799619; http://dx.doi.org/10.1038/sj.onc.1209547 20.,Non-OADS,/arxiv_data1/oa_pdf/52/b4/kcbt-17-04-1156258.PMC4910914.pdf
Oncogene 2007; 26:3227-39; PMID:17496918; http://dx.doi.org/10.1038/sj.onc.1210414 21.,Non-OADS,/arxiv_data1/oa_pdf/52/b4/kcbt-17-04-1156258.PMC4910914.pdf
Sci- ence 1992; 258:478-80; PMID:1411546; http://dx.doi.org/10.1126/science.1411546 22.,OADS,/arxiv_data1/oa_pdf/52/b4/kcbt-17-04-1156258.PMC4910914.pdf
Curr Opin Gas-troenterol 2009; 25:186-94; PMID: 19387255; http://dx.doi.org/10.1097/MOG.0b013e32832962a1 23.,Non-OADS,/arxiv_data1/oa_pdf/52/b4/kcbt-17-04-1156258.PMC4910914.pdf
N Engl J Med 2008; 359:378-90;PMID:18650514; http://dx.doi.org/10.1056/NEJMoa0708857 2 4 .,Non-OADS,/arxiv_data1/oa_pdf/52/b4/kcbt-17-04-1156258.PMC4910914.pdf
Lancet Oncol 2009; 10:25- 34; PMID:19095497; http://dx.doi.org/10.1016/S1470-2045(08)70285-7 25.,Non-OADS,/arxiv_data1/oa_pdf/52/b4/kcbt-17-04-1156258.PMC4910914.pdf
Dig Dis Sci 2012; 57:1122-9; PMID:22451120; http://dx.doi.org/10.1007/s10620-012-2136-1 26.,OADS,/arxiv_data1/oa_pdf/52/b4/kcbt-17-04-1156258.PMC4910914.pdf
Lancet Oncol 2013; 14:e358-69;PMID:23896275; http://dx.doi.org/10.1016/S1470-2045(13)70169-4 2 7 .,Non-OADS,/arxiv_data1/oa_pdf/52/b4/kcbt-17-04-1156258.PMC4910914.pdf
Eur Urol 2014; 66:145-55; PMID:24411988; http://dx.doi.org/10.1016/j.eururo.2013.12.019 28.,OADS,/arxiv_data1/oa_pdf/52/b4/kcbt-17-04-1156258.PMC4910914.pdf
Ann Oncol 2010; 21:ii35; PMID:22806877; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/52/b4/kcbt-17-04-1156258.PMC4910914.pdf
PloS One 2011; 6:e18552;PMID:21533169; http://dx.doi.org/10.1371/journal.pone.0018552 31.,Non-OADS,/arxiv_data1/oa_pdf/52/b4/kcbt-17-04-1156258.PMC4910914.pdf
Cancers 2015; 7:876-907; PMID:26010604; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/52/b4/kcbt-17-04-1156258.PMC4910914.pdf
Cell Death Dis 2015; 6:e1595; PMID:25590805; http://dx.doi.org/10.1038/cddis.2014.555 33.,Non-OADS,/arxiv_data1/oa_pdf/52/b4/kcbt-17-04-1156258.PMC4910914.pdf
Cancer Chemother Pharma- col 2014; 74:1015-22; PMID:25205430; http://dx.doi.org/10.1007/s00280-014-2584-8 34.,Non-OADS,/arxiv_data1/oa_pdf/52/b4/kcbt-17-04-1156258.PMC4910914.pdf
Int J Radiat Biol 2003; 79:973-80; PMID:14713575; http://dx.doi.org/10.1080/09553000310001626135 35.,OADS,/arxiv_data1/oa_pdf/52/b4/kcbt-17-04-1156258.PMC4910914.pdf
Mol Cancer Ther 2008; 7:1985-92; PMID:18645008; http://dx.doi.org/10.1158/1535-7163.,Non-OADS,/arxiv_data1/oa_pdf/52/b4/kcbt-17-04-1156258.PMC4910914.pdf
Invest New Drugs 2014; 32:577-86; PMID:24682747; http://dx.doi.org/10.1007/s10637-014-0095-4 39.,Non-OADS,/arxiv_data1/oa_pdf/52/b4/kcbt-17-04-1156258.PMC4910914.pdf
PloS One 2013; 8:e65726; PMID:23762417;http://dx.doi.org/10.1371/journal.pone.0065726 40.,Non-OADS,/arxiv_data1/oa_pdf/52/b4/kcbt-17-04-1156258.PMC4910914.pdf
Int J Radiat Oncol 2008; 71:1591-9;PMID: 18640502; http://dx.doi.org/10.1016/j.ijrobp.2008.04.025 41.,OADS,/arxiv_data1/oa_pdf/52/b4/kcbt-17-04-1156258.PMC4910914.pdf
Sci Transl Med 2011; 3:103ra99; PMID:21974937; http://dx.doi.org/ 10.1126/scitranslmed.3002018 42.,Non-OADS,/arxiv_data1/oa_pdf/52/b4/kcbt-17-04-1156258.PMC4910914.pdf
Radiat Res 1984; 99:73-84; PMID:6739728; http://dx.doi.org/10.2307/3576448 43.,Non-OADS,/arxiv_data1/oa_pdf/52/b4/kcbt-17-04-1156258.PMC4910914.pdf
Clin CancerRes Off J Am Assoc Cancer Res 2008; 14:5142-9; PMID: 18698032;http://dx.doi.org/10.1158/1078-0432.CCR-07-4072466 S. T. CHETTIAR ET AL.,Non-OADS,/arxiv_data1/oa_pdf/52/b4/kcbt-17-04-1156258.PMC4910914.pdf
"5, 526 –542 http://dx.doi.org/10.1080/15384047.2016.1139230",Non-OADS,/arxiv_data1/oa_pdf/de/a7/kcbt-17-05-1139230.PMC4910922.pdf
"The remaining reads were thenmapped against the collection of human non-coding RNA spe-cies, downloaded from ENSEMBL (http://www.ensembl.org/info/data/ftp/index.html).",OADS,/arxiv_data1/oa_pdf/de/a7/kcbt-17-05-1139230.PMC4910922.pdf
MEK inhibitors are currently undergoing clinical trials for the treatment of both melanoma and thyroid carcinomas (http://www.cancer.gov/clinicaltrials).,Non-OADS,/arxiv_data1/oa_pdf/de/a7/kcbt-17-05-1139230.PMC4910922.pdf
J Carcinog 2004; 3:6; PMID:15046639; http://dx.doi.org/10.1186/1477-3163-3-6 2 .,OADS,/arxiv_data1/oa_pdf/de/a7/kcbt-17-05-1139230.PMC4910922.pdf
J Chin Med Assoc 2010; 73:113-28; PMID:20230995; http://dx.doi.org/10.1016/S1726-4901(10)70025-3 3.,Non-OADS,/arxiv_data1/oa_pdf/de/a7/kcbt-17-05-1139230.PMC4910922.pdf
Nature 2004; 432:294-7; PMID:15549090; http://dx.doi.org/10.1038/nature03095 4.,Non-OADS,/arxiv_data1/oa_pdf/de/a7/kcbt-17-05-1139230.PMC4910922.pdf
N Engl J Med 2011; 364:2507-16; PMID:21639808; http://dx.doi.org/10.1056/NEJMoa1103782 5.,OADS,/arxiv_data1/oa_pdf/de/a7/kcbt-17-05-1139230.PMC4910922.pdf
Nature 2010;468:973-7; PMID:21107323; http://dx.doi.org/10.1038/nature09626 6.,Non-OADS,/arxiv_data1/oa_pdf/de/a7/kcbt-17-05-1139230.PMC4910922.pdf
Nature 2011; 480:387-90; PMID:22113612; http://dx.doi.org/10.1038/nature10662 8.,Non-OADS,/arxiv_data1/oa_pdf/de/a7/kcbt-17-05-1139230.PMC4910922.pdf
Nature 2010; 468:968-72; PMID:21107320; http://dx.doi.org/10.1038/nature09627 9.,Non-OADS,/arxiv_data1/oa_pdf/de/a7/kcbt-17-05-1139230.PMC4910922.pdf
Semin Oncol 2012; 39:204-14; PMID:22484192; http://dx.doi.org/10.1053/j.seminoncol.2012.01.008 10.,Non-OADS,/arxiv_data1/oa_pdf/de/a7/kcbt-17-05-1139230.PMC4910922.pdf
Nature 2006; 439:358-62; PMID:16273091; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/de/a7/kcbt-17-05-1139230.PMC4910922.pdf
Cancer J 2011; 17:505-11; PMID:22157295; http://dx.doi.org/10.1097/PPO.0b013e31823e5357 12.,Non-OADS,/arxiv_data1/oa_pdf/de/a7/kcbt-17-05-1139230.PMC4910922.pdf
Cancer Cell 2010; 18:683-95; PMID:21156289; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/de/a7/kcbt-17-05-1139230.PMC4910922.pdf
Cancer Res 2010; 70:8736-47; PMID:20959481; http://dx.doi.org/10.1158/0008-5472.CAN-10-0902 14.,Non-OADS,/arxiv_data1/oa_pdf/de/a7/kcbt-17-05-1139230.PMC4910922.pdf
Clin Cancer Res 2008; 14:230-9;PMID:18172275; http://dx.doi.org/10.1158/1078-0432.CCR-07-1440 15.,Non-OADS,/arxiv_data1/oa_pdf/de/a7/kcbt-17-05-1139230.PMC4910922.pdf
N Eng J Med 2014; 371:1877-88; PMID:25265492; http://dx.doi.org/10.1056/NEJMoa1406037 16.,OADS,/arxiv_data1/oa_pdf/de/a7/kcbt-17-05-1139230.PMC4910922.pdf
N EnglJ Med 2014; 371:1867-76; PMID:25265494; http://dx.doi.org/10.1056/NEJMoa1408868 17.,OADS,/arxiv_data1/oa_pdf/de/a7/kcbt-17-05-1139230.PMC4910922.pdf
Nat Rev Genet 2012; 13:358-69; PMID:22510765; http://dx.doi.org/10.1038/nrg3198 18.,OADS,/arxiv_data1/oa_pdf/de/a7/kcbt-17-05-1139230.PMC4910922.pdf
Transplantation Proc 2005; 37:525-6; PMID:15808698; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/de/a7/kcbt-17-05-1139230.PMC4910922.pdf
Int J SurgPathol 2005; 13:1-8; PMID:15735849; http://dx.doi.org/10.1177/106689690501300101540 E. R. DORRIS ET AL.,OADS,/arxiv_data1/oa_pdf/de/a7/kcbt-17-05-1139230.PMC4910922.pdf
J Immunol 2012;188:6357-70; PMID:22581862; http://dx.doi.org/10.4049/ jimmunol.1103242 21.,Non-OADS,/arxiv_data1/oa_pdf/de/a7/kcbt-17-05-1139230.PMC4910922.pdf
Genome Biol 2010; 11:R106; http://dx.doi.org/10.1186/gb- 2010-11-10-r106 2 2 .,OADS,/arxiv_data1/oa_pdf/de/a7/kcbt-17-05-1139230.PMC4910922.pdf
Biomaterials 2011; 32:9021-30; PMID:21889204; http://dx.doi.org/10.1016/j.biomaterials.2011.08.033 23.,OADS,/arxiv_data1/oa_pdf/de/a7/kcbt-17-05-1139230.PMC4910922.pdf
Bioinformatics 2004;20:1464-5; PMID:14962934; http://dx.doi.org/10.1093/bioinformatics/ bth088 25.,OADS,/arxiv_data1/oa_pdf/de/a7/kcbt-17-05-1139230.PMC4910922.pdf
Biochem Biophys Res Commun 2011; 404:958- 62; PMID:21185263; http://dx.doi.org/10.1016/j.bbrc.2010.12.088 26.,OADS,/arxiv_data1/oa_pdf/de/a7/kcbt-17-05-1139230.PMC4910922.pdf
Mol Cancer Ther 2010; 9:1968-76; PMID:20587665; http://dx.doi.org/10.1158/1535-7163.MCT-10-0062 27.,Non-OADS,/arxiv_data1/oa_pdf/de/a7/kcbt-17-05-1139230.PMC4910922.pdf
J Clin Endocrinol Metab 2008; 93:2194-201; PMID:18381570; http://dx.doi.org/10.1210/jc.2007-2825 28.,Non-OADS,/arxiv_data1/oa_pdf/de/a7/kcbt-17-05-1139230.PMC4910922.pdf
Nat Biotechnol 2011; 29:443-8; PMID:21490602; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/de/a7/kcbt-17-05-1139230.PMC4910922.pdf
J Transl Med 2009; 7:20; PMID:19309508; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/de/a7/kcbt-17-05-1139230.PMC4910922.pdf
PLoS One 2011; 6:e28688; PMID:22205962; http://dx.doi.org/10.1371/journal.pone.0028688 31.,Non-OADS,/arxiv_data1/oa_pdf/de/a7/kcbt-17-05-1139230.PMC4910922.pdf
Nat Methods 2012; 9:671-5;PMID:22930834; http://dx.doi.org/10.1038/nmeth.2089 32.,OADS,/arxiv_data1/oa_pdf/de/a7/kcbt-17-05-1139230.PMC4910922.pdf
FEBS Lett 2005; 579:5911-22; PMID:16111679; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/de/a7/kcbt-17-05-1139230.PMC4910922.pdf
Development 2005; 132:4653-62; PMID:16224045; http://dx.doi.org/10.1242/dev.02073 34.,OADS,/arxiv_data1/oa_pdf/de/a7/kcbt-17-05-1139230.PMC4910922.pdf
Genome Res 2008; 18:610-21;PMID:18285502; http://dx.doi.org/10.1101/gr.7179508 35.,OADS,/arxiv_data1/oa_pdf/de/a7/kcbt-17-05-1139230.PMC4910922.pdf
Stem Cells Dev 2007;16:1003-16; PMID:18004940; http://dx.doi.org/10.1089/scd.2007.0026 36.,Non-OADS,/arxiv_data1/oa_pdf/de/a7/kcbt-17-05-1139230.PMC4910922.pdf
Dev Biol 2004; 270:488-98;PMID:15183728; http://dx.doi.org/10.1016/j.ydbio.2004.02.01937.,OADS,/arxiv_data1/oa_pdf/de/a7/kcbt-17-05-1139230.PMC4910922.pdf
Mamm Genome 2007; 18:316-27;PMID:17610011; http://dx.doi.org/10.1007/s00335-007-9032-6 38.,OADS,/arxiv_data1/oa_pdf/de/a7/kcbt-17-05-1139230.PMC4910922.pdf
Nucleic Acids Res 2006; 34:e9; PMID:16434699; http://dx.doi.org/10.1093/nar/gnj009 39.,OADS,/arxiv_data1/oa_pdf/de/a7/kcbt-17-05-1139230.PMC4910922.pdf
Dev Cell 2003; 5:351-8; PMID:12919684; http://dx.doi.org/10.1016/S1534-5807(03)00227-2 40.,OADS,/arxiv_data1/oa_pdf/de/a7/kcbt-17-05-1139230.PMC4910922.pdf
Mol Cancer 2006; 5:67; PMID:17140455; http://dx.doi.org/10.1186/1476-4598-5-67 41.,Non-OADS,/arxiv_data1/oa_pdf/de/a7/kcbt-17-05-1139230.PMC4910922.pdf
